data_2e8d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2e8d _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.6 p30 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.828 0.347 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.475 ' CZ ' HD13 ' B' ' 42' ' ' LEU . 4.3 t80 -94.74 139.75 30.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.026 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.53 77.58 1.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.963 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.424 ' HB3' ' HA ' ' B' ' 27' ' ' ASN . 58.9 t30 -67.24 104.65 1.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.527 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.8 p -117.0 154.12 31.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.181 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.519 ' CE2' ' CE1' ' B' ' 29' ' ' TYR . 7.3 t80 179.06 115.19 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -126.88 96.5 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.978 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.1 t 56.72 168.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.993 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.39 -125.15 8.39 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.612 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . 88.1 t80 63.61 137.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.935 0.398 . . . . 0.0 110.967 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.404 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 23.7 m-70 -89.21 152.0 47.35 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.921 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.72 97.42 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.529 2.153 . . . . 0.0 112.324 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 t -176.25 -175.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -109.21 88.03 2.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.736 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 48.8 pt -157.55 -174.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.95 0.405 . . . . 0.0 111.491 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 1.3 mm-40 163.53 -81.34 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.554 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 17' ' ' GLU . 0.9 OUTLIER 167.66 120.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.428 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -138.03 141.54 40.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.052 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.41 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.735 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.718 0.294 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.47 ' CZ ' ' HB2' ' B' ' 27' ' ' ASN . 0.2 OUTLIER -144.95 130.61 18.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.769 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -129.89 117.71 20.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.075 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.47 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 1.7 t30 -105.47 88.66 2.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.645 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 34.3 t -96.24 108.67 21.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.956 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.519 ' CE1' ' CE2' ' A' ' 7' ' ' TYR . 4.3 t80 -135.48 127.13 29.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.71 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.64 154.46 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.983 0.42 . . . . 0.0 111.423 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.2 t 74.41 158.16 0.2 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.156 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.49 -168.0 12.77 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.444 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . 0.413 ' CD2' ' O ' ' B' ' 34' ' ' HIS . 43.9 p90 -179.42 -175.75 0.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.862 0.363 . . . . 0.0 110.986 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.413 ' O ' ' CD2' ' B' ' 33' ' ' PHE . 7.5 m-70 -59.72 165.66 4.17 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' B' ' 34' ' ' HIS . 65.7 Cg_exo -51.85 154.9 9.0 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.462 2.108 . . . . 0.0 112.448 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 8.6 p -178.37 -179.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.747 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.27 96.8 5.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.968 0.413 . . . . 0.0 111.351 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.41 ' CG2' ' HG3' ' A' ' 17' ' ' GLU . 46.2 mt -97.73 112.13 29.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.423 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.8 tt0 -113.8 109.31 18.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.841 0.353 . . . . 0.0 111.777 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.66 124.41 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -140.38 121.78 15.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.874 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.475 HD13 ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -119.22 113.35 20.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.06 85.7 2.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.955 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.896 179.823 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.899 0.381 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 60.45 67.66 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' C' ' 49' ' ' ASN . 9.9 t80 -91.95 104.8 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.728 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.16 101.81 9.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' ASN . . . . . 0.463 ' HB2' ' CE1' ' C' ' 47' ' ' PHE . 28.8 t-20 -116.67 115.82 26.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.497 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 p -126.73 127.93 45.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.175 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.44 ' HB3' ' CD1' ' D' ' 73' ' ' TYR . 55.9 t80 -135.7 123.09 21.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.13 130.58 69.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.244 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' SER . . . . . 0.407 ' O ' ' CZ ' ' C' ' 51' ' ' TYR . 4.8 m 70.35 133.68 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.894 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.02 -177.3 19.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.626 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -152.26 171.8 17.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.915 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.24 -55.09 0.27 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.21 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -86.74 -165.35 0.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.631 2.221 . . . . 0.0 112.616 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 78.14 149.24 0.1 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.218 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -123.01 121.07 35.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.818 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.429 ' CD1' ' N ' ' C' ' 60' ' ' ILE . 0.1 OUTLIER -126.87 110.62 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.978 0.418 . . . . 0.0 111.309 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -106.3 92.89 4.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.734 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 44.6 t -90.27 123.37 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.844 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -133.92 124.03 25.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.156 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' LEU . . . . . 0.458 HD13 ' CE1' ' B' ' 25' ' ' PHE . 0.1 OUTLIER -136.0 120.03 17.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.505 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.438 HD12 ' N ' ' C' ' 65' ' ' LEU . 0.0 OUTLIER -55.78 -20.66 15.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.652 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' LYS . . . . . 0.422 ' N ' HD11 ' C' ' 65' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.908 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.765 0.317 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -62.16 -47.67 83.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . 0.421 ' CD1' HD22 ' D' ' 86' ' ' LEU . 34.8 t80 -92.1 108.82 20.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.741 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.14 78.8 1.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.031 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 71' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -92.56 47.24 1.29 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.824 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 52.7 t -46.42 96.95 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.866 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 73' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' C' ' 51' ' ' TYR . 2.4 m-85 -120.98 131.49 54.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.469 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 9.3 m -145.45 89.18 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.984 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.02 -53.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.705 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.55 -6.14 81.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.944 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 0.49 ' CG ' ' O ' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -49.74 99.93 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.222 0.534 . . . . 0.0 111.284 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 78' ' ' HIS . . . . . 0.655 ' N ' ' HD2' ' D' ' 79' ' ' PRO . 5.9 t-80 -84.88 -32.56 0.48 Allowed Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.647 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 79' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' D' ' 78' ' ' HIS . 37.2 Cg_endo -67.7 -171.12 0.3 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.641 1.561 . . . . 0.0 112.475 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 66.9 -176.68 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.364 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -100.6 79.62 2.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 0.0 110.825 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 82' ' ' ILE . . . . . 0.454 ' CG2' ' CE2' ' D' ' 77' ' ' PHE . 2.3 pp -110.34 120.29 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.286 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -146.28 131.51 18.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.094 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 64.6 t -117.88 118.65 59.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.865 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -89.13 86.71 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 86' ' ' LEU . . . . . 0.43 HD13 ' CE2' ' C' ' 47' ' ' PHE . 0.2 OUTLIER -76.01 92.57 3.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.958 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 m120 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.784 0.326 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.437 ' CZ ' HD11 ' B' ' 42' ' ' LEU . 59.7 t80 -102.61 114.11 28.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.896 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.96 101.07 7.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.773 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.434 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 49.7 t30 -120.37 83.85 2.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.818 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.4 p -90.44 -179.27 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.918 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -171.52 110.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.946 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.7 p -102.91 135.78 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.7 p -43.48 96.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.968 0.413 . . . . 0.0 111.491 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.54 98.91 0.12 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.99 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' B' ' 36' ' ' SER . 2.2 t80 -111.53 -177.2 3.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.057 0.456 . . . . 0.0 111.448 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.454 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -170.51 -61.18 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.267 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 12' ' ' HIS . 18.5 Cg_endo -57.56 -162.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.392 2.062 . . . . 0.0 111.967 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.01 -65.09 1.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.762 0.315 . . . . 0.0 111.503 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -96.97 109.09 21.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.507 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.402 HD12 ' CG ' ' A' ' 13' ' ' PRO . 1.2 mp -126.26 143.55 39.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.559 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.413 ' CB ' ' HB3' ' B' ' 39' ' ' GLU . 0.0 OUTLIER -178.71 156.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.728 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.588 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -178.71 -171.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.625 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.588 ' CB ' ' O ' ' A' ' 18' ' ' VAL . 15.0 m-20 127.28 -129.98 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.348 1.059 . . . . 0.0 110.333 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.97 0.414 . . . . 0.0 111.173 -179.672 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.794 0.33 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.457 ' CZ ' ' HB2' ' B' ' 27' ' ' ASN . 48.6 t80 -128.23 128.79 45.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.711 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.76 91.52 2.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.542 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.457 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 52.1 t-20 -105.52 119.04 38.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 22.3 m -114.15 109.32 18.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.321 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.425 ' CE2' ' CB ' ' B' ' 31' ' ' SER . 87.6 t80 -105.49 125.13 50.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.542 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 17.4 t -126.39 76.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.241 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' SER . . . . . 0.425 ' CB ' ' CE2' ' B' ' 29' ' ' TYR . 0.0 OUTLIER -56.36 174.0 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.64 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.48 45.12 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.261 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -148.21 -177.05 5.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.925 0.393 . . . . 0.0 111.281 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.463 ' CG ' ' HD2' ' B' ' 35' ' ' PRO . 0.0 OUTLIER -86.7 178.74 2.1 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.927 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' B' ' 34' ' ' HIS . 66.2 Cg_exo -39.44 132.59 1.55 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.745 2.297 . . . . 0.0 113.356 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' SER . . . . . 0.434 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 4.2 p -158.91 151.41 21.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.584 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -102.57 107.24 18.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 111.114 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 1.9 mp -129.81 130.8 66.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.413 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 4.5 tp10 -130.92 129.58 42.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.06 0.457 . . . . 0.0 111.329 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.44 ' CG1' ' OD2' ' A' ' 19' ' ' ASP . 96.1 t -125.81 114.87 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.102 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.445 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 1.7 p30 -136.19 104.37 5.63 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' B' ' 43' ' ' LEU . 1.1 mm? -88.32 58.31 4.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.689 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' B' ' 42' ' ' LEU . 0.7 OUTLIER 171.33 -163.31 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.424 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.865 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.849 0.357 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -100.0 -57.63 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.504 ' CE2' HD13 ' D' ' 86' ' ' LEU . 51.3 t80 -98.26 89.48 4.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.857 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.88 77.01 1.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.625 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' ASN . . . . . 0.423 ' CB ' ' CZ ' ' C' ' 47' ' ' PHE . 50.4 t-20 -97.39 136.77 37.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.583 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 6.6 p -150.69 123.03 8.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.406 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.506 ' CE2' ' CZ ' ' D' ' 77' ' ' PHE . 3.5 p90 -121.83 144.29 48.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.442 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' VAL . . . . . 0.415 ' O ' ' CB ' ' C' ' 53' ' ' SER . 12.6 p -141.31 158.81 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.931 0.396 . . . . 0.0 111.763 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' C' ' 52' ' ' VAL . 3.8 t 82.24 -71.09 0.05 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.513 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.4 -174.03 52.55 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.49 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' C' ' 58' ' ' SER . 0.1 OUTLIER -173.97 -177.51 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.346 . . . . 0.0 111.058 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' HIS . . . . . 0.686 ' HB3' ' HD3' ' C' ' 57' ' ' PRO . 6.0 t-80 -109.67 -56.42 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.816 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . 0.686 ' HD3' ' HB3' ' C' ' 56' ' ' HIS . 45.3 Cg_endo -94.64 92.1 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.708 2.272 . . . . 0.0 112.694 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' SER . . . . . 0.436 ' HB3' ' CE1' ' C' ' 55' ' ' PHE . 41.2 t -177.98 171.8 1.71 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.851 0.358 . . . . 0.0 111.067 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -135.44 127.38 29.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.124 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 pp -151.98 101.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.048 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.39 138.57 35.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.191 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 42.3 t -144.54 120.51 4.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.972 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -144.68 133.77 22.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.895 0.379 . . . . 0.0 111.276 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' LEU . . . . . 0.443 ' CD1' ' CZ ' ' B' ' 25' ' ' PHE . 0.8 OUTLIER -120.35 128.94 53.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.966 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.436 ' HB3' ' CB ' ' B' ' 43' ' ' LEU . 4.8 tt -138.76 -42.04 0.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.27 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' C' ' 65' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.309 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.783 0.325 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -105.06 26.68 9.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . 0.445 ' CE1' HD13 ' D' ' 86' ' ' LEU . 7.3 t80 -106.58 86.01 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.044 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.53 93.38 8.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.676 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 71' ' ' ASN . . . . . 0.441 ' HB3' ' CE1' ' D' ' 69' ' ' PHE . 0.6 OUTLIER -96.48 58.66 1.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.979 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -59.7 119.55 7.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.777 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 73' ' ' TYR . . . . . 0.42 ' CD2' ' O ' ' D' ' 71' ' ' ASN . 0.5 OUTLIER -128.84 136.93 51.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.06 0.457 . . . . 0.0 111.233 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.76 58.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.666 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 171.42 176.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.495 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.96 146.36 18.34 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.652 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 0.506 ' CZ ' ' CE2' ' C' ' 51' ' ' TYR . 0.0 OUTLIER -163.55 75.28 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.737 0.303 . . . . 0.0 111.058 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 78' ' ' HIS . . . . . 0.448 ' CB ' ' CD ' ' D' ' 79' ' ' PRO . 5.7 m170 -69.27 -64.94 1.38 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.821 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 79' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' D' ' 78' ' ' HIS . 90.5 Cg_endo -80.25 88.82 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.469 2.112 . . . . 0.0 112.356 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 27.5 t -175.58 154.57 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 111.096 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -79.56 62.96 4.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.604 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 82' ' ' ILE . . . . . 0.448 HD12 HG21 ' D' ' 82' ' ' ILE . 0.2 OUTLIER -113.65 151.16 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.144 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -161.29 92.34 0.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.159 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 84.2 t -105.85 117.75 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.603 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.58 -175.99 1.21 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 0.0 111.18 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 86' ' ' LEU . . . . . 0.504 HD13 ' CE2' ' C' ' 47' ' ' PHE . 0.0 OUTLIER -174.23 -172.17 0.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.642 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.408 ' N ' HD21 ' D' ' 86' ' ' LEU . 8.8 tt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.011 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.2 t30 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.837 0.351 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 5' ' ' ASN . 49.1 t80 -165.08 125.48 1.93 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.01 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.2 mt -130.15 92.15 3.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.041 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.5 OUTLIER -111.56 82.43 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.597 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.4 p -93.17 128.09 38.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.026 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.536 ' CD2' ' CE2' ' B' ' 33' ' ' PHE . 1.5 t80 -113.68 158.78 20.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.727 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -177.1 106.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.564 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.4 t 34.24 98.55 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.542 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.2 123.23 0.7 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.758 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.49 ' CZ ' ' O ' ' A' ' 13' ' ' PRO . 91.5 t80 -179.55 162.98 1.16 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.783 0.325 . . . . 0.0 111.092 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.476 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -164.02 -65.96 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.008 179.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.49 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 43.9 Cg_endo -67.13 115.38 3.61 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.392 2.062 . . . . 0.0 112.04 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.3 m -38.7 -55.67 1.43 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.266 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.39 123.31 30.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.906 0.384 . . . . 0.0 111.267 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.428 ' CD1' ' HG2' ' A' ' 13' ' ' PRO . 16.9 mm -147.6 133.96 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.917 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -147.04 142.36 27.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.867 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.2 t -109.33 159.6 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -146.74 143.46 28.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.45 ' CD2' ' CD1' ' A' ' 3' ' ' PHE . 60.4 tp . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.747 0.308 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.472 ' CE2' HD11 ' C' ' 64' ' ' LEU . 84.4 t80 -100.91 110.73 22.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.733 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.04 93.65 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.928 0.394 . . . . 0.0 111.057 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' C' ' 49' ' ' ASN . 32.3 t-20 -127.25 140.55 52.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.796 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' C' ' 50' ' ' CYS . 5.7 p 177.85 161.89 0.57 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.167 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.551 ' CE2' ' CG ' ' C' ' 51' ' ' TYR . 0.9 OUTLIER -129.68 152.79 48.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.125 0.488 . . . . 0.0 111.514 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 24.3 t -121.28 102.64 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.735 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 40.25 -165.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.125 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.24 49.57 8.09 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.978 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . 0.536 ' CE2' ' CD2' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -120.41 70.75 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.96 0.409 . . . . 0.0 111.507 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.702 ' N ' ' HD3' ' B' ' 35' ' ' PRO . 0.3 OUTLIER -111.93 18.71 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.702 ' HD3' ' N ' ' B' ' 34' ' ' HIS . 50.3 Cg_exo -53.53 -163.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 121.9 1.734 . . . . 0.0 113.124 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 9.9 t -107.69 -72.73 0.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.731 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -130.97 113.87 14.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.369 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.466 HD11 ' CE1' ' A' ' 11' ' ' PHE . 1.7 mp -126.33 139.55 51.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.876 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -146.08 156.47 43.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.812 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.23 127.63 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -121.15 99.71 6.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.238 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.436 ' N ' ' CD2' ' B' ' 42' ' ' LEU . 0.9 OUTLIER -97.96 107.55 20.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.57 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' B' ' 44' ' ' LYS . 1.8 pt? 178.17 -46.63 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.802 0.335 . . . . 0.0 111.218 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.437 ' N ' ' HG ' ' B' ' 43' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.766 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.801 0.334 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -57.57 98.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.958 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.483 ' CZ ' ' CB ' ' C' ' 49' ' ' ASN . 47.6 t80 -102.74 113.46 26.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.36 86.06 2.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.777 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' ASN . . . . . 0.483 ' CB ' ' CZ ' ' C' ' 47' ' ' PHE . 12.2 t-20 -126.32 83.16 2.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.31 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' CYS . . . . . 0.454 ' O ' ' HA ' ' B' ' 28' ' ' CYS . 1.7 p -134.19 -170.97 2.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.277 0.561 . . . . 0.0 112.013 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.551 ' CG ' ' CE2' ' B' ' 29' ' ' TYR . 3.8 p90 -167.48 176.19 6.71 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.611 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' VAL . . . . . 0.559 ' O ' ' CB ' ' C' ' 53' ' ' SER . 15.1 m -136.62 146.69 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.842 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' C' ' 52' ' ' VAL . 5.1 t 99.67 -172.31 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.228 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.07 -16.76 68.86 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.841 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . 0.53 ' CE1' ' CE2' ' B' ' 29' ' ' TYR . 38.4 t80 64.46 120.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.748 0.308 . . . . 0.0 110.89 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' HIS . . . . . 0.402 ' CB ' ' HB3' ' B' ' 34' ' ' HIS . 7.9 m80 -76.72 162.36 70.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.931 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.67 112.0 1.01 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.568 2.179 . . . . 0.0 112.244 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 10.0 t -164.48 159.36 19.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.787 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -100.18 125.8 46.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.008 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 pp -126.04 116.24 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -110.74 85.97 2.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.036 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 49.0 t -80.81 120.83 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.878 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -143.17 117.82 9.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.017 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' LEU . . . . . 0.472 HD11 ' CE2' ' B' ' 25' ' ' PHE . 0.1 OUTLIER -137.28 119.76 15.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.641 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -163.2 -167.0 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.967 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.096 179.826 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.815 0.341 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -154.65 -43.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.153 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' D' ' 71' ' ' ASN . 21.6 t80 -93.64 142.51 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.043 0.449 . . . . 0.0 111.247 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 32.2 mt -159.19 120.49 3.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.969 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 71' ' ' ASN . . . . . 0.631 ' O ' ' N ' ' D' ' 73' ' ' TYR . 4.2 t30 -139.43 173.56 11.42 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 72' ' ' CYS . . . . . 0.411 ' O ' ' HB2' ' C' ' 50' ' ' CYS . 0.5 OUTLIER 37.34 -79.08 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.399 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 73' ' ' TYR . . . . . 0.631 ' N ' ' O ' ' D' ' 71' ' ' ASN . 0.3 OUTLIER 74.83 -87.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 178.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . 0.505 ' HB ' ' HA ' ' C' ' 52' ' ' VAL . 41.1 t -101.94 50.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.108 0.48 . . . . 0.0 111.064 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 75' ' ' SER . . . . . 0.475 ' HA ' ' CZ ' ' C' ' 51' ' ' TYR . 3.3 m -92.86 -160.59 0.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.033 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.93 -4.54 0.64 Allowed Glycine 0 CA--C 1.522 0.492 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.226 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 0.428 ' CE2' ' CE2' ' C' ' 51' ' ' TYR . 0.1 OUTLIER -47.27 171.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 117.05 0.425 . . . . 0.0 111.384 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 78' ' ' HIS . . . . . 0.521 ' CB ' ' HD3' ' D' ' 79' ' ' PRO . 0.0 OUTLIER -115.94 -65.44 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 79' ' ' PRO . . . . . 0.521 ' HD3' ' CB ' ' D' ' 78' ' ' HIS . 60.9 Cg_endo -85.41 -105.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.359 2.039 . . . . 0.0 112.109 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 21.6 t 52.28 175.49 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.964 0.412 . . . . 0.0 111.408 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -120.71 73.06 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.652 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 82' ' ' ILE . . . . . 0.497 HG21 HD13 ' D' ' 82' ' ' ILE . 0.0 OUTLIER -74.29 108.43 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.199 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.89 106.17 7.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.628 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 21.1 t -123.72 131.04 73.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.379 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -136.34 107.17 6.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.518 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 86' ' ' LEU . . . . . 0.445 ' CD1' ' CE1' ' C' ' 47' ' ' PHE . 0.2 OUTLIER -106.08 134.59 48.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.074 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.695 179.678 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 3' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.46 0.046 0 CA-C-O 120.572 0.225 . . . . 0.0 110.932 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.531 ' C ' ' CD1' ' A' ' 3' ' ' PHE . 0.0 OUTLIER 87.03 177.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.901 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.458 ' N ' ' CG ' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -156.4 128.44 7.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 111.119 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -104.8 109.11 20.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.667 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -91.7 125.73 36.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.187 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.403 ' CE2' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -140.59 122.71 15.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.726 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.5 m -149.09 137.24 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.234 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t 71.95 -67.97 0.24 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.38 -150.2 20.39 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.834 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.414 ' CE2' ' O ' ' A' ' 12' ' ' HIS . 6.2 p90 -173.88 -166.09 0.28 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.811 0.339 . . . . 0.0 110.919 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.414 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 19.9 m80 -67.14 154.36 92.81 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.47 120.28 7.54 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.615 2.21 . . . . 0.0 112.2 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.0 p -169.83 -166.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.809 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.76 101.46 7.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.938 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.403 HD13 ' CE2' ' A' ' 7' ' ' TYR . 16.5 tt -87.84 140.72 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -144.32 162.73 35.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.941 0.4 . . . . 0.0 111.153 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.19 131.59 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.901 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -129.78 121.9 27.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.045 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.433 HD22 ' CE2' ' A' ' 3' ' ' PHE . 4.2 mm? . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.926 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.869 0.366 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.515 ' CE1' ' CE2' ' C' ' 47' ' ' PHE . 63.0 t80 -116.95 121.3 41.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.644 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.75 98.03 4.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.2 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.463 ' HB2' ' CE1' ' B' ' 25' ' ' PHE . 0.5 OUTLIER -107.36 83.97 1.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.592 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 12.6 p -106.06 133.18 51.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.173 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.444 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 0.0 OUTLIER -150.41 114.77 5.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.563 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.99 131.1 73.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.077 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 22.6 m 64.43 102.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.654 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.437 ' HA3' ' CD2' ' C' ' 55' ' ' PHE . . . -59.39 -116.71 0.01 OUTLIER Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.782 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' B' ' 33' ' ' PHE . 0.0 OUTLIER 179.15 -100.18 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.396 0.141 . . . . 0.0 110.787 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.46 ' CG ' ' HD2' ' B' ' 35' ' ' PRO . 0.0 OUTLIER -138.16 179.34 1.35 Allowed Pre-proline 0 N--CA 1.455 -0.19 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' B' ' 34' ' ' HIS . 99.7 Cg_exo -44.84 88.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.587 2.191 . . . . 0.0 112.566 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' SER . . . . . 0.446 ' N ' ' O ' ' B' ' 34' ' ' HIS . 3.3 m -136.24 159.0 43.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.272 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -113.88 111.1 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.816 0.341 . . . . 0.0 111.221 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 32.9 mt -99.06 94.74 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.749 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -101.99 88.46 3.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.266 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 95.3 t -91.65 114.92 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.539 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -127.13 112.28 14.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.0 111.492 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.438 HD23 ' CD1' ' A' ' 3' ' ' PHE . 1.2 mp -102.35 116.62 33.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.111 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 76.52 -154.18 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.005 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.785 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.764 0.316 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.7 -73.65 0.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.944 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.515 ' CE2' ' CE1' ' B' ' 25' ' ' PHE . 15.3 t80 -137.28 128.45 27.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.996 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 mt -135.35 112.02 10.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.77 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' ASN . . . . . 0.47 ' HB2' ' CE1' ' C' ' 47' ' ' PHE . 38.2 t30 -113.76 139.29 49.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.96 0.409 . . . . 0.0 111.034 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.46 109.21 7.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.594 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.44 ' CZ ' HG21 ' D' ' 82' ' ' ILE . 1.2 t80 -121.24 94.06 4.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.179 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' VAL . . . . . . . . . . . . . 45.9 t -97.59 109.27 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.594 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' SER . . . . . 0.486 ' CB ' ' HB2' ' D' ' 75' ' ' SER . 0.7 OUTLIER -55.7 -175.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.349 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.48 58.73 0.68 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.033 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . 0.493 ' O ' ' N ' ' C' ' 57' ' ' PRO . 1.3 p90 -171.74 33.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.32 0.105 . . . . 0.0 110.754 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' HIS . . . . . 0.516 ' CB ' ' CD ' ' C' ' 57' ' ' PRO . 0.0 OUTLIER 12.42 -76.45 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.711 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.231 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . 0.516 ' CD ' ' CB ' ' C' ' 56' ' ' HIS . 73.1 Cg_endo -72.45 -162.95 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.233 1.955 . . . . 0.0 112.781 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 79.22 155.52 0.15 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.808 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -129.17 145.62 51.28 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.588 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.464 HD11 ' CZ ' ' C' ' 55' ' ' PHE . 2.1 mp -131.05 112.81 22.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.324 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -114.38 80.71 1.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.739 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 42.1 t -91.93 121.89 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.139 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -151.45 126.98 10.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' C' ' 64' ' ' LEU . 0.0 OUTLIER -135.26 144.67 46.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.942 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 4.9 mt -97.94 102.75 14.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.924 179.991 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 19.1 p . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.863 0.363 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -68.54 97.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -124.05 113.81 18.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.79 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 tp -122.72 99.65 6.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.793 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 71' ' ' ASN . . . . . 0.415 ' O ' ' CD1' ' D' ' 73' ' ' TYR . 12.7 p-10 -93.89 52.66 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 90.5 m -58.86 123.27 15.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.594 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 73' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' D' ' 71' ' ' ASN . 0.1 OUTLIER -174.58 135.16 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.295 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . 0.589 ' O ' ' CB ' ' D' ' 75' ' ' SER . 12.6 p -178.73 160.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.212 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 75' ' ' SER . . . . . 0.589 ' CB ' ' O ' ' D' ' 74' ' ' VAL . 73.7 m 118.18 179.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.872 0.869 . . . . 0.0 110.627 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.51 152.87 20.29 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.44 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 0.487 ' O ' ' HD2' ' D' ' 79' ' ' PRO . 38.4 p90 -161.76 -31.5 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.47 0.176 . . . . 0.0 111.162 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 78' ' ' HIS . . . . . 0.673 ' CB ' ' CD ' ' D' ' 79' ' ' PRO . 17.9 m170 34.67 -90.18 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 79' ' ' PRO . . . . . 0.673 ' CD ' ' CB ' ' D' ' 78' ' ' HIS . 58.2 Cg_endo -69.37 58.07 1.34 Allowed 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.646 1.564 . . . . 0.0 113.007 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 3.7 p -135.84 155.73 49.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.525 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -110.49 100.07 8.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.797 0.332 . . . . 0.0 111.244 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 82' ' ' ILE . . . . . 0.44 HG21 ' CZ ' ' C' ' 51' ' ' TYR . 1.3 pp -122.73 143.87 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.283 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -158.27 124.21 4.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.737 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.58 132.17 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.341 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -128.55 105.59 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.82 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 86' ' ' LEU . . . . . 0.434 ' CD1' ' CZ ' ' C' ' 47' ' ' PHE . 0.0 OUTLIER -107.76 100.23 9.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 55.6 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.943 179.879 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.5 p30 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.937 0.398 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.511 ' CE2' HD11 ' B' ' 42' ' ' LEU . 0.5 OUTLIER -76.95 106.2 8.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.506 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.92 68.07 1.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.542 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.484 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 6.0 p30 -67.92 -177.48 0.82 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.429 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' B' ' 28' ' ' CYS . 2.8 m 64.92 -167.62 0.22 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.302 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.479 ' OH ' ' CD2' ' B' ' 33' ' ' PHE . 25.3 p90 -146.66 151.95 38.08 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.808 0.337 . . . . 0.0 111.402 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.53 83.24 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.879 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.3 p 61.77 117.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.087 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.98 130.89 5.79 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.641 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.46 ' CE1' HG13 ' A' ' 16' ' ' ILE . 33.7 t80 -179.99 148.87 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.919 0.39 . . . . 0.0 111.035 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.428 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 18.6 p80 -82.37 157.36 67.95 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.792 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.452 ' O ' ' HB2' ' A' ' 14' ' ' SER . 19.3 Cg_endo -58.76 -159.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.758 2.305 . . . . 0.0 112.556 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER 73.37 -95.9 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.427 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' B' ' 37' ' ' ASP . 0.1 OUTLIER -177.83 160.61 1.52 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.013 0.435 . . . . 0.0 111.408 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.46 HG13 ' CE1' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -96.16 117.42 40.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.681 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 7.0 pt-20 -107.48 115.0 29.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.962 0.41 . . . . 0.0 110.723 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.7 t -150.71 137.17 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -149.51 126.78 11.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.87 0.367 . . . . 0.0 111.326 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' B' ' 43' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.656 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.696 0.284 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.5 ' CZ ' ' HB2' ' B' ' 27' ' ' ASN . 60.4 t80 -103.66 123.41 46.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.243 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -124.45 122.25 37.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.671 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.5 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 0.8 OUTLIER -126.91 114.99 18.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.531 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 6' ' ' CYS . 2.2 t -116.73 102.2 9.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.356 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.41 ' OH ' ' CE2' ' C' ' 55' ' ' PHE . 3.9 t80 -125.78 88.84 2.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.546 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -103.38 132.68 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.136 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 15.5 t 65.35 151.69 0.05 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.166 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.16 -139.24 8.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.516 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' B' ' 33' ' ' PHE . 0.0 OUTLIER -179.66 -106.65 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 O-C-N 123.008 -0.113 . . . . 0.0 111.149 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.513 ' CB ' ' CD ' ' B' ' 35' ' ' PRO . 0.0 OUTLIER -123.34 -176.7 0.46 Allowed Pre-proline 0 CA--C 1.528 0.106 0 CA-C-O 120.579 0.228 . . . . 0.0 110.589 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' B' ' 34' ' ' HIS . 24.1 Cg_exo -64.26 -0.92 3.19 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.714 2.276 . . . . 0.0 113.092 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.1 t -41.99 160.18 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.935 0.397 . . . . 0.0 111.432 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 7.6 t0 -103.0 143.64 32.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.716 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 26.4 mm -119.27 123.03 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.213 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -123.28 87.26 2.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 50.2 t -100.21 119.07 47.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.135 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.7 122.84 26.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.28 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.511 HD11 ' CE2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -120.2 145.88 46.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.062 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER 56.6 21.92 6.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.319 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 30.8 tttt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.914 179.895 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.839 0.352 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 66.06 120.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.994 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.441 ' CZ ' ' CD1' ' D' ' 86' ' ' LEU . 1.7 t80 -108.41 103.35 12.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.641 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 mp -107.06 110.13 22.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.862 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' B' ' 27' ' ' ASN . 1.5 t30 -122.14 97.9 5.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.082 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 13.9 m -109.84 116.96 32.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.689 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.476 ' OH ' ' CD1' ' D' ' 77' ' ' PHE . 0.7 OUTLIER -139.64 149.48 43.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.965 0.412 . . . . 0.0 111.285 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' VAL . . . . . . . . . . . . . 31.3 t -115.53 110.87 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.588 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 11.7 m -52.96 178.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.409 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.93 48.02 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.233 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . 0.456 ' O ' ' CD1' ' C' ' 55' ' ' PHE . 0.0 OUTLIER -176.64 141.96 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.168 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' HIS . . . . . 0.417 ' CB ' ' CD ' ' C' ' 57' ' ' PRO . 0.2 OUTLIER -87.23 -62.08 0.24 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.276 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' C' ' 56' ' ' HIS . 72.9 Cg_endo -76.27 -163.52 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.507 2.138 . . . . 0.0 112.498 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' C' ' 57' ' ' PRO . 0.4 OUTLIER 80.36 161.89 0.17 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.325 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.06 129.17 47.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.947 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' D' ' 82' ' ' ILE . 0.1 OUTLIER -114.55 96.44 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.93 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -104.28 128.09 52.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.958 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 46.5 t -142.89 120.87 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.957 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -128.44 124.63 36.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.996 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' D' ' 86' ' ' LEU . 0.1 OUTLIER -98.44 106.02 18.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 28.6 tp 64.52 -76.57 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.034 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.985 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 87.4 p . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.845 0.355 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 58.54 32.32 22.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.982 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -107.72 109.63 21.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 tp -132.45 60.02 1.7 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.778 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 71' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -80.59 78.07 7.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.856 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 19.8 t -69.75 123.72 22.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.827 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 73' ' ' TYR . . . . . 0.438 ' HB3' ' CE2' ' C' ' 51' ' ' TYR . 0.2 OUTLIER -131.09 144.85 51.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 18.7 t -121.72 153.09 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.486 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 1.1 t 67.88 -83.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.35 174.37 24.34 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.691 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 0.476 ' CD1' ' OH ' ' C' ' 51' ' ' TYR . 0.3 OUTLIER -169.45 159.44 8.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 111.011 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 78' ' ' HIS . . . . . 0.463 ' N ' ' HD2' ' D' ' 79' ' ' PRO . 6.1 t-160 -178.24 -60.76 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.148 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 79' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' D' ' 78' ' ' HIS . 9.2 Cg_endo -52.75 -34.2 63.67 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.5 2.134 . . . . 0.0 112.485 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 24.8 p -75.19 157.21 34.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.831 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.86 115.22 16.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.742 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 82' ' ' ILE . . . . . 0.46 HG23 ' CD2' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -114.01 146.53 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.977 0.418 . . . . 0.0 111.589 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.64 57.46 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 t -80.54 134.79 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -149.71 137.16 19.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 86' ' ' LEU . . . . . 0.511 ' CD1' ' N ' ' D' ' 86' ' ' LEU . 0.0 OUTLIER -126.19 94.46 4.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.72 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.765 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.0 t30 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.77 0.319 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.485 ' C ' ' CD1' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -165.48 -172.15 2.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.984 179.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -124.45 119.08 28.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.038 0.447 . . . . 0.0 111.08 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER -125.88 61.3 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.691 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' B' ' 28' ' ' CYS . 29.5 p -138.29 145.52 41.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.963 0.411 . . . . 0.0 111.472 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.485 ' OH ' ' CE1' ' B' ' 33' ' ' PHE . 1.0 OUTLIER -150.85 131.43 13.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.805 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.0 p -100.19 99.9 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.162 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.42 ' HA ' ' HA3' ' B' ' 32' ' ' GLY . 0.9 OUTLIER 58.46 105.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.066 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.48 135.24 2.11 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.574 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.458 ' CE2' ' CB ' ' B' ' 36' ' ' SER . 5.0 t80 -158.98 93.86 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.762 0.315 . . . . 0.0 110.964 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.461 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 3.0 t-160 -81.23 -47.77 1.09 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.408 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 12' ' ' HIS . 87.7 Cg_endo -82.57 -177.5 3.45 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.469 2.112 . . . . 0.0 112.55 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -115.04 -60.45 1.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.665 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -112.09 104.45 12.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.644 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.8 pt -117.77 118.87 59.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.264 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -118.7 86.94 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.51 147.71 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.022 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -148.37 149.04 31.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.964 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.784 0.326 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.452 ' CE2' HD13 ' C' ' 64' ' ' LEU . 77.9 t80 -101.92 122.11 43.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.92 122.28 43.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.723 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.423 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 8.8 t-20 -148.56 101.4 3.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.642 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 7.3 m -152.84 132.95 13.45 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.8 0.333 . . . . 0.0 111.753 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.525 ' CD1' ' C ' ' B' ' 29' ' ' TYR . 0.1 OUTLIER -130.24 129.86 43.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.411 178.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' C' ' 52' ' ' VAL . 39.9 t -128.56 119.22 49.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.841 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 14.2 m 50.56 179.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.606 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 9' ' ' SER . . . 46.1 94.42 0.01 OUTLIER Glycine 0 C--N 1.332 0.355 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.835 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . 0.485 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -130.08 -44.12 1.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.664 0.269 . . . . 0.0 111.214 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 63.61 137.58 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.717 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -51.53 93.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.432 2.088 . . . . 0.0 112.171 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' SER . . . . . 0.458 ' CB ' ' CE2' ' A' ' 11' ' ' PHE . 2.4 m -149.51 -167.0 2.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.034 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -141.0 142.62 34.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.073 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.419 HG13 ' CG2' ' C' ' 60' ' ' ILE . 0.8 OUTLIER -150.69 147.01 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.656 179.484 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -143.18 129.66 20.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.821 0.343 . . . . 0.0 111.133 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 44.3 t -110.63 120.66 61.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.826 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -118.73 94.13 4.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.455 HD22 ' CE1' ' A' ' 3' ' ' PHE . 3.0 mp -110.01 117.46 33.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.676 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.06 122.19 32.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.805 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 8.7 tttm . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.927 -179.858 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.779 0.323 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 59.77 78.97 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.452 ' CZ ' ' CD1' ' D' ' 86' ' ' LEU . 31.7 t80 -87.64 102.86 15.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.632 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -103.92 103.24 13.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.903 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' ASN . . . . . 0.44 ' HB2' ' CZ ' ' C' ' 47' ' ' PHE . 1.9 t30 -127.04 116.44 20.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' CYS . . . . . 0.433 ' CB ' ' HB3' ' D' ' 72' ' ' CYS . 18.9 p -159.74 157.19 28.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.18 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.523 ' HB2' ' CE2' ' B' ' 29' ' ' TYR . 0.5 OUTLIER -162.78 147.21 11.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.771 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' VAL . . . . . 0.409 ' CG2' ' CG1' ' B' ' 30' ' ' VAL . 32.8 m -134.53 114.45 18.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.181 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 5.5 t 166.72 -86.39 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.767 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' GLY . . . . . 0.556 ' O ' ' CD1' ' C' ' 55' ' ' PHE . . . 108.92 -56.09 0.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.895 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' C' ' 54' ' ' GLY . 4.9 p90 43.02 -176.97 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.098 0.475 . . . . 0.0 111.99 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' HIS . . . . . 0.507 ' CB ' ' HD3' ' C' ' 57' ' ' PRO . 0.0 OUTLIER -99.51 -61.96 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.783 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . 0.507 ' HD3' ' CB ' ' C' ' 56' ' ' HIS . 52.4 Cg_endo -88.27 -151.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.795 2.33 . . . . 0.0 112.027 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' C' ' 57' ' ' PRO . 1.0 OUTLIER 86.69 125.06 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.181 0.515 . . . . 0.0 111.375 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . 0.43 ' HA ' ' CB ' ' D' ' 81' ' ' ASP . 8.1 t0 -112.51 95.51 5.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.213 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.455 ' CD1' ' N ' ' C' ' 60' ' ' ILE . 0.2 OUTLIER -134.01 140.87 45.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.199 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -156.49 133.41 10.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.053 0.454 . . . . 0.0 111.185 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.29 121.01 61.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.647 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -125.13 128.33 48.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.269 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' LEU . . . . . 0.452 HD13 ' CE2' ' B' ' 25' ' ' PHE . 5.2 mt -124.78 110.05 13.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.563 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 62.91 126.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.789 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 18.1 ttpt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.888 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.694 0.283 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -177.75 -35.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.297 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . 0.421 ' HB2' ' CD1' ' C' ' 47' ' ' PHE . 0.1 OUTLIER -120.37 170.67 9.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.79 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 24.0 tp -152.22 109.06 3.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.117 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 71' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -102.18 65.3 0.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.47 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 72' ' ' CYS . . . . . 0.433 ' HB3' ' CB ' ' C' ' 50' ' ' CYS . 50.9 t -75.03 101.66 4.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 73' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -107.15 128.86 54.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.103 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' D' ' 75' ' ' SER . 10.9 t -133.33 73.87 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.13 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 75' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' D' ' 74' ' ' VAL . 1.4 p 174.63 137.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.451 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 76' ' ' GLY . . . . . 0.485 ' O ' ' CG ' ' D' ' 77' ' ' PHE . . . -50.38 -87.02 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.679 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 0.497 ' CE1' HG13 ' D' ' 82' ' ' ILE . 0.4 OUTLIER 162.8 -60.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 122.482 0.313 . . . . 0.0 110.616 178.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 78' ' ' HIS . . . . . 0.47 ' HB3' ' HD2' ' D' ' 79' ' ' PRO . 20.0 m-70 58.54 164.62 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.545 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 79' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' D' ' 78' ' ' HIS . 18.7 Cg_endo -59.32 75.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.517 2.145 . . . . 0.0 112.344 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 80' ' ' SER . . . . . 0.444 ' N ' ' O ' ' D' ' 78' ' ' HIS . 9.7 p -127.61 -163.34 1.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.454 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 81' ' ' ASP . . . . . 0.43 ' CB ' ' HA ' ' C' ' 59' ' ' ASP . 0.2 OUTLIER -130.78 43.97 3.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.782 0.325 . . . . 0.0 111.31 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 82' ' ' ILE . . . . . 0.497 HG13 ' CE1' ' D' ' 77' ' ' PHE . 35.6 pt -99.7 117.85 45.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.882 0.372 . . . . 0.0 110.814 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -148.02 162.43 39.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.022 0.439 . . . . 0.0 111.523 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 48.0 t -141.76 130.22 22.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.94 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -135.59 108.77 7.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.925 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 86' ' ' LEU . . . . . 0.452 ' CD1' ' CZ ' ' C' ' 47' ' ' PHE . 0.4 OUTLIER -120.03 96.18 5.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.055 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.054 179.94 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.837 0.351 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.484 ' CD1' ' CE2' ' B' ' 25' ' ' PHE . 46.5 t80 -145.67 129.08 16.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.73 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -147.48 83.87 1.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.295 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.422 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 6.5 t-20 -71.97 115.96 11.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.417 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.87 112.13 22.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.958 0.408 . . . . 0.0 111.714 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.47 ' OH ' ' CE1' ' B' ' 33' ' ' PHE . 0.1 OUTLIER -118.09 128.78 55.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.98 179.066 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.5 80.36 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.097 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 43.61 95.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.596 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.5 137.28 3.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.148 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.464 ' CE1' ' HG2' ' B' ' 35' ' ' PRO . 5.6 p90 -177.44 169.3 2.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.686 0.279 . . . . 0.0 110.733 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.529 ' HB3' ' HD2' ' A' ' 13' ' ' PRO . 1.8 m80 -58.89 176.04 0.3 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.719 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 12' ' ' HIS . 86.1 Cg_endo -81.68 175.45 9.42 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.367 2.045 . . . . 0.0 112.158 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m 65.5 -161.56 0.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.743 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -106.36 118.39 36.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.971 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.437 HG12 ' CE2' ' A' ' 11' ' ' PHE . 23.4 mm -79.24 159.11 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.977 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.16 59.56 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.191 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.73 118.46 10.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.498 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' B' ' 41' ' ' ASP . 3.1 p30 -134.76 161.98 33.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.957 0.408 . . . . 0.0 111.398 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.1 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.894 179.843 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 121.014 0.435 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.484 ' CE2' ' CD1' ' A' ' 3' ' ' PHE . 37.6 t80 -121.23 142.15 50.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.784 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -147.42 115.81 6.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.418 ' HB2' ' CE1' ' B' ' 25' ' ' PHE . 46.4 t30 -122.73 90.66 3.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.775 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 91.6 m -81.93 117.44 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.73 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.462 ' CZ ' HG13 ' C' ' 60' ' ' ILE . 1.7 t80 -111.69 104.79 13.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.014 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.446 ' HA ' ' CG2' ' C' ' 52' ' ' VAL . 15.3 t -104.04 105.29 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.567 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 13.8 m -57.21 -178.32 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.982 0.42 . . . . 0.0 111.276 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.18 50.72 0.76 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.464 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . 0.47 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -165.25 161.02 18.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.771 0.319 . . . . 0.0 111.233 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.637 ' N ' ' HD3' ' B' ' 35' ' ' PRO . 4.7 p80 -148.0 53.53 1.54 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.182 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.637 ' HD3' ' N ' ' B' ' 34' ' ' HIS . 2.3 Cg_endo -83.37 -72.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.08 2.52 . . . . 0.0 112.465 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 47.3 t -158.1 -119.94 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.185 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -126.83 163.94 22.49 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.86 0.362 . . . . 0.0 111.015 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 25.0 mt -145.57 136.04 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.927 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -129.92 145.36 51.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.94 0.4 . . . . 0.0 111.227 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 40.7 t -142.85 140.38 27.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.814 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 19' ' ' ASP . 14.5 t0 -162.61 118.1 1.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.658 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.464 ' CD1' ' CE2' ' A' ' 3' ' ' PHE . 0.4 OUTLIER -158.9 -171.0 3.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.051 0.453 . . . . 0.0 111.482 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 58.54 162.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.211 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.99 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.814 0.34 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -175.9 174.39 2.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.102 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.487 ' CZ ' ' HB2' ' C' ' 49' ' ' ASN . 62.1 t80 -85.78 107.64 17.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 21.4 tp -117.37 83.5 2.0 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.983 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' ASN . . . . . 0.487 ' HB2' ' CZ ' ' C' ' 47' ' ' PHE . 3.7 t-20 -98.35 102.9 14.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.593 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.72 115.11 20.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.813 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -116.07 102.75 9.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.063 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' VAL . . . . . 0.446 ' CG2' ' HA ' ' B' ' 30' ' ' VAL . 34.1 m -113.68 114.31 46.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 15.1 p -50.93 178.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.626 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.88 -30.49 2.16 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.087 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . 0.46 ' CZ ' ' CB ' ' D' ' 80' ' ' SER . 0.0 OUTLIER -92.73 -163.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 111.323 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' HIS . . . . . 0.475 ' CB ' ' HD3' ' C' ' 57' ' ' PRO . 0.0 OUTLIER -169.68 -55.63 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.81 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . 0.475 ' HD3' ' CB ' ' C' ' 56' ' ' HIS . 69.0 Cg_endo -94.8 66.61 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.008 2.472 . . . . 0.0 112.617 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.0 158.07 32.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.97 0.414 . . . . 0.0 111.028 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.83 139.14 49.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.795 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.462 HG13 ' CZ ' ' B' ' 29' ' ' TYR . 6.1 mm -139.42 103.71 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.311 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.73 129.41 55.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.692 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.57 145.48 33.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.312 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.52 148.7 43.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.027 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' C' ' 65' ' ' LEU . 0.6 OUTLIER -151.09 73.43 1.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.468 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' C' ' 64' ' ' LEU . 1.2 tm? 157.65 137.17 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.449 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.86 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.746 0.308 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -56.76 129.25 40.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.048 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -130.28 139.78 50.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 12.7 tp -157.41 95.96 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.753 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 71' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -109.09 122.51 47.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.093 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -95.03 62.8 2.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.594 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.02 72.68 1.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.12 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.04 97.59 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.064 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 80.9 p -174.65 -76.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.923 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.75 -33.27 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 0.403 ' O ' ' CG ' ' D' ' 78' ' ' HIS . 22.6 m-85 62.74 104.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.734 0.302 . . . . 0.0 111.025 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 78' ' ' HIS . . . . . 0.46 ' CB ' ' CD ' ' D' ' 79' ' ' PRO . 2.0 m-70 -173.81 -64.04 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.946 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 79' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' D' ' 78' ' ' HIS . 33.1 Cg_endo -66.98 -75.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.366 2.044 . . . . 0.0 112.769 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 80' ' ' SER . . . . . 0.46 ' CB ' ' CZ ' ' C' ' 55' ' ' PHE . 35.3 p -58.9 -178.85 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.912 0.387 . . . . 0.0 111.167 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.3 108.47 13.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.829 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 82' ' ' ILE . . . . . 0.441 ' CD1' ' N ' ' D' ' 82' ' ' ILE . 0.2 OUTLIER -141.55 161.56 21.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.228 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -168.94 126.45 0.99 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.811 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.31 127.49 68.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -139.6 100.06 3.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.716 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 86' ' ' LEU . . . . . 0.46 ' HG ' ' CE2' ' C' ' 47' ' ' PHE . 0.2 OUTLIER -103.1 -168.96 1.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . 0.51 HD22 ' N ' ' D' ' 87' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.215 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.839 0.352 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.438 ' CZ ' ' CD1' ' B' ' 42' ' ' LEU . 90.0 t80 -59.96 114.76 2.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.805 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.9 pp -124.1 98.48 5.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.811 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -83.79 93.01 7.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.889 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.9 m -89.07 102.59 15.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.424 ' OH ' ' CD2' ' B' ' 33' ' ' PHE . 8.3 t80 -108.21 117.91 35.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.69 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.418 ' HA ' HG23 ' B' ' 30' ' ' VAL . 7.1 p -121.39 87.64 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.962 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.414 ' CB ' ' HA3' ' B' ' 32' ' ' GLY . 67.0 p 46.54 -167.85 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.777 0.322 . . . . 0.0 111.084 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.61 159.77 34.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.042 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.444 ' CE2' ' HB3' ' B' ' 36' ' ' SER . 0.2 OUTLIER 177.22 113.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.826 0.346 . . . . 0.0 110.56 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.422 ' HB2' ' HD3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -92.12 -54.3 0.26 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.438 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 12' ' ' HIS . 94.9 Cg_endo -83.53 -97.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.477 2.118 . . . . 0.0 112.646 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.404 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 14.8 p -178.67 -52.81 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.749 0.309 . . . . 0.0 111.102 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -114.86 86.43 2.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.266 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 2.2 pp -156.32 -170.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.683 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 16' ' ' ILE . 37.4 tp10 160.01 -82.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.527 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.8 139.45 37.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.96 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -154.34 83.42 1.12 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.765 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.805 0.336 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' B' ' 27' ' ' ASN . 56.5 t80 -106.35 117.83 35.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.677 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 mp -131.71 95.85 3.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.077 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.447 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 0.1 OUTLIER -102.21 110.06 21.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.656 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.41 ' HA ' ' O ' ' C' ' 50' ' ' CYS . 27.7 p -126.17 128.67 47.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.5 ' CE1' ' CE2' ' C' ' 55' ' ' PHE . 2.4 p90 -133.72 156.39 48.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.001 0.429 . . . . 0.0 111.39 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 8' ' ' VAL . 16.6 m -129.05 134.13 64.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.754 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.0 t -44.74 167.53 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.644 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' A' ' 9' ' ' SER . . . 150.89 -37.76 0.87 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.786 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . 0.483 ' CZ ' ' CE2' ' C' ' 55' ' ' PHE . 6.7 p90 -90.19 163.64 14.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 111.132 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.55 171.64 9.38 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.992 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.421 ' HD3' ' CD2' ' C' ' 56' ' ' HIS . 95.2 Cg_exo -42.45 94.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.746 2.297 . . . . 0.0 112.628 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' SER . . . . . 0.444 ' HB3' ' CE2' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -124.53 -165.37 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.806 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.81 106.4 10.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.981 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -107.94 116.25 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.521 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 18.6 pt-20 -128.19 117.43 21.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.859 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 39.5 t -93.62 122.64 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.997 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -127.76 93.75 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.438 ' CD1' ' CZ ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER -106.53 108.51 20.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.004 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.8 35.4 3.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.03 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.785 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.74 0.305 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -170.77 118.9 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.15 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.513 ' CE2' ' CD1' ' D' ' 86' ' ' LEU . 47.2 t80 -114.43 112.2 22.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.51 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' B' ' 27' ' ' ASN . 0.1 OUTLIER -120.47 94.21 4.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.212 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' ASN . . . . . 0.468 ' HB2' ' CZ ' ' C' ' 47' ' ' PHE . 36.3 t30 -110.12 80.63 1.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.026 0.441 . . . . 0.0 110.676 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' CYS . . . . . 0.472 ' HB3' ' CD2' ' D' ' 73' ' ' TYR . 32.0 p -107.83 154.04 22.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.595 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.491 ' CZ ' ' HA ' ' D' ' 72' ' ' CYS . 0.2 OUTLIER -148.24 160.58 42.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.457 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' VAL . . . . . 0.433 ' HA ' ' HB ' ' D' ' 74' ' ' VAL . 20.2 t -124.84 124.87 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.457 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.26 -172.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.096 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' D' ' 77' ' ' PHE . . . -122.76 172.35 15.81 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.636 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . 0.5 ' CE2' ' CE1' ' B' ' 29' ' ' TYR . 0.1 OUTLIER -143.86 60.21 1.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 111.317 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' HIS . . . . . 0.494 ' HB3' ' HD2' ' C' ' 57' ' ' PRO . 3.0 m-70 59.89 165.47 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.466 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' C' ' 56' ' ' HIS . 34.9 Cg_endo -64.68 79.73 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.416 2.078 . . . . 0.0 112.282 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 1.5 t -96.83 -167.46 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.039 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.09 129.03 44.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.733 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 6.6 mt -127.8 120.1 53.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.294 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -111.04 77.47 1.04 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.552 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.3 t -79.26 124.69 37.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.29 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -149.9 121.22 7.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.759 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' LEU . . . . . 0.438 ' CD1' ' N ' ' C' ' 64' ' ' LEU . 0.0 OUTLIER -137.2 140.79 41.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.3 -66.05 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.861 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.824 179.909 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.828 0.347 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 55.85 96.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.01 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -113.13 128.63 56.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.008 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 70' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' C' ' 48' ' ' LEU . 2.8 tp -155.49 88.0 1.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 71' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' D' ' 73' ' ' TYR . 17.9 p-10 -125.49 -157.53 0.79 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.356 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 72' ' ' CYS . . . . . 0.491 ' HA ' ' CZ ' ' C' ' 51' ' ' TYR . 36.1 t 55.82 -83.36 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.896 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 73' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' D' ' 71' ' ' ASN . 1.0 OUTLIER 66.76 -93.66 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 177.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' C' ' 52' ' ' VAL . 40.1 t -109.44 64.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 120.989 0.423 . . . . 0.0 110.848 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -60.83 -164.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.209 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.47 58.15 0.4 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.874 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 0.418 ' HB3' ' HA2' ' C' ' 54' ' ' GLY . 13.6 p90 -130.61 163.77 26.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 111.314 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 78' ' ' HIS . . . . . 0.464 ' CB ' ' HD2' ' D' ' 79' ' ' PRO . 0.4 OUTLIER -76.65 170.0 18.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.279 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 79' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' D' ' 78' ' ' HIS . 9.4 Cg_endo -52.46 89.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.411 2.074 . . . . 0.0 112.13 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.99 119.69 39.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.709 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -54.02 96.39 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.835 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 82' ' ' ILE . . . . . . . . . . . . . 20.6 pt -111.43 125.21 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.364 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -113.11 107.68 16.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.531 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.15 130.56 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.491 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -134.33 92.6 2.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.664 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 86' ' ' LEU . . . . . 0.513 ' CD1' ' CE2' ' C' ' 47' ' ' PHE . 0.2 OUTLIER -88.46 80.05 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.929 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 27.0 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 179.881 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.806 0.336 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 4' ' ' LEU . 4.9 t80 -109.03 160.06 16.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.756 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.493 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 13.9 tp -145.28 142.64 29.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 0.0 111.346 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.44 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 5.3 t30 -159.02 115.27 2.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.468 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.7 t -126.85 146.23 50.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.316 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -123.18 135.31 54.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.315 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.8 t -144.67 125.71 8.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.814 0.34 . . . . 0.0 111.404 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t 67.12 -160.38 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.041 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.97 -133.95 0.01 OUTLIER Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.757 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.432 ' CZ ' ' HB2' ' B' ' 36' ' ' SER . 0.0 OUTLIER -175.77 -164.89 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.743 0.306 . . . . 0.0 111.077 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.513 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -119.7 -70.02 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.324 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 12' ' ' HIS . 19.1 Cg_endo -58.14 -164.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.312 2.008 . . . . 0.0 112.153 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -130.79 -63.65 0.86 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.934 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -97.84 96.26 8.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.729 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.1 mt -96.88 146.98 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.202 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -149.56 120.85 7.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.872 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.5 t -107.28 129.62 60.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.285 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -145.48 89.92 1.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.745 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.051 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.956 0.408 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.626 ' CE2' ' CD1' ' C' ' 64' ' ' LEU . 0.1 OUTLIER -169.35 159.03 8.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.144 0.497 . . . . 0.0 111.379 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' B' ' 26' ' ' LEU . 0.2 OUTLIER -106.91 119.28 38.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.512 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -97.86 155.69 16.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.264 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 38.1 t -163.74 153.43 14.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.758 0.313 . . . . 0.0 111.221 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.447 ' CD2' ' HB2' ' C' ' 51' ' ' TYR . 0.0 OUTLIER -176.07 125.55 0.2 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.984 0.421 . . . . 0.0 110.964 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 31.1 m -128.37 128.59 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.256 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 73.49 147.12 0.09 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.054 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.69 -148.43 1.62 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.584 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' B' ' 36' ' ' SER . 0.0 OUTLIER -179.05 37.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.651 0.263 . . . . 0.0 111.596 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.416 ' CB ' ' CD ' ' B' ' 35' ' ' PRO . 0.0 OUTLIER 60.74 178.38 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.698 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' B' ' 34' ' ' HIS . 90.2 Cg_exo -43.0 126.15 4.4 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.596 2.197 . . . . 0.0 112.776 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' SER . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 5.3 t 179.74 147.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.657 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.94 135.16 55.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.192 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.413 HD13 ' CZ ' ' B' ' 33' ' ' PHE . 35.1 mt -135.91 111.43 11.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.88 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.14 82.94 1.75 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.749 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 42.2 t -73.43 120.36 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.969 0.414 . . . . 0.0 111.109 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -135.97 110.75 8.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.539 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.49 ' CD1' ' CE1' ' A' ' 3' ' ' PHE . 80.6 mt -133.02 143.08 49.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.143 0.497 . . . . 0.0 111.234 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mt 71.47 137.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.571 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 11.5 mttt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.9 -179.84 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.86 0.362 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -94.11 125.37 38.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.028 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.468 ' CD2' HD11 ' D' ' 86' ' ' LEU . 50.1 t80 -131.72 135.4 46.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.81 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 17.7 tp -130.2 128.67 42.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.69 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -130.34 95.3 3.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.388 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 3.7 p -117.86 103.9 10.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.387 . . . . 0.0 111.833 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.47 ' CE1' ' HB3' ' D' ' 73' ' ' TYR . 3.2 p90 -135.45 153.66 51.7 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.874 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' VAL . . . . . 0.585 ' O ' ' CB ' ' C' ' 53' ' ' SER . 0.8 OUTLIER -176.03 162.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.954 -178.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' C' ' 52' ' ' VAL . 5.9 t 104.58 80.31 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.496 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.91 -63.26 0.05 OUTLIER Glycine 0 C--N 1.332 0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.993 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . 0.445 ' N ' ' O ' ' C' ' 53' ' ' SER . 1.3 t80 78.79 78.37 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.819 0.342 . . . . 0.0 110.516 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' HIS . . . . . 0.595 ' N ' ' CD ' ' C' ' 57' ' ' PRO . 0.3 OUTLIER -140.36 38.86 0.32 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' C' ' 56' ' ' HIS . 36.5 Cg_endo -69.21 -77.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.109 1.872 . . . . 0.0 112.3 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 174.38 -79.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 110.689 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -134.42 134.74 41.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.871 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.401 HG21 HD12 ' C' ' 60' ' ' ILE . 10.1 mt -151.7 106.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -107.21 103.08 12.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.1 t -91.32 124.23 43.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -128.02 129.66 47.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.036 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' LEU . . . . . 0.626 ' CD1' ' CE2' ' B' ' 25' ' ' PHE . 0.2 OUTLIER -139.54 98.1 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.512 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 5.8 mt -94.1 -92.86 0.18 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.372 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.834 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.785 0.326 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -71.47 105.06 3.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' D' ' 71' ' ' ASN . 54.5 t80 -118.42 124.72 48.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.781 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 mt -143.83 95.09 2.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.736 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 71' ' ' ASN . . . . . 0.459 ' O ' ' CD2' ' D' ' 73' ' ' TYR . 2.5 t-20 -100.73 79.95 2.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 1.4 m -73.57 109.31 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.459 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 73' ' ' TYR . . . . . 0.47 ' HB3' ' CE1' ' C' ' 51' ' ' TYR . 1.7 p90 -118.73 118.95 33.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.4 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' C' ' 52' ' ' VAL . 3.5 t -132.72 86.86 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.019 0.438 . . . . 0.0 111.054 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 1.4 t 169.34 -53.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.689 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.38 -154.3 25.56 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.22 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . 0.422 ' CD2' ' OH ' ' C' ' 51' ' ' TYR . 0.1 OUTLIER -177.19 88.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 111.183 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 78' ' ' HIS . . . . . 0.461 ' HB3' ' HD3' ' D' ' 79' ' ' PRO . 9.7 t-160 176.47 -57.94 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 79' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' D' ' 78' ' ' HIS . 55.5 Cg_endo -69.37 62.69 1.56 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.303 2.002 . . . . 0.0 112.389 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 1.9 m 178.77 159.49 0.58 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -96.37 60.26 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.604 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 82' ' ' ILE . . . . . 0.443 HG21 HD11 ' D' ' 82' ' ' ILE . 0.2 OUTLIER -120.6 -179.87 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.243 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -176.57 145.49 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 80.2 t -112.69 117.58 55.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.979 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -138.31 112.57 8.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.543 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 86' ' ' LEU . . . . . 0.468 HD11 ' CD2' ' C' ' 47' ' ' PHE . 1.9 pt? -173.22 175.71 3.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.299 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.037 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.754 0.311 . . . . 0.0 110.849 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.66 ' CE2' ' CD1' ' B' ' 42' ' ' LEU . 16.7 t80 -127.35 110.22 12.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.967 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.05 117.47 34.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.723 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.539 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 1.1 p30 -129.45 67.97 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.047 0.451 . . . . 0.0 110.578 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 52.9 t -90.41 117.54 29.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.578 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.511 ' OH ' ' CE1' ' B' ' 29' ' ' TYR . 0.0 OUTLIER -119.98 132.59 55.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.252 0.549 . . . . 0.0 110.948 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.455 ' CG1' ' CG2' ' B' ' 30' ' ' VAL . 5.5 m -142.51 165.53 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.356 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 p 77.47 -166.47 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.394 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.77 -164.31 28.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.91 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.493 ' HB2' ' CD2' ' B' ' 33' ' ' PHE . 0.0 OUTLIER -130.85 -157.51 0.83 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.739 0.304 . . . . 0.0 110.76 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.429 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -175.15 -60.33 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.85 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 12' ' ' HIS . 34.0 Cg_endo -64.0 -22.94 68.01 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.326 2.017 . . . . 0.0 112.127 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.7 m 69.83 -64.34 0.35 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.226 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.59 127.24 32.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.036 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.1 138.81 4.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.197 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -139.37 137.73 35.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.004 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.3 t -115.3 125.72 72.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.957 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.61 132.42 55.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.044 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.443 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 1.8 mt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.695 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.416 ' HB3' ' CB ' ' C' ' 46' ' ' ASN . 31.8 t-20 . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.545 ' CE2' ' HG ' ' C' ' 64' ' ' LEU . 9.2 t80 -125.59 105.31 8.93 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.73 0.3 . . . . 0.0 111.013 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mp -116.2 90.34 3.31 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.444 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.478 ' HB2' ' CE1' ' B' ' 25' ' ' PHE . 7.0 t-20 -96.88 110.75 23.19 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.904 0.383 . . . . 0.0 110.751 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 4.1 m -112.04 142.46 44.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.114 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.511 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 0.7 OUTLIER -148.71 102.91 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.551 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.455 ' CG2' ' CG1' ' A' ' 8' ' ' VAL . 19.5 m -127.51 135.95 61.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.425 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 76.46 87.66 0.08 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.838 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.63 -173.91 0.49 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.571 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . 0.493 ' CD2' ' HB2' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -163.33 -173.56 3.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 0.0 110.928 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 39.4 m-70 -59.44 162.21 8.86 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.743 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.98 111.92 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.604 2.203 . . . . 0.0 112.639 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' SER . . . . . 0.403 ' HB2' ' CE1' ' B' ' 33' ' ' PHE . 12.7 m -133.2 159.87 38.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.724 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -107.36 105.56 15.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.423 HD12 HG21 ' B' ' 38' ' ' ILE . 0.8 OUTLIER -120.09 118.89 58.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.661 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -131.27 139.15 49.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.884 0.373 . . . . 0.0 111.118 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.11 119.08 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.956 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -122.75 105.1 9.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.765 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.66 ' CD1' ' CE2' ' A' ' 3' ' ' PHE . 0.3 OUTLIER -133.82 176.79 8.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.052 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tp -135.91 -48.86 0.68 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.784 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.98 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 29.8 p . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.825 0.345 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' ASN . . . . . 0.416 ' CB ' ' HB3' ' B' ' 24' ' ' ASN . 73.9 m-20 58.76 62.89 1.79 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.471 ' CE2' HD13 ' D' ' 86' ' ' LEU . 6.1 t80 -105.36 120.09 40.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.52 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 43.4 tp -125.57 109.64 12.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.94 0.4 . . . . 0.0 111.264 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' ASN . . . . . 0.441 ' HB3' ' CE1' ' C' ' 47' ' ' PHE . 1.5 p30 -128.37 102.51 6.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.116 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 13.8 p -116.69 134.35 54.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.372 . . . . 0.0 111.653 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.443 ' CZ ' ' HA ' ' D' ' 73' ' ' TYR . 27.9 p90 -136.96 125.69 23.93 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.771 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' VAL . . . . . 0.437 ' O ' ' CG2' ' C' ' 52' ' ' VAL . 1.7 m -132.41 122.77 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.068 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' C' ' 52' ' ' VAL . 0.4 OUTLIER 165.35 -83.55 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.24 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 180.0 -37.64 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.161 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . 0.409 ' O ' ' HG2' ' D' ' 79' ' ' PRO . 2.0 m-85 65.49 127.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.719 0.295 . . . . 0.0 111.43 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' HIS . . . . . 0.545 ' HB3' ' HD3' ' C' ' 57' ' ' PRO . 2.7 t60 177.82 -50.66 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.039 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' C' ' 56' ' ' HIS . 73.4 Cg_endo -92.3 -54.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.763 2.309 . . . . 0.0 113.245 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -53.02 158.24 1.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.215 0.531 . . . . 0.0 111.743 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -140.1 100.52 3.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.474 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' ILE . . . . . 0.429 ' HB ' ' CB ' ' D' ' 83' ' ' GLU . 18.9 mt -115.28 144.1 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.388 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -136.12 83.81 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.077 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -85.93 119.56 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.273 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' D' ' 85' ' ' ASP . 6.6 p-10 -118.34 125.07 49.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 111.196 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' LEU . . . . . 0.545 ' HG ' ' CE2' ' B' ' 25' ' ' PHE . 0.7 OUTLIER -117.13 131.86 56.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.834 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . 0.42 ' CD2' ' N ' ' C' ' 65' ' ' LEU . 2.4 mm? 60.36 -179.25 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.938 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.89 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.841 0.353 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 p30 54.55 17.97 1.83 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.703 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 69' ' ' PHE . . . . . 0.488 ' CZ ' ' HB2' ' D' ' 71' ' ' ASN . 62.1 t80 -137.98 92.91 2.71 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.777 0.323 . . . . 0.0 110.849 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.17 93.71 5.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.715 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 71' ' ' ASN . . . . . 0.488 ' HB2' ' CZ ' ' D' ' 69' ' ' PHE . 11.5 t-20 -99.67 105.86 17.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.072 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 6.6 t -81.92 68.82 8.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.558 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 73' ' ' TYR . . . . . 0.443 ' HA ' ' CZ ' ' C' ' 51' ' ' TYR . 0.1 OUTLIER -73.53 79.23 1.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.622 -179.545 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . 0.432 ' CG2' ' CG1' ' C' ' 52' ' ' VAL . 0.1 OUTLIER -122.35 83.82 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.943 0.401 . . . . 0.0 110.935 179.493 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.38 -68.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.672 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.12 -52.6 0.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.318 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.82 94.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.412 . . . . 0.0 111.345 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 78' ' ' HIS . . . . . 0.499 ' CB ' ' HD3' ' D' ' 79' ' ' PRO . 0.2 OUTLIER -164.79 -56.59 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.498 179.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 79' ' ' PRO . . . . . 0.499 ' HD3' ' CB ' ' D' ' 78' ' ' HIS . 73.7 Cg_endo -96.4 -164.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.234 2.623 . . . . 0.0 111.57 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 80' ' ' SER . . . . . 0.416 ' OG ' ' N ' ' D' ' 81' ' ' ASP . 1.4 t 55.9 176.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.587 0.232 . . . . 0.0 110.527 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 81' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' D' ' 82' ' ' ILE . 1.6 t0 -85.17 104.26 14.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.321 . . . . 0.0 111.083 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 82' ' ' ILE . . . . . 0.536 ' O ' ' CB ' ' D' ' 83' ' ' GLU . 48.6 mm -2.4 -67.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 83' ' ' GLU . . . . . 0.536 ' CB ' ' O ' ' D' ' 82' ' ' ILE . 0.0 OUTLIER 98.26 -29.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.053 0.541 . . . . 0.0 110.926 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 84' ' ' VAL . . . . . 0.424 ' O ' HG22 ' D' ' 82' ' ' ILE . 59.7 t -111.99 118.63 58.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.864 0.364 . . . . 0.0 111.754 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 85' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' C' ' 63' ' ' ASP . 2.0 m-20 -153.18 123.18 6.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.543 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 86' ' ' LEU . . . . . 0.471 HD13 ' CE2' ' C' ' 47' ' ' PHE . 0.0 OUTLIER -134.43 175.4 9.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.041 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.464 0.273 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.794 -179.602 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.836 0.35 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -177.37 108.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.475 ' CZ ' HD13 ' B' ' 42' ' ' LEU . 4.3 t80 -94.74 139.75 30.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.026 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.53 77.58 1.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.963 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.424 ' HB3' ' HA ' ' B' ' 27' ' ' ASN . 58.9 t30 -67.24 104.65 1.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.527 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.8 p -117.0 154.12 31.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.181 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.519 ' CE2' ' CE1' ' B' ' 29' ' ' TYR . 7.3 t80 179.06 115.19 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -126.88 96.5 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.978 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.1 t 56.72 168.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.993 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.39 -125.15 8.39 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.612 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . 88.1 t80 63.61 137.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.935 0.398 . . . . 0.0 110.967 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.404 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 23.7 m-70 -89.21 152.0 47.35 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.921 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.72 97.42 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.529 2.153 . . . . 0.0 112.324 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 t -176.25 -175.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -109.21 88.03 2.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.736 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 48.8 pt -157.55 -174.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.95 0.405 . . . . 0.0 111.491 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 1.3 mm-40 163.53 -81.34 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.554 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 17' ' ' GLU . 0.9 OUTLIER 167.66 120.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.428 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -138.03 141.54 40.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.052 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.41 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 1.0 OUTLIER -152.38 110.79 3.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.735 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 70.5 mt -90.5 -28.97 18.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.2 tttp . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.8 -179.919 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.884 0.373 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.55 102.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.971 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.47 ' CZ ' ' HB2' ' B' ' 27' ' ' ASN . 0.2 OUTLIER -144.95 130.61 18.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.769 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -129.89 117.71 20.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.075 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.47 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 1.7 t30 -105.47 88.66 2.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.645 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 34.3 t -96.24 108.67 21.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.956 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.519 ' CE1' ' CE2' ' A' ' 7' ' ' TYR . 4.3 t80 -135.48 127.13 29.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.71 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.64 154.46 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.983 0.42 . . . . 0.0 111.423 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 4.2 t 74.41 158.16 0.2 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.156 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.49 -168.0 12.77 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.444 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . 0.413 ' CD2' ' O ' ' B' ' 34' ' ' HIS . 43.9 p90 -179.42 -175.75 0.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.862 0.363 . . . . 0.0 110.986 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.413 ' O ' ' CD2' ' B' ' 33' ' ' PHE . 7.5 m-70 -59.72 165.66 4.17 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' B' ' 34' ' ' HIS . 65.7 Cg_exo -51.85 154.9 9.0 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.462 2.108 . . . . 0.0 112.448 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 8.6 p -178.37 -179.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.747 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.27 96.8 5.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.968 0.413 . . . . 0.0 111.351 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.41 ' CG2' ' HG3' ' A' ' 17' ' ' GLU . 46.2 mt -97.73 112.13 29.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.423 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.8 tt0 -113.8 109.31 18.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.841 0.353 . . . . 0.0 111.777 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.66 124.41 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -140.38 121.78 15.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.874 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.475 HD13 ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -119.22 113.35 20.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.06 85.7 2.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.955 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.896 179.823 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.899 0.381 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 60.45 67.66 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' C' ' 49' ' ' ASN . 9.9 t80 -91.95 104.8 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.728 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.16 101.81 9.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' ASN . . . . . 0.463 ' HB2' ' CE1' ' C' ' 47' ' ' PHE . 28.8 t-20 -116.67 115.82 26.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.497 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 p -126.73 127.93 45.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.175 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.44 ' HB3' ' CD1' ' D' ' 73' ' ' TYR . 55.9 t80 -135.7 123.09 21.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.13 130.58 69.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.244 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' SER . . . . . 0.407 ' O ' ' CZ ' ' C' ' 51' ' ' TYR . 4.8 m 70.35 133.68 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.894 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.02 -177.3 19.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.626 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -152.26 171.8 17.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.915 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.24 -55.09 0.27 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.21 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -86.74 -165.35 0.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.631 2.221 . . . . 0.0 112.616 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 78.14 149.24 0.1 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.218 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -123.01 121.07 35.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.818 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.429 ' CD1' ' N ' ' C' ' 60' ' ' ILE . 0.1 OUTLIER -126.87 110.62 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.978 0.418 . . . . 0.0 111.309 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -106.3 92.89 4.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.734 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 44.6 t -90.27 123.37 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.844 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -133.92 124.03 25.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.156 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' LEU . . . . . 0.458 HD13 ' CE1' ' B' ' 25' ' ' PHE . 0.1 OUTLIER -136.0 120.03 17.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.505 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.438 HD12 ' N ' ' C' ' 65' ' ' LEU . 0.0 OUTLIER -55.78 -20.66 15.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.652 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' LYS . . . . . 0.422 ' N ' HD11 ' C' ' 65' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.908 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.765 0.317 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -62.16 -47.67 83.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . 0.421 ' CD1' HD22 ' D' ' 86' ' ' LEU . 34.8 t80 -92.1 108.82 20.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.741 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.14 78.8 1.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.031 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -92.56 47.24 1.29 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.824 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 52.7 t -46.42 96.95 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.866 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' C' ' 51' ' ' TYR . 2.4 m-85 -120.98 131.49 54.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.469 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 9.3 m -145.45 89.18 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.984 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.02 -53.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.705 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.55 -6.14 81.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.944 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 0.49 ' CG ' ' O ' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -49.74 99.93 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.222 0.534 . . . . 0.0 111.284 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' HIS . . . . . 0.655 ' N ' ' HD2' ' D' ' 79' ' ' PRO . 5.9 t-80 -84.88 -32.56 0.48 Allowed Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.647 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' D' ' 78' ' ' HIS . 37.2 Cg_endo -67.7 -171.12 0.3 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.641 1.561 . . . . 0.0 112.475 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 66.9 -176.68 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.364 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -100.6 79.62 2.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 0.0 110.825 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 82' ' ' ILE . . . . . 0.454 ' CG2' ' CE2' ' D' ' 77' ' ' PHE . 2.3 pp -110.34 120.29 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.286 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -146.28 131.51 18.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.094 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 64.6 t -117.88 118.65 59.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.865 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -89.13 86.71 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . 0.43 HD13 ' CE2' ' C' ' 47' ' ' PHE . 0.2 OUTLIER -76.01 92.57 3.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.68 33.36 2.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.958 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.939 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.814 0.34 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -62.05 98.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.943 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.437 ' CZ ' HD11 ' B' ' 42' ' ' LEU . 59.7 t80 -102.61 114.11 28.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.896 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.96 101.07 7.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.773 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.434 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 49.7 t30 -120.37 83.85 2.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.818 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.4 p -90.44 -179.27 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.918 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -171.52 110.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.946 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.7 p -102.91 135.78 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.7 p -43.48 96.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.968 0.413 . . . . 0.0 111.491 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.54 98.91 0.12 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.99 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' B' ' 36' ' ' SER . 2.2 t80 -111.53 -177.2 3.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.057 0.456 . . . . 0.0 111.448 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.454 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -170.51 -61.18 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.267 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 12' ' ' HIS . 18.5 Cg_endo -57.56 -162.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.392 2.062 . . . . 0.0 111.967 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.01 -65.09 1.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.762 0.315 . . . . 0.0 111.503 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -96.97 109.09 21.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.507 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.402 HD12 ' CG ' ' A' ' 13' ' ' PRO . 1.2 mp -126.26 143.55 39.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.559 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.413 ' CB ' ' HB3' ' B' ' 39' ' ' GLU . 0.0 OUTLIER -178.71 156.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.728 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.588 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -178.71 -171.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.625 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.588 ' CB ' ' O ' ' A' ' 18' ' ' VAL . 15.0 m-20 127.28 -129.98 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.348 1.059 . . . . 0.0 110.333 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.1 mp -150.43 157.69 43.32 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.97 0.414 . . . . 0.0 111.173 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.22 133.96 46.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.603 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.2 mttm . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.934 -179.949 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.846 0.355 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -145.46 -76.47 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.81 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.457 ' CZ ' ' HB2' ' B' ' 27' ' ' ASN . 48.6 t80 -128.23 128.79 45.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.711 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.76 91.52 2.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.542 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.457 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 52.1 t-20 -105.52 119.04 38.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 22.3 m -114.15 109.32 18.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.321 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.425 ' CE2' ' CB ' ' B' ' 31' ' ' SER . 87.6 t80 -105.49 125.13 50.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.542 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 17.4 t -126.39 76.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.241 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' SER . . . . . 0.425 ' CB ' ' CE2' ' B' ' 29' ' ' TYR . 0.0 OUTLIER -56.36 174.0 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.64 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.48 45.12 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.261 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -148.21 -177.05 5.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.925 0.393 . . . . 0.0 111.281 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.463 ' CG ' ' HD2' ' B' ' 35' ' ' PRO . 0.0 OUTLIER -86.7 178.74 2.1 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.927 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' B' ' 34' ' ' HIS . 66.2 Cg_exo -39.44 132.59 1.55 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.745 2.297 . . . . 0.0 113.356 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.434 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 4.2 p -158.91 151.41 21.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.584 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -102.57 107.24 18.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 111.114 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 1.9 mp -129.81 130.8 66.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.413 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 4.5 tp10 -130.92 129.58 42.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.06 0.457 . . . . 0.0 111.329 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.44 ' CG1' ' OD2' ' A' ' 19' ' ' ASP . 96.1 t -125.81 114.87 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.102 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.445 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 1.7 p30 -136.19 104.37 5.63 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' B' ' 43' ' ' LEU . 1.1 mm? -88.32 58.31 4.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.689 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' B' ' 42' ' ' LEU . 0.7 OUTLIER 171.33 -163.31 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.424 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.865 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.849 0.357 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -100.0 -57.63 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.504 ' CE2' HD13 ' D' ' 86' ' ' LEU . 51.3 t80 -98.26 89.48 4.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.857 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.88 77.01 1.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.625 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' ASN . . . . . 0.423 ' CB ' ' CZ ' ' C' ' 47' ' ' PHE . 50.4 t-20 -97.39 136.77 37.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.583 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 6.6 p -150.69 123.03 8.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.406 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.506 ' CE2' ' CZ ' ' D' ' 77' ' ' PHE . 3.5 p90 -121.83 144.29 48.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.442 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . 0.415 ' O ' ' CB ' ' C' ' 53' ' ' SER . 12.6 p -141.31 158.81 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.931 0.396 . . . . 0.0 111.763 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' C' ' 52' ' ' VAL . 3.8 t 82.24 -71.09 0.05 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.513 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.4 -174.03 52.55 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.49 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' C' ' 58' ' ' SER . 0.1 OUTLIER -173.97 -177.51 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.346 . . . . 0.0 111.058 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' HIS . . . . . 0.686 ' HB3' ' HD3' ' C' ' 57' ' ' PRO . 6.0 t-80 -109.67 -56.42 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.816 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . 0.686 ' HD3' ' HB3' ' C' ' 56' ' ' HIS . 45.3 Cg_endo -94.64 92.1 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.708 2.272 . . . . 0.0 112.694 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' SER . . . . . 0.436 ' HB3' ' CE1' ' C' ' 55' ' ' PHE . 41.2 t -177.98 171.8 1.71 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.851 0.358 . . . . 0.0 111.067 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -135.44 127.38 29.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.124 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 pp -151.98 101.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.048 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.39 138.57 35.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.191 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 42.3 t -144.54 120.51 4.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.972 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -144.68 133.77 22.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.895 0.379 . . . . 0.0 111.276 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' LEU . . . . . 0.443 ' CD1' ' CZ ' ' B' ' 25' ' ' PHE . 0.8 OUTLIER -120.35 128.94 53.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.966 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.436 ' HB3' ' CB ' ' B' ' 43' ' ' LEU . 4.8 tt -138.76 -42.04 0.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.27 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' C' ' 65' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.309 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.783 0.325 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -105.06 26.68 9.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . 0.445 ' CE1' HD13 ' D' ' 86' ' ' LEU . 7.3 t80 -106.58 86.01 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.044 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.53 93.38 8.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.676 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 71' ' ' ASN . . . . . 0.441 ' HB3' ' CE1' ' D' ' 69' ' ' PHE . 0.6 OUTLIER -96.48 58.66 1.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.979 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -59.7 119.55 7.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.777 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 73' ' ' TYR . . . . . 0.42 ' CD2' ' O ' ' D' ' 71' ' ' ASN . 0.5 OUTLIER -128.84 136.93 51.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.06 0.457 . . . . 0.0 111.233 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -154.76 58.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.666 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 171.42 176.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.495 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.96 146.36 18.34 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.652 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 0.506 ' CZ ' ' CE2' ' C' ' 51' ' ' TYR . 0.0 OUTLIER -163.55 75.28 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.737 0.303 . . . . 0.0 111.058 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 78' ' ' HIS . . . . . 0.448 ' CB ' ' CD ' ' D' ' 79' ' ' PRO . 5.7 m170 -69.27 -64.94 1.38 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.821 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 79' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' D' ' 78' ' ' HIS . 90.5 Cg_endo -80.25 88.82 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.469 2.112 . . . . 0.0 112.356 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 27.5 t -175.58 154.57 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 111.096 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -79.56 62.96 4.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.604 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 82' ' ' ILE . . . . . 0.448 HD12 HG21 ' D' ' 82' ' ' ILE . 0.2 OUTLIER -113.65 151.16 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.144 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -161.29 92.34 0.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.159 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 84.2 t -105.85 117.75 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.603 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.58 -175.99 1.21 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 0.0 111.18 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . 0.504 HD13 ' CE2' ' C' ' 47' ' ' PHE . 0.0 OUTLIER -174.23 -172.17 0.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.642 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.408 ' N ' HD21 ' D' ' 86' ' ' LEU . 8.8 tt -46.47 102.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.011 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.832 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.4 p . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.825 0.345 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -121.15 140.75 51.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.001 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 5' ' ' ASN . 49.1 t80 -165.08 125.48 1.93 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.01 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.2 mt -130.15 92.15 3.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.041 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.5 OUTLIER -111.56 82.43 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.597 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.4 p -93.17 128.09 38.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.026 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.536 ' CD2' ' CE2' ' B' ' 33' ' ' PHE . 1.5 t80 -113.68 158.78 20.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.727 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -177.1 106.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.564 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.4 t 34.24 98.55 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.542 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.2 123.23 0.7 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.758 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.49 ' CZ ' ' O ' ' A' ' 13' ' ' PRO . 91.5 t80 -179.55 162.98 1.16 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.783 0.325 . . . . 0.0 111.092 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.476 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -164.02 -65.96 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.008 179.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.49 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 43.9 Cg_endo -67.13 115.38 3.61 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.392 2.062 . . . . 0.0 112.04 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.3 m -38.7 -55.67 1.43 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.266 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.39 123.31 30.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.906 0.384 . . . . 0.0 111.267 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.428 ' CD1' ' HG2' ' A' ' 13' ' ' PRO . 16.9 mm -147.6 133.96 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.917 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -147.04 142.36 27.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.867 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.2 t -109.33 159.6 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -146.74 143.46 28.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.45 ' CD2' ' CD1' ' A' ' 3' ' ' PHE . 60.4 tp -127.65 141.6 51.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 78.38 96.06 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.917 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.761 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.867 0.365 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -84.69 -79.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.811 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.472 ' CE2' HD11 ' C' ' 64' ' ' LEU . 84.4 t80 -100.91 110.73 22.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.733 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.04 93.65 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.928 0.394 . . . . 0.0 111.057 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' C' ' 49' ' ' ASN . 32.3 t-20 -127.25 140.55 52.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.796 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' C' ' 50' ' ' CYS . 5.7 p 177.85 161.89 0.57 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.167 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.551 ' CE2' ' CG ' ' C' ' 51' ' ' TYR . 0.9 OUTLIER -129.68 152.79 48.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.125 0.488 . . . . 0.0 111.514 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 24.3 t -121.28 102.64 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.735 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 40.25 -165.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.125 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.24 49.57 8.09 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.978 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . 0.536 ' CE2' ' CD2' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -120.41 70.75 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.96 0.409 . . . . 0.0 111.507 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.702 ' N ' ' HD3' ' B' ' 35' ' ' PRO . 0.3 OUTLIER -111.93 18.71 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.702 ' HD3' ' N ' ' B' ' 34' ' ' HIS . 50.3 Cg_exo -53.53 -163.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 121.9 1.734 . . . . 0.0 113.124 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 9.9 t -107.69 -72.73 0.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.731 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -130.97 113.87 14.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.369 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.466 HD11 ' CE1' ' A' ' 11' ' ' PHE . 1.7 mp -126.33 139.55 51.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.876 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -146.08 156.47 43.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.812 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.23 127.63 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -121.15 99.71 6.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.238 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.436 ' N ' ' CD2' ' B' ' 42' ' ' LEU . 0.9 OUTLIER -97.96 107.55 20.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.57 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' B' ' 44' ' ' LYS . 1.8 pt? 178.17 -46.63 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.802 0.335 . . . . 0.0 111.218 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.437 ' N ' ' HG ' ' B' ' 43' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.766 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.801 0.334 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -57.57 98.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.958 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.483 ' CZ ' ' CB ' ' C' ' 49' ' ' ASN . 47.6 t80 -102.74 113.46 26.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.36 86.06 2.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.777 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' ASN . . . . . 0.483 ' CB ' ' CZ ' ' C' ' 47' ' ' PHE . 12.2 t-20 -126.32 83.16 2.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.31 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' CYS . . . . . 0.454 ' O ' ' HA ' ' B' ' 28' ' ' CYS . 1.7 p -134.19 -170.97 2.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.277 0.561 . . . . 0.0 112.013 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.551 ' CG ' ' CE2' ' B' ' 29' ' ' TYR . 3.8 p90 -167.48 176.19 6.71 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.611 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . 0.559 ' O ' ' CB ' ' C' ' 53' ' ' SER . 15.1 m -136.62 146.69 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.842 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' C' ' 52' ' ' VAL . 5.1 t 99.67 -172.31 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.228 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.07 -16.76 68.86 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.841 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . 0.53 ' CE1' ' CE2' ' B' ' 29' ' ' TYR . 38.4 t80 64.46 120.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.748 0.308 . . . . 0.0 110.89 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' HIS . . . . . 0.402 ' CB ' ' HB3' ' B' ' 34' ' ' HIS . 7.9 m80 -76.72 162.36 70.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.931 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.67 112.0 1.01 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.568 2.179 . . . . 0.0 112.244 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 10.0 t -164.48 159.36 19.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.787 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -100.18 125.8 46.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.008 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 pp -126.04 116.24 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -110.74 85.97 2.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.036 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 49.0 t -80.81 120.83 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.878 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -143.17 117.82 9.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.017 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' LEU . . . . . 0.472 HD11 ' CE2' ' B' ' 25' ' ' PHE . 0.1 OUTLIER -137.28 119.76 15.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.641 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -163.2 -167.0 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.967 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.096 179.826 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.815 0.341 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -154.65 -43.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.153 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' D' ' 71' ' ' ASN . 21.6 t80 -93.64 142.51 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.043 0.449 . . . . 0.0 111.247 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 32.2 mt -159.19 120.49 3.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.969 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 71' ' ' ASN . . . . . 0.631 ' O ' ' N ' ' D' ' 73' ' ' TYR . 4.2 t30 -139.43 173.56 11.42 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 72' ' ' CYS . . . . . 0.411 ' O ' ' HB2' ' C' ' 50' ' ' CYS . 0.5 OUTLIER 37.34 -79.08 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.399 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 73' ' ' TYR . . . . . 0.631 ' N ' ' O ' ' D' ' 71' ' ' ASN . 0.3 OUTLIER 74.83 -87.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 178.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . 0.505 ' HB ' ' HA ' ' C' ' 52' ' ' VAL . 41.1 t -101.94 50.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.108 0.48 . . . . 0.0 111.064 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 75' ' ' SER . . . . . 0.475 ' HA ' ' CZ ' ' C' ' 51' ' ' TYR . 3.3 m -92.86 -160.59 0.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.033 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.93 -4.54 0.64 Allowed Glycine 0 CA--C 1.522 0.492 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.226 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 0.428 ' CE2' ' CE2' ' C' ' 51' ' ' TYR . 0.1 OUTLIER -47.27 171.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 117.05 0.425 . . . . 0.0 111.384 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 78' ' ' HIS . . . . . 0.521 ' CB ' ' HD3' ' D' ' 79' ' ' PRO . 0.0 OUTLIER -115.94 -65.44 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 79' ' ' PRO . . . . . 0.521 ' HD3' ' CB ' ' D' ' 78' ' ' HIS . 60.9 Cg_endo -85.41 -105.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.359 2.039 . . . . 0.0 112.109 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 21.6 t 52.28 175.49 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.964 0.412 . . . . 0.0 111.408 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -120.71 73.06 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.652 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 82' ' ' ILE . . . . . 0.497 HG21 HD13 ' D' ' 82' ' ' ILE . 0.0 OUTLIER -74.29 108.43 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.199 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.89 106.17 7.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.628 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 21.1 t -123.72 131.04 73.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.379 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -136.34 107.17 6.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.518 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . 0.445 ' CD1' ' CE1' ' C' ' 47' ' ' PHE . 0.2 OUTLIER -106.08 134.59 48.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.074 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -120.27 -172.67 2.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.695 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mttm . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.827 -179.943 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.899 0.381 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 3' ' ' PHE . 0.9 OUTLIER 61.12 -174.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.932 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.531 ' C ' ' CD1' ' A' ' 3' ' ' PHE . 0.0 OUTLIER 87.03 177.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.901 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.458 ' N ' ' CG ' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -156.4 128.44 7.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 111.119 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -104.8 109.11 20.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.667 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -91.7 125.73 36.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.187 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.403 ' CE2' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -140.59 122.71 15.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.726 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.5 m -149.09 137.24 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.234 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t 71.95 -67.97 0.24 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.38 -150.2 20.39 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.834 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.414 ' CE2' ' O ' ' A' ' 12' ' ' HIS . 6.2 p90 -173.88 -166.09 0.28 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.811 0.339 . . . . 0.0 110.919 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.414 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 19.9 m80 -67.14 154.36 92.81 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.47 120.28 7.54 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.615 2.21 . . . . 0.0 112.2 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.0 p -169.83 -166.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.809 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.76 101.46 7.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.938 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.403 HD13 ' CE2' ' A' ' 7' ' ' TYR . 16.5 tt -87.84 140.72 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -144.32 162.73 35.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.941 0.4 . . . . 0.0 111.153 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.19 131.59 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.901 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -129.78 121.9 27.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.045 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.433 HD22 ' CE2' ' A' ' 3' ' ' PHE . 4.2 mm? -104.99 132.28 51.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.926 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 tp -136.49 -59.48 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 ptmm? . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.861 -179.919 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.898 0.38 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -176.66 113.64 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.075 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.515 ' CE1' ' CE2' ' C' ' 47' ' ' PHE . 63.0 t80 -116.95 121.3 41.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.644 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.75 98.03 4.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.2 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.463 ' HB2' ' CE1' ' B' ' 25' ' ' PHE . 0.5 OUTLIER -107.36 83.97 1.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.592 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 12.6 p -106.06 133.18 51.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.173 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.444 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 0.0 OUTLIER -150.41 114.77 5.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.563 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 34.6 m -121.99 131.1 73.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.077 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 22.6 m 64.43 102.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.654 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.437 ' HA3' ' CD2' ' C' ' 55' ' ' PHE . . . -59.39 -116.71 0.01 OUTLIER Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.782 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' B' ' 33' ' ' PHE . 0.0 OUTLIER 179.15 -100.18 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.396 0.141 . . . . 0.0 110.787 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.46 ' CG ' ' HD2' ' B' ' 35' ' ' PRO . 0.0 OUTLIER -138.16 179.34 1.35 Allowed Pre-proline 0 N--CA 1.455 -0.19 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' B' ' 34' ' ' HIS . 99.7 Cg_exo -44.84 88.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.587 2.191 . . . . 0.0 112.566 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.446 ' N ' ' O ' ' B' ' 34' ' ' HIS . 3.3 m -136.24 159.0 43.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.272 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -113.88 111.1 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.816 0.341 . . . . 0.0 111.221 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 32.9 mt -99.06 94.74 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.749 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -101.99 88.46 3.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.266 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 95.3 t -91.65 114.92 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.539 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -127.13 112.28 14.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.0 111.492 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.438 HD23 ' CD1' ' A' ' 3' ' ' PHE . 1.2 mp -102.35 116.62 33.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.111 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 76.52 -154.18 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.005 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.785 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.764 0.316 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.7 -73.65 0.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.944 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.515 ' CE2' ' CE1' ' B' ' 25' ' ' PHE . 15.3 t80 -137.28 128.45 27.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.996 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 mt -135.35 112.02 10.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.77 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' ASN . . . . . 0.47 ' HB2' ' CE1' ' C' ' 47' ' ' PHE . 38.2 t30 -113.76 139.29 49.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.96 0.409 . . . . 0.0 111.034 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.46 109.21 7.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.594 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.44 ' CZ ' HG21 ' D' ' 82' ' ' ILE . 1.2 t80 -121.24 94.06 4.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.179 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . . . . . . . . . 45.9 t -97.59 109.27 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.594 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' SER . . . . . 0.486 ' CB ' ' HB2' ' D' ' 75' ' ' SER . 0.7 OUTLIER -55.7 -175.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.349 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.48 58.73 0.68 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.033 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . 0.493 ' O ' ' N ' ' C' ' 57' ' ' PRO . 1.3 p90 -171.74 33.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.32 0.105 . . . . 0.0 110.754 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' HIS . . . . . 0.516 ' CB ' ' CD ' ' C' ' 57' ' ' PRO . 0.0 OUTLIER 12.42 -76.45 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.711 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.231 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . 0.516 ' CD ' ' CB ' ' C' ' 56' ' ' HIS . 73.1 Cg_endo -72.45 -162.95 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.233 1.955 . . . . 0.0 112.781 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 79.22 155.52 0.15 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.808 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -129.17 145.62 51.28 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.588 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.464 HD11 ' CZ ' ' C' ' 55' ' ' PHE . 2.1 mp -131.05 112.81 22.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.324 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -114.38 80.71 1.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.739 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 42.1 t -91.93 121.89 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.139 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -151.45 126.98 10.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' C' ' 64' ' ' LEU . 0.0 OUTLIER -135.26 144.67 46.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.942 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 4.9 mt -97.94 102.75 14.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.924 179.991 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 19.1 p . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.863 0.363 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -68.54 97.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -124.05 113.81 18.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.79 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 tp -122.72 99.65 6.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.793 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 71' ' ' ASN . . . . . 0.415 ' O ' ' CD1' ' D' ' 73' ' ' TYR . 12.7 p-10 -93.89 52.66 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 90.5 m -58.86 123.27 15.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.594 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 73' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' D' ' 71' ' ' ASN . 0.1 OUTLIER -174.58 135.16 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.295 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . 0.589 ' O ' ' CB ' ' D' ' 75' ' ' SER . 12.6 p -178.73 160.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.212 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 75' ' ' SER . . . . . 0.589 ' CB ' ' O ' ' D' ' 74' ' ' VAL . 73.7 m 118.18 179.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.872 0.869 . . . . 0.0 110.627 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.51 152.87 20.29 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.44 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 0.487 ' O ' ' HD2' ' D' ' 79' ' ' PRO . 38.4 p90 -161.76 -31.5 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.47 0.176 . . . . 0.0 111.162 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 78' ' ' HIS . . . . . 0.673 ' CB ' ' CD ' ' D' ' 79' ' ' PRO . 17.9 m170 34.67 -90.18 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 79' ' ' PRO . . . . . 0.673 ' CD ' ' CB ' ' D' ' 78' ' ' HIS . 58.2 Cg_endo -69.37 58.07 1.34 Allowed 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.646 1.564 . . . . 0.0 113.007 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 3.7 p -135.84 155.73 49.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.525 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -110.49 100.07 8.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.797 0.332 . . . . 0.0 111.244 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 82' ' ' ILE . . . . . 0.44 HG21 ' CZ ' ' C' ' 51' ' ' TYR . 1.3 pp -122.73 143.87 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.283 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -158.27 124.21 4.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.737 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.58 132.17 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.341 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -128.55 105.59 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.82 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . 0.434 ' CD1' ' CZ ' ' C' ' 47' ' ' PHE . 0.0 OUTLIER -107.76 100.23 9.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 55.6 tp 58.01 104.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.943 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.913 -179.974 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.716 0.293 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.5 p30 44.39 95.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.685 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.511 ' CE2' HD11 ' B' ' 42' ' ' LEU . 0.5 OUTLIER -76.95 106.2 8.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.506 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.92 68.07 1.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.542 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.484 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 6.0 p30 -67.92 -177.48 0.82 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.429 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.475 ' HB3' ' O ' ' B' ' 28' ' ' CYS . 2.8 m 64.92 -167.62 0.22 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.302 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.479 ' OH ' ' CD2' ' B' ' 33' ' ' PHE . 25.3 p90 -146.66 151.95 38.08 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.808 0.337 . . . . 0.0 111.402 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.53 83.24 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.879 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.3 p 61.77 117.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.087 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.98 130.89 5.79 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.641 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.46 ' CE1' HG13 ' A' ' 16' ' ' ILE . 33.7 t80 -179.99 148.87 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.919 0.39 . . . . 0.0 111.035 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.428 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 18.6 p80 -82.37 157.36 67.95 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.792 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.452 ' O ' ' HB2' ' A' ' 14' ' ' SER . 19.3 Cg_endo -58.76 -159.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.758 2.305 . . . . 0.0 112.556 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER 73.37 -95.9 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.427 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' B' ' 37' ' ' ASP . 0.1 OUTLIER -177.83 160.61 1.52 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.013 0.435 . . . . 0.0 111.408 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.46 HG13 ' CE1' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -96.16 117.42 40.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.681 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 7.0 pt-20 -107.48 115.0 29.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.962 0.41 . . . . 0.0 110.723 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.7 t -150.71 137.17 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -149.51 126.78 11.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.87 0.367 . . . . 0.0 111.326 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' B' ' 43' ' ' LEU . 0.6 OUTLIER 66.6 -66.91 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.656 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.499 ' CB ' ' CZ ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER 41.97 77.19 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.425 -179.462 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.403 ' HA ' ' NZ ' ' A' ' 22' ' ' LYS . 1.8 tpmp? . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.9 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.804 0.335 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.84 -44.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.022 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.5 ' CZ ' ' HB2' ' B' ' 27' ' ' ASN . 60.4 t80 -103.66 123.41 46.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.243 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -124.45 122.25 37.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.671 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.5 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 0.8 OUTLIER -126.91 114.99 18.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.531 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 6' ' ' CYS . 2.2 t -116.73 102.2 9.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.356 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.41 ' OH ' ' CE2' ' C' ' 55' ' ' PHE . 3.9 t80 -125.78 88.84 2.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.546 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -103.38 132.68 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.136 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 15.5 t 65.35 151.69 0.05 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.166 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.16 -139.24 8.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.516 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' B' ' 33' ' ' PHE . 0.0 OUTLIER -179.66 -106.65 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 O-C-N 123.008 -0.113 . . . . 0.0 111.149 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.513 ' CB ' ' CD ' ' B' ' 35' ' ' PRO . 0.0 OUTLIER -123.34 -176.7 0.46 Allowed Pre-proline 0 CA--C 1.528 0.106 0 CA-C-O 120.579 0.228 . . . . 0.0 110.589 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' B' ' 34' ' ' HIS . 24.1 Cg_exo -64.26 -0.92 3.19 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.714 2.276 . . . . 0.0 113.092 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.1 t -41.99 160.18 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.935 0.397 . . . . 0.0 111.432 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 7.6 t0 -103.0 143.64 32.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.716 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 26.4 mm -119.27 123.03 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.213 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -123.28 87.26 2.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 50.2 t -100.21 119.07 47.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.135 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.7 122.84 26.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.28 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.511 HD11 ' CE2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -120.2 145.88 46.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.062 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER 56.6 21.92 6.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.319 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 30.8 tttt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.914 179.895 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.839 0.352 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 66.06 120.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.994 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.441 ' CZ ' ' CD1' ' D' ' 86' ' ' LEU . 1.7 t80 -108.41 103.35 12.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.641 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 mp -107.06 110.13 22.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.862 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' B' ' 27' ' ' ASN . 1.5 t30 -122.14 97.9 5.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.082 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 13.9 m -109.84 116.96 32.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.689 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.476 ' OH ' ' CD1' ' D' ' 77' ' ' PHE . 0.7 OUTLIER -139.64 149.48 43.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.965 0.412 . . . . 0.0 111.285 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . . . . . . . . . 31.3 t -115.53 110.87 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.588 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 11.7 m -52.96 178.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.409 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.93 48.02 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.233 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . 0.456 ' O ' ' CD1' ' C' ' 55' ' ' PHE . 0.0 OUTLIER -176.64 141.96 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.168 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' HIS . . . . . 0.417 ' CB ' ' CD ' ' C' ' 57' ' ' PRO . 0.2 OUTLIER -87.23 -62.08 0.24 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.276 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' C' ' 56' ' ' HIS . 72.9 Cg_endo -76.27 -163.52 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.507 2.138 . . . . 0.0 112.498 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' C' ' 57' ' ' PRO . 0.4 OUTLIER 80.36 161.89 0.17 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.325 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.06 129.17 47.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.947 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' D' ' 82' ' ' ILE . 0.1 OUTLIER -114.55 96.44 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.93 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -104.28 128.09 52.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.958 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 46.5 t -142.89 120.87 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.957 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -128.44 124.63 36.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.996 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' D' ' 86' ' ' LEU . 0.1 OUTLIER -98.44 106.02 18.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 28.6 tp 64.52 -76.57 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.034 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.985 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 87.4 p . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.845 0.355 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 58.54 32.32 22.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.982 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -107.72 109.63 21.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 tp -132.45 60.02 1.7 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.778 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 71' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -80.59 78.07 7.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.856 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 19.8 t -69.75 123.72 22.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.827 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 73' ' ' TYR . . . . . 0.438 ' HB3' ' CE2' ' C' ' 51' ' ' TYR . 0.2 OUTLIER -131.09 144.85 51.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 18.7 t -121.72 153.09 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.486 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 1.1 t 67.88 -83.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.35 174.37 24.34 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.691 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 0.476 ' CD1' ' OH ' ' C' ' 51' ' ' TYR . 0.3 OUTLIER -169.45 159.44 8.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 111.011 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 78' ' ' HIS . . . . . 0.463 ' N ' ' HD2' ' D' ' 79' ' ' PRO . 6.1 t-160 -178.24 -60.76 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.148 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 79' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' D' ' 78' ' ' HIS . 9.2 Cg_endo -52.75 -34.2 63.67 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.5 2.134 . . . . 0.0 112.485 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 24.8 p -75.19 157.21 34.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.831 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.86 115.22 16.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.742 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 82' ' ' ILE . . . . . 0.46 HG23 ' CD2' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -114.01 146.53 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.977 0.418 . . . . 0.0 111.589 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.64 57.46 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 t -80.54 134.79 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -149.71 137.16 19.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . 0.511 ' CD1' ' N ' ' D' ' 86' ' ' LEU . 0.0 OUTLIER -126.19 94.46 4.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.72 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 60.34 99.18 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.765 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.86 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.761 0.315 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -162.08 97.17 1.02 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.094 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.485 ' C ' ' CD1' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -165.48 -172.15 2.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.984 179.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -124.45 119.08 28.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.038 0.447 . . . . 0.0 111.08 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER -125.88 61.3 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.691 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' B' ' 28' ' ' CYS . 29.5 p -138.29 145.52 41.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.963 0.411 . . . . 0.0 111.472 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.485 ' OH ' ' CE1' ' B' ' 33' ' ' PHE . 1.0 OUTLIER -150.85 131.43 13.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.805 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.0 p -100.19 99.9 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.162 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.42 ' HA ' ' HA3' ' B' ' 32' ' ' GLY . 0.9 OUTLIER 58.46 105.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.066 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.48 135.24 2.11 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.574 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.458 ' CE2' ' CB ' ' B' ' 36' ' ' SER . 5.0 t80 -158.98 93.86 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.762 0.315 . . . . 0.0 110.964 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.461 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 3.0 t-160 -81.23 -47.77 1.09 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.408 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 12' ' ' HIS . 87.7 Cg_endo -82.57 -177.5 3.45 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.469 2.112 . . . . 0.0 112.55 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -115.04 -60.45 1.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.665 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -112.09 104.45 12.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.644 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.8 pt -117.77 118.87 59.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.264 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -118.7 86.94 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.51 147.71 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.022 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -148.37 149.04 31.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.964 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.7 112.97 7.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 tp -58.98 -68.86 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.998 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.864 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.879 0.371 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -161.01 106.95 1.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.452 ' CE2' HD13 ' C' ' 64' ' ' LEU . 77.9 t80 -101.92 122.11 43.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.92 122.28 43.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.723 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.423 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 8.8 t-20 -148.56 101.4 3.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.642 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 7.3 m -152.84 132.95 13.45 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.8 0.333 . . . . 0.0 111.753 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.525 ' CD1' ' C ' ' B' ' 29' ' ' TYR . 0.1 OUTLIER -130.24 129.86 43.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.411 178.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' C' ' 52' ' ' VAL . 39.9 t -128.56 119.22 49.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.841 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 14.2 m 50.56 179.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.606 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 9' ' ' SER . . . 46.1 94.42 0.01 OUTLIER Glycine 0 C--N 1.332 0.355 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.835 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . 0.485 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -130.08 -44.12 1.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.664 0.269 . . . . 0.0 111.214 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 63.61 137.58 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.717 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -51.53 93.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.432 2.088 . . . . 0.0 112.171 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.458 ' CB ' ' CE2' ' A' ' 11' ' ' PHE . 2.4 m -149.51 -167.0 2.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.034 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -141.0 142.62 34.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.073 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.419 HG13 ' CG2' ' C' ' 60' ' ' ILE . 0.8 OUTLIER -150.69 147.01 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.656 179.484 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -143.18 129.66 20.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.821 0.343 . . . . 0.0 111.133 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 44.3 t -110.63 120.66 61.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.826 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -118.73 94.13 4.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.455 HD22 ' CE1' ' A' ' 3' ' ' PHE . 3.0 mp -110.01 117.46 33.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.676 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.06 122.19 32.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.805 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 8.7 tttm . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.927 -179.858 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.779 0.323 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 59.77 78.97 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.452 ' CZ ' ' CD1' ' D' ' 86' ' ' LEU . 31.7 t80 -87.64 102.86 15.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.632 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -103.92 103.24 13.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.903 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' ASN . . . . . 0.44 ' HB2' ' CZ ' ' C' ' 47' ' ' PHE . 1.9 t30 -127.04 116.44 20.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' CYS . . . . . 0.433 ' CB ' ' HB3' ' D' ' 72' ' ' CYS . 18.9 p -159.74 157.19 28.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.18 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.523 ' HB2' ' CE2' ' B' ' 29' ' ' TYR . 0.5 OUTLIER -162.78 147.21 11.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.771 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . 0.409 ' CG2' ' CG1' ' B' ' 30' ' ' VAL . 32.8 m -134.53 114.45 18.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.181 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 5.5 t 166.72 -86.39 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.767 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' GLY . . . . . 0.556 ' O ' ' CD1' ' C' ' 55' ' ' PHE . . . 108.92 -56.09 0.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.895 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' C' ' 54' ' ' GLY . 4.9 p90 43.02 -176.97 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.098 0.475 . . . . 0.0 111.99 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' HIS . . . . . 0.507 ' CB ' ' HD3' ' C' ' 57' ' ' PRO . 0.0 OUTLIER -99.51 -61.96 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.783 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . 0.507 ' HD3' ' CB ' ' C' ' 56' ' ' HIS . 52.4 Cg_endo -88.27 -151.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.795 2.33 . . . . 0.0 112.027 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' C' ' 57' ' ' PRO . 1.0 OUTLIER 86.69 125.06 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.181 0.515 . . . . 0.0 111.375 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . 0.43 ' HA ' ' CB ' ' D' ' 81' ' ' ASP . 8.1 t0 -112.51 95.51 5.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.213 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.455 ' CD1' ' N ' ' C' ' 60' ' ' ILE . 0.2 OUTLIER -134.01 140.87 45.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.199 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -156.49 133.41 10.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.053 0.454 . . . . 0.0 111.185 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.29 121.01 61.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.647 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -125.13 128.33 48.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.269 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' LEU . . . . . 0.452 HD13 ' CE2' ' B' ' 25' ' ' PHE . 5.2 mt -124.78 110.05 13.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.563 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 62.91 126.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.789 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 18.1 ttpt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.888 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.694 0.283 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -177.75 -35.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.297 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . 0.421 ' HB2' ' CD1' ' C' ' 47' ' ' PHE . 0.1 OUTLIER -120.37 170.67 9.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.79 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 24.0 tp -152.22 109.06 3.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.117 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 71' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -102.18 65.3 0.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.47 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 72' ' ' CYS . . . . . 0.433 ' HB3' ' CB ' ' C' ' 50' ' ' CYS . 50.9 t -75.03 101.66 4.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 73' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -107.15 128.86 54.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.103 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' D' ' 75' ' ' SER . 10.9 t -133.33 73.87 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.13 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 75' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' D' ' 74' ' ' VAL . 1.4 p 174.63 137.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.451 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . 0.485 ' O ' ' CG ' ' D' ' 77' ' ' PHE . . . -50.38 -87.02 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.679 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 0.497 ' CE1' HG13 ' D' ' 82' ' ' ILE . 0.4 OUTLIER 162.8 -60.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 122.482 0.313 . . . . 0.0 110.616 178.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 78' ' ' HIS . . . . . 0.47 ' HB3' ' HD2' ' D' ' 79' ' ' PRO . 20.0 m-70 58.54 164.62 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.545 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 79' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' D' ' 78' ' ' HIS . 18.7 Cg_endo -59.32 75.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.517 2.145 . . . . 0.0 112.344 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 80' ' ' SER . . . . . 0.444 ' N ' ' O ' ' D' ' 78' ' ' HIS . 9.7 p -127.61 -163.34 1.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.454 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 81' ' ' ASP . . . . . 0.43 ' CB ' ' HA ' ' C' ' 59' ' ' ASP . 0.2 OUTLIER -130.78 43.97 3.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.782 0.325 . . . . 0.0 111.31 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 82' ' ' ILE . . . . . 0.497 HG13 ' CE1' ' D' ' 77' ' ' PHE . 35.6 pt -99.7 117.85 45.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.882 0.372 . . . . 0.0 110.814 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -148.02 162.43 39.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.022 0.439 . . . . 0.0 111.523 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 48.0 t -141.76 130.22 22.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.94 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -135.59 108.77 7.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.925 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . 0.452 ' CD1' ' CZ ' ' C' ' 47' ' ' PHE . 0.4 OUTLIER -120.03 96.18 5.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.055 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mp 60.57 -81.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.054 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 88' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' D' ' 86' ' ' LEU . 3.4 tttp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.097 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.739 0.304 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -61.33 136.98 58.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.789 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.484 ' CD1' ' CE2' ' B' ' 25' ' ' PHE . 46.5 t80 -145.67 129.08 16.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.73 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -147.48 83.87 1.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.295 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.422 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 6.5 t-20 -71.97 115.96 11.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.417 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.87 112.13 22.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.958 0.408 . . . . 0.0 111.714 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.47 ' OH ' ' CE1' ' B' ' 33' ' ' PHE . 0.1 OUTLIER -118.09 128.78 55.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.98 179.066 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.5 80.36 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.097 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 43.61 95.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.596 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.5 137.28 3.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.148 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.464 ' CE1' ' HG2' ' B' ' 35' ' ' PRO . 5.6 p90 -177.44 169.3 2.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.686 0.279 . . . . 0.0 110.733 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.529 ' HB3' ' HD2' ' A' ' 13' ' ' PRO . 1.8 m80 -58.89 176.04 0.3 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.719 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 12' ' ' HIS . 86.1 Cg_endo -81.68 175.45 9.42 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.367 2.045 . . . . 0.0 112.158 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m 65.5 -161.56 0.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.743 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -106.36 118.39 36.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.971 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.437 HG12 ' CE2' ' A' ' 11' ' ' PHE . 23.4 mm -79.24 159.11 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.977 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.16 59.56 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.191 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.73 118.46 10.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.498 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' B' ' 41' ' ' ASP . 3.1 p30 -134.76 161.98 33.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.957 0.408 . . . . 0.0 111.398 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.1 mt -152.95 122.9 6.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.894 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 63.7 -178.69 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.731 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.852 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.851 0.358 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 43.01 46.71 4.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.463 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.484 ' CE2' ' CD1' ' A' ' 3' ' ' PHE . 37.6 t80 -121.23 142.15 50.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.784 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -147.42 115.81 6.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.418 ' HB2' ' CE1' ' B' ' 25' ' ' PHE . 46.4 t30 -122.73 90.66 3.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.775 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 91.6 m -81.93 117.44 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.73 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.462 ' CZ ' HG13 ' C' ' 60' ' ' ILE . 1.7 t80 -111.69 104.79 13.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.014 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.446 ' HA ' ' CG2' ' C' ' 52' ' ' VAL . 15.3 t -104.04 105.29 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.567 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 13.8 m -57.21 -178.32 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.982 0.42 . . . . 0.0 111.276 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.18 50.72 0.76 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.464 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . 0.47 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -165.25 161.02 18.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.771 0.319 . . . . 0.0 111.233 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.637 ' N ' ' HD3' ' B' ' 35' ' ' PRO . 4.7 p80 -148.0 53.53 1.54 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.182 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.637 ' HD3' ' N ' ' B' ' 34' ' ' HIS . 2.3 Cg_endo -83.37 -72.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.08 2.52 . . . . 0.0 112.465 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 47.3 t -158.1 -119.94 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.185 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -126.83 163.94 22.49 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.86 0.362 . . . . 0.0 111.015 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 25.0 mt -145.57 136.04 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.927 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -129.92 145.36 51.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.94 0.4 . . . . 0.0 111.227 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 40.7 t -142.85 140.38 27.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.814 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 19' ' ' ASP . 14.5 t0 -162.61 118.1 1.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.658 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.464 ' CD1' ' CE2' ' A' ' 3' ' ' PHE . 0.4 OUTLIER -158.9 -171.0 3.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.051 0.453 . . . . 0.0 111.482 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 58.54 162.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.211 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.99 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.814 0.34 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -175.9 174.39 2.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.102 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.487 ' CZ ' ' HB2' ' C' ' 49' ' ' ASN . 62.1 t80 -85.78 107.64 17.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 21.4 tp -117.37 83.5 2.0 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.983 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' ASN . . . . . 0.487 ' HB2' ' CZ ' ' C' ' 47' ' ' PHE . 3.7 t-20 -98.35 102.9 14.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.593 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.72 115.11 20.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.813 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -116.07 102.75 9.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.063 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . 0.446 ' CG2' ' HA ' ' B' ' 30' ' ' VAL . 34.1 m -113.68 114.31 46.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 15.1 p -50.93 178.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.626 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.88 -30.49 2.16 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.087 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . 0.46 ' CZ ' ' CB ' ' D' ' 80' ' ' SER . 0.0 OUTLIER -92.73 -163.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 111.323 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' HIS . . . . . 0.475 ' CB ' ' HD3' ' C' ' 57' ' ' PRO . 0.0 OUTLIER -169.68 -55.63 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.81 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . 0.475 ' HD3' ' CB ' ' C' ' 56' ' ' HIS . 69.0 Cg_endo -94.8 66.61 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.008 2.472 . . . . 0.0 112.617 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.0 158.07 32.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.97 0.414 . . . . 0.0 111.028 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.83 139.14 49.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.795 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.462 HG13 ' CZ ' ' B' ' 29' ' ' TYR . 6.1 mm -139.42 103.71 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.311 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.73 129.41 55.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.692 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.57 145.48 33.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.312 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.52 148.7 43.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.027 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' C' ' 65' ' ' LEU . 0.6 OUTLIER -151.09 73.43 1.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.468 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' C' ' 64' ' ' LEU . 1.2 tm? 157.65 137.17 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.449 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.86 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.746 0.308 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -56.76 129.25 40.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.048 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -130.28 139.78 50.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 12.7 tp -157.41 95.96 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.753 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 71' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -109.09 122.51 47.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.093 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -95.03 62.8 2.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.594 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.02 72.68 1.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.12 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.04 97.59 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.064 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 80.9 p -174.65 -76.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.923 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.75 -33.27 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 0.403 ' O ' ' CG ' ' D' ' 78' ' ' HIS . 22.6 m-85 62.74 104.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.734 0.302 . . . . 0.0 111.025 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 78' ' ' HIS . . . . . 0.46 ' CB ' ' CD ' ' D' ' 79' ' ' PRO . 2.0 m-70 -173.81 -64.04 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.946 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 79' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' D' ' 78' ' ' HIS . 33.1 Cg_endo -66.98 -75.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.366 2.044 . . . . 0.0 112.769 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 80' ' ' SER . . . . . 0.46 ' CB ' ' CZ ' ' C' ' 55' ' ' PHE . 35.3 p -58.9 -178.85 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.912 0.387 . . . . 0.0 111.167 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.3 108.47 13.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.829 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 82' ' ' ILE . . . . . 0.441 ' CD1' ' N ' ' D' ' 82' ' ' ILE . 0.2 OUTLIER -141.55 161.56 21.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.228 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -168.94 126.45 0.99 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.811 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.31 127.49 68.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -139.6 100.06 3.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.716 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . 0.46 ' HG ' ' CE2' ' C' ' 47' ' ' PHE . 0.2 OUTLIER -103.1 -168.96 1.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . 0.51 HD22 ' N ' ' D' ' 87' ' ' LEU . 0.0 OUTLIER -67.32 66.54 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.215 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.96 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 84.2 p . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.838 0.351 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 60.8 55.66 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.995 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.438 ' CZ ' ' CD1' ' B' ' 42' ' ' LEU . 90.0 t80 -59.96 114.76 2.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.805 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.9 pp -124.1 98.48 5.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.811 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -83.79 93.01 7.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.889 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.9 m -89.07 102.59 15.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.424 ' OH ' ' CD2' ' B' ' 33' ' ' PHE . 8.3 t80 -108.21 117.91 35.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.69 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.418 ' HA ' HG23 ' B' ' 30' ' ' VAL . 7.1 p -121.39 87.64 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.962 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.414 ' CB ' ' HA3' ' B' ' 32' ' ' GLY . 67.0 p 46.54 -167.85 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.777 0.322 . . . . 0.0 111.084 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.61 159.77 34.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.042 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.444 ' CE2' ' HB3' ' B' ' 36' ' ' SER . 0.2 OUTLIER 177.22 113.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.826 0.346 . . . . 0.0 110.56 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.422 ' HB2' ' HD3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -92.12 -54.3 0.26 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.438 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 12' ' ' HIS . 94.9 Cg_endo -83.53 -97.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.477 2.118 . . . . 0.0 112.646 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.404 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 14.8 p -178.67 -52.81 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.749 0.309 . . . . 0.0 111.102 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -114.86 86.43 2.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.266 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 2.2 pp -156.32 -170.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.683 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 16' ' ' ILE . 37.4 tp10 160.01 -82.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.527 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -139.8 139.45 37.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.96 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -154.34 83.42 1.12 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 3.2 mm? -86.91 87.26 7.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.765 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 0.9 OUTLIER 33.38 94.61 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.144 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.947 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 72.1 m . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.876 0.37 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 61.01 89.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' B' ' 27' ' ' ASN . 56.5 t80 -106.35 117.83 35.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.677 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 mp -131.71 95.85 3.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.077 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.447 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 0.1 OUTLIER -102.21 110.06 21.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.656 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.41 ' HA ' ' O ' ' C' ' 50' ' ' CYS . 27.7 p -126.17 128.67 47.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.5 ' CE1' ' CE2' ' C' ' 55' ' ' PHE . 2.4 p90 -133.72 156.39 48.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.001 0.429 . . . . 0.0 111.39 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 8' ' ' VAL . 16.6 m -129.05 134.13 64.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.754 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.0 t -44.74 167.53 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.644 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' A' ' 9' ' ' SER . . . 150.89 -37.76 0.87 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.786 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . 0.483 ' CZ ' ' CE2' ' C' ' 55' ' ' PHE . 6.7 p90 -90.19 163.64 14.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 111.132 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.55 171.64 9.38 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.992 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.421 ' HD3' ' CD2' ' C' ' 56' ' ' HIS . 95.2 Cg_exo -42.45 94.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.746 2.297 . . . . 0.0 112.628 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.444 ' HB3' ' CE2' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -124.53 -165.37 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.806 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.81 106.4 10.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.981 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -107.94 116.25 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.521 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 18.6 pt-20 -128.19 117.43 21.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.859 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 39.5 t -93.62 122.64 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.997 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -127.76 93.75 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.438 ' CD1' ' CZ ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER -106.53 108.51 20.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.004 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.8 35.4 3.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.03 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.785 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.74 0.305 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -170.77 118.9 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.15 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.513 ' CE2' ' CD1' ' D' ' 86' ' ' LEU . 47.2 t80 -114.43 112.2 22.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.51 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' B' ' 27' ' ' ASN . 0.1 OUTLIER -120.47 94.21 4.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.212 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' ASN . . . . . 0.468 ' HB2' ' CZ ' ' C' ' 47' ' ' PHE . 36.3 t30 -110.12 80.63 1.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.026 0.441 . . . . 0.0 110.676 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' CYS . . . . . 0.472 ' HB3' ' CD2' ' D' ' 73' ' ' TYR . 32.0 p -107.83 154.04 22.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.595 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.491 ' CZ ' ' HA ' ' D' ' 72' ' ' CYS . 0.2 OUTLIER -148.24 160.58 42.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.457 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . 0.433 ' HA ' ' HB ' ' D' ' 74' ' ' VAL . 20.2 t -124.84 124.87 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.457 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.26 -172.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.096 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' D' ' 77' ' ' PHE . . . -122.76 172.35 15.81 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.636 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . 0.5 ' CE2' ' CE1' ' B' ' 29' ' ' TYR . 0.1 OUTLIER -143.86 60.21 1.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 111.317 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' HIS . . . . . 0.494 ' HB3' ' HD2' ' C' ' 57' ' ' PRO . 3.0 m-70 59.89 165.47 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.466 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' C' ' 56' ' ' HIS . 34.9 Cg_endo -64.68 79.73 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.416 2.078 . . . . 0.0 112.282 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 1.5 t -96.83 -167.46 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.039 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.09 129.03 44.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.733 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 6.6 mt -127.8 120.1 53.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.294 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -111.04 77.47 1.04 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.552 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.3 t -79.26 124.69 37.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.29 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -149.9 121.22 7.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.759 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' LEU . . . . . 0.438 ' CD1' ' N ' ' C' ' 64' ' ' LEU . 0.0 OUTLIER -137.2 140.79 41.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.3 -66.05 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.861 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.824 179.909 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.828 0.347 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 55.85 96.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.01 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -113.13 128.63 56.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.008 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 70' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' C' ' 48' ' ' LEU . 2.8 tp -155.49 88.0 1.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 71' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' D' ' 73' ' ' TYR . 17.9 p-10 -125.49 -157.53 0.79 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.356 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 72' ' ' CYS . . . . . 0.491 ' HA ' ' CZ ' ' C' ' 51' ' ' TYR . 36.1 t 55.82 -83.36 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.896 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 73' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' D' ' 71' ' ' ASN . 1.0 OUTLIER 66.76 -93.66 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 177.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' C' ' 52' ' ' VAL . 40.1 t -109.44 64.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 120.989 0.423 . . . . 0.0 110.848 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -60.83 -164.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.209 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.47 58.15 0.4 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.874 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 0.418 ' HB3' ' HA2' ' C' ' 54' ' ' GLY . 13.6 p90 -130.61 163.77 26.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 111.314 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 78' ' ' HIS . . . . . 0.464 ' CB ' ' HD2' ' D' ' 79' ' ' PRO . 0.4 OUTLIER -76.65 170.0 18.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.279 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 79' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' D' ' 78' ' ' HIS . 9.4 Cg_endo -52.46 89.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.411 2.074 . . . . 0.0 112.13 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.99 119.69 39.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.709 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -54.02 96.39 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.835 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 82' ' ' ILE . . . . . . . . . . . . . 20.6 pt -111.43 125.21 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.364 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -113.11 107.68 16.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.531 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.15 130.56 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.491 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -134.33 92.6 2.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.664 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . 0.513 ' CD1' ' CE2' ' C' ' 47' ' ' PHE . 0.2 OUTLIER -88.46 80.05 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.929 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 27.0 tp 60.42 111.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.889 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.865 0.364 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -176.55 86.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.835 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 4' ' ' LEU . 4.9 t80 -109.03 160.06 16.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.756 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.493 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 13.9 tp -145.28 142.64 29.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 0.0 111.346 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.44 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 5.3 t30 -159.02 115.27 2.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.468 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.7 t -126.85 146.23 50.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.316 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -123.18 135.31 54.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.315 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.8 t -144.67 125.71 8.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.814 0.34 . . . . 0.0 111.404 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t 67.12 -160.38 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.041 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.97 -133.95 0.01 OUTLIER Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.757 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.432 ' CZ ' ' HB2' ' B' ' 36' ' ' SER . 0.0 OUTLIER -175.77 -164.89 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.743 0.306 . . . . 0.0 111.077 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.513 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -119.7 -70.02 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.324 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 12' ' ' HIS . 19.1 Cg_endo -58.14 -164.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.312 2.008 . . . . 0.0 112.153 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -130.79 -63.65 0.86 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.934 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -97.84 96.26 8.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.729 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.1 mt -96.88 146.98 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.202 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -149.56 120.85 7.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.872 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.5 t -107.28 129.62 60.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.285 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -145.48 89.92 1.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.745 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.1 127.7 55.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.051 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mp -134.98 -171.08 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.828 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.841 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.773 0.32 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.37 55.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.956 0.408 . . . . 0.0 110.943 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.626 ' CE2' ' CD1' ' C' ' 64' ' ' LEU . 0.1 OUTLIER -169.35 159.03 8.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.144 0.497 . . . . 0.0 111.379 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' B' ' 26' ' ' LEU . 0.2 OUTLIER -106.91 119.28 38.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.512 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -97.86 155.69 16.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.264 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 38.1 t -163.74 153.43 14.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.758 0.313 . . . . 0.0 111.221 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.447 ' CD2' ' HB2' ' C' ' 51' ' ' TYR . 0.0 OUTLIER -176.07 125.55 0.2 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.984 0.421 . . . . 0.0 110.964 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 31.1 m -128.37 128.59 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.256 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 73.49 147.12 0.09 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.054 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.69 -148.43 1.62 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.584 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' B' ' 36' ' ' SER . 0.0 OUTLIER -179.05 37.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.651 0.263 . . . . 0.0 111.596 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.416 ' CB ' ' CD ' ' B' ' 35' ' ' PRO . 0.0 OUTLIER 60.74 178.38 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.698 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' B' ' 34' ' ' HIS . 90.2 Cg_exo -43.0 126.15 4.4 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.596 2.197 . . . . 0.0 112.776 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 5.3 t 179.74 147.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.657 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.94 135.16 55.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.192 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.413 HD13 ' CZ ' ' B' ' 33' ' ' PHE . 35.1 mt -135.91 111.43 11.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.88 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.14 82.94 1.75 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.749 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 42.2 t -73.43 120.36 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.969 0.414 . . . . 0.0 111.109 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -135.97 110.75 8.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.539 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.49 ' CD1' ' CE1' ' A' ' 3' ' ' PHE . 80.6 mt -133.02 143.08 49.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.143 0.497 . . . . 0.0 111.234 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mt 71.47 137.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.571 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 11.5 mttt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.9 -179.84 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.86 0.362 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -94.11 125.37 38.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.028 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.468 ' CD2' HD11 ' D' ' 86' ' ' LEU . 50.1 t80 -131.72 135.4 46.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.81 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 17.7 tp -130.2 128.67 42.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.69 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -130.34 95.3 3.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.388 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 3.7 p -117.86 103.9 10.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.387 . . . . 0.0 111.833 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.47 ' CE1' ' HB3' ' D' ' 73' ' ' TYR . 3.2 p90 -135.45 153.66 51.7 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.874 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . 0.585 ' O ' ' CB ' ' C' ' 53' ' ' SER . 0.8 OUTLIER -176.03 162.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.954 -178.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' C' ' 52' ' ' VAL . 5.9 t 104.58 80.31 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.496 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.91 -63.26 0.05 OUTLIER Glycine 0 C--N 1.332 0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.993 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . 0.445 ' N ' ' O ' ' C' ' 53' ' ' SER . 1.3 t80 78.79 78.37 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.819 0.342 . . . . 0.0 110.516 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' HIS . . . . . 0.595 ' N ' ' CD ' ' C' ' 57' ' ' PRO . 0.3 OUTLIER -140.36 38.86 0.32 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' C' ' 56' ' ' HIS . 36.5 Cg_endo -69.21 -77.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.109 1.872 . . . . 0.0 112.3 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 174.38 -79.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 110.689 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -134.42 134.74 41.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.871 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.401 HG21 HD12 ' C' ' 60' ' ' ILE . 10.1 mt -151.7 106.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -107.21 103.08 12.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.1 t -91.32 124.23 43.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -128.02 129.66 47.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.036 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' LEU . . . . . 0.626 ' CD1' ' CE2' ' B' ' 25' ' ' PHE . 0.2 OUTLIER -139.54 98.1 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.512 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 5.8 mt -94.1 -92.86 0.18 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.372 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.834 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.785 0.326 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -71.47 105.06 3.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' D' ' 71' ' ' ASN . 54.5 t80 -118.42 124.72 48.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.781 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 mt -143.83 95.09 2.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.736 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 71' ' ' ASN . . . . . 0.459 ' O ' ' CD2' ' D' ' 73' ' ' TYR . 2.5 t-20 -100.73 79.95 2.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 1.4 m -73.57 109.31 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.459 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 73' ' ' TYR . . . . . 0.47 ' HB3' ' CE1' ' C' ' 51' ' ' TYR . 1.7 p90 -118.73 118.95 33.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.4 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' C' ' 52' ' ' VAL . 3.5 t -132.72 86.86 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.019 0.438 . . . . 0.0 111.054 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 1.4 t 169.34 -53.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.689 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.38 -154.3 25.56 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.22 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . 0.422 ' CD2' ' OH ' ' C' ' 51' ' ' TYR . 0.1 OUTLIER -177.19 88.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 111.183 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 78' ' ' HIS . . . . . 0.461 ' HB3' ' HD3' ' D' ' 79' ' ' PRO . 9.7 t-160 176.47 -57.94 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 79' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' D' ' 78' ' ' HIS . 55.5 Cg_endo -69.37 62.69 1.56 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.303 2.002 . . . . 0.0 112.389 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 1.9 m 178.77 159.49 0.58 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -96.37 60.26 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.604 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 82' ' ' ILE . . . . . 0.443 HG21 HD11 ' D' ' 82' ' ' ILE . 0.2 OUTLIER -120.6 -179.87 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.243 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -176.57 145.49 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 80.2 t -112.69 117.58 55.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.979 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -138.31 112.57 8.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.543 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . 0.468 HD11 ' CD2' ' C' ' 47' ' ' PHE . 1.9 pt? -173.22 175.71 3.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.299 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 55.66 89.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.037 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 5.4 mttt . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.75 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.845 0.355 . . . . 0.0 111.195 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.32 85.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.66 ' CE2' ' CD1' ' B' ' 42' ' ' LEU . 16.7 t80 -127.35 110.22 12.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.967 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.05 117.47 34.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.723 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.539 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 1.1 p30 -129.45 67.97 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.047 0.451 . . . . 0.0 110.578 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 52.9 t -90.41 117.54 29.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.578 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.511 ' OH ' ' CE1' ' B' ' 29' ' ' TYR . 0.0 OUTLIER -119.98 132.59 55.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.252 0.549 . . . . 0.0 110.948 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.455 ' CG1' ' CG2' ' B' ' 30' ' ' VAL . 5.5 m -142.51 165.53 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.356 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 p 77.47 -166.47 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.394 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.77 -164.31 28.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.91 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.493 ' HB2' ' CD2' ' B' ' 33' ' ' PHE . 0.0 OUTLIER -130.85 -157.51 0.83 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.739 0.304 . . . . 0.0 110.76 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.429 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -175.15 -60.33 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.85 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 12' ' ' HIS . 34.0 Cg_endo -64.0 -22.94 68.01 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.326 2.017 . . . . 0.0 112.127 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.7 m 69.83 -64.34 0.35 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.226 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.59 127.24 32.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.036 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.1 138.81 4.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.197 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -139.37 137.73 35.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.004 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.3 t -115.3 125.72 72.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.957 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.61 132.42 55.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.044 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.443 ' CD1' ' CD1' ' A' ' 3' ' ' PHE . 1.8 mt -170.44 35.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.695 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 tt -100.95 -61.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.7 mttm . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.915 -179.925 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.875 0.369 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.416 ' HB3' ' CB ' ' C' ' 46' ' ' ASN . 31.8 t-20 65.36 -89.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.381 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.545 ' CE2' ' HG ' ' C' ' 64' ' ' LEU . 9.2 t80 -125.59 105.31 8.93 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.73 0.3 . . . . 0.0 111.013 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mp -116.2 90.34 3.31 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.444 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.478 ' HB2' ' CE1' ' B' ' 25' ' ' PHE . 7.0 t-20 -96.88 110.75 23.19 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.904 0.383 . . . . 0.0 110.751 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 4.1 m -112.04 142.46 44.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.114 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.511 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 0.7 OUTLIER -148.71 102.91 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.551 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.455 ' CG2' ' CG1' ' A' ' 8' ' ' VAL . 19.5 m -127.51 135.95 61.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.425 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 76.46 87.66 0.08 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.838 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.63 -173.91 0.49 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.571 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . 0.493 ' CD2' ' HB2' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -163.33 -173.56 3.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 0.0 110.928 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 39.4 m-70 -59.44 162.21 8.86 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.743 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.98 111.92 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.604 2.203 . . . . 0.0 112.639 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.403 ' HB2' ' CE1' ' B' ' 33' ' ' PHE . 12.7 m -133.2 159.87 38.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.724 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -107.36 105.56 15.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.423 HD12 HG21 ' B' ' 38' ' ' ILE . 0.8 OUTLIER -120.09 118.89 58.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.661 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -131.27 139.15 49.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.884 0.373 . . . . 0.0 111.118 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.11 119.08 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.956 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -122.75 105.1 9.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.765 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.66 ' CD1' ' CE2' ' A' ' 3' ' ' PHE . 0.3 OUTLIER -133.82 176.79 8.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.052 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tp -135.91 -48.86 0.68 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.784 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.98 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 29.8 p . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.825 0.345 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' ASN . . . . . 0.416 ' CB ' ' HB3' ' B' ' 24' ' ' ASN . 73.9 m-20 58.76 62.89 1.79 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.471 ' CE2' HD13 ' D' ' 86' ' ' LEU . 6.1 t80 -105.36 120.09 40.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.52 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 43.4 tp -125.57 109.64 12.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.94 0.4 . . . . 0.0 111.264 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' ASN . . . . . 0.441 ' HB3' ' CE1' ' C' ' 47' ' ' PHE . 1.5 p30 -128.37 102.51 6.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.116 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 13.8 p -116.69 134.35 54.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.372 . . . . 0.0 111.653 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.443 ' CZ ' ' HA ' ' D' ' 73' ' ' TYR . 27.9 p90 -136.96 125.69 23.93 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.771 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . 0.437 ' O ' ' CG2' ' C' ' 52' ' ' VAL . 1.7 m -132.41 122.77 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.068 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' C' ' 52' ' ' VAL . 0.4 OUTLIER 165.35 -83.55 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.24 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 180.0 -37.64 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.161 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . 0.409 ' O ' ' HG2' ' D' ' 79' ' ' PRO . 2.0 m-85 65.49 127.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.719 0.295 . . . . 0.0 111.43 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' HIS . . . . . 0.545 ' HB3' ' HD3' ' C' ' 57' ' ' PRO . 2.7 t60 177.82 -50.66 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.039 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' C' ' 56' ' ' HIS . 73.4 Cg_endo -92.3 -54.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.763 2.309 . . . . 0.0 113.245 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -53.02 158.24 1.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.215 0.531 . . . . 0.0 111.743 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -140.1 100.52 3.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.474 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' ILE . . . . . 0.429 ' HB ' ' CB ' ' D' ' 83' ' ' GLU . 18.9 mt -115.28 144.1 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.388 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -136.12 83.81 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.077 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -85.93 119.56 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.273 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' D' ' 85' ' ' ASP . 6.6 p-10 -118.34 125.07 49.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 111.196 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' LEU . . . . . 0.545 ' HG ' ' CE2' ' B' ' 25' ' ' PHE . 0.7 OUTLIER -117.13 131.86 56.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.834 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . 0.42 ' CD2' ' N ' ' C' ' 65' ' ' LEU . 2.4 mm? 60.36 -179.25 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.938 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.89 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.841 0.353 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 p30 54.55 17.97 1.83 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.703 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 69' ' ' PHE . . . . . 0.488 ' CZ ' ' HB2' ' D' ' 71' ' ' ASN . 62.1 t80 -137.98 92.91 2.71 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.777 0.323 . . . . 0.0 110.849 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.17 93.71 5.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.715 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 71' ' ' ASN . . . . . 0.488 ' HB2' ' CZ ' ' D' ' 69' ' ' PHE . 11.5 t-20 -99.67 105.86 17.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.072 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 6.6 t -81.92 68.82 8.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.558 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 73' ' ' TYR . . . . . 0.443 ' HA ' ' CZ ' ' C' ' 51' ' ' TYR . 0.1 OUTLIER -73.53 79.23 1.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.622 -179.545 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . 0.432 ' CG2' ' CG1' ' C' ' 52' ' ' VAL . 0.1 OUTLIER -122.35 83.82 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.943 0.401 . . . . 0.0 110.935 179.493 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.38 -68.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.672 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.12 -52.6 0.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.318 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.82 94.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.412 . . . . 0.0 111.345 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 78' ' ' HIS . . . . . 0.499 ' CB ' ' HD3' ' D' ' 79' ' ' PRO . 0.2 OUTLIER -164.79 -56.59 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.498 179.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 79' ' ' PRO . . . . . 0.499 ' HD3' ' CB ' ' D' ' 78' ' ' HIS . 73.7 Cg_endo -96.4 -164.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.234 2.623 . . . . 0.0 111.57 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 80' ' ' SER . . . . . 0.416 ' OG ' ' N ' ' D' ' 81' ' ' ASP . 1.4 t 55.9 176.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.587 0.232 . . . . 0.0 110.527 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 81' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' D' ' 82' ' ' ILE . 1.6 t0 -85.17 104.26 14.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.321 . . . . 0.0 111.083 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 82' ' ' ILE . . . . . 0.536 ' O ' ' CB ' ' D' ' 83' ' ' GLU . 48.6 mm -2.4 -67.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 83' ' ' GLU . . . . . 0.536 ' CB ' ' O ' ' D' ' 82' ' ' ILE . 0.0 OUTLIER 98.26 -29.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.053 0.541 . . . . 0.0 110.926 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 84' ' ' VAL . . . . . 0.424 ' O ' HG22 ' D' ' 82' ' ' ILE . 59.7 t -111.99 118.63 58.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.864 0.364 . . . . 0.0 111.754 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 85' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' C' ' 63' ' ' ASP . 2.0 m-20 -153.18 123.18 6.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.543 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . 0.471 HD13 ' CE2' ' C' ' 47' ' ' PHE . 0.0 OUTLIER -134.43 175.4 9.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.041 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pp -39.04 107.62 0.07 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.794 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.923 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.6 p30 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.828 0.347 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.737 ' CE2' HD12 ' B' ' 42' ' ' LEU . 4.3 t80 -94.74 139.75 30.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.026 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.6 HD12 HD13 ' B' ' 26' ' ' LEU . 0.2 OUTLIER -132.53 77.58 1.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.963 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' B' ' 27' ' ' ASN . 58.9 t30 -67.24 104.65 1.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.527 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.8 p -117.0 154.12 31.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.181 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.519 ' CE2' ' CE1' ' B' ' 29' ' ' TYR . 7.3 t80 179.06 115.19 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.802 HG23 ' CG1' ' B' ' 30' ' ' VAL . 7.7 p -126.88 96.5 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.978 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.1 t 56.72 168.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.993 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.39 -125.15 8.39 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.612 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . 88.1 t80 63.61 137.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.935 0.398 . . . . 0.0 110.967 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.404 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 23.7 m-70 -89.21 152.0 47.35 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.921 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.72 97.42 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.529 2.153 . . . . 0.0 112.324 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 t -176.25 -175.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.402 ' C ' HG23 ' A' ' 16' ' ' ILE . 58.0 t0 -109.21 88.03 2.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.736 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.402 HG23 ' C ' ' A' ' 15' ' ' ASP . 48.8 pt -157.55 -174.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.95 0.405 . . . . 0.0 111.491 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.673 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.3 mm-40 163.53 -81.34 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.554 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 17' ' ' GLU . 0.9 OUTLIER 167.66 120.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.428 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -138.03 141.54 40.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.052 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.495 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.735 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.718 0.294 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.836 ' CZ ' HD13 ' C' ' 64' ' ' LEU . 0.2 OUTLIER -144.95 130.61 18.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.769 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.692 HD12 ' C ' ' B' ' 25' ' ' PHE . 5.4 mp -129.89 117.71 20.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.075 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.494 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 1.7 t30 -105.47 88.66 2.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.645 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 34.3 t -96.24 108.67 21.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.956 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.519 ' CE1' ' CE2' ' A' ' 7' ' ' TYR . 4.3 t80 -135.48 127.13 29.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.71 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.802 ' CG1' HG23 ' A' ' 8' ' ' VAL . 7.6 p -142.64 154.46 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.983 0.42 . . . . 0.0 111.423 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' SER . . . . . 0.43 ' N ' HG22 ' B' ' 30' ' ' VAL . 4.2 t 74.41 158.16 0.2 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.156 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.49 -168.0 12.77 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.444 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' PHE . . . . . 0.694 ' HZ ' HD11 ' B' ' 38' ' ' ILE . 43.9 p90 -179.42 -175.75 0.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.862 0.363 . . . . 0.0 110.986 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.442 ' HB3' ' HD2' ' B' ' 35' ' ' PRO . 7.5 m-70 -59.72 165.66 4.17 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' B' ' 34' ' ' HIS . 65.7 Cg_exo -51.85 154.9 9.0 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.462 2.108 . . . . 0.0 112.448 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 8.6 p -178.37 -179.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.747 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.27 96.8 5.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.968 0.413 . . . . 0.0 111.351 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.694 HD11 ' HZ ' ' B' ' 33' ' ' PHE . 46.2 mt -97.73 112.13 29.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.423 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.8 tt0 -113.8 109.31 18.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.841 0.353 . . . . 0.0 111.777 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.66 124.41 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.577 ' C ' HD13 ' B' ' 42' ' ' LEU . 9.2 t70 -140.38 121.78 15.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.874 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.737 HD12 ' CE2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -119.22 113.35 20.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' C' ' 65' ' ' LEU . 0.3 OUTLIER -134.06 85.7 2.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.955 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.417 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 3.2 mtpm? . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.896 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.899 0.381 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 60.45 67.66 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.76 ' CE2' HD11 ' D' ' 86' ' ' LEU . 9.9 t80 -91.95 104.8 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.728 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.16 101.81 9.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 49' ' ' ASN . . . . . 0.488 ' HB2' ' CE1' ' C' ' 47' ' ' PHE . 28.8 t-20 -116.67 115.82 26.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.497 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 p -126.73 127.93 45.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.175 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.453 ' HB3' ' CD1' ' D' ' 73' ' ' TYR . 55.9 t80 -135.7 123.09 21.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 52' ' ' VAL . . . . . 0.572 ' HB ' HG23 ' B' ' 30' ' ' VAL . 22.0 t -115.13 130.58 69.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.244 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 53' ' ' SER . . . . . 0.407 ' O ' ' CZ ' ' C' ' 51' ' ' TYR . 4.8 m 70.35 133.68 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.894 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.02 -177.3 19.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.626 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' PHE . . . . . 0.404 ' HZ ' HD12 ' C' ' 60' ' ' ILE . 3.3 p90 -152.26 171.8 17.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.915 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 56' ' ' HIS . . . . . 0.406 ' CB ' ' HD3' ' C' ' 57' ' ' PRO . 0.5 OUTLIER -91.24 -55.09 0.27 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.21 -179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 57' ' ' PRO . . . . . 0.406 ' HD3' ' CB ' ' C' ' 56' ' ' HIS . 90.0 Cg_endo -86.74 -165.35 0.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.631 2.221 . . . . 0.0 112.616 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 78.14 149.24 0.1 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.218 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.403 ' CB ' ' HB2' ' D' ' 81' ' ' ASP . 7.9 m-20 -123.01 121.07 35.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.818 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.972 HD11 HG22 ' D' ' 82' ' ' ILE . 0.1 OUTLIER -126.87 110.62 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.978 0.418 . . . . 0.0 111.309 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -106.3 92.89 4.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.734 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.817 HG12 HD21 ' C' ' 64' ' ' LEU . 44.6 t -90.27 123.37 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.844 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 63' ' ' ASP . . . . . 0.782 ' C ' HD23 ' C' ' 64' ' ' LEU . 4.9 m-20 -133.92 124.03 25.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.156 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 64' ' ' LEU . . . . . 0.836 HD13 ' CZ ' ' B' ' 25' ' ' PHE . 0.1 OUTLIER -136.0 120.03 17.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.505 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.872 HD13 ' N ' ' C' ' 66' ' ' LYS . 0.0 OUTLIER -55.78 -20.66 15.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.652 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 66' ' ' LYS . . . . . 0.872 ' N ' HD13 ' C' ' 65' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.908 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.613 ' O ' HD13 ' D' ' 70' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.765 0.317 . . . . 0.0 111.231 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -62.16 -47.67 83.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 69' ' ' PHE . . . . . 0.725 ' CE1' HD21 ' D' ' 86' ' ' LEU . 34.8 t80 -92.1 108.82 20.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.741 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 70' ' ' LEU . . . . . 0.675 HD12 ' O ' ' D' ' 69' ' ' PHE . 5.1 mp -130.14 78.8 1.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.031 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 71' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -92.56 47.24 1.29 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.824 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 52.7 t -46.42 96.95 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.866 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 73' ' ' TYR . . . . . 0.453 ' CD1' ' HB3' ' C' ' 51' ' ' TYR . 2.4 m-85 -120.98 131.49 54.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.469 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 74' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' C' ' 52' ' ' VAL . 9.3 m -145.45 89.18 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.984 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.02 -53.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.705 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.55 -6.14 81.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.944 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.836 ' CE2' HG21 ' D' ' 82' ' ' ILE . 0.1 OUTLIER -49.74 99.93 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.222 0.534 . . . . 0.0 111.284 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 78' ' ' HIS . . . . . 0.688 ' N ' ' HD2' ' D' ' 79' ' ' PRO . 5.9 t-80 -84.88 -32.56 0.48 Allowed Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.647 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 79' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' D' ' 78' ' ' HIS . 37.2 Cg_endo -67.7 -171.12 0.3 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.641 1.561 . . . . 0.0 112.475 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 80' ' ' SER . . . . . 0.442 ' OG ' HG23 ' D' ' 82' ' ' ILE . 0.0 OUTLIER 66.9 -176.68 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.364 -179.465 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 81' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' C' ' 59' ' ' ASP . 1.5 m-20 -100.6 79.62 2.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 0.0 110.825 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 82' ' ' ILE . . . . . 0.972 HG22 HD11 ' C' ' 60' ' ' ILE . 2.3 pp -110.34 120.29 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.286 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -146.28 131.51 18.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.094 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 64.6 t -117.88 118.65 59.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.865 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 85' ' ' ASP . . . . . 0.403 ' CB ' ' HA ' ' C' ' 63' ' ' ASP . 2.7 t0 -89.13 86.71 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 86' ' ' LEU . . . . . 0.76 HD11 ' CE2' ' C' ' 47' ' ' PHE . 0.2 OUTLIER -76.01 92.57 3.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.958 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 m120 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.784 0.326 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.739 ' CZ ' HD11 ' B' ' 42' ' ' LEU . 59.7 t80 -102.61 114.11 28.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.896 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.731 HD13 ' C ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -118.96 101.07 7.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.773 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.458 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 49.7 t30 -120.37 83.85 2.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.818 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.4 p -90.44 -179.27 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.918 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -171.52 110.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.946 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.7 p -102.91 135.78 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.7 p -43.48 96.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.968 0.413 . . . . 0.0 111.491 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.54 98.91 0.12 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.99 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' B' ' 36' ' ' SER . 2.2 t80 -111.53 -177.2 3.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.057 0.456 . . . . 0.0 111.448 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.462 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -170.51 -61.18 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.267 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 12' ' ' HIS . 18.5 Cg_endo -57.56 -162.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.392 2.062 . . . . 0.0 111.967 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.01 -65.09 1.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.762 0.315 . . . . 0.0 111.503 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -96.97 109.09 21.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.507 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.414 HG22 HG23 ' B' ' 38' ' ' ILE . 1.2 mp -126.26 143.55 39.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.559 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.432 ' CB ' ' HB3' ' B' ' 39' ' ' GLU . 0.0 OUTLIER -178.71 156.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.728 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.67 HG13 ' N ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -178.71 -171.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.625 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.67 ' N ' HG13 ' A' ' 18' ' ' VAL . 15.0 m-20 127.28 -129.98 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.348 1.059 . . . . 0.0 110.333 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.427 HD12 ' C ' ' A' ' 19' ' ' ASP . 5.1 mp . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.97 0.414 . . . . 0.0 111.173 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.794 0.33 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.863 ' CZ ' HD11 ' C' ' 64' ' ' LEU . 48.6 t80 -128.23 128.79 45.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.711 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.76 91.52 2.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.542 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.484 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 52.1 t-20 -105.52 119.04 38.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 22.3 m -114.15 109.32 18.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.321 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.425 ' CE2' ' CB ' ' B' ' 31' ' ' SER . 87.6 t80 -105.49 125.13 50.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.542 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 17.4 t -126.39 76.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.241 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' SER . . . . . 0.425 ' CB ' ' CE2' ' B' ' 29' ' ' TYR . 0.0 OUTLIER -56.36 174.0 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.64 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.48 45.12 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.261 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -148.21 -177.05 5.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.925 0.393 . . . . 0.0 111.281 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.499 ' CG ' ' HD2' ' B' ' 35' ' ' PRO . 0.0 OUTLIER -86.7 178.74 2.1 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.927 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.499 ' HD2' ' CG ' ' B' ' 34' ' ' HIS . 66.2 Cg_exo -39.44 132.59 1.55 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.745 2.297 . . . . 0.0 113.356 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' SER . . . . . 0.462 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 4.2 p -158.91 151.41 21.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.584 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -102.57 107.24 18.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 111.114 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.414 HG23 HG22 ' A' ' 16' ' ' ILE . 1.9 mp -129.81 130.8 66.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.432 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 4.5 tp10 -130.92 129.58 42.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.06 0.457 . . . . 0.0 111.329 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.471 HG13 ' OD2' ' A' ' 19' ' ' ASP . 96.1 t -125.81 114.87 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.102 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.445 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 1.7 p30 -136.19 104.37 5.63 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.739 HD11 ' CZ ' ' A' ' 3' ' ' PHE . 1.1 mm? -88.32 58.31 4.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.689 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.69 HD13 ' CB ' ' C' ' 65' ' ' LEU . 0.7 OUTLIER 171.33 -163.31 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.424 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.865 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.849 0.357 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -100.0 -57.63 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.642 ' CZ ' HD12 ' D' ' 86' ' ' LEU . 51.3 t80 -98.26 89.48 4.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.857 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.88 77.01 1.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.625 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 49' ' ' ASN . . . . . 0.494 ' ND2' HG13 ' D' ' 84' ' ' VAL . 50.4 t-20 -97.39 136.77 37.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.583 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 50' ' ' CYS . . . . . 0.401 ' HB3' ' CB ' ' D' ' 72' ' ' CYS . 6.6 p -150.69 123.03 8.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.406 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.506 ' CE2' ' CZ ' ' D' ' 77' ' ' PHE . 3.5 p90 -121.83 144.29 48.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.442 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 52' ' ' VAL . . . . . 0.491 HG22 ' N ' ' C' ' 53' ' ' SER . 12.6 p -141.31 158.81 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.931 0.396 . . . . 0.0 111.763 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 53' ' ' SER . . . . . 0.491 ' N ' HG22 ' C' ' 52' ' ' VAL . 3.8 t 82.24 -71.09 0.05 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.513 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.4 -174.03 52.55 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.49 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 55' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' C' ' 58' ' ' SER . 0.1 OUTLIER -173.97 -177.51 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.346 . . . . 0.0 111.058 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 56' ' ' HIS . . . . . 0.711 ' HB3' ' HD3' ' C' ' 57' ' ' PRO . 6.0 t-80 -109.67 -56.42 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.816 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 57' ' ' PRO . . . . . 0.711 ' HD3' ' HB3' ' C' ' 56' ' ' HIS . 45.3 Cg_endo -94.64 92.1 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.708 2.272 . . . . 0.0 112.694 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 58' ' ' SER . . . . . 0.436 ' HB3' ' CE1' ' C' ' 55' ' ' PHE . 41.2 t -177.98 171.8 1.71 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.851 0.358 . . . . 0.0 111.067 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -135.44 127.38 29.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.124 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.753 HG13 HG22 ' D' ' 82' ' ' ILE . 1.4 pp -151.98 101.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.048 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.39 138.57 35.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.191 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.429 HG22 ' HB ' ' B' ' 40' ' ' VAL . 42.3 t -144.54 120.51 4.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.972 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -144.68 133.77 22.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.895 0.379 . . . . 0.0 111.276 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 64' ' ' LEU . . . . . 0.863 HD11 ' CZ ' ' B' ' 25' ' ' PHE . 0.8 OUTLIER -120.35 128.94 53.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.966 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.839 HD23 ' O ' ' C' ' 66' ' ' LYS . 4.8 tt -138.76 -42.04 0.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.27 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 66' ' ' LYS . . . . . 0.839 ' O ' HD23 ' C' ' 65' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.309 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.783 0.325 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -105.06 26.68 9.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 69' ' ' PHE . . . . . 0.566 ' CE2' ' ND2' ' D' ' 71' ' ' ASN . 7.3 t80 -106.58 86.01 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.044 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.53 93.38 8.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.676 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 71' ' ' ASN . . . . . 0.566 ' ND2' ' CE2' ' D' ' 69' ' ' PHE . 6.0 p30 -96.48 58.66 1.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.979 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 72' ' ' CYS . . . . . 0.401 ' CB ' ' HB3' ' C' ' 50' ' ' CYS . 0.6 OUTLIER -59.7 119.55 7.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.777 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 73' ' ' TYR . . . . . 0.42 ' CD2' ' O ' ' D' ' 71' ' ' ASN . 0.5 OUTLIER -128.84 136.93 51.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.06 0.457 . . . . 0.0 111.233 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 74' ' ' VAL . . . . . 0.448 HG23 ' CB ' ' C' ' 52' ' ' VAL . 0.3 OUTLIER -154.76 58.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.666 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 75' ' ' SER . . . . . 0.402 ' HB2' ' N ' ' C' ' 53' ' ' SER . 0.1 OUTLIER 171.42 176.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.495 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.96 146.36 18.34 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.652 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.506 ' CZ ' ' CE2' ' C' ' 51' ' ' TYR . 0.0 OUTLIER -163.55 75.28 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.737 0.303 . . . . 0.0 111.058 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 78' ' ' HIS . . . . . 0.475 ' HB2' ' HD3' ' D' ' 79' ' ' PRO . 5.7 m170 -69.27 -64.94 1.38 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.821 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 79' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' D' ' 78' ' ' HIS . 90.5 Cg_endo -80.25 88.82 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.469 2.112 . . . . 0.0 112.356 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 27.5 t -175.58 154.57 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 111.096 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -79.56 62.96 4.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.604 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 82' ' ' ILE . . . . . 0.753 HG22 HG13 ' C' ' 60' ' ' ILE . 0.2 OUTLIER -113.65 151.16 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.144 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -161.29 92.34 0.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.159 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 84' ' ' VAL . . . . . 0.494 HG13 ' ND2' ' C' ' 49' ' ' ASN . 84.2 t -105.85 117.75 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.603 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.58 -175.99 1.21 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 0.0 111.18 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 86' ' ' LEU . . . . . 0.642 HD12 ' CZ ' ' C' ' 47' ' ' PHE . 0.0 OUTLIER -174.23 -172.17 0.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.642 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.605 ' O ' HD23 ' D' ' 87' ' ' LEU . 8.8 tt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.011 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.2 t30 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.837 0.351 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.866 ' CD1' HD22 ' A' ' 20' ' ' LEU . 49.1 t80 -165.08 125.48 1.93 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.01 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 3' ' ' PHE . 11.2 mt -130.15 92.15 3.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.041 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.471 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 0.5 OUTLIER -111.56 82.43 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.597 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.4 p -93.17 128.09 38.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.026 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.536 ' CD2' ' CE2' ' B' ' 33' ' ' PHE . 1.5 t80 -113.68 158.78 20.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.727 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.625 HG23 ' HB ' ' B' ' 30' ' ' VAL . 9.3 p -177.1 106.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.564 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.4 t 34.24 98.55 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.542 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.2 123.23 0.7 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.758 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.74 ' CE1' HD11 ' B' ' 38' ' ' ILE . 91.5 t80 -179.55 162.98 1.16 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.783 0.325 . . . . 0.0 111.092 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.476 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -164.02 -65.96 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.008 179.81 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.788 ' HG2' HD11 ' A' ' 16' ' ' ILE . 43.9 Cg_endo -67.13 115.38 3.61 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.392 2.062 . . . . 0.0 112.04 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.3 m -38.7 -55.67 1.43 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.266 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.39 123.31 30.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.906 0.384 . . . . 0.0 111.267 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.788 HD11 ' HG2' ' A' ' 13' ' ' PRO . 16.9 mm -147.6 133.96 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.917 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -147.04 142.36 27.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.867 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.665 ' HB ' HG13 ' B' ' 40' ' ' VAL . 19.2 t -109.33 159.6 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.49 ' N ' HG12 ' A' ' 18' ' ' VAL . 2.3 t0 -146.74 143.46 28.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.866 HD22 ' CD1' ' A' ' 3' ' ' PHE . 60.4 tp . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.747 0.308 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.713 ' CZ ' HD13 ' C' ' 64' ' ' LEU . 84.4 t80 -100.91 110.73 22.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.733 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.402 ' HA ' ' HB3' ' C' ' 48' ' ' LEU . 0.6 OUTLIER -119.04 93.65 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.928 0.394 . . . . 0.0 111.057 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' C' ' 49' ' ' ASN . 32.3 t-20 -127.25 140.55 52.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.796 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' C' ' 50' ' ' CYS . 5.7 p 177.85 161.89 0.57 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.167 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.551 ' CE2' ' CG ' ' C' ' 51' ' ' TYR . 0.9 OUTLIER -129.68 152.79 48.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.125 0.488 . . . . 0.0 111.514 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.625 ' HB ' HG23 ' A' ' 8' ' ' VAL . 24.3 t -121.28 102.64 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.735 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 40.25 -165.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.125 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.24 49.57 8.09 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.978 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' PHE . . . . . 0.536 ' CE2' ' CD2' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -120.41 70.75 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.96 0.409 . . . . 0.0 111.507 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.738 ' N ' ' HD3' ' B' ' 35' ' ' PRO . 0.3 OUTLIER -111.93 18.71 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.738 ' HD3' ' N ' ' B' ' 34' ' ' HIS . 50.3 Cg_exo -53.53 -163.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 121.9 1.734 . . . . 0.0 113.124 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 9.9 t -107.69 -72.73 0.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.731 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ASP . . . . . 0.592 ' C ' HD12 ' B' ' 38' ' ' ILE . 14.4 t70 -130.97 113.87 14.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.369 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.74 HD11 ' CE1' ' A' ' 11' ' ' PHE . 1.7 mp -126.33 139.55 51.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.876 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -146.08 156.47 43.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.812 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.665 HG13 ' HB ' ' A' ' 18' ' ' VAL . 21.7 t -134.23 127.63 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -121.15 99.71 6.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.238 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.689 HD22 ' N ' ' B' ' 42' ' ' LEU . 0.9 OUTLIER -97.96 107.55 20.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.57 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.615 HD23 ' N ' ' B' ' 43' ' ' LEU . 1.8 pt? 178.17 -46.63 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.802 0.335 . . . . 0.0 111.218 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.455 ' N ' ' HG ' ' B' ' 43' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.766 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.801 0.334 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -57.57 98.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.958 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.568 ' HE1' HD11 ' C' ' 64' ' ' LEU . 47.6 t80 -102.74 113.46 26.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.548 ' CD2' HD12 ' D' ' 70' ' ' LEU . 0.1 OUTLIER -121.36 86.06 2.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.777 179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 49' ' ' ASN . . . . . 0.483 ' CB ' ' CZ ' ' C' ' 47' ' ' PHE . 5.3 t30 -126.32 83.16 2.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.31 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 50' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' B' ' 28' ' ' CYS . 1.7 p -134.19 -170.97 2.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.277 0.561 . . . . 0.0 112.013 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.551 ' CG ' ' CE2' ' B' ' 29' ' ' TYR . 3.8 p90 -167.48 176.19 6.71 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.611 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 52' ' ' VAL . . . . . 0.58 HG12 ' HB ' ' D' ' 74' ' ' VAL . 15.1 m -136.62 146.69 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.842 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 53' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' C' ' 52' ' ' VAL . 5.1 t 99.67 -172.31 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.228 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.07 -16.76 68.86 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.841 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' PHE . . . . . 0.53 ' CE1' ' CE2' ' B' ' 29' ' ' TYR . 38.4 t80 64.46 120.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.748 0.308 . . . . 0.0 110.89 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 56' ' ' HIS . . . . . 0.421 ' CB ' ' HB3' ' B' ' 34' ' ' HIS . 7.9 m80 -76.72 162.36 70.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.931 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.67 112.0 1.01 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.568 2.179 . . . . 0.0 112.244 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 10.0 t -164.48 159.36 19.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.787 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -100.18 125.8 46.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.008 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.433 HD11 ' HA ' ' D' ' 82' ' ' ILE . 1.6 pp -126.04 116.24 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -110.74 85.97 2.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.036 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.696 HG12 HD21 ' C' ' 64' ' ' LEU . 49.0 t -80.81 120.83 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.878 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 63' ' ' ASP . . . . . 0.758 ' C ' HD23 ' C' ' 64' ' ' LEU . 1.2 m-20 -143.17 117.82 9.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.017 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 64' ' ' LEU . . . . . 0.758 HD23 ' C ' ' C' ' 63' ' ' ASP . 0.1 OUTLIER -137.28 119.76 15.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.641 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.41 HD23 ' N ' ' C' ' 65' ' ' LEU . 2.6 pt? -163.2 -167.0 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.967 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.096 179.826 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.815 0.341 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -154.65 -43.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.153 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 69' ' ' PHE . . . . . 0.423 ' CZ ' ' HB2' ' D' ' 71' ' ' ASN . 21.6 t80 -93.64 142.51 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.043 0.449 . . . . 0.0 111.247 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 70' ' ' LEU . . . . . 0.776 HD22 ' CE2' ' D' ' 73' ' ' TYR . 32.2 mt -159.19 120.49 3.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.969 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 71' ' ' ASN . . . . . 0.631 ' O ' ' N ' ' D' ' 73' ' ' TYR . 4.2 t30 -139.43 173.56 11.42 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 72' ' ' CYS . . . . . 0.443 ' O ' ' HB2' ' C' ' 50' ' ' CYS . 0.5 OUTLIER 37.34 -79.08 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.399 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 73' ' ' TYR . . . . . 0.776 ' CE2' HD22 ' D' ' 70' ' ' LEU . 0.3 OUTLIER 74.83 -87.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 178.279 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 74' ' ' VAL . . . . . 0.58 ' HB ' HG12 ' C' ' 52' ' ' VAL . 41.1 t -101.94 50.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.108 0.48 . . . . 0.0 111.064 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 75' ' ' SER . . . . . 0.481 ' HA ' ' CZ ' ' C' ' 51' ' ' TYR . 3.3 m -92.86 -160.59 0.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.033 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.93 -4.54 0.64 Allowed Glycine 0 CA--C 1.522 0.492 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.226 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.428 ' CE2' ' CE2' ' C' ' 51' ' ' TYR . 0.1 OUTLIER -47.27 171.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 117.05 0.425 . . . . 0.0 111.384 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 78' ' ' HIS . . . . . 0.54 ' CB ' ' HD3' ' D' ' 79' ' ' PRO . 0.0 OUTLIER -115.94 -65.44 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 79' ' ' PRO . . . . . 0.54 ' HD3' ' CB ' ' D' ' 78' ' ' HIS . 60.9 Cg_endo -85.41 -105.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.359 2.039 . . . . 0.0 112.109 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 21.6 t 52.28 175.49 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.964 0.412 . . . . 0.0 111.408 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -120.71 73.06 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.652 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 82' ' ' ILE . . . . . 0.609 HG23 ' O ' ' D' ' 82' ' ' ILE . 0.0 OUTLIER -74.29 108.43 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.199 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.89 106.17 7.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.628 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 21.1 t -123.72 131.04 73.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.379 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -136.34 107.17 6.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.518 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 86' ' ' LEU . . . . . 0.666 ' N ' HD22 ' D' ' 86' ' ' LEU . 0.2 OUTLIER -106.08 134.59 48.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.074 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.4 ' HB2' ' HB3' ' C' ' 65' ' ' LEU . 2.7 mm? . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.695 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 3' ' ' PHE . 1.2 m-20 . . . . . 0 N--CA 1.46 0.046 0 CA-C-O 120.572 0.225 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.757 ' CZ ' HD11 ' B' ' 42' ' ' LEU . 0.0 OUTLIER 87.03 177.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.901 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.458 ' N ' ' CG ' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -156.4 128.44 7.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 111.119 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -104.8 109.11 20.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.667 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -91.7 125.73 36.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.187 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.402 ' CE2' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -140.59 122.71 15.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.726 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.524 HG12 HG22 ' B' ' 30' ' ' VAL . 9.5 m -149.09 137.24 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.234 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t 71.95 -67.97 0.24 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.38 -150.2 20.39 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.834 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.414 ' CE2' ' O ' ' A' ' 12' ' ' HIS . 6.2 p90 -173.88 -166.09 0.28 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.811 0.339 . . . . 0.0 110.919 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.414 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 19.9 m80 -67.14 154.36 92.81 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.47 120.28 7.54 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.615 2.21 . . . . 0.0 112.2 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.0 p -169.83 -166.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.809 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.76 101.46 7.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.938 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.466 HG23 ' HA ' ' B' ' 38' ' ' ILE . 16.5 tt -87.84 140.72 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -144.32 162.73 35.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.941 0.4 . . . . 0.0 111.153 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.19 131.59 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.901 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -129.78 121.9 27.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.045 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.926 179.814 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.869 0.366 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.709 ' CE2' HD22 ' B' ' 42' ' ' LEU . 63.0 t80 -116.95 121.3 41.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.644 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.709 ' CD1' HD12 ' C' ' 48' ' ' LEU . 0.3 OUTLIER -133.75 98.03 4.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.2 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.511 ' OD1' HG13 ' C' ' 62' ' ' VAL . 0.5 OUTLIER -107.36 83.97 1.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.592 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 12.6 p -106.06 133.18 51.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.173 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.444 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 0.0 OUTLIER -150.41 114.77 5.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.563 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.746 HG12 ' CG2' ' C' ' 52' ' ' VAL . 34.6 m -121.99 131.1 73.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.077 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 22.6 m 64.43 102.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.654 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.448 ' HA3' ' CD2' ' C' ' 55' ' ' PHE . . . -59.39 -116.71 0.01 OUTLIER Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.782 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' PHE . . . . . 0.571 ' CZ ' HD11 ' B' ' 38' ' ' ILE . 0.0 OUTLIER 179.15 -100.18 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.396 0.141 . . . . 0.0 110.787 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.494 ' CG ' ' HD2' ' B' ' 35' ' ' PRO . 0.0 OUTLIER -138.16 179.34 1.35 Allowed Pre-proline 0 N--CA 1.455 -0.19 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.494 ' HD2' ' CG ' ' B' ' 34' ' ' HIS . 99.7 Cg_exo -44.84 88.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.587 2.191 . . . . 0.0 112.566 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' SER . . . . . 0.446 ' N ' ' O ' ' B' ' 34' ' ' HIS . 3.3 m -136.24 159.0 43.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.272 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -113.88 111.1 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.816 0.341 . . . . 0.0 111.221 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.571 HD11 ' CZ ' ' B' ' 33' ' ' PHE . 32.9 mt -99.06 94.74 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.749 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -101.99 88.46 3.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.266 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.405 HG23 HG22 ' B' ' 38' ' ' ILE . 95.3 t -91.65 114.92 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.539 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -127.13 112.28 14.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.0 111.492 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.757 HD11 ' CZ ' ' A' ' 3' ' ' PHE . 1.2 mp -102.35 116.62 33.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.111 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.418 HD22 ' H ' ' B' ' 44' ' ' LYS . 0.5 OUTLIER 76.52 -154.18 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.005 -179.3 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.418 ' H ' HD22 ' B' ' 43' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.785 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.764 0.316 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.7 -73.65 0.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.944 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.903 ' O ' HD23 ' C' ' 48' ' ' LEU . 15.3 t80 -137.28 128.45 27.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.996 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.903 HD23 ' O ' ' C' ' 47' ' ' PHE . 6.0 mt -135.35 112.02 10.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.77 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 49' ' ' ASN . . . . . 0.497 ' HB2' ' CE1' ' C' ' 47' ' ' PHE . 38.2 t30 -113.76 139.29 49.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.96 0.409 . . . . 0.0 111.034 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.46 109.21 7.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.594 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.619 ' CZ ' HG21 ' D' ' 82' ' ' ILE . 1.2 t80 -121.24 94.06 4.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.179 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 52' ' ' VAL . . . . . 0.746 ' CG2' HG12 ' B' ' 30' ' ' VAL . 45.9 t -97.59 109.27 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.594 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 53' ' ' SER . . . . . 0.509 ' CB ' ' HB2' ' D' ' 75' ' ' SER . 0.7 OUTLIER -55.7 -175.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.349 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.48 58.73 0.68 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.033 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' PHE . . . . . 0.687 ' CE2' HD11 ' C' ' 60' ' ' ILE . 1.3 p90 -171.74 33.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.32 0.105 . . . . 0.0 110.754 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 56' ' ' HIS . . . . . 0.546 ' CD2' ' HD3' ' C' ' 57' ' ' PRO . 0.0 OUTLIER 12.42 -76.45 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.711 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.231 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 57' ' ' PRO . . . . . 0.546 ' HD3' ' CD2' ' C' ' 56' ' ' HIS . 73.1 Cg_endo -72.45 -162.95 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.233 1.955 . . . . 0.0 112.781 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 79.22 155.52 0.15 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.808 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.496 ' C ' HD12 ' C' ' 60' ' ' ILE . 7.8 t0 -129.17 145.62 51.28 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.588 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.79 HD13 ' CG2' ' D' ' 82' ' ' ILE . 2.1 mp -131.05 112.81 22.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.324 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -114.38 80.71 1.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.739 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.644 HG23 HG22 ' C' ' 60' ' ' ILE . 42.1 t -91.93 121.89 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.139 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -151.45 126.98 10.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 64' ' ' LEU . . . . . 0.727 ' N ' HD13 ' C' ' 64' ' ' LEU . 0.0 OUTLIER -135.26 144.67 46.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.942 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 4.9 mt -97.94 102.75 14.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.924 179.991 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 19.1 p . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.863 0.363 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -68.54 97.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -124.05 113.81 18.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.79 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 70' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' D' ' 70' ' ' LEU . 5.3 tp -122.72 99.65 6.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.793 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 71' ' ' ASN . . . . . 0.415 ' O ' ' CD1' ' D' ' 73' ' ' TYR . 12.7 p-10 -93.89 52.66 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 90.5 m -58.86 123.27 15.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.594 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 73' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' D' ' 71' ' ' ASN . 0.1 OUTLIER -174.58 135.16 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.295 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 74' ' ' VAL . . . . . 0.589 ' O ' ' CB ' ' D' ' 75' ' ' SER . 12.6 p -178.73 160.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.212 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 75' ' ' SER . . . . . 0.589 ' CB ' ' O ' ' D' ' 74' ' ' VAL . 73.7 m 118.18 179.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.872 0.869 . . . . 0.0 110.627 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.51 152.87 20.29 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.44 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.486 ' HD1' ' HG ' ' D' ' 80' ' ' SER . 38.4 p90 -161.76 -31.5 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.47 0.176 . . . . 0.0 111.162 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 78' ' ' HIS . . . . . 0.673 ' CB ' ' CD ' ' D' ' 79' ' ' PRO . 17.9 m170 34.67 -90.18 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 79' ' ' PRO . . . . . 0.673 ' CD ' ' CB ' ' D' ' 78' ' ' HIS . 58.2 Cg_endo -69.37 58.07 1.34 Allowed 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.646 1.564 . . . . 0.0 113.007 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 80' ' ' SER . . . . . 0.486 ' HG ' ' HD1' ' D' ' 77' ' ' PHE . 3.7 p -135.84 155.73 49.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.525 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -110.49 100.07 8.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.797 0.332 . . . . 0.0 111.244 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 82' ' ' ILE . . . . . 0.79 ' CG2' HD13 ' C' ' 60' ' ' ILE . 1.3 pp -122.73 143.87 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.283 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -158.27 124.21 4.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.737 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 84' ' ' VAL . . . . . 0.754 ' CG1' HD11 ' D' ' 86' ' ' LEU . 21.9 t -112.58 132.17 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.341 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 85' ' ' ASP . . . . . 0.528 ' C ' HD13 ' D' ' 86' ' ' LEU . 3.5 m-20 -128.55 105.59 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.82 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 86' ' ' LEU . . . . . 0.793 HD12 ' CZ ' ' C' ' 47' ' ' PHE . 0.0 OUTLIER -107.76 100.23 9.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 55.6 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.943 179.879 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.439 ' OD1' HD11 ' A' ' 4' ' ' LEU . 7.5 p30 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.937 0.398 . . . . 0.0 111.685 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.917 ' CZ ' HD12 ' B' ' 42' ' ' LEU . 0.5 OUTLIER -76.95 106.2 8.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.506 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.439 HD11 ' OD1' ' A' ' 2' ' ' ASN . 0.5 OUTLIER -97.92 68.07 1.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.542 179.53 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.506 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 6.0 p30 -67.92 -177.48 0.82 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.429 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' B' ' 28' ' ' CYS . 2.8 m 64.92 -167.62 0.22 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.302 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -146.66 151.95 38.08 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.808 0.337 . . . . 0.0 111.402 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 8' ' ' VAL . 7.1 p -95.53 83.24 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.879 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.3 p 61.77 117.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.087 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.98 130.89 5.79 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.641 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.663 ' CE2' HD12 ' A' ' 16' ' ' ILE . 33.7 t80 -179.99 148.87 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.919 0.39 . . . . 0.0 111.035 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.428 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 18.6 p80 -82.37 157.36 67.95 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.792 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 14' ' ' SER . 19.3 Cg_endo -58.76 -159.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.758 2.305 . . . . 0.0 112.556 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER 73.37 -95.9 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.427 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' B' ' 37' ' ' ASP . 0.1 OUTLIER -177.83 160.61 1.52 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.013 0.435 . . . . 0.0 111.408 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.663 HD12 ' CE2' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -96.16 117.42 40.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.681 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 7.0 pt-20 -107.48 115.0 29.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.962 0.41 . . . . 0.0 110.723 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.7 t -150.71 137.17 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -149.51 126.78 11.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.87 0.367 . . . . 0.0 111.326 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' B' ' 43' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.656 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.696 0.284 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.87 ' CE1' HD11 ' C' ' 64' ' ' LEU . 60.4 t80 -103.66 123.41 46.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.243 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.74 HD12 ' C ' ' B' ' 25' ' ' PHE . 7.2 mp -124.45 122.25 37.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.671 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.521 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 0.8 OUTLIER -126.91 114.99 18.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.531 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 6' ' ' CYS . 2.2 t -116.73 102.2 9.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.356 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.48 ' CE2' HG21 ' C' ' 60' ' ' ILE . 3.9 t80 -125.78 88.84 2.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.546 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -103.38 132.68 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.136 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 15.5 t 65.35 151.69 0.05 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.166 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.16 -139.24 8.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.516 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' PHE . . . . . 0.608 ' CZ ' HD11 ' B' ' 38' ' ' ILE . 0.0 OUTLIER -179.66 -106.65 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 O-C-N 123.008 -0.113 . . . . 0.0 111.149 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.513 ' CB ' ' CD ' ' B' ' 35' ' ' PRO . 0.1 OUTLIER -123.34 -176.7 0.46 Allowed Pre-proline 0 CA--C 1.528 0.106 0 CA-C-O 120.579 0.228 . . . . 0.0 110.589 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' B' ' 34' ' ' HIS . 24.1 Cg_exo -64.26 -0.92 3.19 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.714 2.276 . . . . 0.0 113.092 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.1 t -41.99 160.18 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.935 0.397 . . . . 0.0 111.432 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 7.6 t0 -103.0 143.64 32.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.716 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.608 HD11 ' CZ ' ' B' ' 33' ' ' PHE . 26.4 mm -119.27 123.03 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.213 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -123.28 87.26 2.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.518 HG23 HG22 ' B' ' 38' ' ' ILE . 50.2 t -100.21 119.07 47.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.135 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.779 ' C ' HD13 ' B' ' 42' ' ' LEU . 0.3 OUTLIER -131.7 122.84 26.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.28 179.412 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.917 HD12 ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -120.2 145.88 46.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.062 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.677 HD12 HD13 ' C' ' 65' ' ' LEU . 0.1 OUTLIER 56.6 21.92 6.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.319 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 30.8 tttt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.914 179.895 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.839 0.352 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 66.06 120.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.994 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.909 ' CZ ' HD12 ' D' ' 86' ' ' LEU . 1.7 t80 -108.41 103.35 12.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.641 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.494 HD11 HD23 ' D' ' 70' ' ' LEU . 1.6 mp -107.06 110.13 22.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.862 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 49' ' ' ASN . . . . . 0.424 ' HA ' ' HB3' ' B' ' 27' ' ' ASN . 22.5 t-20 -122.14 97.9 5.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.082 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 13.9 m -109.84 116.96 32.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.689 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.476 ' OH ' ' CD1' ' D' ' 77' ' ' PHE . 0.7 OUTLIER -139.64 149.48 43.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.965 0.412 . . . . 0.0 111.285 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 52' ' ' VAL . . . . . . . . . . . . . 31.3 t -115.53 110.87 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.588 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 11.7 m -52.96 178.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.409 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.93 48.02 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.233 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' PHE . . . . . 0.639 ' HZ ' HD12 ' C' ' 60' ' ' ILE . 0.0 OUTLIER -176.64 141.96 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.168 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 56' ' ' HIS . . . . . 0.43 ' CE1' ' HG3' ' D' ' 79' ' ' PRO . 0.2 OUTLIER -87.23 -62.08 0.24 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.276 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 57' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' C' ' 56' ' ' HIS . 72.9 Cg_endo -76.27 -163.52 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.507 2.138 . . . . 0.0 112.498 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 58' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' C' ' 57' ' ' PRO . 0.4 OUTLIER 80.36 161.89 0.17 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.325 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.06 129.17 47.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.947 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.639 HD12 ' HZ ' ' C' ' 55' ' ' PHE . 0.1 OUTLIER -114.55 96.44 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.93 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -104.28 128.09 52.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.958 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 46.5 t -142.89 120.87 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.957 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -128.44 124.63 36.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.996 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 64' ' ' LEU . . . . . 0.87 HD11 ' CE1' ' B' ' 25' ' ' PHE . 0.1 OUTLIER -98.44 106.02 18.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.677 HD13 HD12 ' B' ' 43' ' ' LEU . 28.6 tp 64.52 -76.57 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.034 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.985 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 87.4 p . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.845 0.355 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 58.54 32.32 22.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.982 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -107.72 109.63 21.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 70' ' ' LEU . . . . . 0.494 HD23 HD11 ' C' ' 48' ' ' LEU . 9.4 tp -132.45 60.02 1.7 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.778 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 71' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -80.59 78.07 7.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.856 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 19.8 t -69.75 123.72 22.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.827 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 73' ' ' TYR . . . . . 0.46 ' HB3' ' CE2' ' C' ' 51' ' ' TYR . 0.2 OUTLIER -131.09 144.85 51.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 18.7 t -121.72 153.09 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.486 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 1.1 t 67.88 -83.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.35 174.37 24.34 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.691 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.618 ' CD2' HG21 ' D' ' 82' ' ' ILE . 0.3 OUTLIER -169.45 159.44 8.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 111.011 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 78' ' ' HIS . . . . . 0.471 ' N ' ' HD2' ' D' ' 79' ' ' PRO . 6.1 t-160 -178.24 -60.76 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.148 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 79' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' D' ' 78' ' ' HIS . 9.2 Cg_endo -52.75 -34.2 63.67 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.5 2.134 . . . . 0.0 112.485 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 24.8 p -75.19 157.21 34.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.831 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.86 115.22 16.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.742 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 82' ' ' ILE . . . . . 0.618 HG21 ' CD2' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -114.01 146.53 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.977 0.418 . . . . 0.0 111.589 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.64 57.46 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 t -80.54 134.79 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 85' ' ' ASP . . . . . 0.68 ' C ' HD13 ' D' ' 86' ' ' LEU . 40.0 m-20 -149.71 137.16 19.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 86' ' ' LEU . . . . . 0.909 HD12 ' CZ ' ' C' ' 47' ' ' PHE . 0.0 OUTLIER -126.19 94.46 4.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.72 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.651 ' CD1' HD23 ' C' ' 65' ' ' LEU . 4.0 mm? . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.765 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.678 HD21 ' N ' ' B' ' 24' ' ' ASN . 28.1 t-20 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.77 0.319 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.715 ' CZ ' HD11 ' B' ' 42' ' ' LEU . 0.0 OUTLIER -165.48 -172.15 2.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.984 179.674 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.591 HD23 ' H ' ' A' ' 4' ' ' LEU . 1.5 pt? -124.45 119.08 28.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.038 0.447 . . . . 0.0 111.08 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.54 ' ND2' ' CZ ' ' A' ' 3' ' ' PHE . 0.9 OUTLIER -125.88 61.3 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.691 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' B' ' 28' ' ' CYS . 29.5 p -138.29 145.52 41.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.963 0.411 . . . . 0.0 111.472 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -150.85 131.43 13.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.805 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.634 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.0 p -100.19 99.9 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.162 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.428 ' HA ' ' HA3' ' B' ' 32' ' ' GLY . 0.9 OUTLIER 58.46 105.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.066 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.48 135.24 2.11 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.574 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.458 ' CE2' ' CB ' ' B' ' 36' ' ' SER . 5.0 t80 -158.98 93.86 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.762 0.315 . . . . 0.0 110.964 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.462 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 3.0 t-160 -81.23 -47.77 1.09 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.408 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 12' ' ' HIS . 87.7 Cg_endo -82.57 -177.5 3.45 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.469 2.112 . . . . 0.0 112.55 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -115.04 -60.45 1.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.665 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -112.09 104.45 12.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.644 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.8 pt -117.77 118.87 59.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.264 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -118.7 86.94 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.52 HG11 ' HE2' ' A' ' 3' ' ' PHE . 21.3 t -69.51 147.71 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.022 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -148.37 149.04 31.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.964 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.678 ' N ' HD21 ' A' ' 2' ' ' ASN . 50.8 t30 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.784 0.326 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.862 ' CZ ' HD11 ' C' ' 64' ' ' LEU . 77.9 t80 -101.92 122.11 43.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.92 122.28 43.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.723 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.441 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 8.8 t-20 -148.56 101.4 3.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.642 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 7.3 m -152.84 132.95 13.45 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.8 0.333 . . . . 0.0 111.753 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.535 ' CE2' ' HB2' ' C' ' 51' ' ' TYR . 0.1 OUTLIER -130.24 129.86 43.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.411 178.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.938 HG13 ' CG2' ' C' ' 52' ' ' VAL . 39.9 t -128.56 119.22 49.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.841 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 14.2 m 50.56 179.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.606 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 9' ' ' SER . . . 46.1 94.42 0.01 OUTLIER Glycine 0 C--N 1.332 0.355 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.835 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' PHE . . . . . 0.518 ' CE2' HG21 ' C' ' 60' ' ' ILE . 0.1 OUTLIER -130.08 -44.12 1.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.664 0.269 . . . . 0.0 111.214 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 63.61 137.58 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.717 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -51.53 93.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.432 2.088 . . . . 0.0 112.171 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' SER . . . . . 0.458 ' CB ' ' CE2' ' A' ' 11' ' ' PHE . 2.4 m -149.51 -167.0 2.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.034 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -141.0 142.62 34.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.073 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.712 HG13 HG22 ' C' ' 60' ' ' ILE . 0.8 OUTLIER -150.69 147.01 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.656 179.484 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -143.18 129.66 20.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.821 0.343 . . . . 0.0 111.133 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.631 ' HB ' HG13 ' C' ' 62' ' ' VAL . 44.3 t -110.63 120.66 61.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.826 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -118.73 94.13 4.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.837 ' HB2' HD22 ' C' ' 64' ' ' LEU . 3.0 mp -110.01 117.46 33.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.676 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.06 122.19 32.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.805 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.825 ' HB3' HD12 ' C' ' 65' ' ' LEU . 8.7 tttm . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.927 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.779 0.323 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 59.77 78.97 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.888 ' CZ ' HD13 ' D' ' 86' ' ' LEU . 31.7 t80 -87.64 102.86 15.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.632 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -103.92 103.24 13.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.903 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' ASN . . . . . 0.459 ' HB2' ' CZ ' ' C' ' 47' ' ' PHE . 23.0 t-20 -127.04 116.44 20.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 50' ' ' CYS . . . . . 0.442 ' CB ' ' HB3' ' D' ' 72' ' ' CYS . 18.9 p -159.74 157.19 28.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.18 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.592 ' HE2' HD12 ' D' ' 82' ' ' ILE . 0.5 OUTLIER -162.78 147.21 11.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.771 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 52' ' ' VAL . . . . . 0.938 ' CG2' HG13 ' B' ' 30' ' ' VAL . 32.8 m -134.53 114.45 18.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.181 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 5.5 t 166.72 -86.39 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.767 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' GLY . . . . . 0.556 ' O ' ' CD1' ' C' ' 55' ' ' PHE . . . 108.92 -56.09 0.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.895 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 55' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' C' ' 54' ' ' GLY . 4.9 p90 43.02 -176.97 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.098 0.475 . . . . 0.0 111.99 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 56' ' ' HIS . . . . . 0.528 ' CB ' ' HD3' ' C' ' 57' ' ' PRO . 0.0 OUTLIER -99.51 -61.96 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.783 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 57' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' C' ' 56' ' ' HIS . 52.4 Cg_endo -88.27 -151.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.795 2.33 . . . . 0.0 112.027 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 58' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' C' ' 57' ' ' PRO . 1.0 OUTLIER 86.69 125.06 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.181 0.515 . . . . 0.0 111.375 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.445 ' HA ' ' CB ' ' D' ' 81' ' ' ASP . 8.1 t0 -112.51 95.51 5.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.213 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.797 HD11 HG22 ' D' ' 82' ' ' ILE . 0.2 OUTLIER -134.01 140.87 45.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.199 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -156.49 133.41 10.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.053 0.454 . . . . 0.0 111.185 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.631 HG13 ' HB ' ' B' ' 40' ' ' VAL . 48.0 t -109.29 121.01 61.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.647 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 63' ' ' ASP . . . . . 0.776 ' C ' HD23 ' C' ' 64' ' ' LEU . 5.1 p-10 -125.13 128.33 48.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.269 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 64' ' ' LEU . . . . . 0.862 HD11 ' CZ ' ' B' ' 25' ' ' PHE . 5.2 mt -124.78 110.05 13.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.563 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.825 HD12 ' HB3' ' B' ' 44' ' ' LYS . 0.5 OUTLIER 62.91 126.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.789 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 18.1 ttpt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.888 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.694 0.283 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -177.75 -35.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.297 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 69' ' ' PHE . . . . . 0.422 ' HB2' ' CD1' ' C' ' 47' ' ' PHE . 0.1 OUTLIER -120.37 170.67 9.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.79 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 24.0 tp -152.22 109.06 3.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.117 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 71' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -102.18 65.3 0.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.47 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 72' ' ' CYS . . . . . 0.442 ' HB3' ' CB ' ' C' ' 50' ' ' CYS . 50.9 t -75.03 101.66 4.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 73' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -107.15 128.86 54.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.103 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 74' ' ' VAL . . . . . 0.885 ' HB ' HG12 ' C' ' 52' ' ' VAL . 10.9 t -133.33 73.87 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.13 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 75' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' D' ' 74' ' ' VAL . 1.4 p 174.63 137.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.451 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 76' ' ' GLY . . . . . 0.485 ' O ' ' CG ' ' D' ' 77' ' ' PHE . . . -50.38 -87.02 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.679 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.657 ' HD1' HD11 ' D' ' 82' ' ' ILE . 0.4 OUTLIER 162.8 -60.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 122.482 0.313 . . . . 0.0 110.616 178.803 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 78' ' ' HIS . . . . . 0.467 ' HB3' ' HD2' ' D' ' 79' ' ' PRO . 20.0 m-70 58.54 164.62 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.545 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 79' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' D' ' 78' ' ' HIS . 18.7 Cg_endo -59.32 75.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.517 2.145 . . . . 0.0 112.344 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 80' ' ' SER . . . . . 0.444 ' N ' ' O ' ' D' ' 78' ' ' HIS . 9.7 p -127.61 -163.34 1.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.454 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 81' ' ' ASP . . . . . 0.445 ' CB ' ' HA ' ' C' ' 59' ' ' ASP . 0.2 OUTLIER -130.78 43.97 3.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.782 0.325 . . . . 0.0 111.31 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 82' ' ' ILE . . . . . 0.797 HG22 HD11 ' C' ' 60' ' ' ILE . 35.6 pt -99.7 117.85 45.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.882 0.372 . . . . 0.0 110.814 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -148.02 162.43 39.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.022 0.439 . . . . 0.0 111.523 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 48.0 t -141.76 130.22 22.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.94 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -135.59 108.77 7.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.925 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 86' ' ' LEU . . . . . 0.888 HD13 ' CZ ' ' C' ' 47' ' ' PHE . 0.4 OUTLIER -120.03 96.18 5.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.055 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.054 179.94 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.837 0.351 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.703 ' C ' HD13 ' A' ' 4' ' ' LEU . 46.5 t80 -145.67 129.08 16.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.73 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.72 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -147.48 83.87 1.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.295 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 6.5 t-20 -71.97 115.96 11.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.417 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.87 112.13 22.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.958 0.408 . . . . 0.0 111.714 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.47 ' OH ' ' CE1' ' B' ' 33' ' ' PHE . 0.1 OUTLIER -118.09 128.78 55.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.98 179.066 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.5 80.36 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.097 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 43.61 95.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.596 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.5 137.28 3.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.148 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.511 ' CD1' HD11 ' B' ' 38' ' ' ILE . 5.6 p90 -177.44 169.3 2.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.686 0.279 . . . . 0.0 110.733 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.588 ' HB3' ' HD2' ' A' ' 13' ' ' PRO . 1.8 m80 -58.89 176.04 0.3 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.719 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 12' ' ' HIS . 86.1 Cg_endo -81.68 175.45 9.42 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.367 2.045 . . . . 0.0 112.158 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m 65.5 -161.56 0.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.743 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -106.36 118.39 36.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.971 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 17' ' ' GLU . 23.4 mm -79.24 159.11 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.977 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.473 ' N ' HG22 ' A' ' 16' ' ' ILE . 0.7 OUTLIER -146.16 59.56 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.191 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.73 118.46 10.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.498 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' B' ' 41' ' ' ASP . 3.1 p30 -134.76 161.98 33.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.957 0.408 . . . . 0.0 111.398 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.667 HD12 ' CE2' ' A' ' 3' ' ' PHE . 24.1 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.894 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 121.014 0.435 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.95 ' CZ ' HD11 ' C' ' 64' ' ' LEU . 37.6 t80 -121.23 142.15 50.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.784 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -147.42 115.81 6.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.442 ' HB2' ' CE1' ' B' ' 25' ' ' PHE . 46.4 t30 -122.73 90.66 3.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.775 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 91.6 m -81.93 117.44 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.73 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.461 ' CZ ' HG13 ' C' ' 60' ' ' ILE . 1.7 t80 -111.69 104.79 13.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.014 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.453 ' HA ' ' CG2' ' C' ' 52' ' ' VAL . 15.3 t -104.04 105.29 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.567 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 13.8 m -57.21 -178.32 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.982 0.42 . . . . 0.0 111.276 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.18 50.72 0.76 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.464 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' PHE . . . . . 0.47 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -165.25 161.02 18.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.771 0.319 . . . . 0.0 111.233 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.637 ' N ' ' HD3' ' B' ' 35' ' ' PRO . 4.7 p80 -148.0 53.53 1.54 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.182 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.637 ' HD3' ' N ' ' B' ' 34' ' ' HIS . 2.3 Cg_endo -83.37 -72.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.08 2.52 . . . . 0.0 112.465 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 47.3 t -158.1 -119.94 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.185 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -126.83 163.94 22.49 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.86 0.362 . . . . 0.0 111.015 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.511 HD11 ' CD1' ' A' ' 11' ' ' PHE . 25.0 mt -145.57 136.04 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.927 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -129.92 145.36 51.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.94 0.4 . . . . 0.0 111.227 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.403 ' HB ' ' HA ' ' C' ' 62' ' ' VAL . 40.7 t -142.85 140.38 27.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.814 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 19' ' ' ASP . 14.5 t0 -162.61 118.1 1.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.658 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.589 ' HG ' HD23 ' B' ' 43' ' ' LEU . 0.4 OUTLIER -158.9 -171.0 3.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.051 0.453 . . . . 0.0 111.482 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.589 HD23 ' HG ' ' B' ' 42' ' ' LEU . 2.6 mm? 58.54 162.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.211 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.99 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.814 0.34 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 46' ' ' ASN . . . . . 0.411 ' CB ' ' HB2' ' D' ' 68' ' ' ASN . 8.2 p-10 -175.9 174.39 2.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.102 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.643 ' CZ ' HD11 ' D' ' 86' ' ' LEU . 62.1 t80 -85.78 107.64 17.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.632 HD13 HD23 ' D' ' 70' ' ' LEU . 21.4 tp -117.37 83.5 2.0 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.983 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 49' ' ' ASN . . . . . 0.513 ' HB2' ' CZ ' ' C' ' 47' ' ' PHE . 3.7 t-20 -98.35 102.9 14.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.593 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.72 115.11 20.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.813 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -116.07 102.75 9.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.063 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 52' ' ' VAL . . . . . 0.559 HG23 ' O ' ' C' ' 52' ' ' VAL . 34.1 m -113.68 114.31 46.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 15.1 p -50.93 178.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.626 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.88 -30.49 2.16 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.087 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' PHE . . . . . 0.46 ' CZ ' ' CB ' ' D' ' 80' ' ' SER . 0.0 OUTLIER -92.73 -163.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 111.323 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 56' ' ' HIS . . . . . 0.483 ' CB ' ' HD3' ' C' ' 57' ' ' PRO . 0.0 OUTLIER -169.68 -55.63 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.81 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 57' ' ' PRO . . . . . 0.483 ' HD3' ' CB ' ' C' ' 56' ' ' HIS . 69.0 Cg_endo -94.8 66.61 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.008 2.472 . . . . 0.0 112.617 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.0 158.07 32.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.97 0.414 . . . . 0.0 111.028 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.825 ' O ' HD13 ' C' ' 60' ' ' ILE . 0.2 OUTLIER -113.83 139.14 49.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.795 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.825 HD13 ' O ' ' C' ' 59' ' ' ASP . 6.1 mm -139.42 103.71 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.311 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.73 129.41 55.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.692 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.403 ' HA ' ' HB ' ' B' ' 40' ' ' VAL . 21.2 t -133.57 145.48 33.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.312 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 63' ' ' ASP . . . . . 0.544 ' O ' HD12 ' C' ' 64' ' ' LEU . 0.4 OUTLIER -139.52 148.7 43.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.027 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 64' ' ' LEU . . . . . 0.95 HD11 ' CZ ' ' B' ' 25' ' ' PHE . 0.6 OUTLIER -151.09 73.43 1.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.468 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.803 HD22 ' N ' ' C' ' 66' ' ' LYS . 1.2 tm? 157.65 137.17 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.449 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 66' ' ' LYS . . . . . 0.803 ' N ' HD22 ' C' ' 65' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.86 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.746 0.308 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 68' ' ' ASN . . . . . 0.411 ' HB2' ' CB ' ' C' ' 46' ' ' ASN . 76.1 m-20 -56.76 129.25 40.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.048 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 69' ' ' PHE . . . . . 0.449 ' HE2' HD23 ' D' ' 86' ' ' LEU . 24.6 t80 -130.28 139.78 50.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 70' ' ' LEU . . . . . 0.632 HD23 HD13 ' C' ' 48' ' ' LEU . 12.7 tp -157.41 95.96 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.753 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 71' ' ' ASN . . . . . 0.46 HD21 HG21 ' D' ' 84' ' ' VAL . 50.0 t-20 -109.09 122.51 47.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.093 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -95.03 62.8 2.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.594 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.02 72.68 1.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.12 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.04 97.59 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.064 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 80.9 p -174.65 -76.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.923 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.75 -33.27 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.403 ' O ' ' CG ' ' D' ' 78' ' ' HIS . 22.6 m-85 62.74 104.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.734 0.302 . . . . 0.0 111.025 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 78' ' ' HIS . . . . . 0.46 ' CB ' ' CD ' ' D' ' 79' ' ' PRO . 2.0 m-70 -173.81 -64.04 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.946 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 79' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' D' ' 78' ' ' HIS . 33.1 Cg_endo -66.98 -75.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.366 2.044 . . . . 0.0 112.769 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 80' ' ' SER . . . . . 0.46 ' CB ' ' CZ ' ' C' ' 55' ' ' PHE . 35.3 p -58.9 -178.85 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.912 0.387 . . . . 0.0 111.167 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.3 108.47 13.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.829 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 82' ' ' ILE . . . . . 0.712 HG22 ' HB ' ' C' ' 60' ' ' ILE . 0.2 OUTLIER -141.55 161.56 21.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.228 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -168.94 126.45 0.99 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.811 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 84' ' ' VAL . . . . . 0.667 HG12 HD21 ' D' ' 86' ' ' LEU . 21.6 t -111.31 127.49 68.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -139.6 100.06 3.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.716 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 86' ' ' LEU . . . . . 0.679 HD12 ' HB2' ' C' ' 64' ' ' LEU . 0.2 OUTLIER -103.1 -168.96 1.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.678 ' H ' HD13 ' D' ' 87' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.215 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.839 0.352 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.771 ' O ' HD12 ' B' ' 26' ' ' LEU . 90.0 t80 -59.96 114.76 2.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.805 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 4' ' ' LEU . 1.9 pp -124.1 98.48 5.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.811 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -83.79 93.01 7.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.889 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.9 m -89.07 102.59 15.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' B' ' 29' ' ' TYR . 8.3 t80 -108.21 117.91 35.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.69 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.745 ' HA ' HG22 ' B' ' 30' ' ' VAL . 7.1 p -121.39 87.64 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.962 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.418 ' CB ' ' HA3' ' B' ' 32' ' ' GLY . 67.0 p 46.54 -167.85 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.777 0.322 . . . . 0.0 111.084 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.61 159.77 34.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.042 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' B' ' 36' ' ' SER . 0.2 OUTLIER 177.22 113.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.826 0.346 . . . . 0.0 110.56 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.415 ' HB2' ' HD3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -92.12 -54.3 0.26 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.438 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.428 ' CG ' HG12 ' A' ' 16' ' ' ILE . 94.9 Cg_endo -83.53 -97.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.477 2.118 . . . . 0.0 112.646 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.404 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 14.8 p -178.67 -52.81 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.749 0.309 . . . . 0.0 111.102 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -114.86 86.43 2.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.266 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.75 HD12 ' N ' ' A' ' 17' ' ' GLU . 2.2 pp -156.32 -170.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.683 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.751 ' HG3' HG23 ' A' ' 18' ' ' VAL . 37.4 tp10 160.01 -82.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.527 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.788 ' HB ' HG13 ' B' ' 40' ' ' VAL . 47.7 t -139.8 139.45 37.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.96 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -154.34 83.42 1.12 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.765 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.805 0.336 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.722 ' CZ ' HD12 ' C' ' 64' ' ' LEU . 56.5 t80 -106.35 117.83 35.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.677 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.771 HD12 ' O ' ' A' ' 3' ' ' PHE . 1.4 mp -131.71 95.85 3.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.077 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.462 ' HB2' ' CE1' ' B' ' 25' ' ' PHE . 0.1 OUTLIER -102.21 110.06 21.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.656 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' C' ' 50' ' ' CYS . 27.7 p -126.17 128.67 47.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.5 ' CE1' ' CE2' ' C' ' 55' ' ' PHE . 2.4 p90 -133.72 156.39 48.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.001 0.429 . . . . 0.0 111.39 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.745 HG22 ' HA ' ' A' ' 8' ' ' VAL . 16.6 m -129.05 134.13 64.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.754 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.0 t -44.74 167.53 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.644 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 9' ' ' SER . . . 150.89 -37.76 0.87 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.786 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' PHE . . . . . 0.483 ' CZ ' ' CE2' ' C' ' 55' ' ' PHE . 6.7 p90 -90.19 163.64 14.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 111.132 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.55 171.64 9.38 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.992 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -42.45 94.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.746 2.297 . . . . 0.0 112.628 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' SER . . . . . 0.451 ' HB3' ' CE2' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -124.53 -165.37 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.806 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.81 106.4 10.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.981 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.451 HD12 ' CZ ' ' B' ' 33' ' ' PHE . 0.0 OUTLIER -107.94 116.25 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.521 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 18.6 pt-20 -128.19 117.43 21.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.859 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.788 HG13 ' HB ' ' A' ' 18' ' ' VAL . 39.5 t -93.62 122.64 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.997 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -127.76 93.75 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.438 ' CD1' ' CZ ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER -106.53 108.51 20.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.004 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.574 HD13 HD12 ' C' ' 65' ' ' LEU . 4.4 mm? -112.8 35.4 3.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.03 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.785 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.74 0.305 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -170.77 118.9 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.15 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.573 ' CE2' HD12 ' D' ' 86' ' ' LEU . 47.2 t80 -114.43 112.2 22.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.51 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.448 HD22 HD23 ' B' ' 26' ' ' LEU . 0.1 OUTLIER -120.47 94.21 4.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.212 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 49' ' ' ASN . . . . . 0.495 ' HB2' ' CZ ' ' C' ' 47' ' ' PHE . 36.3 t30 -110.12 80.63 1.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.026 0.441 . . . . 0.0 110.676 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 50' ' ' CYS . . . . . 0.495 ' HB3' ' CD2' ' D' ' 73' ' ' TYR . 32.0 p -107.83 154.04 22.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.595 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.499 ' CZ ' ' HA ' ' D' ' 72' ' ' CYS . 0.2 OUTLIER -148.24 160.58 42.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.457 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 52' ' ' VAL . . . . . 0.563 HG13 HG11 ' D' ' 74' ' ' VAL . 20.2 t -124.84 124.87 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.457 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.26 -172.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.096 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 54' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' D' ' 77' ' ' PHE . . . -122.76 172.35 15.81 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.636 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 55' ' ' PHE . . . . . 0.5 ' CE2' ' CE1' ' B' ' 29' ' ' TYR . 0.1 OUTLIER -143.86 60.21 1.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 111.317 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 56' ' ' HIS . . . . . 0.527 ' HB3' ' HD2' ' C' ' 57' ' ' PRO . 1.2 m80 59.89 165.47 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.466 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 57' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' C' ' 56' ' ' HIS . 34.9 Cg_endo -64.68 79.73 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.416 2.078 . . . . 0.0 112.282 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 1.5 t -96.83 -167.46 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.039 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.09 129.03 44.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.733 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.634 HD12 HG22 ' D' ' 82' ' ' ILE . 6.6 mt -127.8 120.1 53.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.294 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -111.04 77.47 1.04 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.552 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.596 HG12 HD11 ' C' ' 64' ' ' LEU . 22.3 t -79.26 124.69 37.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.29 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 63' ' ' ASP . . . . . 0.791 ' C ' HD13 ' C' ' 64' ' ' LEU . 6.6 t0 -149.9 121.22 7.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.759 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 64' ' ' LEU . . . . . 0.791 HD13 ' C ' ' C' ' 63' ' ' ASP . 0.0 OUTLIER -137.2 140.79 41.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.574 HD12 HD13 ' B' ' 43' ' ' LEU . 0.9 OUTLIER -89.3 -66.05 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.861 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.824 179.909 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.828 0.347 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 55.85 96.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.01 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -113.13 128.63 56.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.008 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 70' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' D' ' 70' ' ' LEU . 2.8 tp -155.49 88.0 1.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 71' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' D' ' 73' ' ' TYR . 17.9 p-10 -125.49 -157.53 0.79 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.356 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 72' ' ' CYS . . . . . 0.499 ' HA ' ' CZ ' ' C' ' 51' ' ' TYR . 36.1 t 55.82 -83.36 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.896 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 73' ' ' TYR . . . . . 0.495 ' CD2' ' HB3' ' C' ' 50' ' ' CYS . 1.0 OUTLIER 66.76 -93.66 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 177.764 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 74' ' ' VAL . . . . . 0.563 HG11 HG13 ' C' ' 52' ' ' VAL . 40.1 t -109.44 64.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 120.989 0.423 . . . . 0.0 110.848 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -60.83 -164.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.209 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.47 58.15 0.4 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.874 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.458 ' HB3' ' HA2' ' C' ' 54' ' ' GLY . 13.6 p90 -130.61 163.77 26.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 111.314 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 78' ' ' HIS . . . . . 0.469 ' CB ' ' HD2' ' D' ' 79' ' ' PRO . 0.4 OUTLIER -76.65 170.0 18.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.279 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 79' ' ' PRO . . . . . 0.469 ' HD2' ' CB ' ' D' ' 78' ' ' HIS . 9.4 Cg_endo -52.46 89.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.411 2.074 . . . . 0.0 112.13 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.99 119.69 39.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.709 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -54.02 96.39 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.835 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 82' ' ' ILE . . . . . 0.634 HG22 HD12 ' C' ' 60' ' ' ILE . 20.6 pt -111.43 125.21 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.364 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -113.11 107.68 16.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.531 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 84' ' ' VAL . . . . . 0.559 ' CG1' HD11 ' D' ' 86' ' ' LEU . 21.5 t -94.15 130.56 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.491 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 85' ' ' ASP . . . . . 0.418 ' O ' HD22 ' C' ' 64' ' ' LEU . 1.8 m-20 -134.33 92.6 2.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.664 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 86' ' ' LEU . . . . . 0.642 ' H ' HD22 ' D' ' 86' ' ' LEU . 0.2 OUTLIER -88.46 80.05 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.929 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 27.0 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 179.881 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.806 0.336 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.738 ' CZ ' HD11 ' B' ' 42' ' ' LEU . 4.9 t80 -109.03 160.06 16.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.756 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.493 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 13.9 tp -145.28 142.64 29.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 0.0 111.346 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.466 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 5.3 t30 -159.02 115.27 2.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.468 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.7 t -126.85 146.23 50.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.316 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.402 ' HH ' ' HD2' ' B' ' 33' ' ' PHE . 0.5 OUTLIER -123.18 135.31 54.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.315 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.8 t -144.67 125.71 8.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.814 0.34 . . . . 0.0 111.404 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t 67.12 -160.38 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.041 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.97 -133.95 0.01 OUTLIER Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.757 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.443 ' CZ ' ' HB2' ' B' ' 36' ' ' SER . 0.0 OUTLIER -175.77 -164.89 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.743 0.306 . . . . 0.0 111.077 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.513 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -119.7 -70.02 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.324 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 12' ' ' HIS . 19.1 Cg_endo -58.14 -164.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.312 2.008 . . . . 0.0 112.153 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -130.79 -63.65 0.86 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.934 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -97.84 96.26 8.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.729 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.1 mt -96.88 146.98 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.202 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -149.56 120.85 7.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.872 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.436 HG12 HD21 ' B' ' 42' ' ' LEU . 16.5 t -107.28 129.62 60.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.285 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -145.48 89.92 1.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.745 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.507 ' CB ' HD22 ' B' ' 42' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.051 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.956 0.408 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.87 ' CE2' HD11 ' C' ' 64' ' ' LEU . 0.1 OUTLIER -169.35 159.03 8.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.144 0.497 . . . . 0.0 111.379 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.794 HD12 ' HB2' ' C' ' 48' ' ' LEU . 0.2 OUTLIER -106.91 119.28 38.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.512 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -97.86 155.69 16.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.264 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 38.1 t -163.74 153.43 14.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.758 0.313 . . . . 0.0 111.221 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.468 ' CD2' ' HB2' ' C' ' 51' ' ' TYR . 0.0 OUTLIER -176.07 125.55 0.2 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.984 0.421 . . . . 0.0 110.964 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 31.1 m -128.37 128.59 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.256 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 73.49 147.12 0.09 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.054 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.69 -148.43 1.62 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.584 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' PHE . . . . . 0.723 ' HE2' HD11 ' B' ' 38' ' ' ILE . 0.0 OUTLIER -179.05 37.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.651 0.263 . . . . 0.0 111.596 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.443 ' CG ' ' HD2' ' B' ' 35' ' ' PRO . 0.0 OUTLIER 60.74 178.38 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.698 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.443 ' HD2' ' CG ' ' B' ' 34' ' ' HIS . 90.2 Cg_exo -43.0 126.15 4.4 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.596 2.197 . . . . 0.0 112.776 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' SER . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 5.3 t 179.74 147.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.657 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.94 135.16 55.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.192 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.723 HD11 ' HE2' ' B' ' 33' ' ' PHE . 35.1 mt -135.91 111.43 11.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.88 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.14 82.94 1.75 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.749 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 42.2 t -73.43 120.36 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.969 0.414 . . . . 0.0 111.109 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.55 ' O ' HD23 ' B' ' 42' ' ' LEU . 16.7 m-20 -135.97 110.75 8.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.539 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.738 HD11 ' CZ ' ' A' ' 3' ' ' PHE . 80.6 mt -133.02 143.08 49.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.143 0.497 . . . . 0.0 111.234 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.401 ' HB3' ' N ' ' C' ' 66' ' ' LYS . 3.0 mt 71.47 137.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.571 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 11.5 mttt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.9 -179.84 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.86 0.362 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -94.11 125.37 38.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.028 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.69 ' CE1' HD13 ' C' ' 64' ' ' LEU . 50.1 t80 -131.72 135.4 46.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.81 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 48' ' ' LEU . . . . . 0.794 ' HB2' HD12 ' B' ' 26' ' ' LEU . 17.7 tp -130.2 128.67 42.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.69 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -130.34 95.3 3.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.388 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 3.7 p -117.86 103.9 10.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.387 . . . . 0.0 111.833 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' D' ' 73' ' ' TYR . 3.2 p90 -135.45 153.66 51.7 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.874 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 52' ' ' VAL . . . . . 0.585 ' O ' ' CB ' ' C' ' 53' ' ' SER . 0.8 OUTLIER -176.03 162.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.954 -178.754 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 53' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' C' ' 52' ' ' VAL . 5.9 t 104.58 80.31 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.496 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.91 -63.26 0.05 OUTLIER Glycine 0 C--N 1.332 0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.993 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' PHE . . . . . 0.541 ' CZ ' HG21 ' D' ' 82' ' ' ILE . 1.3 t80 78.79 78.37 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.819 0.342 . . . . 0.0 110.516 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 56' ' ' HIS . . . . . 0.595 ' N ' ' CD ' ' C' ' 57' ' ' PRO . 0.0 OUTLIER -140.36 38.86 0.32 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 57' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' C' ' 56' ' ' HIS . 36.5 Cg_endo -69.21 -77.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.109 1.872 . . . . 0.0 112.3 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 58' ' ' SER . . . . . 0.423 ' OG ' ' HA ' ' B' ' 35' ' ' PRO . 0.4 OUTLIER 174.38 -79.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 110.689 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -134.42 134.74 41.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.871 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 10.1 mt -151.7 106.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -107.21 103.08 12.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.1 t -91.32 124.23 43.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -128.02 129.66 47.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.036 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 64' ' ' LEU . . . . . 0.87 HD11 ' CE2' ' B' ' 25' ' ' PHE . 0.2 OUTLIER -139.54 98.1 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.512 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 5.8 mt -94.1 -92.86 0.18 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.372 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 66' ' ' LYS . . . . . 0.401 ' N ' ' HB3' ' B' ' 43' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.834 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.785 0.326 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -71.47 105.06 3.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 69' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' D' ' 71' ' ' ASN . 54.5 t80 -118.42 124.72 48.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.781 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 mt -143.83 95.09 2.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.736 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 71' ' ' ASN . . . . . 0.459 ' O ' ' CD2' ' D' ' 73' ' ' TYR . 2.5 t-20 -100.73 79.95 2.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 1.4 m -73.57 109.31 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.459 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 73' ' ' TYR . . . . . 0.49 ' HB3' ' CE1' ' C' ' 51' ' ' TYR . 1.7 p90 -118.73 118.95 33.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.4 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 74' ' ' VAL . . . . . 0.525 ' HB ' ' HB ' ' C' ' 52' ' ' VAL . 3.5 t -132.72 86.86 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.019 0.438 . . . . 0.0 111.054 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 1.4 t 169.34 -53.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.689 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.38 -154.3 25.56 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.22 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 77' ' ' PHE . . . . . 0.459 ' HZ ' HG23 ' D' ' 84' ' ' VAL . 0.1 OUTLIER -177.19 88.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 111.183 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 78' ' ' HIS . . . . . 0.492 ' HB3' ' HD3' ' D' ' 79' ' ' PRO . 9.7 t-160 176.47 -57.94 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 79' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' D' ' 78' ' ' HIS . 55.5 Cg_endo -69.37 62.69 1.56 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.303 2.002 . . . . 0.0 112.389 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 80' ' ' SER . . . . . 0.423 ' CB ' HD12 ' D' ' 82' ' ' ILE . 1.9 m 178.77 159.49 0.58 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -96.37 60.26 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.604 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 82' ' ' ILE . . . . . 0.719 ' H ' HD13 ' D' ' 82' ' ' ILE . 0.2 OUTLIER -120.6 -179.87 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.243 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -176.57 145.49 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 84' ' ' VAL . . . . . 0.459 HG23 ' HZ ' ' D' ' 77' ' ' PHE . 80.2 t -112.69 117.58 55.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.979 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -138.31 112.57 8.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.543 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 86' ' ' LEU . . . . . 0.674 HD11 ' CE2' ' C' ' 47' ' ' PHE . 1.9 pt? -173.22 175.71 3.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.299 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.037 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.754 0.311 . . . . 0.0 110.849 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.66 ' CE2' ' CD1' ' B' ' 42' ' ' LEU . 16.7 t80 -127.35 110.22 12.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.967 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.542 ' O ' HD12 ' A' ' 4' ' ' LEU . 0.4 OUTLIER -108.05 117.47 34.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.723 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 1.1 p30 -129.45 67.97 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.047 0.451 . . . . 0.0 110.578 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 52.9 t -90.41 117.54 29.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.578 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.511 ' OH ' ' CE1' ' B' ' 29' ' ' TYR . 0.0 OUTLIER -119.98 132.59 55.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.252 0.549 . . . . 0.0 110.948 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.952 HG12 HG22 ' B' ' 30' ' ' VAL . 5.5 m -142.51 165.53 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.356 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 p 77.47 -166.47 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.394 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.77 -164.31 28.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.91 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.494 ' HB2' ' CD2' ' B' ' 33' ' ' PHE . 0.0 OUTLIER -130.85 -157.51 0.83 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.739 0.304 . . . . 0.0 110.76 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.443 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -175.15 -60.33 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.85 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 12' ' ' HIS . 34.0 Cg_endo -64.0 -22.94 68.01 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.326 2.017 . . . . 0.0 112.127 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.7 m 69.83 -64.34 0.35 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.226 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.59 127.24 32.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.036 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.795 HD13 ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -158.1 138.81 4.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.197 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.795 ' N ' HD13 ' A' ' 16' ' ' ILE . 4.4 pt-20 -139.37 137.73 35.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.004 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.481 ' HB ' HG13 ' B' ' 40' ' ' VAL . 25.3 t -115.3 125.72 72.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.957 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.61 132.42 55.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.044 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.936 ' HB2' HD22 ' B' ' 42' ' ' LEU . 1.8 mt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.695 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.432 ' HB3' ' CB ' ' C' ' 46' ' ' ASN . 31.8 t-20 . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.817 ' CZ ' HD11 ' C' ' 64' ' ' LEU . 9.2 t80 -125.59 105.31 8.93 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.73 0.3 . . . . 0.0 111.013 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mp -116.2 90.34 3.31 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.444 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.487 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 7.0 t-20 -96.88 110.75 23.19 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.904 0.383 . . . . 0.0 110.751 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 4.1 m -112.04 142.46 44.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.114 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.511 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 0.7 OUTLIER -148.71 102.91 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.551 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.952 HG22 HG12 ' A' ' 8' ' ' VAL . 19.5 m -127.51 135.95 61.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.425 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 76.46 87.66 0.08 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.838 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.63 -173.91 0.49 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.571 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -163.33 -173.56 3.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 0.0 110.928 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.415 ' HB3' ' HD2' ' B' ' 35' ' ' PRO . 39.4 m-70 -59.44 162.21 8.86 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.743 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' B' ' 34' ' ' HIS . 83.6 Cg_exo -47.98 111.92 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.604 2.203 . . . . 0.0 112.639 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' SER . . . . . 0.411 ' HB2' ' CE1' ' B' ' 33' ' ' PHE . 12.7 m -133.2 159.87 38.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.724 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ASP . . . . . 0.409 ' C ' HD13 ' B' ' 38' ' ' ILE . 6.0 t0 -107.36 105.56 15.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.679 HG23 ' CG2' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -120.09 118.89 58.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.661 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -131.27 139.15 49.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.884 0.373 . . . . 0.0 111.118 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.481 HG13 ' HB ' ' A' ' 18' ' ' VAL . 62.0 t -134.11 119.08 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.956 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.796 ' C ' HD23 ' B' ' 42' ' ' LEU . 14.0 p-10 -122.75 105.1 9.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.765 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.936 HD22 ' HB2' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -133.82 176.79 8.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.052 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' C' ' 65' ' ' LEU . 1.3 tp -135.91 -48.86 0.68 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.784 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.98 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 29.8 p . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.825 0.345 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 46' ' ' ASN . . . . . 0.432 ' CB ' ' HB3' ' B' ' 24' ' ' ASN . 73.9 m-20 58.76 62.89 1.79 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.63 ' CZ ' HD12 ' D' ' 86' ' ' LEU . 6.1 t80 -105.36 120.09 40.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.52 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 43.4 tp -125.57 109.64 12.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.94 0.4 . . . . 0.0 111.264 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 49' ' ' ASN . . . . . 0.442 ' HB3' ' CE1' ' C' ' 47' ' ' PHE . 1.5 p30 -128.37 102.51 6.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.116 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 50' ' ' CYS . . . . . 0.4 ' HB2' ' HB3' ' D' ' 72' ' ' CYS . 13.8 p -116.69 134.35 54.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.372 . . . . 0.0 111.653 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.449 ' CZ ' ' HA ' ' D' ' 73' ' ' TYR . 27.9 p90 -136.96 125.69 23.93 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.771 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 52' ' ' VAL . . . . . 0.901 HG12 ' CG2' ' D' ' 74' ' ' VAL . 1.7 m -132.41 122.77 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.068 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 53' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' C' ' 52' ' ' VAL . 0.4 OUTLIER 165.35 -83.55 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.24 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 180.0 -37.64 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.161 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' PHE . . . . . 0.426 ' O ' ' HG2' ' D' ' 79' ' ' PRO . 2.0 m-85 65.49 127.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.719 0.295 . . . . 0.0 111.43 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 56' ' ' HIS . . . . . 0.568 ' HB3' ' HD3' ' C' ' 57' ' ' PRO . 2.7 t60 177.82 -50.66 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.039 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 57' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' C' ' 56' ' ' HIS . 73.4 Cg_endo -92.3 -54.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.763 2.309 . . . . 0.0 113.245 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -53.02 158.24 1.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.215 0.531 . . . . 0.0 111.743 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.421 ' HA ' ' HB2' ' D' ' 81' ' ' ASP . 1.1 m-20 -140.1 100.52 3.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.474 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 60' ' ' ILE . . . . . 0.548 HG23 ' HB ' ' B' ' 38' ' ' ILE . 18.9 mt -115.28 144.1 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.388 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -136.12 83.81 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.077 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -85.93 119.56 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.273 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 63' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' D' ' 85' ' ' ASP . 6.6 p-10 -118.34 125.07 49.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 111.196 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 64' ' ' LEU . . . . . 0.817 HD11 ' CZ ' ' B' ' 25' ' ' PHE . 0.7 OUTLIER -117.13 131.86 56.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.834 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 65' ' ' LEU . . . . . 0.616 ' N ' HD22 ' C' ' 65' ' ' LEU . 2.4 mm? 60.36 -179.25 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.938 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.89 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.841 0.353 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 68' ' ' ASN . . . . . 0.478 ' O ' ' ND2' ' D' ' 68' ' ' ASN . 0.3 OUTLIER 54.55 17.97 1.83 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.703 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 69' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' D' ' 71' ' ' ASN . 62.1 t80 -137.98 92.91 2.71 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.777 0.323 . . . . 0.0 110.849 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.17 93.71 5.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.715 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 71' ' ' ASN . . . . . 0.504 ' HB2' ' CZ ' ' D' ' 69' ' ' PHE . 11.5 t-20 -99.67 105.86 17.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.072 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 72' ' ' CYS . . . . . 0.4 ' HB3' ' HB2' ' C' ' 50' ' ' CYS . 6.6 t -81.92 68.82 8.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.558 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 73' ' ' TYR . . . . . 0.449 ' HA ' ' CZ ' ' C' ' 51' ' ' TYR . 0.1 OUTLIER -73.53 79.23 1.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.622 -179.545 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 74' ' ' VAL . . . . . 0.901 ' CG2' HG12 ' C' ' 52' ' ' VAL . 0.1 OUTLIER -122.35 83.82 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.943 0.401 . . . . 0.0 110.935 179.493 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.38 -68.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.672 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.12 -52.6 0.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.318 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.82 94.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.412 . . . . 0.0 111.345 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 78' ' ' HIS . . . . . 0.505 ' CB ' ' HD3' ' D' ' 79' ' ' PRO . 0.2 OUTLIER -164.79 -56.59 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.498 179.523 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 79' ' ' PRO . . . . . 0.505 ' HD3' ' CB ' ' D' ' 78' ' ' HIS . 73.7 Cg_endo -96.4 -164.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.234 2.623 . . . . 0.0 111.57 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 80' ' ' SER . . . . . 0.416 ' OG ' ' N ' ' D' ' 81' ' ' ASP . 1.4 t 55.9 176.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.587 0.232 . . . . 0.0 110.527 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 81' ' ' ASP . . . . . 0.448 ' HB3' ' N ' ' C' ' 60' ' ' ILE . 1.6 t0 -85.17 104.26 14.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.321 . . . . 0.0 111.083 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 82' ' ' ILE . . . . . 0.795 HG22 ' H ' ' D' ' 84' ' ' VAL . 48.6 mm -2.4 -67.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 83' ' ' GLU . . . . . 0.753 ' HG3' HG23 ' D' ' 84' ' ' VAL . 0.0 OUTLIER 98.26 -29.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.053 0.541 . . . . 0.0 110.926 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 84' ' ' VAL . . . . . 0.795 ' H ' HG22 ' D' ' 82' ' ' ILE . 59.7 t -111.99 118.63 58.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.864 0.364 . . . . 0.0 111.754 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 85' ' ' ASP . . . . . 0.492 ' C ' HD13 ' D' ' 86' ' ' LEU . 2.0 m-20 -153.18 123.18 6.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.543 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 86' ' ' LEU . . . . . 0.852 ' H ' HD22 ' D' ' 86' ' ' LEU . 0.0 OUTLIER -134.43 175.4 9.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.041 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 87' ' ' LEU . . . . . 0.64 ' O ' HD12 ' D' ' 87' ' ' LEU . 2.2 pp . . . . . 0 N--CA 1.464 0.273 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.794 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.836 0.35 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -177.37 108.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.737 ' CE2' HD12 ' B' ' 42' ' ' LEU . 4.3 t80 -94.74 139.75 30.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.026 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.6 HD12 HD13 ' B' ' 26' ' ' LEU . 0.2 OUTLIER -132.53 77.58 1.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.963 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' B' ' 27' ' ' ASN . 58.9 t30 -67.24 104.65 1.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.527 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.8 p -117.0 154.12 31.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.181 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.519 ' CE2' ' CE1' ' B' ' 29' ' ' TYR . 7.3 t80 179.06 115.19 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.802 HG23 ' CG1' ' B' ' 30' ' ' VAL . 7.7 p -126.88 96.5 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.978 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.1 t 56.72 168.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.993 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.39 -125.15 8.39 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.612 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . 88.1 t80 63.61 137.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.935 0.398 . . . . 0.0 110.967 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.404 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 23.7 m-70 -89.21 152.0 47.35 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.921 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.72 97.42 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.529 2.153 . . . . 0.0 112.324 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 t -176.25 -175.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.402 ' C ' HG23 ' A' ' 16' ' ' ILE . 58.0 t0 -109.21 88.03 2.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.736 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.402 HG23 ' C ' ' A' ' 15' ' ' ASP . 48.8 pt -157.55 -174.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.95 0.405 . . . . 0.0 111.491 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.673 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.3 mm-40 163.53 -81.34 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.554 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 17' ' ' GLU . 0.9 OUTLIER 167.66 120.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.428 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -138.03 141.54 40.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.052 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.495 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.0 OUTLIER -152.38 110.79 3.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.735 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.417 ' HA ' ' HB3' ' B' ' 43' ' ' LEU . 70.5 mt -90.5 -28.97 18.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.2 tttp . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.8 -179.919 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.884 0.373 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.55 102.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.971 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.836 ' CZ ' HD13 ' C' ' 64' ' ' LEU . 0.2 OUTLIER -144.95 130.61 18.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.769 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.692 HD12 ' C ' ' B' ' 25' ' ' PHE . 5.4 mp -129.89 117.71 20.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.075 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.494 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 1.7 t30 -105.47 88.66 2.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.645 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 34.3 t -96.24 108.67 21.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.956 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.519 ' CE1' ' CE2' ' A' ' 7' ' ' TYR . 4.3 t80 -135.48 127.13 29.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.71 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.802 ' CG1' HG23 ' A' ' 8' ' ' VAL . 7.6 p -142.64 154.46 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.983 0.42 . . . . 0.0 111.423 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.43 ' N ' HG22 ' B' ' 30' ' ' VAL . 4.2 t 74.41 158.16 0.2 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.156 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.49 -168.0 12.77 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.444 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' PHE . . . . . 0.694 ' HZ ' HD11 ' B' ' 38' ' ' ILE . 43.9 p90 -179.42 -175.75 0.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.862 0.363 . . . . 0.0 110.986 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.442 ' HB3' ' HD2' ' B' ' 35' ' ' PRO . 7.5 m-70 -59.72 165.66 4.17 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' B' ' 34' ' ' HIS . 65.7 Cg_exo -51.85 154.9 9.0 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.462 2.108 . . . . 0.0 112.448 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 8.6 p -178.37 -179.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.747 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.27 96.8 5.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.968 0.413 . . . . 0.0 111.351 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.694 HD11 ' HZ ' ' B' ' 33' ' ' PHE . 46.2 mt -97.73 112.13 29.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.423 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.8 tt0 -113.8 109.31 18.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.841 0.353 . . . . 0.0 111.777 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.66 124.41 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.577 ' C ' HD13 ' B' ' 42' ' ' LEU . 9.2 t70 -140.38 121.78 15.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.874 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.737 HD12 ' CE2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -119.22 113.35 20.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' C' ' 65' ' ' LEU . 0.3 OUTLIER -134.06 85.7 2.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.955 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.417 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 3.2 mtpm? . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.896 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.899 0.381 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 60.45 67.66 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.76 ' CE2' HD11 ' D' ' 86' ' ' LEU . 9.9 t80 -91.95 104.8 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.728 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.16 101.81 9.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 49' ' ' ASN . . . . . 0.488 ' HB2' ' CE1' ' C' ' 47' ' ' PHE . 28.8 t-20 -116.67 115.82 26.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.497 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 p -126.73 127.93 45.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.175 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.453 ' HB3' ' CD1' ' D' ' 73' ' ' TYR . 55.9 t80 -135.7 123.09 21.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 52' ' ' VAL . . . . . 0.572 ' HB ' HG23 ' B' ' 30' ' ' VAL . 22.0 t -115.13 130.58 69.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.244 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 53' ' ' SER . . . . . 0.407 ' O ' ' CZ ' ' C' ' 51' ' ' TYR . 4.8 m 70.35 133.68 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.894 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.02 -177.3 19.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.626 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' PHE . . . . . 0.404 ' HZ ' HD12 ' C' ' 60' ' ' ILE . 3.3 p90 -152.26 171.8 17.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.915 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 56' ' ' HIS . . . . . 0.406 ' CB ' ' HD3' ' C' ' 57' ' ' PRO . 0.5 OUTLIER -91.24 -55.09 0.27 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.21 -179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 57' ' ' PRO . . . . . 0.406 ' HD3' ' CB ' ' C' ' 56' ' ' HIS . 90.0 Cg_endo -86.74 -165.35 0.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.631 2.221 . . . . 0.0 112.616 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 78.14 149.24 0.1 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.218 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.403 ' CB ' ' HB2' ' D' ' 81' ' ' ASP . 7.9 m-20 -123.01 121.07 35.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.818 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.972 HD11 HG22 ' D' ' 82' ' ' ILE . 0.1 OUTLIER -126.87 110.62 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.978 0.418 . . . . 0.0 111.309 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -106.3 92.89 4.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.734 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.817 HG12 HD21 ' C' ' 64' ' ' LEU . 44.6 t -90.27 123.37 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.844 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 63' ' ' ASP . . . . . 0.782 ' C ' HD23 ' C' ' 64' ' ' LEU . 4.9 m-20 -133.92 124.03 25.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.156 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 64' ' ' LEU . . . . . 0.836 HD13 ' CZ ' ' B' ' 25' ' ' PHE . 0.1 OUTLIER -136.0 120.03 17.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.505 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.872 HD13 ' N ' ' C' ' 66' ' ' LYS . 0.0 OUTLIER -55.78 -20.66 15.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.652 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 66' ' ' LYS . . . . . 0.872 ' N ' HD13 ' C' ' 65' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.908 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.613 ' O ' HD13 ' D' ' 70' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.765 0.317 . . . . 0.0 111.231 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -62.16 -47.67 83.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 69' ' ' PHE . . . . . 0.725 ' CE1' HD21 ' D' ' 86' ' ' LEU . 34.8 t80 -92.1 108.82 20.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.741 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 70' ' ' LEU . . . . . 0.675 HD12 ' O ' ' D' ' 69' ' ' PHE . 5.1 mp -130.14 78.8 1.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.031 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 71' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -92.56 47.24 1.29 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.824 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 52.7 t -46.42 96.95 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.866 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 73' ' ' TYR . . . . . 0.453 ' CD1' ' HB3' ' C' ' 51' ' ' TYR . 2.4 m-85 -120.98 131.49 54.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.469 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 74' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' C' ' 52' ' ' VAL . 9.3 m -145.45 89.18 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.984 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.02 -53.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.705 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.55 -6.14 81.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.944 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.836 ' CE2' HG21 ' D' ' 82' ' ' ILE . 0.1 OUTLIER -49.74 99.93 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.222 0.534 . . . . 0.0 111.284 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 78' ' ' HIS . . . . . 0.688 ' N ' ' HD2' ' D' ' 79' ' ' PRO . 5.9 t-80 -84.88 -32.56 0.48 Allowed Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.647 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 79' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' D' ' 78' ' ' HIS . 37.2 Cg_endo -67.7 -171.12 0.3 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.641 1.561 . . . . 0.0 112.475 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 80' ' ' SER . . . . . 0.442 ' OG ' HG23 ' D' ' 82' ' ' ILE . 0.0 OUTLIER 66.9 -176.68 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.364 -179.465 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 81' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' C' ' 59' ' ' ASP . 1.5 m-20 -100.6 79.62 2.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 0.0 110.825 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 82' ' ' ILE . . . . . 0.972 HG22 HD11 ' C' ' 60' ' ' ILE . 2.3 pp -110.34 120.29 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.286 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -146.28 131.51 18.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.094 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 64.6 t -117.88 118.65 59.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.865 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 85' ' ' ASP . . . . . 0.403 ' CB ' ' HA ' ' C' ' 63' ' ' ASP . 2.7 t0 -89.13 86.71 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.76 HD11 ' CE2' ' C' ' 47' ' ' PHE . 0.2 OUTLIER -76.01 92.57 3.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.68 33.36 2.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.958 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.939 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.814 0.34 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -62.05 98.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.943 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.739 ' CZ ' HD11 ' B' ' 42' ' ' LEU . 59.7 t80 -102.61 114.11 28.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.896 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.731 HD13 ' C ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -118.96 101.07 7.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.773 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.458 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 49.7 t30 -120.37 83.85 2.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.818 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.4 p -90.44 -179.27 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.918 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -171.52 110.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.946 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.7 p -102.91 135.78 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.7 p -43.48 96.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.968 0.413 . . . . 0.0 111.491 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.54 98.91 0.12 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.99 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' B' ' 36' ' ' SER . 2.2 t80 -111.53 -177.2 3.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.057 0.456 . . . . 0.0 111.448 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.462 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -170.51 -61.18 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.267 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 12' ' ' HIS . 18.5 Cg_endo -57.56 -162.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.392 2.062 . . . . 0.0 111.967 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.01 -65.09 1.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.762 0.315 . . . . 0.0 111.503 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -96.97 109.09 21.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.507 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.414 HG22 HG23 ' B' ' 38' ' ' ILE . 1.2 mp -126.26 143.55 39.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.559 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.432 ' CB ' ' HB3' ' B' ' 39' ' ' GLU . 0.0 OUTLIER -178.71 156.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.728 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.67 HG13 ' N ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -178.71 -171.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.625 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.67 ' N ' HG13 ' A' ' 18' ' ' VAL . 15.0 m-20 127.28 -129.98 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.348 1.059 . . . . 0.0 110.333 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.427 HD12 ' C ' ' A' ' 19' ' ' ASP . 5.1 mp -150.43 157.69 43.32 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.97 0.414 . . . . 0.0 111.173 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.547 HD13 ' HA ' ' B' ' 44' ' ' LYS . 0.2 OUTLIER -102.22 133.96 46.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.603 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.2 mttm . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.934 -179.949 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.846 0.355 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -145.46 -76.47 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.81 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.863 ' CZ ' HD11 ' C' ' 64' ' ' LEU . 48.6 t80 -128.23 128.79 45.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.711 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.76 91.52 2.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.542 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.484 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 52.1 t-20 -105.52 119.04 38.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 22.3 m -114.15 109.32 18.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.321 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.425 ' CE2' ' CB ' ' B' ' 31' ' ' SER . 87.6 t80 -105.49 125.13 50.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.542 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 17.4 t -126.39 76.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.241 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.425 ' CB ' ' CE2' ' B' ' 29' ' ' TYR . 0.0 OUTLIER -56.36 174.0 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.64 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.48 45.12 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.261 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -148.21 -177.05 5.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.925 0.393 . . . . 0.0 111.281 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.499 ' CG ' ' HD2' ' B' ' 35' ' ' PRO . 0.0 OUTLIER -86.7 178.74 2.1 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.927 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.499 ' HD2' ' CG ' ' B' ' 34' ' ' HIS . 66.2 Cg_exo -39.44 132.59 1.55 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.745 2.297 . . . . 0.0 113.356 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.462 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 4.2 p -158.91 151.41 21.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.584 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -102.57 107.24 18.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 111.114 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.414 HG23 HG22 ' A' ' 16' ' ' ILE . 1.9 mp -129.81 130.8 66.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.432 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 4.5 tp10 -130.92 129.58 42.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.06 0.457 . . . . 0.0 111.329 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.471 HG13 ' OD2' ' A' ' 19' ' ' ASP . 96.1 t -125.81 114.87 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.102 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.445 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 1.7 p30 -136.19 104.37 5.63 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.739 HD11 ' CZ ' ' A' ' 3' ' ' PHE . 1.1 mm? -88.32 58.31 4.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.689 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.69 HD13 ' CB ' ' C' ' 65' ' ' LEU . 0.7 OUTLIER 171.33 -163.31 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.424 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.547 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.865 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.849 0.357 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -100.0 -57.63 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.642 ' CZ ' HD12 ' D' ' 86' ' ' LEU . 51.3 t80 -98.26 89.48 4.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.857 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.88 77.01 1.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.625 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 49' ' ' ASN . . . . . 0.494 ' ND2' HG13 ' D' ' 84' ' ' VAL . 50.4 t-20 -97.39 136.77 37.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.583 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 50' ' ' CYS . . . . . 0.401 ' HB3' ' CB ' ' D' ' 72' ' ' CYS . 6.6 p -150.69 123.03 8.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.406 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.506 ' CE2' ' CZ ' ' D' ' 77' ' ' PHE . 3.5 p90 -121.83 144.29 48.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.442 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 52' ' ' VAL . . . . . 0.491 HG22 ' N ' ' C' ' 53' ' ' SER . 12.6 p -141.31 158.81 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.931 0.396 . . . . 0.0 111.763 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 53' ' ' SER . . . . . 0.491 ' N ' HG22 ' C' ' 52' ' ' VAL . 3.8 t 82.24 -71.09 0.05 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.513 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.4 -174.03 52.55 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.49 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 55' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' C' ' 58' ' ' SER . 0.1 OUTLIER -173.97 -177.51 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.346 . . . . 0.0 111.058 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 56' ' ' HIS . . . . . 0.711 ' HB3' ' HD3' ' C' ' 57' ' ' PRO . 6.0 t-80 -109.67 -56.42 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.816 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 57' ' ' PRO . . . . . 0.711 ' HD3' ' HB3' ' C' ' 56' ' ' HIS . 45.3 Cg_endo -94.64 92.1 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.708 2.272 . . . . 0.0 112.694 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 58' ' ' SER . . . . . 0.436 ' HB3' ' CE1' ' C' ' 55' ' ' PHE . 41.2 t -177.98 171.8 1.71 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.851 0.358 . . . . 0.0 111.067 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -135.44 127.38 29.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.124 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.753 HG13 HG22 ' D' ' 82' ' ' ILE . 1.4 pp -151.98 101.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.048 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.39 138.57 35.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.191 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.429 HG22 ' HB ' ' B' ' 40' ' ' VAL . 42.3 t -144.54 120.51 4.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.972 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -144.68 133.77 22.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.895 0.379 . . . . 0.0 111.276 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' LEU . . . . . 0.863 HD11 ' CZ ' ' B' ' 25' ' ' PHE . 0.8 OUTLIER -120.35 128.94 53.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.966 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.839 HD23 ' O ' ' C' ' 66' ' ' LYS . 4.8 tt -138.76 -42.04 0.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.27 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 66' ' ' LYS . . . . . 0.839 ' O ' HD23 ' C' ' 65' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.309 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.783 0.325 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -105.06 26.68 9.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 69' ' ' PHE . . . . . 0.566 ' CE2' ' ND2' ' D' ' 71' ' ' ASN . 7.3 t80 -106.58 86.01 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.044 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.53 93.38 8.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.676 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 71' ' ' ASN . . . . . 0.566 ' ND2' ' CE2' ' D' ' 69' ' ' PHE . 6.0 p30 -96.48 58.66 1.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.979 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 72' ' ' CYS . . . . . 0.401 ' CB ' ' HB3' ' C' ' 50' ' ' CYS . 0.6 OUTLIER -59.7 119.55 7.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.777 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 73' ' ' TYR . . . . . 0.42 ' CD2' ' O ' ' D' ' 71' ' ' ASN . 0.5 OUTLIER -128.84 136.93 51.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.06 0.457 . . . . 0.0 111.233 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 74' ' ' VAL . . . . . 0.448 HG23 ' CB ' ' C' ' 52' ' ' VAL . 0.3 OUTLIER -154.76 58.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.666 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 75' ' ' SER . . . . . 0.402 ' HB2' ' N ' ' C' ' 53' ' ' SER . 0.1 OUTLIER 171.42 176.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.495 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.96 146.36 18.34 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.652 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.506 ' CZ ' ' CE2' ' C' ' 51' ' ' TYR . 0.0 OUTLIER -163.55 75.28 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.737 0.303 . . . . 0.0 111.058 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 78' ' ' HIS . . . . . 0.475 ' HB2' ' HD3' ' D' ' 79' ' ' PRO . 5.7 m170 -69.27 -64.94 1.38 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.821 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 79' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' D' ' 78' ' ' HIS . 90.5 Cg_endo -80.25 88.82 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.469 2.112 . . . . 0.0 112.356 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 27.5 t -175.58 154.57 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 111.096 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -79.56 62.96 4.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.604 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 82' ' ' ILE . . . . . 0.753 HG22 HG13 ' C' ' 60' ' ' ILE . 0.2 OUTLIER -113.65 151.16 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.144 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -161.29 92.34 0.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.159 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 84' ' ' VAL . . . . . 0.494 HG13 ' ND2' ' C' ' 49' ' ' ASN . 84.2 t -105.85 117.75 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.603 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.58 -175.99 1.21 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 0.0 111.18 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.642 HD12 ' CZ ' ' C' ' 47' ' ' PHE . 0.0 OUTLIER -174.23 -172.17 0.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.642 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.605 ' O ' HD23 ' D' ' 87' ' ' LEU . 8.8 tt -46.47 102.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.011 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.832 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.4 p . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.825 0.345 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -121.15 140.75 51.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.001 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.866 ' CD1' HD22 ' A' ' 20' ' ' LEU . 49.1 t80 -165.08 125.48 1.93 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.01 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 3' ' ' PHE . 11.2 mt -130.15 92.15 3.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.041 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.471 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 0.5 OUTLIER -111.56 82.43 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.597 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.4 p -93.17 128.09 38.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.026 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.536 ' CD2' ' CE2' ' B' ' 33' ' ' PHE . 1.5 t80 -113.68 158.78 20.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.727 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.625 HG23 ' HB ' ' B' ' 30' ' ' VAL . 9.3 p -177.1 106.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.564 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.4 t 34.24 98.55 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.542 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.2 123.23 0.7 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.758 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.74 ' CE1' HD11 ' B' ' 38' ' ' ILE . 91.5 t80 -179.55 162.98 1.16 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.783 0.325 . . . . 0.0 111.092 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.476 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -164.02 -65.96 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.008 179.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.788 ' HG2' HD11 ' A' ' 16' ' ' ILE . 43.9 Cg_endo -67.13 115.38 3.61 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.392 2.062 . . . . 0.0 112.04 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.3 m -38.7 -55.67 1.43 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.266 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.39 123.31 30.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.906 0.384 . . . . 0.0 111.267 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.788 HD11 ' HG2' ' A' ' 13' ' ' PRO . 16.9 mm -147.6 133.96 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.917 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -147.04 142.36 27.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.867 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.665 ' HB ' HG13 ' B' ' 40' ' ' VAL . 19.2 t -109.33 159.6 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.49 ' N ' HG12 ' A' ' 18' ' ' VAL . 2.3 t0 -146.74 143.46 28.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.866 HD22 ' CD1' ' A' ' 3' ' ' PHE . 60.4 tp -127.65 141.6 51.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 78.38 96.06 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.917 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.761 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.867 0.365 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -84.69 -79.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.811 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.713 ' CZ ' HD13 ' C' ' 64' ' ' LEU . 84.4 t80 -100.91 110.73 22.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.733 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.402 ' HA ' ' HB3' ' C' ' 48' ' ' LEU . 0.6 OUTLIER -119.04 93.65 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.928 0.394 . . . . 0.0 111.057 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' C' ' 49' ' ' ASN . 32.3 t-20 -127.25 140.55 52.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.796 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' C' ' 50' ' ' CYS . 5.7 p 177.85 161.89 0.57 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.167 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.551 ' CE2' ' CG ' ' C' ' 51' ' ' TYR . 0.9 OUTLIER -129.68 152.79 48.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.125 0.488 . . . . 0.0 111.514 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.625 ' HB ' HG23 ' A' ' 8' ' ' VAL . 24.3 t -121.28 102.64 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.735 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 40.25 -165.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.125 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.24 49.57 8.09 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.978 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' PHE . . . . . 0.536 ' CE2' ' CD2' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -120.41 70.75 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.96 0.409 . . . . 0.0 111.507 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.738 ' N ' ' HD3' ' B' ' 35' ' ' PRO . 0.3 OUTLIER -111.93 18.71 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.738 ' HD3' ' N ' ' B' ' 34' ' ' HIS . 50.3 Cg_exo -53.53 -163.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 121.9 1.734 . . . . 0.0 113.124 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 9.9 t -107.69 -72.73 0.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.731 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.592 ' C ' HD12 ' B' ' 38' ' ' ILE . 14.4 t70 -130.97 113.87 14.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.369 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.74 HD11 ' CE1' ' A' ' 11' ' ' PHE . 1.7 mp -126.33 139.55 51.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.876 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -146.08 156.47 43.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.812 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.665 HG13 ' HB ' ' A' ' 18' ' ' VAL . 21.7 t -134.23 127.63 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -121.15 99.71 6.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.238 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.689 HD22 ' N ' ' B' ' 42' ' ' LEU . 0.9 OUTLIER -97.96 107.55 20.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.57 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.615 HD23 ' N ' ' B' ' 43' ' ' LEU . 1.8 pt? 178.17 -46.63 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.802 0.335 . . . . 0.0 111.218 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.455 ' N ' ' HG ' ' B' ' 43' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.766 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.801 0.334 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -57.57 98.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.958 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.568 ' HE1' HD11 ' C' ' 64' ' ' LEU . 47.6 t80 -102.74 113.46 26.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.548 ' CD2' HD12 ' D' ' 70' ' ' LEU . 0.1 OUTLIER -121.36 86.06 2.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.777 179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 49' ' ' ASN . . . . . 0.483 ' CB ' ' CZ ' ' C' ' 47' ' ' PHE . 5.3 t30 -126.32 83.16 2.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.31 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 50' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' B' ' 28' ' ' CYS . 1.7 p -134.19 -170.97 2.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.277 0.561 . . . . 0.0 112.013 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.551 ' CG ' ' CE2' ' B' ' 29' ' ' TYR . 3.8 p90 -167.48 176.19 6.71 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.611 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 52' ' ' VAL . . . . . 0.58 HG12 ' HB ' ' D' ' 74' ' ' VAL . 15.1 m -136.62 146.69 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.842 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 53' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' C' ' 52' ' ' VAL . 5.1 t 99.67 -172.31 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.228 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.07 -16.76 68.86 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.841 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' PHE . . . . . 0.53 ' CE1' ' CE2' ' B' ' 29' ' ' TYR . 38.4 t80 64.46 120.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.748 0.308 . . . . 0.0 110.89 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 56' ' ' HIS . . . . . 0.421 ' CB ' ' HB3' ' B' ' 34' ' ' HIS . 7.9 m80 -76.72 162.36 70.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.931 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.67 112.0 1.01 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.568 2.179 . . . . 0.0 112.244 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 10.0 t -164.48 159.36 19.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.787 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -100.18 125.8 46.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.008 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.433 HD11 ' HA ' ' D' ' 82' ' ' ILE . 1.6 pp -126.04 116.24 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -110.74 85.97 2.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.036 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.696 HG12 HD21 ' C' ' 64' ' ' LEU . 49.0 t -80.81 120.83 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.878 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 63' ' ' ASP . . . . . 0.758 ' C ' HD23 ' C' ' 64' ' ' LEU . 1.2 m-20 -143.17 117.82 9.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.017 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 64' ' ' LEU . . . . . 0.758 HD23 ' C ' ' C' ' 63' ' ' ASP . 0.1 OUTLIER -137.28 119.76 15.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.641 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.41 HD23 ' N ' ' C' ' 65' ' ' LEU . 2.6 pt? -163.2 -167.0 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.967 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.096 179.826 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.815 0.341 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -154.65 -43.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.153 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 69' ' ' PHE . . . . . 0.423 ' CZ ' ' HB2' ' D' ' 71' ' ' ASN . 21.6 t80 -93.64 142.51 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.043 0.449 . . . . 0.0 111.247 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 70' ' ' LEU . . . . . 0.776 HD22 ' CE2' ' D' ' 73' ' ' TYR . 32.2 mt -159.19 120.49 3.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.969 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 71' ' ' ASN . . . . . 0.631 ' O ' ' N ' ' D' ' 73' ' ' TYR . 4.2 t30 -139.43 173.56 11.42 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 72' ' ' CYS . . . . . 0.443 ' O ' ' HB2' ' C' ' 50' ' ' CYS . 0.5 OUTLIER 37.34 -79.08 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.399 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 73' ' ' TYR . . . . . 0.776 ' CE2' HD22 ' D' ' 70' ' ' LEU . 0.3 OUTLIER 74.83 -87.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 178.279 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 74' ' ' VAL . . . . . 0.58 ' HB ' HG12 ' C' ' 52' ' ' VAL . 41.1 t -101.94 50.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.108 0.48 . . . . 0.0 111.064 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 75' ' ' SER . . . . . 0.481 ' HA ' ' CZ ' ' C' ' 51' ' ' TYR . 3.3 m -92.86 -160.59 0.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.033 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.93 -4.54 0.64 Allowed Glycine 0 CA--C 1.522 0.492 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.226 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.428 ' CE2' ' CE2' ' C' ' 51' ' ' TYR . 0.1 OUTLIER -47.27 171.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 117.05 0.425 . . . . 0.0 111.384 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 78' ' ' HIS . . . . . 0.54 ' CB ' ' HD3' ' D' ' 79' ' ' PRO . 0.0 OUTLIER -115.94 -65.44 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 79' ' ' PRO . . . . . 0.54 ' HD3' ' CB ' ' D' ' 78' ' ' HIS . 60.9 Cg_endo -85.41 -105.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.359 2.039 . . . . 0.0 112.109 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 21.6 t 52.28 175.49 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.964 0.412 . . . . 0.0 111.408 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -120.71 73.06 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.652 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 82' ' ' ILE . . . . . 0.609 HG23 ' O ' ' D' ' 82' ' ' ILE . 0.0 OUTLIER -74.29 108.43 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.199 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.89 106.17 7.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.628 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 21.1 t -123.72 131.04 73.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.379 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -136.34 107.17 6.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.518 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.666 ' N ' HD22 ' D' ' 86' ' ' LEU . 0.2 OUTLIER -106.08 134.59 48.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.074 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.4 ' HB2' ' HB3' ' C' ' 65' ' ' LEU . 2.7 mm? -120.27 -172.67 2.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.695 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mttm . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.827 -179.943 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.435 ' N ' HD23 ' B' ' 42' ' ' LEU . 4.1 p . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.899 0.381 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 3' ' ' PHE . 1.2 m-20 61.12 -174.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.932 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.757 ' CZ ' HD11 ' B' ' 42' ' ' LEU . 0.0 OUTLIER 87.03 177.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.901 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.458 ' N ' ' CG ' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -156.4 128.44 7.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 111.119 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -104.8 109.11 20.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.667 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -91.7 125.73 36.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.187 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.402 ' CE2' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -140.59 122.71 15.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.726 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.524 HG12 HG22 ' B' ' 30' ' ' VAL . 9.5 m -149.09 137.24 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.234 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t 71.95 -67.97 0.24 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.38 -150.2 20.39 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.834 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.414 ' CE2' ' O ' ' A' ' 12' ' ' HIS . 6.2 p90 -173.88 -166.09 0.28 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.811 0.339 . . . . 0.0 110.919 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.414 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 19.9 m80 -67.14 154.36 92.81 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.47 120.28 7.54 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.615 2.21 . . . . 0.0 112.2 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.0 p -169.83 -166.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.809 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.76 101.46 7.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.938 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.466 HG23 ' HA ' ' B' ' 38' ' ' ILE . 16.5 tt -87.84 140.72 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -144.32 162.73 35.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.941 0.4 . . . . 0.0 111.153 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.19 131.59 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.901 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -129.78 121.9 27.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.045 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -104.99 132.28 51.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.926 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.441 HD23 ' HD2' ' A' ' 22' ' ' LYS . 2.1 tp -136.49 -59.48 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.441 ' HD2' HD23 ' A' ' 21' ' ' LEU . 1.9 ptmm? . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.861 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.898 0.38 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -176.66 113.64 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.075 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.709 ' CE2' HD22 ' B' ' 42' ' ' LEU . 63.0 t80 -116.95 121.3 41.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.644 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.709 ' CD1' HD12 ' C' ' 48' ' ' LEU . 0.3 OUTLIER -133.75 98.03 4.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.2 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.511 ' OD1' HG13 ' C' ' 62' ' ' VAL . 0.5 OUTLIER -107.36 83.97 1.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.592 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 12.6 p -106.06 133.18 51.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.173 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.444 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 0.0 OUTLIER -150.41 114.77 5.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.563 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.746 HG12 ' CG2' ' C' ' 52' ' ' VAL . 34.6 m -121.99 131.1 73.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.077 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 22.6 m 64.43 102.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.654 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.448 ' HA3' ' CD2' ' C' ' 55' ' ' PHE . . . -59.39 -116.71 0.01 OUTLIER Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.782 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' PHE . . . . . 0.571 ' CZ ' HD11 ' B' ' 38' ' ' ILE . 0.0 OUTLIER 179.15 -100.18 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.396 0.141 . . . . 0.0 110.787 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.494 ' CG ' ' HD2' ' B' ' 35' ' ' PRO . 0.0 OUTLIER -138.16 179.34 1.35 Allowed Pre-proline 0 N--CA 1.455 -0.19 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.494 ' HD2' ' CG ' ' B' ' 34' ' ' HIS . 99.7 Cg_exo -44.84 88.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.587 2.191 . . . . 0.0 112.566 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.446 ' N ' ' O ' ' B' ' 34' ' ' HIS . 3.3 m -136.24 159.0 43.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.272 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -113.88 111.1 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.816 0.341 . . . . 0.0 111.221 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.571 HD11 ' CZ ' ' B' ' 33' ' ' PHE . 32.9 mt -99.06 94.74 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.749 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -101.99 88.46 3.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.266 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.405 HG23 HG22 ' B' ' 38' ' ' ILE . 95.3 t -91.65 114.92 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.539 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -127.13 112.28 14.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.0 111.492 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.757 HD11 ' CZ ' ' A' ' 3' ' ' PHE . 1.2 mp -102.35 116.62 33.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.111 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.418 HD22 ' H ' ' B' ' 44' ' ' LYS . 0.5 OUTLIER 76.52 -154.18 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.005 -179.3 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.418 ' H ' HD22 ' B' ' 43' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.785 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.764 0.316 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.7 -73.65 0.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.944 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.903 ' O ' HD23 ' C' ' 48' ' ' LEU . 15.3 t80 -137.28 128.45 27.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.996 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.903 HD23 ' O ' ' C' ' 47' ' ' PHE . 6.0 mt -135.35 112.02 10.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.77 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 49' ' ' ASN . . . . . 0.497 ' HB2' ' CE1' ' C' ' 47' ' ' PHE . 38.2 t30 -113.76 139.29 49.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.96 0.409 . . . . 0.0 111.034 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.46 109.21 7.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.594 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.619 ' CZ ' HG21 ' D' ' 82' ' ' ILE . 1.2 t80 -121.24 94.06 4.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.179 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 52' ' ' VAL . . . . . 0.746 ' CG2' HG12 ' B' ' 30' ' ' VAL . 45.9 t -97.59 109.27 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.594 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 53' ' ' SER . . . . . 0.509 ' CB ' ' HB2' ' D' ' 75' ' ' SER . 0.7 OUTLIER -55.7 -175.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.349 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.48 58.73 0.68 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.033 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' PHE . . . . . 0.687 ' CE2' HD11 ' C' ' 60' ' ' ILE . 1.3 p90 -171.74 33.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.32 0.105 . . . . 0.0 110.754 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 56' ' ' HIS . . . . . 0.546 ' CD2' ' HD3' ' C' ' 57' ' ' PRO . 0.0 OUTLIER 12.42 -76.45 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.711 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.231 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 57' ' ' PRO . . . . . 0.546 ' HD3' ' CD2' ' C' ' 56' ' ' HIS . 73.1 Cg_endo -72.45 -162.95 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.233 1.955 . . . . 0.0 112.781 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 79.22 155.52 0.15 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.808 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.496 ' C ' HD12 ' C' ' 60' ' ' ILE . 7.8 t0 -129.17 145.62 51.28 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.588 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.79 HD13 ' CG2' ' D' ' 82' ' ' ILE . 2.1 mp -131.05 112.81 22.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.324 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -114.38 80.71 1.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.739 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.644 HG23 HG22 ' C' ' 60' ' ' ILE . 42.1 t -91.93 121.89 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.139 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -151.45 126.98 10.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' LEU . . . . . 0.727 ' N ' HD13 ' C' ' 64' ' ' LEU . 0.0 OUTLIER -135.26 144.67 46.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.942 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 4.9 mt -97.94 102.75 14.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.924 179.991 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 19.1 p . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.863 0.363 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -68.54 97.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -124.05 113.81 18.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.79 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 70' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' D' ' 70' ' ' LEU . 5.3 tp -122.72 99.65 6.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.793 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 71' ' ' ASN . . . . . 0.415 ' O ' ' CD1' ' D' ' 73' ' ' TYR . 12.7 p-10 -93.89 52.66 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 90.5 m -58.86 123.27 15.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.594 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 73' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' D' ' 71' ' ' ASN . 0.1 OUTLIER -174.58 135.16 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.295 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 74' ' ' VAL . . . . . 0.589 ' O ' ' CB ' ' D' ' 75' ' ' SER . 12.6 p -178.73 160.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.212 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 75' ' ' SER . . . . . 0.589 ' CB ' ' O ' ' D' ' 74' ' ' VAL . 73.7 m 118.18 179.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.872 0.869 . . . . 0.0 110.627 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.51 152.87 20.29 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.44 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.486 ' HD1' ' HG ' ' D' ' 80' ' ' SER . 38.4 p90 -161.76 -31.5 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.47 0.176 . . . . 0.0 111.162 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 78' ' ' HIS . . . . . 0.673 ' CB ' ' CD ' ' D' ' 79' ' ' PRO . 17.9 m170 34.67 -90.18 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 79' ' ' PRO . . . . . 0.673 ' CD ' ' CB ' ' D' ' 78' ' ' HIS . 58.2 Cg_endo -69.37 58.07 1.34 Allowed 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.646 1.564 . . . . 0.0 113.007 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 80' ' ' SER . . . . . 0.486 ' HG ' ' HD1' ' D' ' 77' ' ' PHE . 3.7 p -135.84 155.73 49.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.525 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -110.49 100.07 8.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.797 0.332 . . . . 0.0 111.244 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 82' ' ' ILE . . . . . 0.79 ' CG2' HD13 ' C' ' 60' ' ' ILE . 1.3 pp -122.73 143.87 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.283 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -158.27 124.21 4.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.737 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 84' ' ' VAL . . . . . 0.754 ' CG1' HD11 ' D' ' 86' ' ' LEU . 21.9 t -112.58 132.17 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.341 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 85' ' ' ASP . . . . . 0.528 ' C ' HD13 ' D' ' 86' ' ' LEU . 3.5 m-20 -128.55 105.59 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.82 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.793 HD12 ' CZ ' ' C' ' 47' ' ' PHE . 0.0 OUTLIER -107.76 100.23 9.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 55.6 tp 58.01 104.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.943 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.913 -179.974 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.412 ' CA ' ' HE2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.716 0.293 . . . . 0.0 111.212 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.439 ' OD1' HD11 ' A' ' 4' ' ' LEU . 7.5 p30 44.39 95.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.685 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.917 ' CZ ' HD12 ' B' ' 42' ' ' LEU . 0.5 OUTLIER -76.95 106.2 8.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.506 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.439 HD11 ' OD1' ' A' ' 2' ' ' ASN . 0.5 OUTLIER -97.92 68.07 1.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.542 179.53 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.506 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 6.0 p30 -67.92 -177.48 0.82 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.429 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' B' ' 28' ' ' CYS . 2.8 m 64.92 -167.62 0.22 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.302 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -146.66 151.95 38.08 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.808 0.337 . . . . 0.0 111.402 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 8' ' ' VAL . 7.1 p -95.53 83.24 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.879 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.3 p 61.77 117.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.087 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.98 130.89 5.79 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.641 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.663 ' CE2' HD12 ' A' ' 16' ' ' ILE . 33.7 t80 -179.99 148.87 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.919 0.39 . . . . 0.0 111.035 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.428 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 18.6 p80 -82.37 157.36 67.95 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.792 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 14' ' ' SER . 19.3 Cg_endo -58.76 -159.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.758 2.305 . . . . 0.0 112.556 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER 73.37 -95.9 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.427 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' B' ' 37' ' ' ASP . 0.1 OUTLIER -177.83 160.61 1.52 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.013 0.435 . . . . 0.0 111.408 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.663 HD12 ' CE2' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -96.16 117.42 40.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.681 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 7.0 pt-20 -107.48 115.0 29.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.962 0.41 . . . . 0.0 110.723 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.7 t -150.71 137.17 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -149.51 126.78 11.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.87 0.367 . . . . 0.0 111.326 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' B' ' 43' ' ' LEU . 0.6 OUTLIER 66.6 -66.91 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.656 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.528 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER 41.97 77.19 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.425 -179.462 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.472 ' N ' HD13 ' A' ' 20' ' ' LEU . 1.8 tpmp? . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.9 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.804 0.335 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.84 -44.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.022 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.87 ' CE1' HD11 ' C' ' 64' ' ' LEU . 60.4 t80 -103.66 123.41 46.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.243 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.74 HD12 ' C ' ' B' ' 25' ' ' PHE . 7.2 mp -124.45 122.25 37.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.671 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.521 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 0.8 OUTLIER -126.91 114.99 18.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.531 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 6' ' ' CYS . 2.2 t -116.73 102.2 9.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.356 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.48 ' CE2' HG21 ' C' ' 60' ' ' ILE . 3.9 t80 -125.78 88.84 2.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.546 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -103.38 132.68 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.136 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 15.5 t 65.35 151.69 0.05 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.166 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.16 -139.24 8.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.516 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' PHE . . . . . 0.608 ' CZ ' HD11 ' B' ' 38' ' ' ILE . 0.0 OUTLIER -179.66 -106.65 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 O-C-N 123.008 -0.113 . . . . 0.0 111.149 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.513 ' CB ' ' CD ' ' B' ' 35' ' ' PRO . 0.1 OUTLIER -123.34 -176.7 0.46 Allowed Pre-proline 0 CA--C 1.528 0.106 0 CA-C-O 120.579 0.228 . . . . 0.0 110.589 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' B' ' 34' ' ' HIS . 24.1 Cg_exo -64.26 -0.92 3.19 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.714 2.276 . . . . 0.0 113.092 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.1 t -41.99 160.18 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.935 0.397 . . . . 0.0 111.432 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 7.6 t0 -103.0 143.64 32.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.716 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.608 HD11 ' CZ ' ' B' ' 33' ' ' PHE . 26.4 mm -119.27 123.03 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.213 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -123.28 87.26 2.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.518 HG23 HG22 ' B' ' 38' ' ' ILE . 50.2 t -100.21 119.07 47.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.135 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.779 ' C ' HD13 ' B' ' 42' ' ' LEU . 0.3 OUTLIER -131.7 122.84 26.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.28 179.412 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.917 HD12 ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -120.2 145.88 46.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.062 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.677 HD12 HD13 ' C' ' 65' ' ' LEU . 0.1 OUTLIER 56.6 21.92 6.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.319 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 30.8 tttt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.914 179.895 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.839 0.352 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 66.06 120.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.994 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.909 ' CZ ' HD12 ' D' ' 86' ' ' LEU . 1.7 t80 -108.41 103.35 12.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.641 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.494 HD11 HD23 ' D' ' 70' ' ' LEU . 1.6 mp -107.06 110.13 22.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.862 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 49' ' ' ASN . . . . . 0.424 ' HA ' ' HB3' ' B' ' 27' ' ' ASN . 22.5 t-20 -122.14 97.9 5.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.082 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 13.9 m -109.84 116.96 32.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.689 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.476 ' OH ' ' CD1' ' D' ' 77' ' ' PHE . 0.7 OUTLIER -139.64 149.48 43.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.965 0.412 . . . . 0.0 111.285 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 52' ' ' VAL . . . . . . . . . . . . . 31.3 t -115.53 110.87 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.588 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 11.7 m -52.96 178.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.409 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.93 48.02 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.233 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' PHE . . . . . 0.639 ' HZ ' HD12 ' C' ' 60' ' ' ILE . 0.0 OUTLIER -176.64 141.96 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.168 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 56' ' ' HIS . . . . . 0.43 ' CE1' ' HG3' ' D' ' 79' ' ' PRO . 0.2 OUTLIER -87.23 -62.08 0.24 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.276 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 57' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' C' ' 56' ' ' HIS . 72.9 Cg_endo -76.27 -163.52 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.507 2.138 . . . . 0.0 112.498 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 58' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' C' ' 57' ' ' PRO . 0.4 OUTLIER 80.36 161.89 0.17 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.325 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.06 129.17 47.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.947 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.639 HD12 ' HZ ' ' C' ' 55' ' ' PHE . 0.1 OUTLIER -114.55 96.44 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.93 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -104.28 128.09 52.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.958 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 46.5 t -142.89 120.87 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.957 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -128.44 124.63 36.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.996 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 64' ' ' LEU . . . . . 0.87 HD11 ' CE1' ' B' ' 25' ' ' PHE . 0.1 OUTLIER -98.44 106.02 18.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.677 HD13 HD12 ' B' ' 43' ' ' LEU . 28.6 tp 64.52 -76.57 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.034 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.985 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 87.4 p . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.845 0.355 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 58.54 32.32 22.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.982 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -107.72 109.63 21.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 70' ' ' LEU . . . . . 0.494 HD23 HD11 ' C' ' 48' ' ' LEU . 9.4 tp -132.45 60.02 1.7 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.778 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 71' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -80.59 78.07 7.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.856 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 19.8 t -69.75 123.72 22.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.827 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 73' ' ' TYR . . . . . 0.46 ' HB3' ' CE2' ' C' ' 51' ' ' TYR . 0.2 OUTLIER -131.09 144.85 51.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 18.7 t -121.72 153.09 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.486 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 1.1 t 67.88 -83.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.35 174.37 24.34 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.691 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.618 ' CD2' HG21 ' D' ' 82' ' ' ILE . 0.3 OUTLIER -169.45 159.44 8.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 111.011 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 78' ' ' HIS . . . . . 0.471 ' N ' ' HD2' ' D' ' 79' ' ' PRO . 6.1 t-160 -178.24 -60.76 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.148 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 79' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' D' ' 78' ' ' HIS . 9.2 Cg_endo -52.75 -34.2 63.67 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.5 2.134 . . . . 0.0 112.485 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 24.8 p -75.19 157.21 34.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.831 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.86 115.22 16.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.742 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 82' ' ' ILE . . . . . 0.618 HG21 ' CD2' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -114.01 146.53 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.977 0.418 . . . . 0.0 111.589 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.64 57.46 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 t -80.54 134.79 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 85' ' ' ASP . . . . . 0.68 ' C ' HD13 ' D' ' 86' ' ' LEU . 40.0 m-20 -149.71 137.16 19.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.909 HD12 ' CZ ' ' C' ' 47' ' ' PHE . 0.0 OUTLIER -126.19 94.46 4.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.72 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.651 ' CD1' HD23 ' C' ' 65' ' ' LEU . 4.0 mm? 60.34 99.18 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.765 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.86 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.822 ' CB ' HD23 ' B' ' 42' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.761 0.315 . . . . 0.0 111.078 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -162.08 97.17 1.02 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.094 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.715 ' CZ ' HD11 ' B' ' 42' ' ' LEU . 0.0 OUTLIER -165.48 -172.15 2.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.984 179.674 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.591 HD23 ' H ' ' A' ' 4' ' ' LEU . 1.5 pt? -124.45 119.08 28.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.038 0.447 . . . . 0.0 111.08 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.54 ' ND2' ' CZ ' ' A' ' 3' ' ' PHE . 0.9 OUTLIER -125.88 61.3 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.691 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' B' ' 28' ' ' CYS . 29.5 p -138.29 145.52 41.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.963 0.411 . . . . 0.0 111.472 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -150.85 131.43 13.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.805 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.634 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.0 p -100.19 99.9 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.162 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.428 ' HA ' ' HA3' ' B' ' 32' ' ' GLY . 0.9 OUTLIER 58.46 105.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.066 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.48 135.24 2.11 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.574 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.458 ' CE2' ' CB ' ' B' ' 36' ' ' SER . 5.0 t80 -158.98 93.86 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.762 0.315 . . . . 0.0 110.964 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.462 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 3.0 t-160 -81.23 -47.77 1.09 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.408 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 12' ' ' HIS . 87.7 Cg_endo -82.57 -177.5 3.45 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.469 2.112 . . . . 0.0 112.55 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -115.04 -60.45 1.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.665 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -112.09 104.45 12.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.644 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.8 pt -117.77 118.87 59.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.264 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -118.7 86.94 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.52 HG11 ' HE2' ' A' ' 3' ' ' PHE . 21.3 t -69.51 147.71 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.022 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -148.37 149.04 31.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.964 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.7 112.97 7.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 tp -58.98 -68.86 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.998 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.864 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.879 0.371 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -161.01 106.95 1.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.862 ' CZ ' HD11 ' C' ' 64' ' ' LEU . 77.9 t80 -101.92 122.11 43.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.92 122.28 43.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.723 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.441 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 8.8 t-20 -148.56 101.4 3.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.642 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 7.3 m -152.84 132.95 13.45 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.8 0.333 . . . . 0.0 111.753 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.535 ' CE2' ' HB2' ' C' ' 51' ' ' TYR . 0.1 OUTLIER -130.24 129.86 43.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.411 178.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.938 HG13 ' CG2' ' C' ' 52' ' ' VAL . 39.9 t -128.56 119.22 49.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.841 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 14.2 m 50.56 179.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.606 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 9' ' ' SER . . . 46.1 94.42 0.01 OUTLIER Glycine 0 C--N 1.332 0.355 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.835 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' PHE . . . . . 0.518 ' CE2' HG21 ' C' ' 60' ' ' ILE . 0.1 OUTLIER -130.08 -44.12 1.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.664 0.269 . . . . 0.0 111.214 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 63.61 137.58 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.717 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -51.53 93.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.432 2.088 . . . . 0.0 112.171 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.458 ' CB ' ' CE2' ' A' ' 11' ' ' PHE . 2.4 m -149.51 -167.0 2.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.034 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -141.0 142.62 34.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.073 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.712 HG13 HG22 ' C' ' 60' ' ' ILE . 0.8 OUTLIER -150.69 147.01 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.656 179.484 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -143.18 129.66 20.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.821 0.343 . . . . 0.0 111.133 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.631 ' HB ' HG13 ' C' ' 62' ' ' VAL . 44.3 t -110.63 120.66 61.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.826 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -118.73 94.13 4.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.837 ' HB2' HD22 ' C' ' 64' ' ' LEU . 3.0 mp -110.01 117.46 33.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.676 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.06 122.19 32.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.805 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.825 ' HB3' HD12 ' C' ' 65' ' ' LEU . 8.7 tttm . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.927 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.779 0.323 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 59.77 78.97 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.888 ' CZ ' HD13 ' D' ' 86' ' ' LEU . 31.7 t80 -87.64 102.86 15.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.632 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -103.92 103.24 13.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.903 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' ASN . . . . . 0.459 ' HB2' ' CZ ' ' C' ' 47' ' ' PHE . 23.0 t-20 -127.04 116.44 20.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 50' ' ' CYS . . . . . 0.442 ' CB ' ' HB3' ' D' ' 72' ' ' CYS . 18.9 p -159.74 157.19 28.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.18 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.592 ' HE2' HD12 ' D' ' 82' ' ' ILE . 0.5 OUTLIER -162.78 147.21 11.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.771 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 52' ' ' VAL . . . . . 0.938 ' CG2' HG13 ' B' ' 30' ' ' VAL . 32.8 m -134.53 114.45 18.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.181 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 5.5 t 166.72 -86.39 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.767 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 54' ' ' GLY . . . . . 0.556 ' O ' ' CD1' ' C' ' 55' ' ' PHE . . . 108.92 -56.09 0.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.895 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 55' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' C' ' 54' ' ' GLY . 4.9 p90 43.02 -176.97 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.098 0.475 . . . . 0.0 111.99 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 56' ' ' HIS . . . . . 0.528 ' CB ' ' HD3' ' C' ' 57' ' ' PRO . 0.0 OUTLIER -99.51 -61.96 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.783 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 57' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' C' ' 56' ' ' HIS . 52.4 Cg_endo -88.27 -151.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.795 2.33 . . . . 0.0 112.027 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 58' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' C' ' 57' ' ' PRO . 1.0 OUTLIER 86.69 125.06 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.181 0.515 . . . . 0.0 111.375 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.445 ' HA ' ' CB ' ' D' ' 81' ' ' ASP . 8.1 t0 -112.51 95.51 5.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.213 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.797 HD11 HG22 ' D' ' 82' ' ' ILE . 0.2 OUTLIER -134.01 140.87 45.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.199 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -156.49 133.41 10.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.053 0.454 . . . . 0.0 111.185 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.631 HG13 ' HB ' ' B' ' 40' ' ' VAL . 48.0 t -109.29 121.01 61.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.647 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 63' ' ' ASP . . . . . 0.776 ' C ' HD23 ' C' ' 64' ' ' LEU . 5.1 p-10 -125.13 128.33 48.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.269 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 64' ' ' LEU . . . . . 0.862 HD11 ' CZ ' ' B' ' 25' ' ' PHE . 5.2 mt -124.78 110.05 13.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.563 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.825 HD12 ' HB3' ' B' ' 44' ' ' LYS . 0.5 OUTLIER 62.91 126.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.789 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 18.1 ttpt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.888 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.694 0.283 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -177.75 -35.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.297 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 69' ' ' PHE . . . . . 0.422 ' HB2' ' CD1' ' C' ' 47' ' ' PHE . 0.1 OUTLIER -120.37 170.67 9.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.79 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 24.0 tp -152.22 109.06 3.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.117 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 71' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -102.18 65.3 0.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.47 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 72' ' ' CYS . . . . . 0.442 ' HB3' ' CB ' ' C' ' 50' ' ' CYS . 50.9 t -75.03 101.66 4.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 73' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -107.15 128.86 54.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.103 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 74' ' ' VAL . . . . . 0.885 ' HB ' HG12 ' C' ' 52' ' ' VAL . 10.9 t -133.33 73.87 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.13 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 75' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' D' ' 74' ' ' VAL . 1.4 p 174.63 137.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.451 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 76' ' ' GLY . . . . . 0.485 ' O ' ' CG ' ' D' ' 77' ' ' PHE . . . -50.38 -87.02 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.679 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.657 ' HD1' HD11 ' D' ' 82' ' ' ILE . 0.4 OUTLIER 162.8 -60.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 122.482 0.313 . . . . 0.0 110.616 178.803 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 78' ' ' HIS . . . . . 0.467 ' HB3' ' HD2' ' D' ' 79' ' ' PRO . 20.0 m-70 58.54 164.62 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.545 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 79' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' D' ' 78' ' ' HIS . 18.7 Cg_endo -59.32 75.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.517 2.145 . . . . 0.0 112.344 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 80' ' ' SER . . . . . 0.444 ' N ' ' O ' ' D' ' 78' ' ' HIS . 9.7 p -127.61 -163.34 1.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.454 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 81' ' ' ASP . . . . . 0.445 ' CB ' ' HA ' ' C' ' 59' ' ' ASP . 0.2 OUTLIER -130.78 43.97 3.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.782 0.325 . . . . 0.0 111.31 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 82' ' ' ILE . . . . . 0.797 HG22 HD11 ' C' ' 60' ' ' ILE . 35.6 pt -99.7 117.85 45.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.882 0.372 . . . . 0.0 110.814 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -148.02 162.43 39.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.022 0.439 . . . . 0.0 111.523 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 48.0 t -141.76 130.22 22.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.94 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -135.59 108.77 7.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.925 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.888 HD13 ' CZ ' ' C' ' 47' ' ' PHE . 0.4 OUTLIER -120.03 96.18 5.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.055 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mp 60.57 -81.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.054 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 88' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' D' ' 86' ' ' LEU . 3.4 tttp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.097 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.739 0.304 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -61.33 136.98 58.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.789 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.703 ' C ' HD13 ' A' ' 4' ' ' LEU . 46.5 t80 -145.67 129.08 16.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.73 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.72 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -147.48 83.87 1.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.295 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 6.5 t-20 -71.97 115.96 11.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.417 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.87 112.13 22.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.958 0.408 . . . . 0.0 111.714 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.47 ' OH ' ' CE1' ' B' ' 33' ' ' PHE . 0.1 OUTLIER -118.09 128.78 55.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.98 179.066 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.5 80.36 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.097 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 43.61 95.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.596 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.5 137.28 3.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.148 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.511 ' CD1' HD11 ' B' ' 38' ' ' ILE . 5.6 p90 -177.44 169.3 2.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.686 0.279 . . . . 0.0 110.733 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.588 ' HB3' ' HD2' ' A' ' 13' ' ' PRO . 1.8 m80 -58.89 176.04 0.3 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.719 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 12' ' ' HIS . 86.1 Cg_endo -81.68 175.45 9.42 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.367 2.045 . . . . 0.0 112.158 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m 65.5 -161.56 0.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.743 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -106.36 118.39 36.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.971 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 17' ' ' GLU . 23.4 mm -79.24 159.11 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.977 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.473 ' N ' HG22 ' A' ' 16' ' ' ILE . 0.7 OUTLIER -146.16 59.56 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.191 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.73 118.46 10.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.498 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' B' ' 41' ' ' ASP . 3.1 p30 -134.76 161.98 33.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.957 0.408 . . . . 0.0 111.398 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.667 HD12 ' CE2' ' A' ' 3' ' ' PHE . 24.1 mt -152.95 122.9 6.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.894 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.586 ' N ' HD22 ' A' ' 21' ' ' LEU . 2.6 mm? 63.7 -178.69 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.731 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.852 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.851 0.358 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 43.01 46.71 4.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.463 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.95 ' CZ ' HD11 ' C' ' 64' ' ' LEU . 37.6 t80 -121.23 142.15 50.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.784 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -147.42 115.81 6.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.442 ' HB2' ' CE1' ' B' ' 25' ' ' PHE . 46.4 t30 -122.73 90.66 3.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.775 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 91.6 m -81.93 117.44 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.73 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.461 ' CZ ' HG13 ' C' ' 60' ' ' ILE . 1.7 t80 -111.69 104.79 13.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.014 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.453 ' HA ' ' CG2' ' C' ' 52' ' ' VAL . 15.3 t -104.04 105.29 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.567 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 13.8 m -57.21 -178.32 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.982 0.42 . . . . 0.0 111.276 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.18 50.72 0.76 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.464 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' PHE . . . . . 0.47 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -165.25 161.02 18.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.771 0.319 . . . . 0.0 111.233 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.637 ' N ' ' HD3' ' B' ' 35' ' ' PRO . 4.7 p80 -148.0 53.53 1.54 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.182 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.637 ' HD3' ' N ' ' B' ' 34' ' ' HIS . 2.3 Cg_endo -83.37 -72.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.08 2.52 . . . . 0.0 112.465 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 47.3 t -158.1 -119.94 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.185 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -126.83 163.94 22.49 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.86 0.362 . . . . 0.0 111.015 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.511 HD11 ' CD1' ' A' ' 11' ' ' PHE . 25.0 mt -145.57 136.04 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.927 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -129.92 145.36 51.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.94 0.4 . . . . 0.0 111.227 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.403 ' HB ' ' HA ' ' C' ' 62' ' ' VAL . 40.7 t -142.85 140.38 27.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.814 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 19' ' ' ASP . 14.5 t0 -162.61 118.1 1.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.658 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.589 ' HG ' HD23 ' B' ' 43' ' ' LEU . 0.4 OUTLIER -158.9 -171.0 3.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.051 0.453 . . . . 0.0 111.482 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.589 HD23 ' HG ' ' B' ' 42' ' ' LEU . 2.6 mm? 58.54 162.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.211 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.99 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.814 0.34 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 46' ' ' ASN . . . . . 0.411 ' CB ' ' HB2' ' D' ' 68' ' ' ASN . 8.2 p-10 -175.9 174.39 2.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.102 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.643 ' CZ ' HD11 ' D' ' 86' ' ' LEU . 62.1 t80 -85.78 107.64 17.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.632 HD13 HD23 ' D' ' 70' ' ' LEU . 21.4 tp -117.37 83.5 2.0 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.983 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 49' ' ' ASN . . . . . 0.513 ' HB2' ' CZ ' ' C' ' 47' ' ' PHE . 3.7 t-20 -98.35 102.9 14.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.593 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.72 115.11 20.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.813 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -116.07 102.75 9.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.063 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 52' ' ' VAL . . . . . 0.559 HG23 ' O ' ' C' ' 52' ' ' VAL . 34.1 m -113.68 114.31 46.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 15.1 p -50.93 178.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.626 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.88 -30.49 2.16 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.087 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' PHE . . . . . 0.46 ' CZ ' ' CB ' ' D' ' 80' ' ' SER . 0.0 OUTLIER -92.73 -163.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 111.323 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 56' ' ' HIS . . . . . 0.483 ' CB ' ' HD3' ' C' ' 57' ' ' PRO . 0.0 OUTLIER -169.68 -55.63 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.81 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 57' ' ' PRO . . . . . 0.483 ' HD3' ' CB ' ' C' ' 56' ' ' HIS . 69.0 Cg_endo -94.8 66.61 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.008 2.472 . . . . 0.0 112.617 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.0 158.07 32.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.97 0.414 . . . . 0.0 111.028 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.825 ' O ' HD13 ' C' ' 60' ' ' ILE . 0.2 OUTLIER -113.83 139.14 49.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.795 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.825 HD13 ' O ' ' C' ' 59' ' ' ASP . 6.1 mm -139.42 103.71 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.311 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.73 129.41 55.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.692 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.403 ' HA ' ' HB ' ' B' ' 40' ' ' VAL . 21.2 t -133.57 145.48 33.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.312 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 63' ' ' ASP . . . . . 0.544 ' O ' HD12 ' C' ' 64' ' ' LEU . 0.4 OUTLIER -139.52 148.7 43.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.027 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 64' ' ' LEU . . . . . 0.95 HD11 ' CZ ' ' B' ' 25' ' ' PHE . 0.6 OUTLIER -151.09 73.43 1.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.468 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.803 HD22 ' N ' ' C' ' 66' ' ' LYS . 1.2 tm? 157.65 137.17 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.449 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 66' ' ' LYS . . . . . 0.803 ' N ' HD22 ' C' ' 65' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.86 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.746 0.308 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 68' ' ' ASN . . . . . 0.411 ' HB2' ' CB ' ' C' ' 46' ' ' ASN . 76.1 m-20 -56.76 129.25 40.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.048 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 69' ' ' PHE . . . . . 0.449 ' HE2' HD23 ' D' ' 86' ' ' LEU . 24.6 t80 -130.28 139.78 50.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 70' ' ' LEU . . . . . 0.632 HD23 HD13 ' C' ' 48' ' ' LEU . 12.7 tp -157.41 95.96 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.753 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 71' ' ' ASN . . . . . 0.46 HD21 HG21 ' D' ' 84' ' ' VAL . 50.0 t-20 -109.09 122.51 47.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.093 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -95.03 62.8 2.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.594 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.02 72.68 1.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.12 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.04 97.59 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.064 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 80.9 p -174.65 -76.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.923 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.75 -33.27 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.403 ' O ' ' CG ' ' D' ' 78' ' ' HIS . 22.6 m-85 62.74 104.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.734 0.302 . . . . 0.0 111.025 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 78' ' ' HIS . . . . . 0.46 ' CB ' ' CD ' ' D' ' 79' ' ' PRO . 2.0 m-70 -173.81 -64.04 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.946 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 79' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' D' ' 78' ' ' HIS . 33.1 Cg_endo -66.98 -75.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.366 2.044 . . . . 0.0 112.769 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 80' ' ' SER . . . . . 0.46 ' CB ' ' CZ ' ' C' ' 55' ' ' PHE . 35.3 p -58.9 -178.85 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.912 0.387 . . . . 0.0 111.167 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.3 108.47 13.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.829 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 82' ' ' ILE . . . . . 0.712 HG22 ' HB ' ' C' ' 60' ' ' ILE . 0.2 OUTLIER -141.55 161.56 21.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.228 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -168.94 126.45 0.99 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.811 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 84' ' ' VAL . . . . . 0.667 HG12 HD21 ' D' ' 86' ' ' LEU . 21.6 t -111.31 127.49 68.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -139.6 100.06 3.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.716 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.679 HD12 ' HB2' ' C' ' 64' ' ' LEU . 0.2 OUTLIER -103.1 -168.96 1.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.678 ' H ' HD13 ' D' ' 87' ' ' LEU . 0.0 OUTLIER -67.32 66.54 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.215 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.96 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 84.2 p . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.838 0.351 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 60.8 55.66 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.995 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.771 ' O ' HD12 ' B' ' 26' ' ' LEU . 90.0 t80 -59.96 114.76 2.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.805 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 4' ' ' LEU . 1.9 pp -124.1 98.48 5.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.811 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -83.79 93.01 7.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.889 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.9 m -89.07 102.59 15.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' B' ' 29' ' ' TYR . 8.3 t80 -108.21 117.91 35.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.69 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.745 ' HA ' HG22 ' B' ' 30' ' ' VAL . 7.1 p -121.39 87.64 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.962 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.418 ' CB ' ' HA3' ' B' ' 32' ' ' GLY . 67.0 p 46.54 -167.85 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.777 0.322 . . . . 0.0 111.084 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.61 159.77 34.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.042 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' B' ' 36' ' ' SER . 0.2 OUTLIER 177.22 113.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.826 0.346 . . . . 0.0 110.56 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.415 ' HB2' ' HD3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -92.12 -54.3 0.26 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.438 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.428 ' CG ' HG12 ' A' ' 16' ' ' ILE . 94.9 Cg_endo -83.53 -97.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.477 2.118 . . . . 0.0 112.646 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.404 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 14.8 p -178.67 -52.81 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.749 0.309 . . . . 0.0 111.102 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -114.86 86.43 2.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.266 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.75 HD12 ' N ' ' A' ' 17' ' ' GLU . 2.2 pp -156.32 -170.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.683 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.751 ' HG3' HG23 ' A' ' 18' ' ' VAL . 37.4 tp10 160.01 -82.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.527 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.788 ' HB ' HG13 ' B' ' 40' ' ' VAL . 47.7 t -139.8 139.45 37.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.96 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -154.34 83.42 1.12 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 3.2 mm? -86.91 87.26 7.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.765 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.764 HD11 ' HG3' ' B' ' 44' ' ' LYS . 0.9 OUTLIER 33.38 94.61 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.144 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.947 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 72.1 m . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.876 0.37 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 61.01 89.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.722 ' CZ ' HD12 ' C' ' 64' ' ' LEU . 56.5 t80 -106.35 117.83 35.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.677 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.771 HD12 ' O ' ' A' ' 3' ' ' PHE . 1.4 mp -131.71 95.85 3.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.077 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.462 ' HB2' ' CE1' ' B' ' 25' ' ' PHE . 0.1 OUTLIER -102.21 110.06 21.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.656 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' C' ' 50' ' ' CYS . 27.7 p -126.17 128.67 47.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.5 ' CE1' ' CE2' ' C' ' 55' ' ' PHE . 2.4 p90 -133.72 156.39 48.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.001 0.429 . . . . 0.0 111.39 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.745 HG22 ' HA ' ' A' ' 8' ' ' VAL . 16.6 m -129.05 134.13 64.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.754 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.0 t -44.74 167.53 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.644 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 9' ' ' SER . . . 150.89 -37.76 0.87 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.786 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' PHE . . . . . 0.483 ' CZ ' ' CE2' ' C' ' 55' ' ' PHE . 6.7 p90 -90.19 163.64 14.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 111.132 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.55 171.64 9.38 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.992 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -42.45 94.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.746 2.297 . . . . 0.0 112.628 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.451 ' HB3' ' CE2' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -124.53 -165.37 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.806 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.81 106.4 10.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.981 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.451 HD12 ' CZ ' ' B' ' 33' ' ' PHE . 0.0 OUTLIER -107.94 116.25 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.521 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 18.6 pt-20 -128.19 117.43 21.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.859 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.788 HG13 ' HB ' ' A' ' 18' ' ' VAL . 39.5 t -93.62 122.64 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.997 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -127.76 93.75 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.438 ' CD1' ' CZ ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER -106.53 108.51 20.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.004 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.574 HD13 HD12 ' C' ' 65' ' ' LEU . 4.4 mm? -112.8 35.4 3.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.03 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.764 ' HG3' HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.785 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.74 0.305 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -170.77 118.9 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.15 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.573 ' CE2' HD12 ' D' ' 86' ' ' LEU . 47.2 t80 -114.43 112.2 22.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.51 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.448 HD22 HD23 ' B' ' 26' ' ' LEU . 0.1 OUTLIER -120.47 94.21 4.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.212 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 49' ' ' ASN . . . . . 0.495 ' HB2' ' CZ ' ' C' ' 47' ' ' PHE . 36.3 t30 -110.12 80.63 1.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.026 0.441 . . . . 0.0 110.676 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 50' ' ' CYS . . . . . 0.495 ' HB3' ' CD2' ' D' ' 73' ' ' TYR . 32.0 p -107.83 154.04 22.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.595 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.499 ' CZ ' ' HA ' ' D' ' 72' ' ' CYS . 0.2 OUTLIER -148.24 160.58 42.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.457 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 52' ' ' VAL . . . . . 0.563 HG13 HG11 ' D' ' 74' ' ' VAL . 20.2 t -124.84 124.87 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.457 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.26 -172.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.096 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 54' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' D' ' 77' ' ' PHE . . . -122.76 172.35 15.81 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.636 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 55' ' ' PHE . . . . . 0.5 ' CE2' ' CE1' ' B' ' 29' ' ' TYR . 0.1 OUTLIER -143.86 60.21 1.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 111.317 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 56' ' ' HIS . . . . . 0.527 ' HB3' ' HD2' ' C' ' 57' ' ' PRO . 1.2 m80 59.89 165.47 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.466 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 57' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' C' ' 56' ' ' HIS . 34.9 Cg_endo -64.68 79.73 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.416 2.078 . . . . 0.0 112.282 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 1.5 t -96.83 -167.46 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.039 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.09 129.03 44.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.733 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.634 HD12 HG22 ' D' ' 82' ' ' ILE . 6.6 mt -127.8 120.1 53.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.294 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -111.04 77.47 1.04 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.552 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.596 HG12 HD11 ' C' ' 64' ' ' LEU . 22.3 t -79.26 124.69 37.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.29 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 63' ' ' ASP . . . . . 0.791 ' C ' HD13 ' C' ' 64' ' ' LEU . 6.6 t0 -149.9 121.22 7.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.759 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 64' ' ' LEU . . . . . 0.791 HD13 ' C ' ' C' ' 63' ' ' ASP . 0.0 OUTLIER -137.2 140.79 41.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.574 HD12 HD13 ' B' ' 43' ' ' LEU . 0.9 OUTLIER -89.3 -66.05 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.861 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.824 179.909 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.828 0.347 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 55.85 96.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.01 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -113.13 128.63 56.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.008 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 70' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' D' ' 70' ' ' LEU . 2.8 tp -155.49 88.0 1.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 71' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' D' ' 73' ' ' TYR . 17.9 p-10 -125.49 -157.53 0.79 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.356 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 72' ' ' CYS . . . . . 0.499 ' HA ' ' CZ ' ' C' ' 51' ' ' TYR . 36.1 t 55.82 -83.36 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.896 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 73' ' ' TYR . . . . . 0.495 ' CD2' ' HB3' ' C' ' 50' ' ' CYS . 1.0 OUTLIER 66.76 -93.66 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 177.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 74' ' ' VAL . . . . . 0.563 HG11 HG13 ' C' ' 52' ' ' VAL . 40.1 t -109.44 64.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 120.989 0.423 . . . . 0.0 110.848 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -60.83 -164.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.209 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.47 58.15 0.4 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.874 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.458 ' HB3' ' HA2' ' C' ' 54' ' ' GLY . 13.6 p90 -130.61 163.77 26.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 111.314 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 78' ' ' HIS . . . . . 0.469 ' CB ' ' HD2' ' D' ' 79' ' ' PRO . 0.4 OUTLIER -76.65 170.0 18.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.279 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 79' ' ' PRO . . . . . 0.469 ' HD2' ' CB ' ' D' ' 78' ' ' HIS . 9.4 Cg_endo -52.46 89.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.411 2.074 . . . . 0.0 112.13 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.99 119.69 39.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.709 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -54.02 96.39 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.835 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 82' ' ' ILE . . . . . 0.634 HG22 HD12 ' C' ' 60' ' ' ILE . 20.6 pt -111.43 125.21 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.364 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -113.11 107.68 16.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.531 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 84' ' ' VAL . . . . . 0.559 ' CG1' HD11 ' D' ' 86' ' ' LEU . 21.5 t -94.15 130.56 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.491 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 85' ' ' ASP . . . . . 0.418 ' O ' HD22 ' C' ' 64' ' ' LEU . 1.8 m-20 -134.33 92.6 2.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.664 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.642 ' H ' HD22 ' D' ' 86' ' ' LEU . 0.2 OUTLIER -88.46 80.05 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.929 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 27.0 tp 60.42 111.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.889 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.865 0.364 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -176.55 86.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.835 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.738 ' CZ ' HD11 ' B' ' 42' ' ' LEU . 4.9 t80 -109.03 160.06 16.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.756 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.493 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 13.9 tp -145.28 142.64 29.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 0.0 111.346 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.466 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 5.3 t30 -159.02 115.27 2.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.468 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.7 t -126.85 146.23 50.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.316 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.402 ' HH ' ' HD2' ' B' ' 33' ' ' PHE . 0.5 OUTLIER -123.18 135.31 54.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.315 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.8 t -144.67 125.71 8.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.814 0.34 . . . . 0.0 111.404 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t 67.12 -160.38 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.041 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.97 -133.95 0.01 OUTLIER Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.757 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.443 ' CZ ' ' HB2' ' B' ' 36' ' ' SER . 0.0 OUTLIER -175.77 -164.89 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.743 0.306 . . . . 0.0 111.077 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.513 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -119.7 -70.02 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.324 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 12' ' ' HIS . 19.1 Cg_endo -58.14 -164.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.312 2.008 . . . . 0.0 112.153 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -130.79 -63.65 0.86 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.934 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -97.84 96.26 8.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.729 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.1 mt -96.88 146.98 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.202 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -149.56 120.85 7.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.872 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.436 HG12 HD21 ' B' ' 42' ' ' LEU . 16.5 t -107.28 129.62 60.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.285 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -145.48 89.92 1.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.745 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.507 ' CB ' HD22 ' B' ' 42' ' ' LEU . 0.3 OUTLIER -111.1 127.7 55.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.051 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mp -134.98 -171.08 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.828 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.841 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.489 ' HA ' HD23 ' C' ' 64' ' ' LEU . 66.4 m . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.773 0.32 . . . . 0.0 111.313 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -176.37 55.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.956 0.408 . . . . 0.0 110.943 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.87 ' CE2' HD11 ' C' ' 64' ' ' LEU . 0.1 OUTLIER -169.35 159.03 8.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.144 0.497 . . . . 0.0 111.379 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.794 HD12 ' HB2' ' C' ' 48' ' ' LEU . 0.2 OUTLIER -106.91 119.28 38.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.512 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -97.86 155.69 16.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.264 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 38.1 t -163.74 153.43 14.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.758 0.313 . . . . 0.0 111.221 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.468 ' CD2' ' HB2' ' C' ' 51' ' ' TYR . 0.0 OUTLIER -176.07 125.55 0.2 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.984 0.421 . . . . 0.0 110.964 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 31.1 m -128.37 128.59 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.256 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 73.49 147.12 0.09 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.054 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.69 -148.43 1.62 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.584 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' PHE . . . . . 0.723 ' HE2' HD11 ' B' ' 38' ' ' ILE . 0.0 OUTLIER -179.05 37.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.651 0.263 . . . . 0.0 111.596 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.443 ' CG ' ' HD2' ' B' ' 35' ' ' PRO . 0.0 OUTLIER 60.74 178.38 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.698 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.443 ' HD2' ' CG ' ' B' ' 34' ' ' HIS . 90.2 Cg_exo -43.0 126.15 4.4 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.596 2.197 . . . . 0.0 112.776 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 5.3 t 179.74 147.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.657 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.94 135.16 55.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.192 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.723 HD11 ' HE2' ' B' ' 33' ' ' PHE . 35.1 mt -135.91 111.43 11.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.88 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.14 82.94 1.75 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.749 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 42.2 t -73.43 120.36 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.969 0.414 . . . . 0.0 111.109 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.55 ' O ' HD23 ' B' ' 42' ' ' LEU . 16.7 m-20 -135.97 110.75 8.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.539 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.738 HD11 ' CZ ' ' A' ' 3' ' ' PHE . 80.6 mt -133.02 143.08 49.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.143 0.497 . . . . 0.0 111.234 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.401 ' HB3' ' N ' ' C' ' 66' ' ' LYS . 3.0 mt 71.47 137.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.571 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 11.5 mttt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.9 -179.84 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.86 0.362 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -94.11 125.37 38.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.028 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.69 ' CE1' HD13 ' C' ' 64' ' ' LEU . 50.1 t80 -131.72 135.4 46.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.81 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 48' ' ' LEU . . . . . 0.794 ' HB2' HD12 ' B' ' 26' ' ' LEU . 17.7 tp -130.2 128.67 42.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.69 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -130.34 95.3 3.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.388 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 3.7 p -117.86 103.9 10.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.387 . . . . 0.0 111.833 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' D' ' 73' ' ' TYR . 3.2 p90 -135.45 153.66 51.7 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.874 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 52' ' ' VAL . . . . . 0.585 ' O ' ' CB ' ' C' ' 53' ' ' SER . 0.8 OUTLIER -176.03 162.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.954 -178.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 53' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' C' ' 52' ' ' VAL . 5.9 t 104.58 80.31 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.496 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.91 -63.26 0.05 OUTLIER Glycine 0 C--N 1.332 0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.993 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' PHE . . . . . 0.541 ' CZ ' HG21 ' D' ' 82' ' ' ILE . 1.3 t80 78.79 78.37 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.819 0.342 . . . . 0.0 110.516 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 56' ' ' HIS . . . . . 0.595 ' N ' ' CD ' ' C' ' 57' ' ' PRO . 0.0 OUTLIER -140.36 38.86 0.32 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 57' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' C' ' 56' ' ' HIS . 36.5 Cg_endo -69.21 -77.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.109 1.872 . . . . 0.0 112.3 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 58' ' ' SER . . . . . 0.423 ' OG ' ' HA ' ' B' ' 35' ' ' PRO . 0.4 OUTLIER 174.38 -79.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 110.689 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -134.42 134.74 41.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.871 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 10.1 mt -151.7 106.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -107.21 103.08 12.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.1 t -91.32 124.23 43.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -128.02 129.66 47.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.036 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 64' ' ' LEU . . . . . 0.87 HD11 ' CE2' ' B' ' 25' ' ' PHE . 0.2 OUTLIER -139.54 98.1 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.512 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 5.8 mt -94.1 -92.86 0.18 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.372 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 66' ' ' LYS . . . . . 0.401 ' N ' ' HB3' ' B' ' 43' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.834 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.785 0.326 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -71.47 105.06 3.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 69' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' D' ' 71' ' ' ASN . 54.5 t80 -118.42 124.72 48.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.781 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 mt -143.83 95.09 2.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.736 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 71' ' ' ASN . . . . . 0.459 ' O ' ' CD2' ' D' ' 73' ' ' TYR . 2.5 t-20 -100.73 79.95 2.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 1.4 m -73.57 109.31 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.459 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 73' ' ' TYR . . . . . 0.49 ' HB3' ' CE1' ' C' ' 51' ' ' TYR . 1.7 p90 -118.73 118.95 33.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.4 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 74' ' ' VAL . . . . . 0.525 ' HB ' ' HB ' ' C' ' 52' ' ' VAL . 3.5 t -132.72 86.86 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.019 0.438 . . . . 0.0 111.054 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 1.4 t 169.34 -53.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.689 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.38 -154.3 25.56 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.22 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 77' ' ' PHE . . . . . 0.459 ' HZ ' HG23 ' D' ' 84' ' ' VAL . 0.1 OUTLIER -177.19 88.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 111.183 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 78' ' ' HIS . . . . . 0.492 ' HB3' ' HD3' ' D' ' 79' ' ' PRO . 9.7 t-160 176.47 -57.94 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 79' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' D' ' 78' ' ' HIS . 55.5 Cg_endo -69.37 62.69 1.56 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.303 2.002 . . . . 0.0 112.389 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 80' ' ' SER . . . . . 0.423 ' CB ' HD12 ' D' ' 82' ' ' ILE . 1.9 m 178.77 159.49 0.58 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -96.37 60.26 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.604 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 82' ' ' ILE . . . . . 0.719 ' H ' HD13 ' D' ' 82' ' ' ILE . 0.2 OUTLIER -120.6 -179.87 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.243 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -176.57 145.49 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 84' ' ' VAL . . . . . 0.459 HG23 ' HZ ' ' D' ' 77' ' ' PHE . 80.2 t -112.69 117.58 55.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.979 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -138.31 112.57 8.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.543 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.674 HD11 ' CE2' ' C' ' 47' ' ' PHE . 1.9 pt? -173.22 175.71 3.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.299 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 55.66 89.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.037 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 5.4 mttt . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.75 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.845 0.355 . . . . 0.0 111.195 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.32 85.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.66 ' CE2' ' CD1' ' B' ' 42' ' ' LEU . 16.7 t80 -127.35 110.22 12.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.967 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.542 ' O ' HD12 ' A' ' 4' ' ' LEU . 0.4 OUTLIER -108.05 117.47 34.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.723 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 1.1 p30 -129.45 67.97 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.047 0.451 . . . . 0.0 110.578 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 52.9 t -90.41 117.54 29.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.578 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.511 ' OH ' ' CE1' ' B' ' 29' ' ' TYR . 0.0 OUTLIER -119.98 132.59 55.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.252 0.549 . . . . 0.0 110.948 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.952 HG12 HG22 ' B' ' 30' ' ' VAL . 5.5 m -142.51 165.53 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.356 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 p 77.47 -166.47 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.394 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.77 -164.31 28.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.91 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.494 ' HB2' ' CD2' ' B' ' 33' ' ' PHE . 0.0 OUTLIER -130.85 -157.51 0.83 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.739 0.304 . . . . 0.0 110.76 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.443 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -175.15 -60.33 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.85 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 12' ' ' HIS . 34.0 Cg_endo -64.0 -22.94 68.01 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.326 2.017 . . . . 0.0 112.127 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.7 m 69.83 -64.34 0.35 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.226 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.59 127.24 32.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.036 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.795 HD13 ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -158.1 138.81 4.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.197 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.795 ' N ' HD13 ' A' ' 16' ' ' ILE . 4.4 pt-20 -139.37 137.73 35.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.004 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.481 ' HB ' HG13 ' B' ' 40' ' ' VAL . 25.3 t -115.3 125.72 72.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.957 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.61 132.42 55.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.044 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.936 ' HB2' HD22 ' B' ' 42' ' ' LEU . 1.8 mt -170.44 35.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.695 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.591 HD23 ' OXT' ' A' ' 22' ' ' LYS . 2.5 tt -100.95 -61.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.884 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.591 ' OXT' HD23 ' A' ' 21' ' ' LEU . 2.7 mttm . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.915 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.587 ' HB2' HD13 ' B' ' 26' ' ' LEU . 5.9 p . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.875 0.369 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.432 ' HB3' ' CB ' ' C' ' 46' ' ' ASN . 31.8 t-20 65.36 -89.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.381 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.817 ' CZ ' HD11 ' C' ' 64' ' ' LEU . 9.2 t80 -125.59 105.31 8.93 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.73 0.3 . . . . 0.0 111.013 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.587 HD13 ' HB2' ' B' ' 23' ' ' SER . 9.3 mp -116.2 90.34 3.31 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.444 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.487 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 7.0 t-20 -96.88 110.75 23.19 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.904 0.383 . . . . 0.0 110.751 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 4.1 m -112.04 142.46 44.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.114 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.511 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 0.7 OUTLIER -148.71 102.91 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.551 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.952 HG22 HG12 ' A' ' 8' ' ' VAL . 19.5 m -127.51 135.95 61.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.425 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 76.46 87.66 0.08 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.838 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.63 -173.91 0.49 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.571 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -163.33 -173.56 3.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 0.0 110.928 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.415 ' HB3' ' HD2' ' B' ' 35' ' ' PRO . 39.4 m-70 -59.44 162.21 8.86 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.743 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' B' ' 34' ' ' HIS . 83.6 Cg_exo -47.98 111.92 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.604 2.203 . . . . 0.0 112.639 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.411 ' HB2' ' CE1' ' B' ' 33' ' ' PHE . 12.7 m -133.2 159.87 38.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.724 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.409 ' C ' HD13 ' B' ' 38' ' ' ILE . 6.0 t0 -107.36 105.56 15.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.679 HG23 ' CG2' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -120.09 118.89 58.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.661 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -131.27 139.15 49.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.884 0.373 . . . . 0.0 111.118 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.481 HG13 ' HB ' ' A' ' 18' ' ' VAL . 62.0 t -134.11 119.08 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.956 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.796 ' C ' HD23 ' B' ' 42' ' ' LEU . 14.0 p-10 -122.75 105.1 9.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.765 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.936 HD22 ' HB2' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -133.82 176.79 8.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.052 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' C' ' 65' ' ' LEU . 1.3 tp -135.91 -48.86 0.68 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.784 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.98 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 29.8 p . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.825 0.345 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 46' ' ' ASN . . . . . 0.432 ' CB ' ' HB3' ' B' ' 24' ' ' ASN . 73.9 m-20 58.76 62.89 1.79 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.63 ' CZ ' HD12 ' D' ' 86' ' ' LEU . 6.1 t80 -105.36 120.09 40.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.52 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 43.4 tp -125.57 109.64 12.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.94 0.4 . . . . 0.0 111.264 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 49' ' ' ASN . . . . . 0.442 ' HB3' ' CE1' ' C' ' 47' ' ' PHE . 1.5 p30 -128.37 102.51 6.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.116 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 50' ' ' CYS . . . . . 0.4 ' HB2' ' HB3' ' D' ' 72' ' ' CYS . 13.8 p -116.69 134.35 54.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.372 . . . . 0.0 111.653 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.449 ' CZ ' ' HA ' ' D' ' 73' ' ' TYR . 27.9 p90 -136.96 125.69 23.93 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.771 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 52' ' ' VAL . . . . . 0.901 HG12 ' CG2' ' D' ' 74' ' ' VAL . 1.7 m -132.41 122.77 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.068 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 53' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' C' ' 52' ' ' VAL . 0.4 OUTLIER 165.35 -83.55 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.24 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 180.0 -37.64 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.161 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' PHE . . . . . 0.426 ' O ' ' HG2' ' D' ' 79' ' ' PRO . 2.0 m-85 65.49 127.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.719 0.295 . . . . 0.0 111.43 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 56' ' ' HIS . . . . . 0.568 ' HB3' ' HD3' ' C' ' 57' ' ' PRO . 2.7 t60 177.82 -50.66 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.039 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 57' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' C' ' 56' ' ' HIS . 73.4 Cg_endo -92.3 -54.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.763 2.309 . . . . 0.0 113.245 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -53.02 158.24 1.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.215 0.531 . . . . 0.0 111.743 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.421 ' HA ' ' HB2' ' D' ' 81' ' ' ASP . 1.1 m-20 -140.1 100.52 3.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.474 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 60' ' ' ILE . . . . . 0.548 HG23 ' HB ' ' B' ' 38' ' ' ILE . 18.9 mt -115.28 144.1 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.388 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -136.12 83.81 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.077 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -85.93 119.56 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.273 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' D' ' 85' ' ' ASP . 6.6 p-10 -118.34 125.07 49.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 111.196 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 64' ' ' LEU . . . . . 0.817 HD11 ' CZ ' ' B' ' 25' ' ' PHE . 0.7 OUTLIER -117.13 131.86 56.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.834 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 65' ' ' LEU . . . . . 0.616 ' N ' HD22 ' C' ' 65' ' ' LEU . 2.4 mm? 60.36 -179.25 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.938 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.89 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.841 0.353 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 68' ' ' ASN . . . . . 0.478 ' O ' ' ND2' ' D' ' 68' ' ' ASN . 0.3 OUTLIER 54.55 17.97 1.83 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.703 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 69' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' D' ' 71' ' ' ASN . 62.1 t80 -137.98 92.91 2.71 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.777 0.323 . . . . 0.0 110.849 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.17 93.71 5.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.715 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 71' ' ' ASN . . . . . 0.504 ' HB2' ' CZ ' ' D' ' 69' ' ' PHE . 11.5 t-20 -99.67 105.86 17.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.072 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 72' ' ' CYS . . . . . 0.4 ' HB3' ' HB2' ' C' ' 50' ' ' CYS . 6.6 t -81.92 68.82 8.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.558 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 73' ' ' TYR . . . . . 0.449 ' HA ' ' CZ ' ' C' ' 51' ' ' TYR . 0.1 OUTLIER -73.53 79.23 1.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.622 -179.545 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 74' ' ' VAL . . . . . 0.901 ' CG2' HG12 ' C' ' 52' ' ' VAL . 0.1 OUTLIER -122.35 83.82 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.943 0.401 . . . . 0.0 110.935 179.493 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.38 -68.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.672 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.12 -52.6 0.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.318 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.82 94.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.412 . . . . 0.0 111.345 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 78' ' ' HIS . . . . . 0.505 ' CB ' ' HD3' ' D' ' 79' ' ' PRO . 0.2 OUTLIER -164.79 -56.59 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.498 179.523 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 79' ' ' PRO . . . . . 0.505 ' HD3' ' CB ' ' D' ' 78' ' ' HIS . 73.7 Cg_endo -96.4 -164.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.234 2.623 . . . . 0.0 111.57 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 80' ' ' SER . . . . . 0.416 ' OG ' ' N ' ' D' ' 81' ' ' ASP . 1.4 t 55.9 176.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.587 0.232 . . . . 0.0 110.527 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 81' ' ' ASP . . . . . 0.448 ' HB3' ' N ' ' C' ' 60' ' ' ILE . 1.6 t0 -85.17 104.26 14.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.321 . . . . 0.0 111.083 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 82' ' ' ILE . . . . . 0.795 HG22 ' H ' ' D' ' 84' ' ' VAL . 48.6 mm -2.4 -67.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 83' ' ' GLU . . . . . 0.753 ' HG3' HG23 ' D' ' 84' ' ' VAL . 0.0 OUTLIER 98.26 -29.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.053 0.541 . . . . 0.0 110.926 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 84' ' ' VAL . . . . . 0.795 ' H ' HG22 ' D' ' 82' ' ' ILE . 59.7 t -111.99 118.63 58.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.864 0.364 . . . . 0.0 111.754 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 85' ' ' ASP . . . . . 0.492 ' C ' HD13 ' D' ' 86' ' ' LEU . 2.0 m-20 -153.18 123.18 6.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.543 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.852 ' H ' HD22 ' D' ' 86' ' ' LEU . 0.0 OUTLIER -134.43 175.4 9.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.041 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 87' ' ' LEU . . . . . 0.64 ' O ' HD12 ' D' ' 87' ' ' LEU . 2.2 pp -39.04 107.62 0.07 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.794 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.923 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.6 p30 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.828 0.347 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.737 ' CE2' HD12 ' B' ' 42' ' ' LEU . 4.3 t80 -94.74 139.75 30.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.026 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.6 HD12 HD13 ' B' ' 26' ' ' LEU . 0.2 OUTLIER -132.53 77.58 1.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.963 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' B' ' 27' ' ' ASN . 58.9 t30 -67.24 104.65 1.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.527 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.8 p -117.0 154.12 31.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.181 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.519 ' CE2' ' CE1' ' B' ' 29' ' ' TYR . 7.3 t80 179.06 115.19 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.802 HG23 ' CG1' ' B' ' 30' ' ' VAL . 7.7 p -126.88 96.5 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.978 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.1 t 56.72 168.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.993 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.39 -125.15 8.39 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.612 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . 88.1 t80 63.61 137.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.935 0.398 . . . . 0.0 110.967 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.404 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 23.7 m-70 -89.21 152.0 47.35 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.921 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.72 97.42 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.529 2.153 . . . . 0.0 112.324 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 t -176.25 -175.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.402 ' C ' HG23 ' A' ' 16' ' ' ILE . 58.0 t0 -109.21 88.03 2.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.736 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.402 HG23 ' C ' ' A' ' 15' ' ' ASP . 48.8 pt -157.55 -174.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.95 0.405 . . . . 0.0 111.491 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.673 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.3 mm-40 163.53 -81.34 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.554 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 17' ' ' GLU . 0.9 OUTLIER 167.66 120.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.428 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -138.03 141.54 40.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.052 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.495 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.735 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.718 0.294 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.836 ' CZ ' HD13 ' C' ' 64' ' ' LEU . 0.2 OUTLIER -144.95 130.61 18.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.769 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.692 HD12 ' C ' ' B' ' 25' ' ' PHE . 5.4 mp -129.89 117.71 20.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.075 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.494 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 1.7 t30 -105.47 88.66 2.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.645 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 34.3 t -96.24 108.67 21.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.956 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.519 ' CE1' ' CE2' ' A' ' 7' ' ' TYR . 4.3 t80 -135.48 127.13 29.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.71 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.802 ' CG1' HG23 ' A' ' 8' ' ' VAL . 7.6 p -142.64 154.46 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.983 0.42 . . . . 0.0 111.423 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . 0.43 ' N ' HG22 ' B' ' 30' ' ' VAL . 4.2 t 74.41 158.16 0.2 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.156 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.49 -168.0 12.77 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.444 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . 0.694 ' HZ ' HD11 ' B' ' 38' ' ' ILE . 43.9 p90 -179.42 -175.75 0.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.862 0.363 . . . . 0.0 110.986 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.442 ' HB3' ' HD2' ' B' ' 35' ' ' PRO . 7.5 m-70 -59.72 165.66 4.17 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' B' ' 34' ' ' HIS . 65.7 Cg_exo -51.85 154.9 9.0 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.462 2.108 . . . . 0.0 112.448 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 8.6 p -178.37 -179.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.747 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.27 96.8 5.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.968 0.413 . . . . 0.0 111.351 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.694 HD11 ' HZ ' ' B' ' 33' ' ' PHE . 46.2 mt -97.73 112.13 29.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.423 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.8 tt0 -113.8 109.31 18.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.841 0.353 . . . . 0.0 111.777 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.66 124.41 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.577 ' C ' HD13 ' B' ' 42' ' ' LEU . 9.2 t70 -140.38 121.78 15.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.874 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.737 HD12 ' CE2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -119.22 113.35 20.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' C' ' 65' ' ' LEU . 0.3 OUTLIER -134.06 85.7 2.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.955 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.417 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 3.2 mtpm? . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.896 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.899 0.381 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 60.45 67.66 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.76 ' CE2' HD11 ' D' ' 86' ' ' LEU . 9.9 t80 -91.95 104.8 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.728 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.16 101.81 9.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' ASN . . . . . 0.488 ' HB2' ' CE1' ' C' ' 47' ' ' PHE . 28.8 t-20 -116.67 115.82 26.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.497 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 p -126.73 127.93 45.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.175 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.453 ' HB3' ' CD1' ' D' ' 73' ' ' TYR . 55.9 t80 -135.7 123.09 21.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' VAL . . . . . 0.572 ' HB ' HG23 ' B' ' 30' ' ' VAL . 22.0 t -115.13 130.58 69.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.244 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' SER . . . . . 0.407 ' O ' ' CZ ' ' C' ' 51' ' ' TYR . 4.8 m 70.35 133.68 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.894 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.02 -177.3 19.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.626 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . 0.404 ' HZ ' HD12 ' C' ' 60' ' ' ILE . 3.3 p90 -152.26 171.8 17.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.915 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' HIS . . . . . 0.406 ' CB ' ' HD3' ' C' ' 57' ' ' PRO . 0.5 OUTLIER -91.24 -55.09 0.27 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.21 -179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . 0.406 ' HD3' ' CB ' ' C' ' 56' ' ' HIS . 90.0 Cg_endo -86.74 -165.35 0.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.631 2.221 . . . . 0.0 112.616 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 78.14 149.24 0.1 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.218 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.403 ' CB ' ' HB2' ' D' ' 81' ' ' ASP . 7.9 m-20 -123.01 121.07 35.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.818 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.972 HD11 HG22 ' D' ' 82' ' ' ILE . 0.1 OUTLIER -126.87 110.62 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.978 0.418 . . . . 0.0 111.309 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -106.3 92.89 4.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.734 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.817 HG12 HD21 ' C' ' 64' ' ' LEU . 44.6 t -90.27 123.37 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.844 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' ASP . . . . . 0.782 ' C ' HD23 ' C' ' 64' ' ' LEU . 4.9 m-20 -133.92 124.03 25.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.156 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' LEU . . . . . 0.836 HD13 ' CZ ' ' B' ' 25' ' ' PHE . 0.1 OUTLIER -136.0 120.03 17.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.505 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.872 HD13 ' N ' ' C' ' 66' ' ' LYS . 0.0 OUTLIER -55.78 -20.66 15.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.652 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' LYS . . . . . 0.872 ' N ' HD13 ' C' ' 65' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.908 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.613 ' O ' HD13 ' D' ' 70' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.765 0.317 . . . . 0.0 111.231 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -62.16 -47.67 83.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . 0.725 ' CE1' HD21 ' D' ' 86' ' ' LEU . 34.8 t80 -92.1 108.82 20.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.741 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 70' ' ' LEU . . . . . 0.675 HD12 ' O ' ' D' ' 69' ' ' PHE . 5.1 mp -130.14 78.8 1.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.031 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 71' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -92.56 47.24 1.29 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.824 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 52.7 t -46.42 96.95 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.866 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 73' ' ' TYR . . . . . 0.453 ' CD1' ' HB3' ' C' ' 51' ' ' TYR . 2.4 m-85 -120.98 131.49 54.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.469 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' C' ' 52' ' ' VAL . 9.3 m -145.45 89.18 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.984 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.02 -53.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.705 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.55 -6.14 81.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.944 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.836 ' CE2' HG21 ' D' ' 82' ' ' ILE . 0.1 OUTLIER -49.74 99.93 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.222 0.534 . . . . 0.0 111.284 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 78' ' ' HIS . . . . . 0.688 ' N ' ' HD2' ' D' ' 79' ' ' PRO . 5.9 t-80 -84.88 -32.56 0.48 Allowed Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.647 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 79' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' D' ' 78' ' ' HIS . 37.2 Cg_endo -67.7 -171.12 0.3 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.641 1.561 . . . . 0.0 112.475 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 80' ' ' SER . . . . . 0.442 ' OG ' HG23 ' D' ' 82' ' ' ILE . 0.0 OUTLIER 66.9 -176.68 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.364 -179.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 81' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' C' ' 59' ' ' ASP . 1.5 m-20 -100.6 79.62 2.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 0.0 110.825 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 82' ' ' ILE . . . . . 0.972 HG22 HD11 ' C' ' 60' ' ' ILE . 2.3 pp -110.34 120.29 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.286 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -146.28 131.51 18.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.094 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 64.6 t -117.88 118.65 59.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.865 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . 0.403 ' CB ' ' HA ' ' C' ' 63' ' ' ASP . 2.7 t0 -89.13 86.71 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 86' ' ' LEU . . . . . 0.76 HD11 ' CE2' ' C' ' 47' ' ' PHE . 0.2 OUTLIER -76.01 92.57 3.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.958 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 m120 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.784 0.326 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.739 ' CZ ' HD11 ' B' ' 42' ' ' LEU . 59.7 t80 -102.61 114.11 28.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.896 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.731 HD13 ' C ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -118.96 101.07 7.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.773 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.458 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 49.7 t30 -120.37 83.85 2.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.818 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.4 p -90.44 -179.27 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.918 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -171.52 110.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.946 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.7 p -102.91 135.78 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.7 p -43.48 96.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.968 0.413 . . . . 0.0 111.491 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.54 98.91 0.12 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.99 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' B' ' 36' ' ' SER . 2.2 t80 -111.53 -177.2 3.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.057 0.456 . . . . 0.0 111.448 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.462 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -170.51 -61.18 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.267 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 12' ' ' HIS . 18.5 Cg_endo -57.56 -162.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.392 2.062 . . . . 0.0 111.967 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.01 -65.09 1.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.762 0.315 . . . . 0.0 111.503 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -96.97 109.09 21.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.507 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.414 HG22 HG23 ' B' ' 38' ' ' ILE . 1.2 mp -126.26 143.55 39.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.559 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.432 ' CB ' ' HB3' ' B' ' 39' ' ' GLU . 0.0 OUTLIER -178.71 156.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.728 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.67 HG13 ' N ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -178.71 -171.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.625 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.67 ' N ' HG13 ' A' ' 18' ' ' VAL . 15.0 m-20 127.28 -129.98 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.348 1.059 . . . . 0.0 110.333 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.427 HD12 ' C ' ' A' ' 19' ' ' ASP . 5.1 mp . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.97 0.414 . . . . 0.0 111.173 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.794 0.33 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.863 ' CZ ' HD11 ' C' ' 64' ' ' LEU . 48.6 t80 -128.23 128.79 45.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.711 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.76 91.52 2.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.542 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.484 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 52.1 t-20 -105.52 119.04 38.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 22.3 m -114.15 109.32 18.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.321 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.425 ' CE2' ' CB ' ' B' ' 31' ' ' SER . 87.6 t80 -105.49 125.13 50.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.542 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 17.4 t -126.39 76.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.241 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . 0.425 ' CB ' ' CE2' ' B' ' 29' ' ' TYR . 0.0 OUTLIER -56.36 174.0 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.64 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.48 45.12 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.261 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -148.21 -177.05 5.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.925 0.393 . . . . 0.0 111.281 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.499 ' CG ' ' HD2' ' B' ' 35' ' ' PRO . 0.0 OUTLIER -86.7 178.74 2.1 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.927 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.499 ' HD2' ' CG ' ' B' ' 34' ' ' HIS . 66.2 Cg_exo -39.44 132.59 1.55 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.745 2.297 . . . . 0.0 113.356 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . 0.462 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 4.2 p -158.91 151.41 21.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.584 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -102.57 107.24 18.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 111.114 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.414 HG23 HG22 ' A' ' 16' ' ' ILE . 1.9 mp -129.81 130.8 66.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.432 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 4.5 tp10 -130.92 129.58 42.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.06 0.457 . . . . 0.0 111.329 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.471 HG13 ' OD2' ' A' ' 19' ' ' ASP . 96.1 t -125.81 114.87 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.102 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.445 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 1.7 p30 -136.19 104.37 5.63 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.739 HD11 ' CZ ' ' A' ' 3' ' ' PHE . 1.1 mm? -88.32 58.31 4.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.689 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.69 HD13 ' CB ' ' C' ' 65' ' ' LEU . 0.7 OUTLIER 171.33 -163.31 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.424 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.865 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.849 0.357 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -100.0 -57.63 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.642 ' CZ ' HD12 ' D' ' 86' ' ' LEU . 51.3 t80 -98.26 89.48 4.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.857 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.88 77.01 1.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.625 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' ASN . . . . . 0.494 ' ND2' HG13 ' D' ' 84' ' ' VAL . 50.4 t-20 -97.39 136.77 37.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.583 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' CYS . . . . . 0.401 ' HB3' ' CB ' ' D' ' 72' ' ' CYS . 6.6 p -150.69 123.03 8.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.406 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.506 ' CE2' ' CZ ' ' D' ' 77' ' ' PHE . 3.5 p90 -121.83 144.29 48.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.442 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' VAL . . . . . 0.491 HG22 ' N ' ' C' ' 53' ' ' SER . 12.6 p -141.31 158.81 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.931 0.396 . . . . 0.0 111.763 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' SER . . . . . 0.491 ' N ' HG22 ' C' ' 52' ' ' VAL . 3.8 t 82.24 -71.09 0.05 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.513 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.4 -174.03 52.55 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.49 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' C' ' 58' ' ' SER . 0.1 OUTLIER -173.97 -177.51 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.346 . . . . 0.0 111.058 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' HIS . . . . . 0.711 ' HB3' ' HD3' ' C' ' 57' ' ' PRO . 6.0 t-80 -109.67 -56.42 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.816 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . 0.711 ' HD3' ' HB3' ' C' ' 56' ' ' HIS . 45.3 Cg_endo -94.64 92.1 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.708 2.272 . . . . 0.0 112.694 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . 0.436 ' HB3' ' CE1' ' C' ' 55' ' ' PHE . 41.2 t -177.98 171.8 1.71 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.851 0.358 . . . . 0.0 111.067 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -135.44 127.38 29.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.124 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.753 HG13 HG22 ' D' ' 82' ' ' ILE . 1.4 pp -151.98 101.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.048 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.39 138.57 35.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.191 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.429 HG22 ' HB ' ' B' ' 40' ' ' VAL . 42.3 t -144.54 120.51 4.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.972 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -144.68 133.77 22.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.895 0.379 . . . . 0.0 111.276 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' LEU . . . . . 0.863 HD11 ' CZ ' ' B' ' 25' ' ' PHE . 0.8 OUTLIER -120.35 128.94 53.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.966 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.839 HD23 ' O ' ' C' ' 66' ' ' LYS . 4.8 tt -138.76 -42.04 0.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.27 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' LYS . . . . . 0.839 ' O ' HD23 ' C' ' 65' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.309 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.783 0.325 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -105.06 26.68 9.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . 0.519 ' CE1' HD11 ' D' ' 86' ' ' LEU . 7.3 t80 -106.58 86.01 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.044 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.53 93.38 8.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.676 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 71' ' ' ASN . . . . . 0.442 ' HB3' ' CE1' ' D' ' 69' ' ' PHE . 0.6 OUTLIER -96.48 58.66 1.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.979 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 72' ' ' CYS . . . . . 0.401 ' CB ' ' HB3' ' C' ' 50' ' ' CYS . 0.6 OUTLIER -59.7 119.55 7.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.777 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 73' ' ' TYR . . . . . 0.42 ' CD2' ' O ' ' D' ' 71' ' ' ASN . 0.5 OUTLIER -128.84 136.93 51.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.06 0.457 . . . . 0.0 111.233 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . 0.448 HG23 ' CB ' ' C' ' 52' ' ' VAL . 0.3 OUTLIER -154.76 58.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.666 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . 0.402 ' HB2' ' N ' ' C' ' 53' ' ' SER . 0.1 OUTLIER 171.42 176.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.495 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.96 146.36 18.34 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.652 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.506 ' CZ ' ' CE2' ' C' ' 51' ' ' TYR . 0.0 OUTLIER -163.55 75.28 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.737 0.303 . . . . 0.0 111.058 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 78' ' ' HIS . . . . . 0.475 ' HB2' ' HD3' ' D' ' 79' ' ' PRO . 5.7 m170 -69.27 -64.94 1.38 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.821 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 79' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' D' ' 78' ' ' HIS . 90.5 Cg_endo -80.25 88.82 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.469 2.112 . . . . 0.0 112.356 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 27.5 t -175.58 154.57 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 111.096 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -79.56 62.96 4.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.604 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 82' ' ' ILE . . . . . 0.753 HG22 HG13 ' C' ' 60' ' ' ILE . 0.2 OUTLIER -113.65 151.16 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.144 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -161.29 92.34 0.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.159 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 84' ' ' VAL . . . . . 0.494 HG13 ' ND2' ' C' ' 49' ' ' ASN . 84.2 t -105.85 117.75 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.603 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.58 -175.99 1.21 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 0.0 111.18 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 86' ' ' LEU . . . . . 0.642 HD12 ' CZ ' ' C' ' 47' ' ' PHE . 0.0 OUTLIER -174.23 -172.17 0.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.642 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.605 ' O ' HD23 ' D' ' 87' ' ' LEU . 8.8 tt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.011 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.2 t30 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.837 0.351 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.866 ' CD1' HD22 ' A' ' 20' ' ' LEU . 49.1 t80 -165.08 125.48 1.93 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.01 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 3' ' ' PHE . 11.2 mt -130.15 92.15 3.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.041 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.471 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 0.5 OUTLIER -111.56 82.43 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.597 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.4 p -93.17 128.09 38.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.026 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.536 ' CD2' ' CE2' ' B' ' 33' ' ' PHE . 1.5 t80 -113.68 158.78 20.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.727 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.625 HG23 ' HB ' ' B' ' 30' ' ' VAL . 9.3 p -177.1 106.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.564 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.4 t 34.24 98.55 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.542 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.2 123.23 0.7 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.758 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.74 ' CE1' HD11 ' B' ' 38' ' ' ILE . 91.5 t80 -179.55 162.98 1.16 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.783 0.325 . . . . 0.0 111.092 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.476 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -164.02 -65.96 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.008 179.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.788 ' HG2' HD11 ' A' ' 16' ' ' ILE . 43.9 Cg_endo -67.13 115.38 3.61 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.392 2.062 . . . . 0.0 112.04 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.3 m -38.7 -55.67 1.43 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.266 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.39 123.31 30.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.906 0.384 . . . . 0.0 111.267 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.788 HD11 ' HG2' ' A' ' 13' ' ' PRO . 16.9 mm -147.6 133.96 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.917 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -147.04 142.36 27.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.867 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.665 ' HB ' HG13 ' B' ' 40' ' ' VAL . 19.2 t -109.33 159.6 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.49 ' N ' HG12 ' A' ' 18' ' ' VAL . 2.3 t0 -146.74 143.46 28.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.866 HD22 ' CD1' ' A' ' 3' ' ' PHE . 60.4 tp . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.747 0.308 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.713 ' CZ ' HD13 ' C' ' 64' ' ' LEU . 84.4 t80 -100.91 110.73 22.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.733 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.402 ' HA ' ' HB3' ' C' ' 48' ' ' LEU . 0.6 OUTLIER -119.04 93.65 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.928 0.394 . . . . 0.0 111.057 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' C' ' 49' ' ' ASN . 32.3 t-20 -127.25 140.55 52.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.796 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' C' ' 50' ' ' CYS . 5.7 p 177.85 161.89 0.57 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.167 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.551 ' CE2' ' CG ' ' C' ' 51' ' ' TYR . 0.9 OUTLIER -129.68 152.79 48.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.125 0.488 . . . . 0.0 111.514 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.625 ' HB ' HG23 ' A' ' 8' ' ' VAL . 24.3 t -121.28 102.64 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.735 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 40.25 -165.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.125 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.24 49.57 8.09 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.978 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . 0.536 ' CE2' ' CD2' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -120.41 70.75 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.96 0.409 . . . . 0.0 111.507 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.738 ' N ' ' HD3' ' B' ' 35' ' ' PRO . 0.3 OUTLIER -111.93 18.71 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.738 ' HD3' ' N ' ' B' ' 34' ' ' HIS . 50.3 Cg_exo -53.53 -163.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 121.9 1.734 . . . . 0.0 113.124 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 9.9 t -107.69 -72.73 0.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.731 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . 0.592 ' C ' HD12 ' B' ' 38' ' ' ILE . 14.4 t70 -130.97 113.87 14.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.369 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.74 HD11 ' CE1' ' A' ' 11' ' ' PHE . 1.7 mp -126.33 139.55 51.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.876 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -146.08 156.47 43.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.812 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.665 HG13 ' HB ' ' A' ' 18' ' ' VAL . 21.7 t -134.23 127.63 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -121.15 99.71 6.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.238 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.689 HD22 ' N ' ' B' ' 42' ' ' LEU . 0.9 OUTLIER -97.96 107.55 20.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.57 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.615 HD23 ' N ' ' B' ' 43' ' ' LEU . 1.8 pt? 178.17 -46.63 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.802 0.335 . . . . 0.0 111.218 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.455 ' N ' ' HG ' ' B' ' 43' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.766 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.801 0.334 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -57.57 98.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.958 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.568 ' HE1' HD11 ' C' ' 64' ' ' LEU . 47.6 t80 -102.74 113.46 26.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.548 ' CD2' HD12 ' D' ' 70' ' ' LEU . 0.1 OUTLIER -121.36 86.06 2.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.777 179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' ASN . . . . . 0.483 ' CB ' ' CZ ' ' C' ' 47' ' ' PHE . 12.2 t-20 -126.32 83.16 2.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.31 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' B' ' 28' ' ' CYS . 1.7 p -134.19 -170.97 2.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.277 0.561 . . . . 0.0 112.013 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.551 ' CG ' ' CE2' ' B' ' 29' ' ' TYR . 3.8 p90 -167.48 176.19 6.71 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.611 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' VAL . . . . . 0.58 HG12 ' HB ' ' D' ' 74' ' ' VAL . 15.1 m -136.62 146.69 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.842 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' C' ' 52' ' ' VAL . 5.1 t 99.67 -172.31 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.228 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.07 -16.76 68.86 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.841 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . 0.53 ' CE1' ' CE2' ' B' ' 29' ' ' TYR . 38.4 t80 64.46 120.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.748 0.308 . . . . 0.0 110.89 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' HIS . . . . . 0.421 ' CB ' ' HB3' ' B' ' 34' ' ' HIS . 7.9 m80 -76.72 162.36 70.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.931 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.67 112.0 1.01 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.568 2.179 . . . . 0.0 112.244 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 10.0 t -164.48 159.36 19.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.787 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -100.18 125.8 46.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.008 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.433 HD11 ' HA ' ' D' ' 82' ' ' ILE . 1.6 pp -126.04 116.24 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -110.74 85.97 2.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.036 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.696 HG12 HD21 ' C' ' 64' ' ' LEU . 49.0 t -80.81 120.83 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.878 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' ASP . . . . . 0.758 ' C ' HD23 ' C' ' 64' ' ' LEU . 1.2 m-20 -143.17 117.82 9.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.017 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' LEU . . . . . 0.758 HD23 ' C ' ' C' ' 63' ' ' ASP . 0.1 OUTLIER -137.28 119.76 15.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.641 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.41 HD23 ' N ' ' C' ' 65' ' ' LEU . 2.6 pt? -163.2 -167.0 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.967 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.096 179.826 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.815 0.341 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -154.65 -43.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.153 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . 0.423 ' CZ ' ' HB2' ' D' ' 71' ' ' ASN . 21.6 t80 -93.64 142.51 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.043 0.449 . . . . 0.0 111.247 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 70' ' ' LEU . . . . . 0.776 HD22 ' CE2' ' D' ' 73' ' ' TYR . 32.2 mt -159.19 120.49 3.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.969 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 71' ' ' ASN . . . . . 0.631 ' O ' ' N ' ' D' ' 73' ' ' TYR . 4.2 t30 -139.43 173.56 11.42 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 72' ' ' CYS . . . . . 0.443 ' O ' ' HB2' ' C' ' 50' ' ' CYS . 0.5 OUTLIER 37.34 -79.08 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.399 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 73' ' ' TYR . . . . . 0.776 ' CE2' HD22 ' D' ' 70' ' ' LEU . 0.3 OUTLIER 74.83 -87.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 178.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . 0.58 ' HB ' HG12 ' C' ' 52' ' ' VAL . 41.1 t -101.94 50.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.108 0.48 . . . . 0.0 111.064 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . 0.481 ' HA ' ' CZ ' ' C' ' 51' ' ' TYR . 3.3 m -92.86 -160.59 0.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.033 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.93 -4.54 0.64 Allowed Glycine 0 CA--C 1.522 0.492 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.226 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.428 ' CE2' ' CE2' ' C' ' 51' ' ' TYR . 0.1 OUTLIER -47.27 171.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 117.05 0.425 . . . . 0.0 111.384 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 78' ' ' HIS . . . . . 0.54 ' CB ' ' HD3' ' D' ' 79' ' ' PRO . 0.0 OUTLIER -115.94 -65.44 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 79' ' ' PRO . . . . . 0.54 ' HD3' ' CB ' ' D' ' 78' ' ' HIS . 60.9 Cg_endo -85.41 -105.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.359 2.039 . . . . 0.0 112.109 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 21.6 t 52.28 175.49 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.964 0.412 . . . . 0.0 111.408 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -120.71 73.06 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.652 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 82' ' ' ILE . . . . . 0.609 HG23 ' O ' ' D' ' 82' ' ' ILE . 0.0 OUTLIER -74.29 108.43 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.199 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.89 106.17 7.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.628 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 21.1 t -123.72 131.04 73.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.379 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -136.34 107.17 6.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.518 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 86' ' ' LEU . . . . . 0.666 ' N ' HD22 ' D' ' 86' ' ' LEU . 0.2 OUTLIER -106.08 134.59 48.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.074 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.4 ' HB2' ' HB3' ' C' ' 65' ' ' LEU . 2.7 mm? . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.695 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 3' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.46 0.046 0 CA-C-O 120.572 0.225 . . . . 0.0 110.932 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.757 ' CZ ' HD11 ' B' ' 42' ' ' LEU . 0.0 OUTLIER 87.03 177.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.901 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.458 ' N ' ' CG ' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -156.4 128.44 7.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 111.119 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -104.8 109.11 20.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.667 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -91.7 125.73 36.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.187 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.402 ' CE2' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -140.59 122.71 15.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.726 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.524 HG12 HG22 ' B' ' 30' ' ' VAL . 9.5 m -149.09 137.24 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.234 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t 71.95 -67.97 0.24 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.38 -150.2 20.39 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.834 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.414 ' CE2' ' O ' ' A' ' 12' ' ' HIS . 6.2 p90 -173.88 -166.09 0.28 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.811 0.339 . . . . 0.0 110.919 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.414 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 19.9 m80 -67.14 154.36 92.81 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.47 120.28 7.54 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.615 2.21 . . . . 0.0 112.2 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.0 p -169.83 -166.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.809 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.76 101.46 7.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.938 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.466 HG23 ' HA ' ' B' ' 38' ' ' ILE . 16.5 tt -87.84 140.72 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -144.32 162.73 35.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.941 0.4 . . . . 0.0 111.153 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.19 131.59 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.901 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -129.78 121.9 27.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.045 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.926 179.814 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.869 0.366 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.709 ' CE2' HD22 ' B' ' 42' ' ' LEU . 63.0 t80 -116.95 121.3 41.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.644 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.709 ' CD1' HD12 ' C' ' 48' ' ' LEU . 0.3 OUTLIER -133.75 98.03 4.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.2 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.511 ' OD1' HG13 ' C' ' 62' ' ' VAL . 0.5 OUTLIER -107.36 83.97 1.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.592 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 12.6 p -106.06 133.18 51.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.173 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.444 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 0.0 OUTLIER -150.41 114.77 5.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.563 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.746 HG12 ' CG2' ' C' ' 52' ' ' VAL . 34.6 m -121.99 131.1 73.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.077 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 22.6 m 64.43 102.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.654 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.448 ' HA3' ' CD2' ' C' ' 55' ' ' PHE . . . -59.39 -116.71 0.01 OUTLIER Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.782 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . 0.571 ' CZ ' HD11 ' B' ' 38' ' ' ILE . 0.0 OUTLIER 179.15 -100.18 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.396 0.141 . . . . 0.0 110.787 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.494 ' CG ' ' HD2' ' B' ' 35' ' ' PRO . 0.0 OUTLIER -138.16 179.34 1.35 Allowed Pre-proline 0 N--CA 1.455 -0.19 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.494 ' HD2' ' CG ' ' B' ' 34' ' ' HIS . 99.7 Cg_exo -44.84 88.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.587 2.191 . . . . 0.0 112.566 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . 0.446 ' N ' ' O ' ' B' ' 34' ' ' HIS . 3.3 m -136.24 159.0 43.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.272 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -113.88 111.1 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.816 0.341 . . . . 0.0 111.221 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.571 HD11 ' CZ ' ' B' ' 33' ' ' PHE . 32.9 mt -99.06 94.74 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.749 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -101.99 88.46 3.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.266 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.405 HG23 HG22 ' B' ' 38' ' ' ILE . 95.3 t -91.65 114.92 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.539 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -127.13 112.28 14.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.0 111.492 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.757 HD11 ' CZ ' ' A' ' 3' ' ' PHE . 1.2 mp -102.35 116.62 33.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.111 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.418 HD22 ' H ' ' B' ' 44' ' ' LYS . 0.5 OUTLIER 76.52 -154.18 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.005 -179.3 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.418 ' H ' HD22 ' B' ' 43' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.785 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.764 0.316 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.7 -73.65 0.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.944 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.903 ' O ' HD23 ' C' ' 48' ' ' LEU . 15.3 t80 -137.28 128.45 27.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.996 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.903 HD23 ' O ' ' C' ' 47' ' ' PHE . 6.0 mt -135.35 112.02 10.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.77 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' ASN . . . . . 0.497 ' HB2' ' CE1' ' C' ' 47' ' ' PHE . 38.2 t30 -113.76 139.29 49.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.96 0.409 . . . . 0.0 111.034 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.46 109.21 7.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.594 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.619 ' CZ ' HG21 ' D' ' 82' ' ' ILE . 1.2 t80 -121.24 94.06 4.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.179 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' VAL . . . . . 0.746 ' CG2' HG12 ' B' ' 30' ' ' VAL . 45.9 t -97.59 109.27 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.594 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' SER . . . . . 0.509 ' CB ' ' HB2' ' D' ' 75' ' ' SER . 0.7 OUTLIER -55.7 -175.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.349 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.48 58.73 0.68 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.033 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . 0.687 ' CE2' HD11 ' C' ' 60' ' ' ILE . 1.3 p90 -171.74 33.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.32 0.105 . . . . 0.0 110.754 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' HIS . . . . . 0.546 ' CD2' ' HD3' ' C' ' 57' ' ' PRO . 0.0 OUTLIER 12.42 -76.45 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.711 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.231 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . 0.546 ' HD3' ' CD2' ' C' ' 56' ' ' HIS . 73.1 Cg_endo -72.45 -162.95 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.233 1.955 . . . . 0.0 112.781 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 79.22 155.52 0.15 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.808 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.496 ' C ' HD12 ' C' ' 60' ' ' ILE . 7.8 t0 -129.17 145.62 51.28 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.588 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.79 HD13 ' CG2' ' D' ' 82' ' ' ILE . 2.1 mp -131.05 112.81 22.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.324 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -114.38 80.71 1.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.739 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.644 HG23 HG22 ' C' ' 60' ' ' ILE . 42.1 t -91.93 121.89 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.139 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -151.45 126.98 10.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' LEU . . . . . 0.727 ' N ' HD13 ' C' ' 64' ' ' LEU . 0.0 OUTLIER -135.26 144.67 46.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.942 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 4.9 mt -97.94 102.75 14.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.924 179.991 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 19.1 p . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.863 0.363 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -68.54 97.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -124.05 113.81 18.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.79 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 70' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' D' ' 70' ' ' LEU . 5.3 tp -122.72 99.65 6.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.793 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 71' ' ' ASN . . . . . 0.415 ' O ' ' CD1' ' D' ' 73' ' ' TYR . 12.7 p-10 -93.89 52.66 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 90.5 m -58.86 123.27 15.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.594 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 73' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' D' ' 71' ' ' ASN . 0.1 OUTLIER -174.58 135.16 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.295 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . 0.589 ' O ' ' CB ' ' D' ' 75' ' ' SER . 12.6 p -178.73 160.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.212 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . 0.589 ' CB ' ' O ' ' D' ' 74' ' ' VAL . 73.7 m 118.18 179.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.872 0.869 . . . . 0.0 110.627 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.51 152.87 20.29 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.44 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.486 ' HD1' ' HG ' ' D' ' 80' ' ' SER . 38.4 p90 -161.76 -31.5 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.47 0.176 . . . . 0.0 111.162 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 78' ' ' HIS . . . . . 0.673 ' CB ' ' CD ' ' D' ' 79' ' ' PRO . 17.9 m170 34.67 -90.18 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 79' ' ' PRO . . . . . 0.673 ' CD ' ' CB ' ' D' ' 78' ' ' HIS . 58.2 Cg_endo -69.37 58.07 1.34 Allowed 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.646 1.564 . . . . 0.0 113.007 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 80' ' ' SER . . . . . 0.486 ' HG ' ' HD1' ' D' ' 77' ' ' PHE . 3.7 p -135.84 155.73 49.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.525 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -110.49 100.07 8.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.797 0.332 . . . . 0.0 111.244 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 82' ' ' ILE . . . . . 0.79 ' CG2' HD13 ' C' ' 60' ' ' ILE . 1.3 pp -122.73 143.87 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.283 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -158.27 124.21 4.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.737 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 84' ' ' VAL . . . . . 0.754 ' CG1' HD11 ' D' ' 86' ' ' LEU . 21.9 t -112.58 132.17 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.341 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . 0.528 ' C ' HD13 ' D' ' 86' ' ' LEU . 3.5 m-20 -128.55 105.59 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.82 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 86' ' ' LEU . . . . . 0.793 HD12 ' CZ ' ' C' ' 47' ' ' PHE . 0.0 OUTLIER -107.76 100.23 9.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 55.6 tp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.943 179.879 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.439 ' OD1' HD11 ' A' ' 4' ' ' LEU . 7.5 p30 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 120.937 0.398 . . . . 0.0 111.685 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.917 ' CZ ' HD12 ' B' ' 42' ' ' LEU . 0.5 OUTLIER -76.95 106.2 8.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.506 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.439 HD11 ' OD1' ' A' ' 2' ' ' ASN . 0.5 OUTLIER -97.92 68.07 1.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.542 179.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.506 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 6.0 p30 -67.92 -177.48 0.82 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.429 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' B' ' 28' ' ' CYS . 2.8 m 64.92 -167.62 0.22 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.302 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -146.66 151.95 38.08 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.808 0.337 . . . . 0.0 111.402 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 8' ' ' VAL . 7.1 p -95.53 83.24 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.879 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.3 p 61.77 117.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.087 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.98 130.89 5.79 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.641 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.663 ' CE2' HD12 ' A' ' 16' ' ' ILE . 33.7 t80 -179.99 148.87 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.919 0.39 . . . . 0.0 111.035 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.428 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 18.6 p80 -82.37 157.36 67.95 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.792 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 14' ' ' SER . 19.3 Cg_endo -58.76 -159.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.758 2.305 . . . . 0.0 112.556 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER 73.37 -95.9 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.427 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' B' ' 37' ' ' ASP . 0.1 OUTLIER -177.83 160.61 1.52 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.013 0.435 . . . . 0.0 111.408 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.663 HD12 ' CE2' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -96.16 117.42 40.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.681 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 7.0 pt-20 -107.48 115.0 29.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.962 0.41 . . . . 0.0 110.723 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.7 t -150.71 137.17 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -149.51 126.78 11.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.87 0.367 . . . . 0.0 111.326 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' B' ' 43' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.656 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.696 0.284 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.87 ' CE1' HD11 ' C' ' 64' ' ' LEU . 60.4 t80 -103.66 123.41 46.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.243 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.74 HD12 ' C ' ' B' ' 25' ' ' PHE . 7.2 mp -124.45 122.25 37.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.671 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.521 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 0.8 OUTLIER -126.91 114.99 18.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.531 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 6' ' ' CYS . 2.2 t -116.73 102.2 9.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.356 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.48 ' CE2' HG21 ' C' ' 60' ' ' ILE . 3.9 t80 -125.78 88.84 2.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.546 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -103.38 132.68 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.136 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 15.5 t 65.35 151.69 0.05 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.166 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.16 -139.24 8.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.516 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . 0.608 ' CZ ' HD11 ' B' ' 38' ' ' ILE . 0.0 OUTLIER -179.66 -106.65 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 O-C-N 123.008 -0.113 . . . . 0.0 111.149 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.513 ' CB ' ' CD ' ' B' ' 35' ' ' PRO . 0.0 OUTLIER -123.34 -176.7 0.46 Allowed Pre-proline 0 CA--C 1.528 0.106 0 CA-C-O 120.579 0.228 . . . . 0.0 110.589 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' B' ' 34' ' ' HIS . 24.1 Cg_exo -64.26 -0.92 3.19 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.714 2.276 . . . . 0.0 113.092 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.1 t -41.99 160.18 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.935 0.397 . . . . 0.0 111.432 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 7.6 t0 -103.0 143.64 32.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.716 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.608 HD11 ' CZ ' ' B' ' 33' ' ' PHE . 26.4 mm -119.27 123.03 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.213 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -123.28 87.26 2.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.518 HG23 HG22 ' B' ' 38' ' ' ILE . 50.2 t -100.21 119.07 47.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.135 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.779 ' C ' HD13 ' B' ' 42' ' ' LEU . 0.3 OUTLIER -131.7 122.84 26.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.28 179.412 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.917 HD12 ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -120.2 145.88 46.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.062 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.677 HD12 HD13 ' C' ' 65' ' ' LEU . 0.1 OUTLIER 56.6 21.92 6.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.319 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 30.8 tttt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.914 179.895 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.839 0.352 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 66.06 120.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.994 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.909 ' CZ ' HD12 ' D' ' 86' ' ' LEU . 1.7 t80 -108.41 103.35 12.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.641 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.494 HD11 HD23 ' D' ' 70' ' ' LEU . 1.6 mp -107.06 110.13 22.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.862 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' ASN . . . . . 0.424 ' HA ' ' HB3' ' B' ' 27' ' ' ASN . 1.5 t30 -122.14 97.9 5.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.082 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 13.9 m -109.84 116.96 32.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.689 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.476 ' OH ' ' CD1' ' D' ' 77' ' ' PHE . 0.7 OUTLIER -139.64 149.48 43.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.965 0.412 . . . . 0.0 111.285 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' VAL . . . . . . . . . . . . . 31.3 t -115.53 110.87 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.588 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 11.7 m -52.96 178.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.409 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.93 48.02 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.233 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . 0.639 ' HZ ' HD12 ' C' ' 60' ' ' ILE . 0.0 OUTLIER -176.64 141.96 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.168 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' HIS . . . . . 0.43 ' CE1' ' HG3' ' D' ' 79' ' ' PRO . 0.2 OUTLIER -87.23 -62.08 0.24 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.276 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' C' ' 56' ' ' HIS . 72.9 Cg_endo -76.27 -163.52 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.507 2.138 . . . . 0.0 112.498 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' C' ' 57' ' ' PRO . 0.4 OUTLIER 80.36 161.89 0.17 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.325 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.06 129.17 47.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.947 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.639 HD12 ' HZ ' ' C' ' 55' ' ' PHE . 0.1 OUTLIER -114.55 96.44 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.93 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -104.28 128.09 52.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.958 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 46.5 t -142.89 120.87 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.957 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -128.44 124.63 36.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.996 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' LEU . . . . . 0.87 HD11 ' CE1' ' B' ' 25' ' ' PHE . 0.1 OUTLIER -98.44 106.02 18.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.677 HD13 HD12 ' B' ' 43' ' ' LEU . 28.6 tp 64.52 -76.57 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.034 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.985 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 87.4 p . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.845 0.355 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 58.54 32.32 22.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.982 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -107.72 109.63 21.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 70' ' ' LEU . . . . . 0.494 HD23 HD11 ' C' ' 48' ' ' LEU . 9.4 tp -132.45 60.02 1.7 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.778 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 71' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -80.59 78.07 7.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.856 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 19.8 t -69.75 123.72 22.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.827 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 73' ' ' TYR . . . . . 0.46 ' HB3' ' CE2' ' C' ' 51' ' ' TYR . 0.2 OUTLIER -131.09 144.85 51.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 18.7 t -121.72 153.09 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.486 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 1.1 t 67.88 -83.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.35 174.37 24.34 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.691 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.618 ' CD2' HG21 ' D' ' 82' ' ' ILE . 0.3 OUTLIER -169.45 159.44 8.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 111.011 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 78' ' ' HIS . . . . . 0.471 ' N ' ' HD2' ' D' ' 79' ' ' PRO . 6.1 t-160 -178.24 -60.76 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.148 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 79' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' D' ' 78' ' ' HIS . 9.2 Cg_endo -52.75 -34.2 63.67 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.5 2.134 . . . . 0.0 112.485 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 24.8 p -75.19 157.21 34.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.831 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.86 115.22 16.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.742 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 82' ' ' ILE . . . . . 0.618 HG21 ' CD2' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -114.01 146.53 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.977 0.418 . . . . 0.0 111.589 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.64 57.46 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 t -80.54 134.79 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . 0.68 ' C ' HD13 ' D' ' 86' ' ' LEU . 40.0 m-20 -149.71 137.16 19.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 86' ' ' LEU . . . . . 0.909 HD12 ' CZ ' ' C' ' 47' ' ' PHE . 0.0 OUTLIER -126.19 94.46 4.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.72 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.651 ' CD1' HD23 ' C' ' 65' ' ' LEU . 4.0 mm? . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.765 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.0 t30 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.77 0.319 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.715 ' CZ ' HD11 ' B' ' 42' ' ' LEU . 0.0 OUTLIER -165.48 -172.15 2.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.984 179.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.591 HD23 ' H ' ' A' ' 4' ' ' LEU . 1.5 pt? -124.45 119.08 28.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.038 0.447 . . . . 0.0 111.08 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER -125.88 61.3 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.691 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' B' ' 28' ' ' CYS . 29.5 p -138.29 145.52 41.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.963 0.411 . . . . 0.0 111.472 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -150.85 131.43 13.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.805 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.634 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.0 p -100.19 99.9 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.162 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.428 ' HA ' ' HA3' ' B' ' 32' ' ' GLY . 0.9 OUTLIER 58.46 105.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.066 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.48 135.24 2.11 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.574 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.458 ' CE2' ' CB ' ' B' ' 36' ' ' SER . 5.0 t80 -158.98 93.86 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.762 0.315 . . . . 0.0 110.964 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.462 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 3.0 t-160 -81.23 -47.77 1.09 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.408 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 12' ' ' HIS . 87.7 Cg_endo -82.57 -177.5 3.45 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.469 2.112 . . . . 0.0 112.55 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -115.04 -60.45 1.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.665 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -112.09 104.45 12.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.644 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.8 pt -117.77 118.87 59.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.264 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -118.7 86.94 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.52 HG11 ' HE2' ' A' ' 3' ' ' PHE . 21.3 t -69.51 147.71 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.022 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -148.37 149.04 31.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.964 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.784 0.326 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.862 ' CZ ' HD11 ' C' ' 64' ' ' LEU . 77.9 t80 -101.92 122.11 43.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.92 122.28 43.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.723 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.441 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 8.8 t-20 -148.56 101.4 3.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.642 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 7.3 m -152.84 132.95 13.45 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.8 0.333 . . . . 0.0 111.753 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.535 ' CE2' ' HB2' ' C' ' 51' ' ' TYR . 0.1 OUTLIER -130.24 129.86 43.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.411 178.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.938 HG13 ' CG2' ' C' ' 52' ' ' VAL . 39.9 t -128.56 119.22 49.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.841 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 14.2 m 50.56 179.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.606 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 9' ' ' SER . . . 46.1 94.42 0.01 OUTLIER Glycine 0 C--N 1.332 0.355 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.835 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . 0.518 ' CE2' HG21 ' C' ' 60' ' ' ILE . 0.1 OUTLIER -130.08 -44.12 1.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.664 0.269 . . . . 0.0 111.214 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 63.61 137.58 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.717 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -51.53 93.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.432 2.088 . . . . 0.0 112.171 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . 0.458 ' CB ' ' CE2' ' A' ' 11' ' ' PHE . 2.4 m -149.51 -167.0 2.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.034 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -141.0 142.62 34.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.073 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.712 HG13 HG22 ' C' ' 60' ' ' ILE . 0.8 OUTLIER -150.69 147.01 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.656 179.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -143.18 129.66 20.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.821 0.343 . . . . 0.0 111.133 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.631 ' HB ' HG13 ' C' ' 62' ' ' VAL . 44.3 t -110.63 120.66 61.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.826 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -118.73 94.13 4.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.837 ' HB2' HD22 ' C' ' 64' ' ' LEU . 3.0 mp -110.01 117.46 33.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.676 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.06 122.19 32.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.805 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.825 ' HB3' HD12 ' C' ' 65' ' ' LEU . 8.7 tttm . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.927 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.779 0.323 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 59.77 78.97 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.888 ' CZ ' HD13 ' D' ' 86' ' ' LEU . 31.7 t80 -87.64 102.86 15.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.632 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -103.92 103.24 13.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.903 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' ASN . . . . . 0.459 ' HB2' ' CZ ' ' C' ' 47' ' ' PHE . 1.9 t30 -127.04 116.44 20.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' CYS . . . . . 0.442 ' CB ' ' HB3' ' D' ' 72' ' ' CYS . 18.9 p -159.74 157.19 28.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.18 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.592 ' HE2' HD12 ' D' ' 82' ' ' ILE . 0.5 OUTLIER -162.78 147.21 11.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.771 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' VAL . . . . . 0.938 ' CG2' HG13 ' B' ' 30' ' ' VAL . 32.8 m -134.53 114.45 18.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.181 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 5.5 t 166.72 -86.39 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.767 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' GLY . . . . . 0.556 ' O ' ' CD1' ' C' ' 55' ' ' PHE . . . 108.92 -56.09 0.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.895 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' C' ' 54' ' ' GLY . 4.9 p90 43.02 -176.97 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.098 0.475 . . . . 0.0 111.99 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' HIS . . . . . 0.528 ' CB ' ' HD3' ' C' ' 57' ' ' PRO . 0.0 OUTLIER -99.51 -61.96 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.783 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' C' ' 56' ' ' HIS . 52.4 Cg_endo -88.27 -151.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.795 2.33 . . . . 0.0 112.027 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' C' ' 57' ' ' PRO . 1.0 OUTLIER 86.69 125.06 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.181 0.515 . . . . 0.0 111.375 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.445 ' HA ' ' CB ' ' D' ' 81' ' ' ASP . 8.1 t0 -112.51 95.51 5.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.213 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.797 HD11 HG22 ' D' ' 82' ' ' ILE . 0.2 OUTLIER -134.01 140.87 45.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.199 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -156.49 133.41 10.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.053 0.454 . . . . 0.0 111.185 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.631 HG13 ' HB ' ' B' ' 40' ' ' VAL . 48.0 t -109.29 121.01 61.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.647 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' ASP . . . . . 0.776 ' C ' HD23 ' C' ' 64' ' ' LEU . 5.1 p-10 -125.13 128.33 48.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.269 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' LEU . . . . . 0.862 HD11 ' CZ ' ' B' ' 25' ' ' PHE . 5.2 mt -124.78 110.05 13.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.563 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.825 HD12 ' HB3' ' B' ' 44' ' ' LYS . 0.5 OUTLIER 62.91 126.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.789 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 18.1 ttpt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.888 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.694 0.283 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -177.75 -35.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.297 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . 0.422 ' HB2' ' CD1' ' C' ' 47' ' ' PHE . 0.1 OUTLIER -120.37 170.67 9.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.79 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 24.0 tp -152.22 109.06 3.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.117 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 71' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -102.18 65.3 0.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.47 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 72' ' ' CYS . . . . . 0.442 ' HB3' ' CB ' ' C' ' 50' ' ' CYS . 50.9 t -75.03 101.66 4.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 73' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -107.15 128.86 54.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.103 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . 0.885 ' HB ' HG12 ' C' ' 52' ' ' VAL . 10.9 t -133.33 73.87 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.13 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' D' ' 74' ' ' VAL . 1.4 p 174.63 137.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.451 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 76' ' ' GLY . . . . . 0.485 ' O ' ' CG ' ' D' ' 77' ' ' PHE . . . -50.38 -87.02 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.679 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.657 ' HD1' HD11 ' D' ' 82' ' ' ILE . 0.4 OUTLIER 162.8 -60.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 122.482 0.313 . . . . 0.0 110.616 178.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 78' ' ' HIS . . . . . 0.467 ' HB3' ' HD2' ' D' ' 79' ' ' PRO . 20.0 m-70 58.54 164.62 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.545 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 79' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' D' ' 78' ' ' HIS . 18.7 Cg_endo -59.32 75.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.517 2.145 . . . . 0.0 112.344 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 80' ' ' SER . . . . . 0.444 ' N ' ' O ' ' D' ' 78' ' ' HIS . 9.7 p -127.61 -163.34 1.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.454 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 81' ' ' ASP . . . . . 0.445 ' CB ' ' HA ' ' C' ' 59' ' ' ASP . 0.2 OUTLIER -130.78 43.97 3.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.782 0.325 . . . . 0.0 111.31 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 82' ' ' ILE . . . . . 0.797 HG22 HD11 ' C' ' 60' ' ' ILE . 35.6 pt -99.7 117.85 45.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.882 0.372 . . . . 0.0 110.814 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -148.02 162.43 39.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.022 0.439 . . . . 0.0 111.523 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 48.0 t -141.76 130.22 22.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.94 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -135.59 108.77 7.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.925 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 86' ' ' LEU . . . . . 0.888 HD13 ' CZ ' ' C' ' 47' ' ' PHE . 0.4 OUTLIER -120.03 96.18 5.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.055 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.054 179.94 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.837 0.351 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.703 ' C ' HD13 ' A' ' 4' ' ' LEU . 46.5 t80 -145.67 129.08 16.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.73 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.72 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -147.48 83.87 1.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.295 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 6.5 t-20 -71.97 115.96 11.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.417 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.87 112.13 22.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.958 0.408 . . . . 0.0 111.714 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.47 ' OH ' ' CE1' ' B' ' 33' ' ' PHE . 0.1 OUTLIER -118.09 128.78 55.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.98 179.066 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.5 80.36 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.097 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 43.61 95.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.596 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.5 137.28 3.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.148 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.511 ' CD1' HD11 ' B' ' 38' ' ' ILE . 5.6 p90 -177.44 169.3 2.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.686 0.279 . . . . 0.0 110.733 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.588 ' HB3' ' HD2' ' A' ' 13' ' ' PRO . 1.8 m80 -58.89 176.04 0.3 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.719 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 12' ' ' HIS . 86.1 Cg_endo -81.68 175.45 9.42 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.367 2.045 . . . . 0.0 112.158 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m 65.5 -161.56 0.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.743 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -106.36 118.39 36.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.971 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 17' ' ' GLU . 23.4 mm -79.24 159.11 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.977 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.473 ' N ' HG22 ' A' ' 16' ' ' ILE . 0.7 OUTLIER -146.16 59.56 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.191 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.73 118.46 10.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.498 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' B' ' 41' ' ' ASP . 3.1 p30 -134.76 161.98 33.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.957 0.408 . . . . 0.0 111.398 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.667 HD12 ' CE2' ' A' ' 3' ' ' PHE . 24.1 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.894 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 121.014 0.435 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.95 ' CZ ' HD11 ' C' ' 64' ' ' LEU . 37.6 t80 -121.23 142.15 50.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.784 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -147.42 115.81 6.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.442 ' HB2' ' CE1' ' B' ' 25' ' ' PHE . 46.4 t30 -122.73 90.66 3.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.775 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 91.6 m -81.93 117.44 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.73 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.461 ' CZ ' HG13 ' C' ' 60' ' ' ILE . 1.7 t80 -111.69 104.79 13.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.014 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.453 ' HA ' ' CG2' ' C' ' 52' ' ' VAL . 15.3 t -104.04 105.29 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.567 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 13.8 m -57.21 -178.32 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.982 0.42 . . . . 0.0 111.276 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.18 50.72 0.76 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.464 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . 0.47 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -165.25 161.02 18.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.771 0.319 . . . . 0.0 111.233 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.637 ' N ' ' HD3' ' B' ' 35' ' ' PRO . 4.7 p80 -148.0 53.53 1.54 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.182 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.637 ' HD3' ' N ' ' B' ' 34' ' ' HIS . 2.3 Cg_endo -83.37 -72.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.08 2.52 . . . . 0.0 112.465 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 47.3 t -158.1 -119.94 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.185 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -126.83 163.94 22.49 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.86 0.362 . . . . 0.0 111.015 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.511 HD11 ' CD1' ' A' ' 11' ' ' PHE . 25.0 mt -145.57 136.04 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.927 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -129.92 145.36 51.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.94 0.4 . . . . 0.0 111.227 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.403 ' HB ' ' HA ' ' C' ' 62' ' ' VAL . 40.7 t -142.85 140.38 27.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.814 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 19' ' ' ASP . 14.5 t0 -162.61 118.1 1.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.658 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.589 ' HG ' HD23 ' B' ' 43' ' ' LEU . 0.4 OUTLIER -158.9 -171.0 3.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.051 0.453 . . . . 0.0 111.482 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.589 HD23 ' HG ' ' B' ' 42' ' ' LEU . 2.6 mm? 58.54 162.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.211 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.99 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.814 0.34 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' ASN . . . . . 0.411 ' CB ' ' HB2' ' D' ' 68' ' ' ASN . 3.8 p30 -175.9 174.39 2.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.102 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.643 ' CZ ' HD11 ' D' ' 86' ' ' LEU . 62.1 t80 -85.78 107.64 17.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.632 HD13 HD23 ' D' ' 70' ' ' LEU . 21.4 tp -117.37 83.5 2.0 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.983 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' ASN . . . . . 0.513 ' HB2' ' CZ ' ' C' ' 47' ' ' PHE . 3.7 t-20 -98.35 102.9 14.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.593 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.72 115.11 20.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.813 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -116.07 102.75 9.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.063 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' VAL . . . . . 0.559 HG23 ' O ' ' C' ' 52' ' ' VAL . 34.1 m -113.68 114.31 46.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 15.1 p -50.93 178.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.626 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.88 -30.49 2.16 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.087 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . 0.46 ' CZ ' ' CB ' ' D' ' 80' ' ' SER . 0.0 OUTLIER -92.73 -163.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 111.323 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' HIS . . . . . 0.483 ' CB ' ' HD3' ' C' ' 57' ' ' PRO . 0.0 OUTLIER -169.68 -55.63 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.81 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . 0.483 ' HD3' ' CB ' ' C' ' 56' ' ' HIS . 69.0 Cg_endo -94.8 66.61 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.008 2.472 . . . . 0.0 112.617 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.0 158.07 32.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.97 0.414 . . . . 0.0 111.028 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.825 ' O ' HD13 ' C' ' 60' ' ' ILE . 0.2 OUTLIER -113.83 139.14 49.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.795 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.825 HD13 ' O ' ' C' ' 59' ' ' ASP . 6.1 mm -139.42 103.71 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.311 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.73 129.41 55.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.692 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.403 ' HA ' ' HB ' ' B' ' 40' ' ' VAL . 21.2 t -133.57 145.48 33.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.312 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' ASP . . . . . 0.544 ' O ' HD12 ' C' ' 64' ' ' LEU . 0.4 OUTLIER -139.52 148.7 43.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.027 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' LEU . . . . . 0.95 HD11 ' CZ ' ' B' ' 25' ' ' PHE . 0.6 OUTLIER -151.09 73.43 1.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.468 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.803 HD22 ' N ' ' C' ' 66' ' ' LYS . 1.2 tm? 157.65 137.17 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.449 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' LYS . . . . . 0.803 ' N ' HD22 ' C' ' 65' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.86 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.746 0.308 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . 0.411 ' HB2' ' CB ' ' C' ' 46' ' ' ASN . 22.4 m120 -56.76 129.25 40.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.048 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . 0.449 ' HE2' HD23 ' D' ' 86' ' ' LEU . 24.6 t80 -130.28 139.78 50.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 70' ' ' LEU . . . . . 0.632 HD23 HD13 ' C' ' 48' ' ' LEU . 12.7 tp -157.41 95.96 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.753 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 71' ' ' ASN . . . . . 0.46 HD21 HG21 ' D' ' 84' ' ' VAL . 50.0 t-20 -109.09 122.51 47.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.093 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -95.03 62.8 2.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.594 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.02 72.68 1.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.12 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.04 97.59 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.064 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 80.9 p -174.65 -76.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.923 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.75 -33.27 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.403 ' O ' ' CG ' ' D' ' 78' ' ' HIS . 22.6 m-85 62.74 104.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.734 0.302 . . . . 0.0 111.025 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 78' ' ' HIS . . . . . 0.46 ' CB ' ' CD ' ' D' ' 79' ' ' PRO . 2.0 m-70 -173.81 -64.04 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.946 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 79' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' D' ' 78' ' ' HIS . 33.1 Cg_endo -66.98 -75.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.366 2.044 . . . . 0.0 112.769 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 80' ' ' SER . . . . . 0.46 ' CB ' ' CZ ' ' C' ' 55' ' ' PHE . 35.3 p -58.9 -178.85 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.912 0.387 . . . . 0.0 111.167 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.3 108.47 13.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.829 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 82' ' ' ILE . . . . . 0.712 HG22 ' HB ' ' C' ' 60' ' ' ILE . 0.2 OUTLIER -141.55 161.56 21.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.228 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -168.94 126.45 0.99 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.811 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 84' ' ' VAL . . . . . 0.667 HG12 HD21 ' D' ' 86' ' ' LEU . 21.6 t -111.31 127.49 68.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -139.6 100.06 3.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.716 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 86' ' ' LEU . . . . . 0.679 HD12 ' HB2' ' C' ' 64' ' ' LEU . 0.2 OUTLIER -103.1 -168.96 1.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.678 ' H ' HD13 ' D' ' 87' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.215 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.839 0.352 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.771 ' O ' HD12 ' B' ' 26' ' ' LEU . 90.0 t80 -59.96 114.76 2.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.805 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 4' ' ' LEU . 1.9 pp -124.1 98.48 5.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.811 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -83.79 93.01 7.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.889 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.9 m -89.07 102.59 15.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' B' ' 29' ' ' TYR . 8.3 t80 -108.21 117.91 35.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.69 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.745 ' HA ' HG22 ' B' ' 30' ' ' VAL . 7.1 p -121.39 87.64 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.962 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.418 ' CB ' ' HA3' ' B' ' 32' ' ' GLY . 67.0 p 46.54 -167.85 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.777 0.322 . . . . 0.0 111.084 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.61 159.77 34.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.042 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' B' ' 36' ' ' SER . 0.2 OUTLIER 177.22 113.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.826 0.346 . . . . 0.0 110.56 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.415 ' HB2' ' HD3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -92.12 -54.3 0.26 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.438 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.428 ' CG ' HG12 ' A' ' 16' ' ' ILE . 94.9 Cg_endo -83.53 -97.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.477 2.118 . . . . 0.0 112.646 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.404 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 14.8 p -178.67 -52.81 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.749 0.309 . . . . 0.0 111.102 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -114.86 86.43 2.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.266 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.75 HD12 ' N ' ' A' ' 17' ' ' GLU . 2.2 pp -156.32 -170.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.683 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.751 ' HG3' HG23 ' A' ' 18' ' ' VAL . 37.4 tp10 160.01 -82.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.527 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.788 ' HB ' HG13 ' B' ' 40' ' ' VAL . 47.7 t -139.8 139.45 37.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.96 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -154.34 83.42 1.12 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.765 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.805 0.336 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.722 ' CZ ' HD12 ' C' ' 64' ' ' LEU . 56.5 t80 -106.35 117.83 35.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.677 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.771 HD12 ' O ' ' A' ' 3' ' ' PHE . 1.4 mp -131.71 95.85 3.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.077 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.462 ' HB2' ' CE1' ' B' ' 25' ' ' PHE . 0.1 OUTLIER -102.21 110.06 21.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.656 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' C' ' 50' ' ' CYS . 27.7 p -126.17 128.67 47.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.5 ' CE1' ' CE2' ' C' ' 55' ' ' PHE . 2.4 p90 -133.72 156.39 48.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.001 0.429 . . . . 0.0 111.39 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.745 HG22 ' HA ' ' A' ' 8' ' ' VAL . 16.6 m -129.05 134.13 64.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.754 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.0 t -44.74 167.53 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.644 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 9' ' ' SER . . . 150.89 -37.76 0.87 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.786 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . 0.483 ' CZ ' ' CE2' ' C' ' 55' ' ' PHE . 6.7 p90 -90.19 163.64 14.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 111.132 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.55 171.64 9.38 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.992 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.431 ' HD3' ' CD2' ' C' ' 56' ' ' HIS . 95.2 Cg_exo -42.45 94.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.746 2.297 . . . . 0.0 112.628 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . 0.451 ' HB3' ' CE2' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -124.53 -165.37 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.806 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.81 106.4 10.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.981 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.451 HD12 ' CZ ' ' B' ' 33' ' ' PHE . 0.0 OUTLIER -107.94 116.25 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.521 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 18.6 pt-20 -128.19 117.43 21.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.859 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.788 HG13 ' HB ' ' A' ' 18' ' ' VAL . 39.5 t -93.62 122.64 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.997 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -127.76 93.75 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.438 ' CD1' ' CZ ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER -106.53 108.51 20.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.004 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.574 HD13 HD12 ' C' ' 65' ' ' LEU . 4.4 mm? -112.8 35.4 3.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.03 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.785 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.74 0.305 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -170.77 118.9 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.15 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.573 ' CE2' HD12 ' D' ' 86' ' ' LEU . 47.2 t80 -114.43 112.2 22.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.51 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.448 HD22 HD23 ' B' ' 26' ' ' LEU . 0.1 OUTLIER -120.47 94.21 4.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.212 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' ASN . . . . . 0.495 ' HB2' ' CZ ' ' C' ' 47' ' ' PHE . 36.3 t30 -110.12 80.63 1.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.026 0.441 . . . . 0.0 110.676 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' CYS . . . . . 0.495 ' HB3' ' CD2' ' D' ' 73' ' ' TYR . 32.0 p -107.83 154.04 22.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.595 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.499 ' CZ ' ' HA ' ' D' ' 72' ' ' CYS . 0.2 OUTLIER -148.24 160.58 42.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.457 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' VAL . . . . . 0.563 HG13 HG11 ' D' ' 74' ' ' VAL . 20.2 t -124.84 124.87 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.457 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.26 -172.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.096 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' D' ' 77' ' ' PHE . . . -122.76 172.35 15.81 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.636 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . 0.5 ' CE2' ' CE1' ' B' ' 29' ' ' TYR . 0.1 OUTLIER -143.86 60.21 1.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 111.317 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' HIS . . . . . 0.527 ' HB3' ' HD2' ' C' ' 57' ' ' PRO . 3.0 m-70 59.89 165.47 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.466 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' C' ' 56' ' ' HIS . 34.9 Cg_endo -64.68 79.73 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.416 2.078 . . . . 0.0 112.282 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 1.5 t -96.83 -167.46 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.039 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.09 129.03 44.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.733 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.634 HD12 HG22 ' D' ' 82' ' ' ILE . 6.6 mt -127.8 120.1 53.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.294 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -111.04 77.47 1.04 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.552 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.596 HG12 HD11 ' C' ' 64' ' ' LEU . 22.3 t -79.26 124.69 37.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.29 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' ASP . . . . . 0.791 ' C ' HD13 ' C' ' 64' ' ' LEU . 6.6 t0 -149.9 121.22 7.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.759 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' LEU . . . . . 0.791 HD13 ' C ' ' C' ' 63' ' ' ASP . 0.0 OUTLIER -137.2 140.79 41.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.574 HD12 HD13 ' B' ' 43' ' ' LEU . 0.9 OUTLIER -89.3 -66.05 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.861 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.824 179.909 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.828 0.347 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 55.85 96.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.01 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -113.13 128.63 56.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.008 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 70' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' D' ' 70' ' ' LEU . 2.8 tp -155.49 88.0 1.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 71' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' D' ' 73' ' ' TYR . 17.9 p-10 -125.49 -157.53 0.79 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.356 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 72' ' ' CYS . . . . . 0.499 ' HA ' ' CZ ' ' C' ' 51' ' ' TYR . 36.1 t 55.82 -83.36 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.896 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 73' ' ' TYR . . . . . 0.495 ' CD2' ' HB3' ' C' ' 50' ' ' CYS . 1.0 OUTLIER 66.76 -93.66 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 177.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . 0.563 HG11 HG13 ' C' ' 52' ' ' VAL . 40.1 t -109.44 64.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 120.989 0.423 . . . . 0.0 110.848 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -60.83 -164.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.209 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.47 58.15 0.4 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.874 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.458 ' HB3' ' HA2' ' C' ' 54' ' ' GLY . 13.6 p90 -130.61 163.77 26.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 111.314 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 78' ' ' HIS . . . . . 0.469 ' CB ' ' HD2' ' D' ' 79' ' ' PRO . 0.4 OUTLIER -76.65 170.0 18.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.279 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 79' ' ' PRO . . . . . 0.469 ' HD2' ' CB ' ' D' ' 78' ' ' HIS . 9.4 Cg_endo -52.46 89.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.411 2.074 . . . . 0.0 112.13 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.99 119.69 39.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.709 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -54.02 96.39 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.835 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 82' ' ' ILE . . . . . 0.634 HG22 HD12 ' C' ' 60' ' ' ILE . 20.6 pt -111.43 125.21 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.364 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -113.11 107.68 16.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.531 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 84' ' ' VAL . . . . . 0.559 ' CG1' HD11 ' D' ' 86' ' ' LEU . 21.5 t -94.15 130.56 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.491 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . 0.418 ' O ' HD22 ' C' ' 64' ' ' LEU . 1.8 m-20 -134.33 92.6 2.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.664 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 86' ' ' LEU . . . . . 0.642 ' H ' HD22 ' D' ' 86' ' ' LEU . 0.2 OUTLIER -88.46 80.05 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.929 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 27.0 tp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 179.881 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.806 0.336 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.738 ' CZ ' HD11 ' B' ' 42' ' ' LEU . 4.9 t80 -109.03 160.06 16.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.756 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.493 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 13.9 tp -145.28 142.64 29.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 0.0 111.346 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.466 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 5.3 t30 -159.02 115.27 2.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.468 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.7 t -126.85 146.23 50.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.316 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.402 ' HH ' ' HD2' ' B' ' 33' ' ' PHE . 0.5 OUTLIER -123.18 135.31 54.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.315 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.8 t -144.67 125.71 8.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.814 0.34 . . . . 0.0 111.404 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t 67.12 -160.38 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.041 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.97 -133.95 0.01 OUTLIER Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.757 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.443 ' CZ ' ' HB2' ' B' ' 36' ' ' SER . 0.0 OUTLIER -175.77 -164.89 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.743 0.306 . . . . 0.0 111.077 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.513 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -119.7 -70.02 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.324 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 12' ' ' HIS . 19.1 Cg_endo -58.14 -164.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.312 2.008 . . . . 0.0 112.153 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -130.79 -63.65 0.86 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.934 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -97.84 96.26 8.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.729 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.1 mt -96.88 146.98 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.202 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -149.56 120.85 7.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.872 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.436 HG12 HD21 ' B' ' 42' ' ' LEU . 16.5 t -107.28 129.62 60.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.285 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -145.48 89.92 1.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.745 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.507 ' CB ' HD22 ' B' ' 42' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.051 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.956 0.408 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.87 ' CE2' HD11 ' C' ' 64' ' ' LEU . 0.1 OUTLIER -169.35 159.03 8.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.144 0.497 . . . . 0.0 111.379 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.794 HD12 ' HB2' ' C' ' 48' ' ' LEU . 0.2 OUTLIER -106.91 119.28 38.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.512 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -97.86 155.69 16.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.264 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 38.1 t -163.74 153.43 14.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.758 0.313 . . . . 0.0 111.221 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.468 ' CD2' ' HB2' ' C' ' 51' ' ' TYR . 0.0 OUTLIER -176.07 125.55 0.2 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.984 0.421 . . . . 0.0 110.964 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 31.1 m -128.37 128.59 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.256 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 73.49 147.12 0.09 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.054 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.69 -148.43 1.62 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.584 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . 0.723 ' HE2' HD11 ' B' ' 38' ' ' ILE . 0.0 OUTLIER -179.05 37.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.651 0.263 . . . . 0.0 111.596 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.443 ' CG ' ' HD2' ' B' ' 35' ' ' PRO . 0.0 OUTLIER 60.74 178.38 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.698 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.443 ' HD2' ' CG ' ' B' ' 34' ' ' HIS . 90.2 Cg_exo -43.0 126.15 4.4 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.596 2.197 . . . . 0.0 112.776 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 5.3 t 179.74 147.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.657 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.94 135.16 55.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.192 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.723 HD11 ' HE2' ' B' ' 33' ' ' PHE . 35.1 mt -135.91 111.43 11.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.88 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.14 82.94 1.75 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.749 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 42.2 t -73.43 120.36 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.969 0.414 . . . . 0.0 111.109 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.55 ' O ' HD23 ' B' ' 42' ' ' LEU . 16.7 m-20 -135.97 110.75 8.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.539 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.738 HD11 ' CZ ' ' A' ' 3' ' ' PHE . 80.6 mt -133.02 143.08 49.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.143 0.497 . . . . 0.0 111.234 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.401 ' HB3' ' N ' ' C' ' 66' ' ' LYS . 3.0 mt 71.47 137.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.571 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 11.5 mttt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.9 -179.84 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.86 0.362 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -94.11 125.37 38.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.028 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.69 ' CE1' HD13 ' C' ' 64' ' ' LEU . 50.1 t80 -131.72 135.4 46.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.81 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . 0.794 ' HB2' HD12 ' B' ' 26' ' ' LEU . 17.7 tp -130.2 128.67 42.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.69 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -130.34 95.3 3.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.388 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 3.7 p -117.86 103.9 10.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.387 . . . . 0.0 111.833 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' D' ' 73' ' ' TYR . 3.2 p90 -135.45 153.66 51.7 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.874 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' VAL . . . . . 0.585 ' O ' ' CB ' ' C' ' 53' ' ' SER . 0.8 OUTLIER -176.03 162.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.954 -178.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' C' ' 52' ' ' VAL . 5.9 t 104.58 80.31 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.496 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.91 -63.26 0.05 OUTLIER Glycine 0 C--N 1.332 0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.993 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . 0.541 ' CZ ' HG21 ' D' ' 82' ' ' ILE . 1.3 t80 78.79 78.37 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.819 0.342 . . . . 0.0 110.516 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' HIS . . . . . 0.595 ' N ' ' CD ' ' C' ' 57' ' ' PRO . 0.3 OUTLIER -140.36 38.86 0.32 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' C' ' 56' ' ' HIS . 36.5 Cg_endo -69.21 -77.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.109 1.872 . . . . 0.0 112.3 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . 0.423 ' OG ' ' HA ' ' B' ' 35' ' ' PRO . 0.4 OUTLIER 174.38 -79.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 110.689 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -134.42 134.74 41.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.871 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 10.1 mt -151.7 106.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -107.21 103.08 12.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.1 t -91.32 124.23 43.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -128.02 129.66 47.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.036 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' LEU . . . . . 0.87 HD11 ' CE2' ' B' ' 25' ' ' PHE . 0.2 OUTLIER -139.54 98.1 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.512 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 5.8 mt -94.1 -92.86 0.18 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.372 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' LYS . . . . . 0.401 ' N ' ' HB3' ' B' ' 43' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.834 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.785 0.326 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -71.47 105.06 3.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' D' ' 71' ' ' ASN . 54.5 t80 -118.42 124.72 48.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.781 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 mt -143.83 95.09 2.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.736 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 71' ' ' ASN . . . . . 0.459 ' O ' ' CD2' ' D' ' 73' ' ' TYR . 2.5 t-20 -100.73 79.95 2.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 1.4 m -73.57 109.31 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.459 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 73' ' ' TYR . . . . . 0.49 ' HB3' ' CE1' ' C' ' 51' ' ' TYR . 1.7 p90 -118.73 118.95 33.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.4 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . 0.525 ' HB ' ' HB ' ' C' ' 52' ' ' VAL . 3.5 t -132.72 86.86 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.019 0.438 . . . . 0.0 111.054 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 1.4 t 169.34 -53.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.689 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.38 -154.3 25.56 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.22 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . 0.459 ' HZ ' HG23 ' D' ' 84' ' ' VAL . 0.1 OUTLIER -177.19 88.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 111.183 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 78' ' ' HIS . . . . . 0.492 ' HB3' ' HD3' ' D' ' 79' ' ' PRO . 9.7 t-160 176.47 -57.94 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 79' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' D' ' 78' ' ' HIS . 55.5 Cg_endo -69.37 62.69 1.56 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.303 2.002 . . . . 0.0 112.389 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 80' ' ' SER . . . . . 0.423 ' CB ' HD12 ' D' ' 82' ' ' ILE . 1.9 m 178.77 159.49 0.58 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -96.37 60.26 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.604 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 82' ' ' ILE . . . . . 0.719 ' H ' HD13 ' D' ' 82' ' ' ILE . 0.2 OUTLIER -120.6 -179.87 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.243 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -176.57 145.49 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 84' ' ' VAL . . . . . 0.459 HG23 ' HZ ' ' D' ' 77' ' ' PHE . 80.2 t -112.69 117.58 55.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.979 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -138.31 112.57 8.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.543 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 86' ' ' LEU . . . . . 0.674 HD11 ' CE2' ' C' ' 47' ' ' PHE . 1.9 pt? -173.22 175.71 3.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.299 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.037 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.754 0.311 . . . . 0.0 110.849 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.66 ' CE2' ' CD1' ' B' ' 42' ' ' LEU . 16.7 t80 -127.35 110.22 12.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.967 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.542 ' O ' HD12 ' A' ' 4' ' ' LEU . 0.4 OUTLIER -108.05 117.47 34.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.723 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 1.1 p30 -129.45 67.97 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.047 0.451 . . . . 0.0 110.578 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 52.9 t -90.41 117.54 29.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.578 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.511 ' OH ' ' CE1' ' B' ' 29' ' ' TYR . 0.0 OUTLIER -119.98 132.59 55.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.252 0.549 . . . . 0.0 110.948 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.952 HG12 HG22 ' B' ' 30' ' ' VAL . 5.5 m -142.51 165.53 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.356 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 p 77.47 -166.47 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.394 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.77 -164.31 28.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.91 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.494 ' HB2' ' CD2' ' B' ' 33' ' ' PHE . 0.0 OUTLIER -130.85 -157.51 0.83 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.739 0.304 . . . . 0.0 110.76 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.443 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -175.15 -60.33 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.85 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 12' ' ' HIS . 34.0 Cg_endo -64.0 -22.94 68.01 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.326 2.017 . . . . 0.0 112.127 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.7 m 69.83 -64.34 0.35 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.226 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.59 127.24 32.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.036 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.795 HD13 ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -158.1 138.81 4.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.197 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.795 ' N ' HD13 ' A' ' 16' ' ' ILE . 4.4 pt-20 -139.37 137.73 35.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.004 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.481 ' HB ' HG13 ' B' ' 40' ' ' VAL . 25.3 t -115.3 125.72 72.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.957 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.61 132.42 55.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.044 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.936 ' HB2' HD22 ' B' ' 42' ' ' LEU . 1.8 mt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.695 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.432 ' HB3' ' CB ' ' C' ' 46' ' ' ASN . 31.8 t-20 . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.817 ' CZ ' HD11 ' C' ' 64' ' ' LEU . 9.2 t80 -125.59 105.31 8.93 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.73 0.3 . . . . 0.0 111.013 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 9.3 mp -116.2 90.34 3.31 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.444 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.487 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 7.0 t-20 -96.88 110.75 23.19 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.904 0.383 . . . . 0.0 110.751 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 4.1 m -112.04 142.46 44.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.114 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.511 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 0.7 OUTLIER -148.71 102.91 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.551 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.952 HG22 HG12 ' A' ' 8' ' ' VAL . 19.5 m -127.51 135.95 61.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.425 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 76.46 87.66 0.08 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.838 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.63 -173.91 0.49 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.571 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -163.33 -173.56 3.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 0.0 110.928 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.415 ' HB3' ' HD2' ' B' ' 35' ' ' PRO . 39.4 m-70 -59.44 162.21 8.86 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.743 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' B' ' 34' ' ' HIS . 83.6 Cg_exo -47.98 111.92 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.604 2.203 . . . . 0.0 112.639 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . 0.411 ' HB2' ' CE1' ' B' ' 33' ' ' PHE . 12.7 m -133.2 159.87 38.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.724 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . 0.409 ' C ' HD13 ' B' ' 38' ' ' ILE . 6.0 t0 -107.36 105.56 15.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.679 HG23 ' CG2' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -120.09 118.89 58.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.661 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -131.27 139.15 49.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.884 0.373 . . . . 0.0 111.118 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.481 HG13 ' HB ' ' A' ' 18' ' ' VAL . 62.0 t -134.11 119.08 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.956 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.796 ' C ' HD23 ' B' ' 42' ' ' LEU . 14.0 p-10 -122.75 105.1 9.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.765 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.936 HD22 ' HB2' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -133.82 176.79 8.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.052 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' C' ' 65' ' ' LEU . 1.3 tp -135.91 -48.86 0.68 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.784 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.98 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 29.8 p . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.825 0.345 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' ASN . . . . . 0.432 ' CB ' ' HB3' ' B' ' 24' ' ' ASN . 73.9 m-20 58.76 62.89 1.79 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.63 ' CZ ' HD12 ' D' ' 86' ' ' LEU . 6.1 t80 -105.36 120.09 40.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.52 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 43.4 tp -125.57 109.64 12.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.94 0.4 . . . . 0.0 111.264 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' ASN . . . . . 0.442 ' HB3' ' CE1' ' C' ' 47' ' ' PHE . 1.5 p30 -128.37 102.51 6.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.116 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' CYS . . . . . 0.4 ' HB2' ' HB3' ' D' ' 72' ' ' CYS . 13.8 p -116.69 134.35 54.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.372 . . . . 0.0 111.653 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.449 ' CZ ' ' HA ' ' D' ' 73' ' ' TYR . 27.9 p90 -136.96 125.69 23.93 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.771 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' VAL . . . . . 0.901 HG12 ' CG2' ' D' ' 74' ' ' VAL . 1.7 m -132.41 122.77 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.068 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' C' ' 52' ' ' VAL . 0.4 OUTLIER 165.35 -83.55 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.24 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 180.0 -37.64 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.161 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . 0.426 ' O ' ' HG2' ' D' ' 79' ' ' PRO . 2.0 m-85 65.49 127.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.719 0.295 . . . . 0.0 111.43 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' HIS . . . . . 0.568 ' HB3' ' HD3' ' C' ' 57' ' ' PRO . 2.7 t60 177.82 -50.66 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.039 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' C' ' 56' ' ' HIS . 73.4 Cg_endo -92.3 -54.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.763 2.309 . . . . 0.0 113.245 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -53.02 158.24 1.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.215 0.531 . . . . 0.0 111.743 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.421 ' HA ' ' HB2' ' D' ' 81' ' ' ASP . 1.1 m-20 -140.1 100.52 3.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.474 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' ILE . . . . . 0.548 HG23 ' HB ' ' B' ' 38' ' ' ILE . 18.9 mt -115.28 144.1 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.388 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -136.12 83.81 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.077 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -85.93 119.56 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.273 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' D' ' 85' ' ' ASP . 6.6 p-10 -118.34 125.07 49.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 111.196 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' LEU . . . . . 0.817 HD11 ' CZ ' ' B' ' 25' ' ' PHE . 0.7 OUTLIER -117.13 131.86 56.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.834 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . 0.616 ' N ' HD22 ' C' ' 65' ' ' LEU . 2.4 mm? 60.36 -179.25 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.938 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.89 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.841 0.353 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 p30 54.55 17.97 1.83 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.703 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 69' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' D' ' 71' ' ' ASN . 62.1 t80 -137.98 92.91 2.71 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.777 0.323 . . . . 0.0 110.849 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.17 93.71 5.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.715 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 71' ' ' ASN . . . . . 0.504 ' HB2' ' CZ ' ' D' ' 69' ' ' PHE . 11.5 t-20 -99.67 105.86 17.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.072 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 72' ' ' CYS . . . . . 0.4 ' HB3' ' HB2' ' C' ' 50' ' ' CYS . 6.6 t -81.92 68.82 8.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.558 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 73' ' ' TYR . . . . . 0.449 ' HA ' ' CZ ' ' C' ' 51' ' ' TYR . 0.1 OUTLIER -73.53 79.23 1.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.622 -179.545 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . 0.901 ' CG2' HG12 ' C' ' 52' ' ' VAL . 0.1 OUTLIER -122.35 83.82 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.943 0.401 . . . . 0.0 110.935 179.493 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.38 -68.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.672 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.12 -52.6 0.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.318 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.82 94.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.412 . . . . 0.0 111.345 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 78' ' ' HIS . . . . . 0.505 ' CB ' ' HD3' ' D' ' 79' ' ' PRO . 0.2 OUTLIER -164.79 -56.59 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.498 179.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 79' ' ' PRO . . . . . 0.505 ' HD3' ' CB ' ' D' ' 78' ' ' HIS . 73.7 Cg_endo -96.4 -164.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.234 2.623 . . . . 0.0 111.57 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 80' ' ' SER . . . . . 0.416 ' OG ' ' N ' ' D' ' 81' ' ' ASP . 1.4 t 55.9 176.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.587 0.232 . . . . 0.0 110.527 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 81' ' ' ASP . . . . . 0.448 ' HB3' ' N ' ' C' ' 60' ' ' ILE . 1.6 t0 -85.17 104.26 14.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.321 . . . . 0.0 111.083 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 82' ' ' ILE . . . . . 0.795 HG22 ' H ' ' D' ' 84' ' ' VAL . 48.6 mm -2.4 -67.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 83' ' ' GLU . . . . . 0.753 ' HG3' HG23 ' D' ' 84' ' ' VAL . 0.0 OUTLIER 98.26 -29.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.053 0.541 . . . . 0.0 110.926 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 84' ' ' VAL . . . . . 0.795 ' H ' HG22 ' D' ' 82' ' ' ILE . 59.7 t -111.99 118.63 58.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.864 0.364 . . . . 0.0 111.754 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 85' ' ' ASP . . . . . 0.492 ' C ' HD13 ' D' ' 86' ' ' LEU . 2.0 m-20 -153.18 123.18 6.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.543 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 86' ' ' LEU . . . . . 0.852 ' H ' HD22 ' D' ' 86' ' ' LEU . 0.0 OUTLIER -134.43 175.4 9.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.041 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 87' ' ' LEU . . . . . 0.64 ' O ' HD12 ' D' ' 87' ' ' LEU . 2.2 pp . . . . . 0 N--CA 1.464 0.273 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.794 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.836 0.35 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -177.37 108.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.737 ' CE2' HD12 ' B' ' 42' ' ' LEU . 4.3 t80 -94.74 139.75 30.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.026 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.6 HD12 HD13 ' B' ' 26' ' ' LEU . 0.2 OUTLIER -132.53 77.58 1.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.963 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' B' ' 27' ' ' ASN . 58.9 t30 -67.24 104.65 1.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.527 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 24.8 p -117.0 154.12 31.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.181 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.519 ' CE2' ' CE1' ' B' ' 29' ' ' TYR . 7.3 t80 179.06 115.19 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.802 HG23 ' CG1' ' B' ' 30' ' ' VAL . 7.7 p -126.88 96.5 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.978 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.1 t 56.72 168.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.993 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.39 -125.15 8.39 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.612 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . 88.1 t80 63.61 137.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.935 0.398 . . . . 0.0 110.967 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.404 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 23.7 m-70 -89.21 152.0 47.35 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.921 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.72 97.42 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.529 2.153 . . . . 0.0 112.324 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.1 t -176.25 -175.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.402 ' C ' HG23 ' A' ' 16' ' ' ILE . 58.0 t0 -109.21 88.03 2.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.736 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.402 HG23 ' C ' ' A' ' 15' ' ' ASP . 48.8 pt -157.55 -174.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.95 0.405 . . . . 0.0 111.491 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.673 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.3 mm-40 163.53 -81.34 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.554 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 17' ' ' GLU . 0.9 OUTLIER 167.66 120.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.428 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -138.03 141.54 40.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.052 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.495 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.0 OUTLIER -152.38 110.79 3.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.735 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.417 ' HA ' ' HB3' ' B' ' 43' ' ' LEU . 70.5 mt -90.5 -28.97 18.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.2 tttp . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.8 -179.919 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.884 0.373 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.55 102.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.971 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.836 ' CZ ' HD13 ' C' ' 64' ' ' LEU . 0.2 OUTLIER -144.95 130.61 18.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.769 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.692 HD12 ' C ' ' B' ' 25' ' ' PHE . 5.4 mp -129.89 117.71 20.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.075 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.494 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 1.7 t30 -105.47 88.66 2.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.645 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 34.3 t -96.24 108.67 21.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.956 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.519 ' CE1' ' CE2' ' A' ' 7' ' ' TYR . 4.3 t80 -135.48 127.13 29.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.71 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.802 ' CG1' HG23 ' A' ' 8' ' ' VAL . 7.6 p -142.64 154.46 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.983 0.42 . . . . 0.0 111.423 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.43 ' N ' HG22 ' B' ' 30' ' ' VAL . 4.2 t 74.41 158.16 0.2 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.156 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.49 -168.0 12.77 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.444 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . 0.694 ' HZ ' HD11 ' B' ' 38' ' ' ILE . 43.9 p90 -179.42 -175.75 0.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.862 0.363 . . . . 0.0 110.986 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.442 ' HB3' ' HD2' ' B' ' 35' ' ' PRO . 7.5 m-70 -59.72 165.66 4.17 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' B' ' 34' ' ' HIS . 65.7 Cg_exo -51.85 154.9 9.0 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.462 2.108 . . . . 0.0 112.448 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 8.6 p -178.37 -179.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.747 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.27 96.8 5.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.968 0.413 . . . . 0.0 111.351 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.694 HD11 ' HZ ' ' B' ' 33' ' ' PHE . 46.2 mt -97.73 112.13 29.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.423 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 2.8 tt0 -113.8 109.31 18.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.841 0.353 . . . . 0.0 111.777 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.66 124.41 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.577 ' C ' HD13 ' B' ' 42' ' ' LEU . 9.2 t70 -140.38 121.78 15.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.874 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.737 HD12 ' CE2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -119.22 113.35 20.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.485 HD12 ' HB3' ' C' ' 65' ' ' LEU . 0.3 OUTLIER -134.06 85.7 2.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.955 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.417 ' HD2' ' CD1' ' A' ' 20' ' ' LEU . 3.2 mtpm? . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.896 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.899 0.381 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 60.45 67.66 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.76 ' CE2' HD11 ' D' ' 86' ' ' LEU . 9.9 t80 -91.95 104.8 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.728 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.16 101.81 9.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.117 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' ASN . . . . . 0.488 ' HB2' ' CE1' ' C' ' 47' ' ' PHE . 28.8 t-20 -116.67 115.82 26.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.497 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 3.5 p -126.73 127.93 45.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.175 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.453 ' HB3' ' CD1' ' D' ' 73' ' ' TYR . 55.9 t80 -135.7 123.09 21.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . 0.572 ' HB ' HG23 ' B' ' 30' ' ' VAL . 22.0 t -115.13 130.58 69.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.244 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' SER . . . . . 0.407 ' O ' ' CZ ' ' C' ' 51' ' ' TYR . 4.8 m 70.35 133.68 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.894 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.02 -177.3 19.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.626 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . 0.404 ' HZ ' HD12 ' C' ' 60' ' ' ILE . 3.3 p90 -152.26 171.8 17.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 0.0 110.915 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' HIS . . . . . 0.406 ' CB ' ' HD3' ' C' ' 57' ' ' PRO . 0.5 OUTLIER -91.24 -55.09 0.27 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.21 -179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . 0.406 ' HD3' ' CB ' ' C' ' 56' ' ' HIS . 90.0 Cg_endo -86.74 -165.35 0.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.631 2.221 . . . . 0.0 112.616 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 78.14 149.24 0.1 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.218 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.403 ' CB ' ' HB2' ' D' ' 81' ' ' ASP . 7.9 m-20 -123.01 121.07 35.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.818 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.972 HD11 HG22 ' D' ' 82' ' ' ILE . 0.1 OUTLIER -126.87 110.62 23.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.978 0.418 . . . . 0.0 111.309 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -106.3 92.89 4.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.734 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.817 HG12 HD21 ' C' ' 64' ' ' LEU . 44.6 t -90.27 123.37 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.844 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' ASP . . . . . 0.782 ' C ' HD23 ' C' ' 64' ' ' LEU . 4.9 m-20 -133.92 124.03 25.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.156 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' LEU . . . . . 0.836 HD13 ' CZ ' ' B' ' 25' ' ' PHE . 0.1 OUTLIER -136.0 120.03 17.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.505 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.872 HD13 ' N ' ' C' ' 66' ' ' LYS . 0.0 OUTLIER -55.78 -20.66 15.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.652 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' LYS . . . . . 0.872 ' N ' HD13 ' C' ' 65' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.908 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.613 ' O ' HD13 ' D' ' 70' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.765 0.317 . . . . 0.0 111.231 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -62.16 -47.67 83.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . 0.725 ' CE1' HD21 ' D' ' 86' ' ' LEU . 34.8 t80 -92.1 108.82 20.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.741 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' LEU . . . . . 0.675 HD12 ' O ' ' D' ' 69' ' ' PHE . 5.1 mp -130.14 78.8 1.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.031 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -92.56 47.24 1.29 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.824 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 52.7 t -46.42 96.95 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.866 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' TYR . . . . . 0.453 ' CD1' ' HB3' ' C' ' 51' ' ' TYR . 2.4 m-85 -120.98 131.49 54.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.469 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' C' ' 52' ' ' VAL . 9.3 m -145.45 89.18 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.984 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.02 -53.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.705 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.55 -6.14 81.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.944 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.836 ' CE2' HG21 ' D' ' 82' ' ' ILE . 0.1 OUTLIER -49.74 99.93 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.222 0.534 . . . . 0.0 111.284 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' HIS . . . . . 0.688 ' N ' ' HD2' ' D' ' 79' ' ' PRO . 5.9 t-80 -84.88 -32.56 0.48 Allowed Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.647 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' D' ' 78' ' ' HIS . 37.2 Cg_endo -67.7 -171.12 0.3 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.641 1.561 . . . . 0.0 112.475 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' SER . . . . . 0.442 ' OG ' HG23 ' D' ' 82' ' ' ILE . 0.0 OUTLIER 66.9 -176.68 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.364 -179.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' C' ' 59' ' ' ASP . 1.5 m-20 -100.6 79.62 2.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 0.0 110.825 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 82' ' ' ILE . . . . . 0.972 HG22 HD11 ' C' ' 60' ' ' ILE . 2.3 pp -110.34 120.29 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.286 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -146.28 131.51 18.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.094 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 64.6 t -117.88 118.65 59.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.865 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . 0.403 ' CB ' ' HA ' ' C' ' 63' ' ' ASP . 2.7 t0 -89.13 86.71 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.76 HD11 ' CE2' ' C' ' 47' ' ' PHE . 0.2 OUTLIER -76.01 92.57 3.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.68 33.36 2.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.958 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.939 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.814 0.34 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -62.05 98.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.943 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.739 ' CZ ' HD11 ' B' ' 42' ' ' LEU . 59.7 t80 -102.61 114.11 28.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.896 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.731 HD13 ' C ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -118.96 101.07 7.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.773 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.458 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 49.7 t30 -120.37 83.85 2.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.818 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.4 p -90.44 -179.27 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.918 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -171.52 110.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.946 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.7 p -102.91 135.78 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.7 p -43.48 96.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.968 0.413 . . . . 0.0 111.491 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.54 98.91 0.12 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.99 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' B' ' 36' ' ' SER . 2.2 t80 -111.53 -177.2 3.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.057 0.456 . . . . 0.0 111.448 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.462 ' N ' ' HD2' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -170.51 -61.18 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.267 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 12' ' ' HIS . 18.5 Cg_endo -57.56 -162.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.392 2.062 . . . . 0.0 111.967 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.01 -65.09 1.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.762 0.315 . . . . 0.0 111.503 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -96.97 109.09 21.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.507 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.414 HG22 HG23 ' B' ' 38' ' ' ILE . 1.2 mp -126.26 143.55 39.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.559 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.432 ' CB ' ' HB3' ' B' ' 39' ' ' GLU . 0.0 OUTLIER -178.71 156.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.728 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.67 HG13 ' N ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -178.71 -171.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.625 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.67 ' N ' HG13 ' A' ' 18' ' ' VAL . 15.0 m-20 127.28 -129.98 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.348 1.059 . . . . 0.0 110.333 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.427 HD12 ' C ' ' A' ' 19' ' ' ASP . 5.1 mp -150.43 157.69 43.32 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.97 0.414 . . . . 0.0 111.173 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.547 HD13 ' HA ' ' B' ' 44' ' ' LYS . 0.2 OUTLIER -102.22 133.96 46.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.603 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.2 mttm . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.934 -179.949 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.846 0.355 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -145.46 -76.47 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.81 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.863 ' CZ ' HD11 ' C' ' 64' ' ' LEU . 48.6 t80 -128.23 128.79 45.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.711 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.76 91.52 2.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.542 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.484 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 52.1 t-20 -105.52 119.04 38.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 22.3 m -114.15 109.32 18.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.321 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.425 ' CE2' ' CB ' ' B' ' 31' ' ' SER . 87.6 t80 -105.49 125.13 50.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.542 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 17.4 t -126.39 76.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.241 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.425 ' CB ' ' CE2' ' B' ' 29' ' ' TYR . 0.0 OUTLIER -56.36 174.0 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.64 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.48 45.12 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.261 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -148.21 -177.05 5.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.925 0.393 . . . . 0.0 111.281 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.499 ' CG ' ' HD2' ' B' ' 35' ' ' PRO . 0.0 OUTLIER -86.7 178.74 2.1 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.927 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.499 ' HD2' ' CG ' ' B' ' 34' ' ' HIS . 66.2 Cg_exo -39.44 132.59 1.55 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.745 2.297 . . . . 0.0 113.356 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.462 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 4.2 p -158.91 151.41 21.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.584 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -102.57 107.24 18.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 111.114 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.414 HG23 HG22 ' A' ' 16' ' ' ILE . 1.9 mp -129.81 130.8 66.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.432 ' HB3' ' CB ' ' A' ' 17' ' ' GLU . 4.5 tp10 -130.92 129.58 42.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.06 0.457 . . . . 0.0 111.329 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.471 HG13 ' OD2' ' A' ' 19' ' ' ASP . 96.1 t -125.81 114.87 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.102 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.445 ' O ' ' CB ' ' A' ' 19' ' ' ASP . 1.7 p30 -136.19 104.37 5.63 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.739 HD11 ' CZ ' ' A' ' 3' ' ' PHE . 1.1 mm? -88.32 58.31 4.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.689 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.69 HD13 ' CB ' ' C' ' 65' ' ' LEU . 0.7 OUTLIER 171.33 -163.31 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.424 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.547 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.865 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.849 0.357 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -100.0 -57.63 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.642 ' CZ ' HD12 ' D' ' 86' ' ' LEU . 51.3 t80 -98.26 89.48 4.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.857 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.88 77.01 1.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.625 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' ASN . . . . . 0.494 ' ND2' HG13 ' D' ' 84' ' ' VAL . 50.4 t-20 -97.39 136.77 37.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.583 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' CYS . . . . . 0.401 ' HB3' ' CB ' ' D' ' 72' ' ' CYS . 6.6 p -150.69 123.03 8.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.406 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.506 ' CE2' ' CZ ' ' D' ' 77' ' ' PHE . 3.5 p90 -121.83 144.29 48.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.442 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . 0.491 HG22 ' N ' ' C' ' 53' ' ' SER . 12.6 p -141.31 158.81 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.931 0.396 . . . . 0.0 111.763 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' SER . . . . . 0.491 ' N ' HG22 ' C' ' 52' ' ' VAL . 3.8 t 82.24 -71.09 0.05 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.513 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.4 -174.03 52.55 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.49 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' C' ' 58' ' ' SER . 0.1 OUTLIER -173.97 -177.51 1.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.346 . . . . 0.0 111.058 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' HIS . . . . . 0.711 ' HB3' ' HD3' ' C' ' 57' ' ' PRO . 6.0 t-80 -109.67 -56.42 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.816 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . 0.711 ' HD3' ' HB3' ' C' ' 56' ' ' HIS . 45.3 Cg_endo -94.64 92.1 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.708 2.272 . . . . 0.0 112.694 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . 0.436 ' HB3' ' CE1' ' C' ' 55' ' ' PHE . 41.2 t -177.98 171.8 1.71 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.851 0.358 . . . . 0.0 111.067 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -135.44 127.38 29.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.124 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.753 HG13 HG22 ' D' ' 82' ' ' ILE . 1.4 pp -151.98 101.45 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.048 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.39 138.57 35.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.191 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.429 HG22 ' HB ' ' B' ' 40' ' ' VAL . 42.3 t -144.54 120.51 4.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.972 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -144.68 133.77 22.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.895 0.379 . . . . 0.0 111.276 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' LEU . . . . . 0.863 HD11 ' CZ ' ' B' ' 25' ' ' PHE . 0.8 OUTLIER -120.35 128.94 53.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.966 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.839 HD23 ' O ' ' C' ' 66' ' ' LYS . 4.8 tt -138.76 -42.04 0.48 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.27 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' LYS . . . . . 0.839 ' O ' HD23 ' C' ' 65' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.309 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.783 0.325 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -105.06 26.68 9.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . 0.519 ' CE1' HD11 ' D' ' 86' ' ' LEU . 7.3 t80 -106.58 86.01 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.044 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.53 93.38 8.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.676 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 71' ' ' ASN . . . . . 0.442 ' HB3' ' CE1' ' D' ' 69' ' ' PHE . 0.6 OUTLIER -96.48 58.66 1.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.979 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 72' ' ' CYS . . . . . 0.401 ' CB ' ' HB3' ' C' ' 50' ' ' CYS . 0.6 OUTLIER -59.7 119.55 7.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.777 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 73' ' ' TYR . . . . . 0.42 ' CD2' ' O ' ' D' ' 71' ' ' ASN . 0.5 OUTLIER -128.84 136.93 51.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.06 0.457 . . . . 0.0 111.233 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . 0.448 HG23 ' CB ' ' C' ' 52' ' ' VAL . 0.3 OUTLIER -154.76 58.3 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.666 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . 0.402 ' HB2' ' N ' ' C' ' 53' ' ' SER . 0.1 OUTLIER 171.42 176.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.495 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.96 146.36 18.34 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.652 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.506 ' CZ ' ' CE2' ' C' ' 51' ' ' TYR . 0.0 OUTLIER -163.55 75.28 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.737 0.303 . . . . 0.0 111.058 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 78' ' ' HIS . . . . . 0.475 ' HB2' ' HD3' ' D' ' 79' ' ' PRO . 5.7 m170 -69.27 -64.94 1.38 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.821 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 79' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' D' ' 78' ' ' HIS . 90.5 Cg_endo -80.25 88.82 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.469 2.112 . . . . 0.0 112.356 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 27.5 t -175.58 154.57 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 111.096 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -79.56 62.96 4.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.604 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 82' ' ' ILE . . . . . 0.753 HG22 HG13 ' C' ' 60' ' ' ILE . 0.2 OUTLIER -113.65 151.16 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.144 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -161.29 92.34 0.9 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.159 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 84' ' ' VAL . . . . . 0.494 HG13 ' ND2' ' C' ' 49' ' ' ASN . 84.2 t -105.85 117.75 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.603 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.58 -175.99 1.21 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 0.0 111.18 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.642 HD12 ' CZ ' ' C' ' 47' ' ' PHE . 0.0 OUTLIER -174.23 -172.17 0.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.642 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.605 ' O ' HD23 ' D' ' 87' ' ' LEU . 8.8 tt -46.47 102.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.011 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.832 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 87.4 p . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.825 0.345 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -121.15 140.75 51.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.001 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.866 ' CD1' HD22 ' A' ' 20' ' ' LEU . 49.1 t80 -165.08 125.48 1.93 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.01 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 3' ' ' PHE . 11.2 mt -130.15 92.15 3.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.041 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.471 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 0.5 OUTLIER -111.56 82.43 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.597 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.4 p -93.17 128.09 38.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.026 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.536 ' CD2' ' CE2' ' B' ' 33' ' ' PHE . 1.5 t80 -113.68 158.78 20.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.727 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.625 HG23 ' HB ' ' B' ' 30' ' ' VAL . 9.3 p -177.1 106.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.564 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.4 t 34.24 98.55 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.542 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.2 123.23 0.7 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.758 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.74 ' CE1' HD11 ' B' ' 38' ' ' ILE . 91.5 t80 -179.55 162.98 1.16 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.783 0.325 . . . . 0.0 111.092 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.476 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -164.02 -65.96 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.008 179.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.788 ' HG2' HD11 ' A' ' 16' ' ' ILE . 43.9 Cg_endo -67.13 115.38 3.61 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.392 2.062 . . . . 0.0 112.04 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.3 m -38.7 -55.67 1.43 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.266 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.39 123.31 30.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.906 0.384 . . . . 0.0 111.267 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.788 HD11 ' HG2' ' A' ' 13' ' ' PRO . 16.9 mm -147.6 133.96 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.917 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -147.04 142.36 27.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.867 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.665 ' HB ' HG13 ' B' ' 40' ' ' VAL . 19.2 t -109.33 159.6 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.49 ' N ' HG12 ' A' ' 18' ' ' VAL . 2.3 t0 -146.74 143.46 28.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.866 HD22 ' CD1' ' A' ' 3' ' ' PHE . 60.4 tp -127.65 141.6 51.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 78.38 96.06 0.06 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.917 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.761 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.867 0.365 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -84.69 -79.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.811 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.713 ' CZ ' HD13 ' C' ' 64' ' ' LEU . 84.4 t80 -100.91 110.73 22.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.733 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.402 ' HA ' ' HB3' ' C' ' 48' ' ' LEU . 0.6 OUTLIER -119.04 93.65 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.928 0.394 . . . . 0.0 111.057 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' C' ' 49' ' ' ASN . 32.3 t-20 -127.25 140.55 52.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.796 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' C' ' 50' ' ' CYS . 5.7 p 177.85 161.89 0.57 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.167 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.551 ' CE2' ' CG ' ' C' ' 51' ' ' TYR . 0.9 OUTLIER -129.68 152.79 48.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.125 0.488 . . . . 0.0 111.514 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.625 ' HB ' HG23 ' A' ' 8' ' ' VAL . 24.3 t -121.28 102.64 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.735 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 40.25 -165.68 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.125 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.24 49.57 8.09 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.978 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . 0.536 ' CE2' ' CD2' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -120.41 70.75 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.96 0.409 . . . . 0.0 111.507 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.738 ' N ' ' HD3' ' B' ' 35' ' ' PRO . 0.3 OUTLIER -111.93 18.71 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.738 ' HD3' ' N ' ' B' ' 34' ' ' HIS . 50.3 Cg_exo -53.53 -163.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 121.9 1.734 . . . . 0.0 113.124 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 9.9 t -107.69 -72.73 0.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.731 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.592 ' C ' HD12 ' B' ' 38' ' ' ILE . 14.4 t70 -130.97 113.87 14.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.369 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.74 HD11 ' CE1' ' A' ' 11' ' ' PHE . 1.7 mp -126.33 139.55 51.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.876 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -146.08 156.47 43.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.812 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.665 HG13 ' HB ' ' A' ' 18' ' ' VAL . 21.7 t -134.23 127.63 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -121.15 99.71 6.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.238 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.689 HD22 ' N ' ' B' ' 42' ' ' LEU . 0.9 OUTLIER -97.96 107.55 20.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.57 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.615 HD23 ' N ' ' B' ' 43' ' ' LEU . 1.8 pt? 178.17 -46.63 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.802 0.335 . . . . 0.0 111.218 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.455 ' N ' ' HG ' ' B' ' 43' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.766 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.801 0.334 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -57.57 98.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.958 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.568 ' HE1' HD11 ' C' ' 64' ' ' LEU . 47.6 t80 -102.74 113.46 26.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.548 ' CD2' HD12 ' D' ' 70' ' ' LEU . 0.1 OUTLIER -121.36 86.06 2.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.777 179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' ASN . . . . . 0.483 ' CB ' ' CZ ' ' C' ' 47' ' ' PHE . 12.2 t-20 -126.32 83.16 2.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.31 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' B' ' 28' ' ' CYS . 1.7 p -134.19 -170.97 2.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.277 0.561 . . . . 0.0 112.013 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.551 ' CG ' ' CE2' ' B' ' 29' ' ' TYR . 3.8 p90 -167.48 176.19 6.71 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.611 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . 0.58 HG12 ' HB ' ' D' ' 74' ' ' VAL . 15.1 m -136.62 146.69 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.842 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' C' ' 52' ' ' VAL . 5.1 t 99.67 -172.31 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.228 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.07 -16.76 68.86 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.841 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . 0.53 ' CE1' ' CE2' ' B' ' 29' ' ' TYR . 38.4 t80 64.46 120.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.748 0.308 . . . . 0.0 110.89 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' HIS . . . . . 0.421 ' CB ' ' HB3' ' B' ' 34' ' ' HIS . 7.9 m80 -76.72 162.36 70.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.931 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.67 112.0 1.01 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.568 2.179 . . . . 0.0 112.244 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 10.0 t -164.48 159.36 19.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.787 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -100.18 125.8 46.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.008 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.433 HD11 ' HA ' ' D' ' 82' ' ' ILE . 1.6 pp -126.04 116.24 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -110.74 85.97 2.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.036 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.696 HG12 HD21 ' C' ' 64' ' ' LEU . 49.0 t -80.81 120.83 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.878 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' ASP . . . . . 0.758 ' C ' HD23 ' C' ' 64' ' ' LEU . 1.2 m-20 -143.17 117.82 9.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.017 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' LEU . . . . . 0.758 HD23 ' C ' ' C' ' 63' ' ' ASP . 0.1 OUTLIER -137.28 119.76 15.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.641 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.41 HD23 ' N ' ' C' ' 65' ' ' LEU . 2.6 pt? -163.2 -167.0 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.967 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.096 179.826 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.815 0.341 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -154.65 -43.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.153 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . 0.423 ' CZ ' ' HB2' ' D' ' 71' ' ' ASN . 21.6 t80 -93.64 142.51 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.043 0.449 . . . . 0.0 111.247 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 70' ' ' LEU . . . . . 0.776 HD22 ' CE2' ' D' ' 73' ' ' TYR . 32.2 mt -159.19 120.49 3.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.969 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 71' ' ' ASN . . . . . 0.631 ' O ' ' N ' ' D' ' 73' ' ' TYR . 4.2 t30 -139.43 173.56 11.42 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 72' ' ' CYS . . . . . 0.443 ' O ' ' HB2' ' C' ' 50' ' ' CYS . 0.5 OUTLIER 37.34 -79.08 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.399 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 73' ' ' TYR . . . . . 0.776 ' CE2' HD22 ' D' ' 70' ' ' LEU . 0.3 OUTLIER 74.83 -87.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 178.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . 0.58 ' HB ' HG12 ' C' ' 52' ' ' VAL . 41.1 t -101.94 50.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.108 0.48 . . . . 0.0 111.064 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . 0.481 ' HA ' ' CZ ' ' C' ' 51' ' ' TYR . 3.3 m -92.86 -160.59 0.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.033 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.93 -4.54 0.64 Allowed Glycine 0 CA--C 1.522 0.492 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.226 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.428 ' CE2' ' CE2' ' C' ' 51' ' ' TYR . 0.1 OUTLIER -47.27 171.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 117.05 0.425 . . . . 0.0 111.384 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 78' ' ' HIS . . . . . 0.54 ' CB ' ' HD3' ' D' ' 79' ' ' PRO . 0.0 OUTLIER -115.94 -65.44 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 79' ' ' PRO . . . . . 0.54 ' HD3' ' CB ' ' D' ' 78' ' ' HIS . 60.9 Cg_endo -85.41 -105.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.359 2.039 . . . . 0.0 112.109 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 21.6 t 52.28 175.49 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.964 0.412 . . . . 0.0 111.408 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -120.71 73.06 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.652 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 82' ' ' ILE . . . . . 0.609 HG23 ' O ' ' D' ' 82' ' ' ILE . 0.0 OUTLIER -74.29 108.43 5.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.199 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.89 106.17 7.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.628 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 21.1 t -123.72 131.04 73.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.379 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -136.34 107.17 6.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.518 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.666 ' N ' HD22 ' D' ' 86' ' ' LEU . 0.2 OUTLIER -106.08 134.59 48.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.074 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.4 ' HB2' ' HB3' ' C' ' 65' ' ' LEU . 2.7 mm? -120.27 -172.67 2.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.695 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mttm . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.827 -179.943 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.435 ' N ' HD23 ' B' ' 42' ' ' LEU . 4.1 p . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.899 0.381 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 3' ' ' PHE . 0.9 OUTLIER 61.12 -174.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.932 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.757 ' CZ ' HD11 ' B' ' 42' ' ' LEU . 0.0 OUTLIER 87.03 177.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.901 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.458 ' N ' ' CG ' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -156.4 128.44 7.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 111.119 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -104.8 109.11 20.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.667 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -91.7 125.73 36.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.187 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.402 ' CE2' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -140.59 122.71 15.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.726 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.524 HG12 HG22 ' B' ' 30' ' ' VAL . 9.5 m -149.09 137.24 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.234 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t 71.95 -67.97 0.24 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.38 -150.2 20.39 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.834 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.414 ' CE2' ' O ' ' A' ' 12' ' ' HIS . 6.2 p90 -173.88 -166.09 0.28 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.811 0.339 . . . . 0.0 110.919 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.414 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 19.9 m80 -67.14 154.36 92.81 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.47 120.28 7.54 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.615 2.21 . . . . 0.0 112.2 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.0 p -169.83 -166.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.809 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.76 101.46 7.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.938 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.466 HG23 ' HA ' ' B' ' 38' ' ' ILE . 16.5 tt -87.84 140.72 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -144.32 162.73 35.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.941 0.4 . . . . 0.0 111.153 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.19 131.59 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.901 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -129.78 121.9 27.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.045 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -104.99 132.28 51.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.926 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.441 HD23 ' HD2' ' A' ' 22' ' ' LYS . 2.1 tp -136.49 -59.48 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.441 ' HD2' HD23 ' A' ' 21' ' ' LEU . 1.9 ptmm? . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.861 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.898 0.38 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -176.66 113.64 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.075 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.709 ' CE2' HD22 ' B' ' 42' ' ' LEU . 63.0 t80 -116.95 121.3 41.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.644 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.709 ' CD1' HD12 ' C' ' 48' ' ' LEU . 0.3 OUTLIER -133.75 98.03 4.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.2 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.511 ' OD1' HG13 ' C' ' 62' ' ' VAL . 0.5 OUTLIER -107.36 83.97 1.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.592 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 12.6 p -106.06 133.18 51.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.173 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.444 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 0.0 OUTLIER -150.41 114.77 5.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.563 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.746 HG12 ' CG2' ' C' ' 52' ' ' VAL . 34.6 m -121.99 131.1 73.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.077 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 22.6 m 64.43 102.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.654 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.448 ' HA3' ' CD2' ' C' ' 55' ' ' PHE . . . -59.39 -116.71 0.01 OUTLIER Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.782 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . 0.571 ' CZ ' HD11 ' B' ' 38' ' ' ILE . 0.0 OUTLIER 179.15 -100.18 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.396 0.141 . . . . 0.0 110.787 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.494 ' CG ' ' HD2' ' B' ' 35' ' ' PRO . 0.0 OUTLIER -138.16 179.34 1.35 Allowed Pre-proline 0 N--CA 1.455 -0.19 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.494 ' HD2' ' CG ' ' B' ' 34' ' ' HIS . 99.7 Cg_exo -44.84 88.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.587 2.191 . . . . 0.0 112.566 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.446 ' N ' ' O ' ' B' ' 34' ' ' HIS . 3.3 m -136.24 159.0 43.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.272 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -113.88 111.1 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.816 0.341 . . . . 0.0 111.221 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.571 HD11 ' CZ ' ' B' ' 33' ' ' PHE . 32.9 mt -99.06 94.74 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.749 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -101.99 88.46 3.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.266 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.405 HG23 HG22 ' B' ' 38' ' ' ILE . 95.3 t -91.65 114.92 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.539 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -127.13 112.28 14.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.0 111.492 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.757 HD11 ' CZ ' ' A' ' 3' ' ' PHE . 1.2 mp -102.35 116.62 33.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.111 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.418 HD22 ' H ' ' B' ' 44' ' ' LYS . 0.5 OUTLIER 76.52 -154.18 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.005 -179.3 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.418 ' H ' HD22 ' B' ' 43' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.785 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.764 0.316 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.7 -73.65 0.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.944 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.903 ' O ' HD23 ' C' ' 48' ' ' LEU . 15.3 t80 -137.28 128.45 27.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.996 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.903 HD23 ' O ' ' C' ' 47' ' ' PHE . 6.0 mt -135.35 112.02 10.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.77 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' ASN . . . . . 0.497 ' HB2' ' CE1' ' C' ' 47' ' ' PHE . 38.2 t30 -113.76 139.29 49.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.96 0.409 . . . . 0.0 111.034 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.46 109.21 7.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.594 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.619 ' CZ ' HG21 ' D' ' 82' ' ' ILE . 1.2 t80 -121.24 94.06 4.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.179 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . 0.746 ' CG2' HG12 ' B' ' 30' ' ' VAL . 45.9 t -97.59 109.27 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.594 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' SER . . . . . 0.509 ' CB ' ' HB2' ' D' ' 75' ' ' SER . 0.7 OUTLIER -55.7 -175.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.349 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.48 58.73 0.68 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.033 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . 0.687 ' CE2' HD11 ' C' ' 60' ' ' ILE . 1.3 p90 -171.74 33.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.32 0.105 . . . . 0.0 110.754 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' HIS . . . . . 0.546 ' CD2' ' HD3' ' C' ' 57' ' ' PRO . 0.0 OUTLIER 12.42 -76.45 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.711 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.231 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . 0.546 ' HD3' ' CD2' ' C' ' 56' ' ' HIS . 73.1 Cg_endo -72.45 -162.95 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.233 1.955 . . . . 0.0 112.781 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 79.22 155.52 0.15 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.808 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.496 ' C ' HD12 ' C' ' 60' ' ' ILE . 7.8 t0 -129.17 145.62 51.28 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.588 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.79 HD13 ' CG2' ' D' ' 82' ' ' ILE . 2.1 mp -131.05 112.81 22.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.324 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -114.38 80.71 1.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.739 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.644 HG23 HG22 ' C' ' 60' ' ' ILE . 42.1 t -91.93 121.89 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.139 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -151.45 126.98 10.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' LEU . . . . . 0.727 ' N ' HD13 ' C' ' 64' ' ' LEU . 0.0 OUTLIER -135.26 144.67 46.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.942 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 4.9 mt -97.94 102.75 14.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.924 179.991 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 19.1 p . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.863 0.363 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -68.54 97.91 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -124.05 113.81 18.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.79 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 70' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' D' ' 70' ' ' LEU . 5.3 tp -122.72 99.65 6.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.793 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 71' ' ' ASN . . . . . 0.415 ' O ' ' CD1' ' D' ' 73' ' ' TYR . 12.7 p-10 -93.89 52.66 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 90.5 m -58.86 123.27 15.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.594 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 73' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' D' ' 71' ' ' ASN . 0.1 OUTLIER -174.58 135.16 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.295 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . 0.589 ' O ' ' CB ' ' D' ' 75' ' ' SER . 12.6 p -178.73 160.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.212 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . 0.589 ' CB ' ' O ' ' D' ' 74' ' ' VAL . 73.7 m 118.18 179.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.872 0.869 . . . . 0.0 110.627 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.51 152.87 20.29 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.44 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.486 ' HD1' ' HG ' ' D' ' 80' ' ' SER . 38.4 p90 -161.76 -31.5 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.47 0.176 . . . . 0.0 111.162 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 78' ' ' HIS . . . . . 0.673 ' CB ' ' CD ' ' D' ' 79' ' ' PRO . 17.9 m170 34.67 -90.18 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 79' ' ' PRO . . . . . 0.673 ' CD ' ' CB ' ' D' ' 78' ' ' HIS . 58.2 Cg_endo -69.37 58.07 1.34 Allowed 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.646 1.564 . . . . 0.0 113.007 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 80' ' ' SER . . . . . 0.486 ' HG ' ' HD1' ' D' ' 77' ' ' PHE . 3.7 p -135.84 155.73 49.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.525 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -110.49 100.07 8.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.797 0.332 . . . . 0.0 111.244 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 82' ' ' ILE . . . . . 0.79 ' CG2' HD13 ' C' ' 60' ' ' ILE . 1.3 pp -122.73 143.87 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.283 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -158.27 124.21 4.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.737 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 84' ' ' VAL . . . . . 0.754 ' CG1' HD11 ' D' ' 86' ' ' LEU . 21.9 t -112.58 132.17 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.341 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . 0.528 ' C ' HD13 ' D' ' 86' ' ' LEU . 3.5 m-20 -128.55 105.59 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.82 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.793 HD12 ' CZ ' ' C' ' 47' ' ' PHE . 0.0 OUTLIER -107.76 100.23 9.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.889 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 55.6 tp 58.01 104.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.943 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.913 -179.974 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.412 ' CA ' ' HE2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.716 0.293 . . . . 0.0 111.212 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.439 ' OD1' HD11 ' A' ' 4' ' ' LEU . 7.5 p30 44.39 95.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.685 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.917 ' CZ ' HD12 ' B' ' 42' ' ' LEU . 0.5 OUTLIER -76.95 106.2 8.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.506 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.439 HD11 ' OD1' ' A' ' 2' ' ' ASN . 0.5 OUTLIER -97.92 68.07 1.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.542 179.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.506 ' HB3' ' CE1' ' A' ' 3' ' ' PHE . 6.0 p30 -67.92 -177.48 0.82 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.429 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' B' ' 28' ' ' CYS . 2.8 m 64.92 -167.62 0.22 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.302 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -146.66 151.95 38.08 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 120.808 0.337 . . . . 0.0 111.402 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 8' ' ' VAL . 7.1 p -95.53 83.24 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.879 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.3 p 61.77 117.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.087 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.98 130.89 5.79 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.641 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.663 ' CE2' HD12 ' A' ' 16' ' ' ILE . 33.7 t80 -179.99 148.87 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.919 0.39 . . . . 0.0 111.035 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.428 ' O ' ' CE2' ' A' ' 11' ' ' PHE . 18.6 p80 -82.37 157.36 67.95 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.792 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 14' ' ' SER . 19.3 Cg_endo -58.76 -159.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.758 2.305 . . . . 0.0 112.556 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 0.5 OUTLIER 73.37 -95.9 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.427 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' B' ' 37' ' ' ASP . 0.1 OUTLIER -177.83 160.61 1.52 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.013 0.435 . . . . 0.0 111.408 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.663 HD12 ' CE2' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -96.16 117.42 40.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.681 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 7.0 pt-20 -107.48 115.0 29.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.962 0.41 . . . . 0.0 110.723 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.7 t -150.71 137.17 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -149.51 126.78 11.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.87 0.367 . . . . 0.0 111.326 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' B' ' 43' ' ' LEU . 0.6 OUTLIER 66.6 -66.91 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.656 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.528 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER 41.97 77.19 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.425 -179.462 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.472 ' N ' HD13 ' A' ' 20' ' ' LEU . 1.8 tpmp? . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.9 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.804 0.335 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.84 -44.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.022 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.87 ' CE1' HD11 ' C' ' 64' ' ' LEU . 60.4 t80 -103.66 123.41 46.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.243 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.74 HD12 ' C ' ' B' ' 25' ' ' PHE . 7.2 mp -124.45 122.25 37.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.671 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.521 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 0.8 OUTLIER -126.91 114.99 18.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.531 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 6' ' ' CYS . 2.2 t -116.73 102.2 9.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.356 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.48 ' CE2' HG21 ' C' ' 60' ' ' ILE . 3.9 t80 -125.78 88.84 2.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.546 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -103.38 132.68 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.136 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 15.5 t 65.35 151.69 0.05 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.166 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.16 -139.24 8.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.516 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . 0.608 ' CZ ' HD11 ' B' ' 38' ' ' ILE . 0.0 OUTLIER -179.66 -106.65 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 O-C-N 123.008 -0.113 . . . . 0.0 111.149 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.513 ' CB ' ' CD ' ' B' ' 35' ' ' PRO . 0.0 OUTLIER -123.34 -176.7 0.46 Allowed Pre-proline 0 CA--C 1.528 0.106 0 CA-C-O 120.579 0.228 . . . . 0.0 110.589 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' B' ' 34' ' ' HIS . 24.1 Cg_exo -64.26 -0.92 3.19 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.714 2.276 . . . . 0.0 113.092 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.1 t -41.99 160.18 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.935 0.397 . . . . 0.0 111.432 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 7.6 t0 -103.0 143.64 32.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.716 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.608 HD11 ' CZ ' ' B' ' 33' ' ' PHE . 26.4 mm -119.27 123.03 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.213 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -123.28 87.26 2.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.858 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.518 HG23 HG22 ' B' ' 38' ' ' ILE . 50.2 t -100.21 119.07 47.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.135 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.779 ' C ' HD13 ' B' ' 42' ' ' LEU . 0.3 OUTLIER -131.7 122.84 26.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.28 179.412 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.917 HD12 ' CZ ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -120.2 145.88 46.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.062 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.677 HD12 HD13 ' C' ' 65' ' ' LEU . 0.1 OUTLIER 56.6 21.92 6.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.319 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 30.8 tttt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.914 179.895 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.839 0.352 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 66.06 120.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.994 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.909 ' CZ ' HD12 ' D' ' 86' ' ' LEU . 1.7 t80 -108.41 103.35 12.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.641 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.494 HD11 HD23 ' D' ' 70' ' ' LEU . 1.6 mp -107.06 110.13 22.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.862 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' ASN . . . . . 0.424 ' HA ' ' HB3' ' B' ' 27' ' ' ASN . 1.5 t30 -122.14 97.9 5.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.082 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 13.9 m -109.84 116.96 32.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.689 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.476 ' OH ' ' CD1' ' D' ' 77' ' ' PHE . 0.7 OUTLIER -139.64 149.48 43.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.965 0.412 . . . . 0.0 111.285 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . . . . . . . . . 31.3 t -115.53 110.87 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.588 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 11.7 m -52.96 178.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.409 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.93 48.02 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.233 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . 0.639 ' HZ ' HD12 ' C' ' 60' ' ' ILE . 0.0 OUTLIER -176.64 141.96 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.168 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' HIS . . . . . 0.43 ' CE1' ' HG3' ' D' ' 79' ' ' PRO . 0.2 OUTLIER -87.23 -62.08 0.24 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.276 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' C' ' 56' ' ' HIS . 72.9 Cg_endo -76.27 -163.52 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.507 2.138 . . . . 0.0 112.498 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' C' ' 57' ' ' PRO . 0.4 OUTLIER 80.36 161.89 0.17 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.325 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.06 129.17 47.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.947 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.639 HD12 ' HZ ' ' C' ' 55' ' ' PHE . 0.1 OUTLIER -114.55 96.44 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.93 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -104.28 128.09 52.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.958 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 46.5 t -142.89 120.87 7.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.957 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -128.44 124.63 36.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.996 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' LEU . . . . . 0.87 HD11 ' CE1' ' B' ' 25' ' ' PHE . 0.1 OUTLIER -98.44 106.02 18.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.677 HD13 HD12 ' B' ' 43' ' ' LEU . 28.6 tp 64.52 -76.57 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.034 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.985 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 87.4 p . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.845 0.355 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 58.54 32.32 22.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.982 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -107.72 109.63 21.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 70' ' ' LEU . . . . . 0.494 HD23 HD11 ' C' ' 48' ' ' LEU . 9.4 tp -132.45 60.02 1.7 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.778 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 71' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -80.59 78.07 7.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.856 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 19.8 t -69.75 123.72 22.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.827 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 73' ' ' TYR . . . . . 0.46 ' HB3' ' CE2' ' C' ' 51' ' ' TYR . 0.2 OUTLIER -131.09 144.85 51.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 18.7 t -121.72 153.09 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.486 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 1.1 t 67.88 -83.13 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.35 174.37 24.34 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.691 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.618 ' CD2' HG21 ' D' ' 82' ' ' ILE . 0.3 OUTLIER -169.45 159.44 8.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 111.011 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 78' ' ' HIS . . . . . 0.471 ' N ' ' HD2' ' D' ' 79' ' ' PRO . 6.1 t-160 -178.24 -60.76 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.148 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 79' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' D' ' 78' ' ' HIS . 9.2 Cg_endo -52.75 -34.2 63.67 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.5 2.134 . . . . 0.0 112.485 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 24.8 p -75.19 157.21 34.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.831 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.86 115.22 16.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.742 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 82' ' ' ILE . . . . . 0.618 HG21 ' CD2' ' D' ' 77' ' ' PHE . 0.1 OUTLIER -114.01 146.53 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.977 0.418 . . . . 0.0 111.589 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.64 57.46 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 t -80.54 134.79 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . 0.68 ' C ' HD13 ' D' ' 86' ' ' LEU . 40.0 m-20 -149.71 137.16 19.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.909 HD12 ' CZ ' ' C' ' 47' ' ' PHE . 0.0 OUTLIER -126.19 94.46 4.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.72 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.651 ' CD1' HD23 ' C' ' 65' ' ' LEU . 4.0 mm? 60.34 99.18 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.765 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.86 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.822 ' CB ' HD23 ' B' ' 42' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.761 0.315 . . . . 0.0 111.078 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -162.08 97.17 1.02 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.094 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.715 ' CZ ' HD11 ' B' ' 42' ' ' LEU . 0.0 OUTLIER -165.48 -172.15 2.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.984 179.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.591 HD23 ' H ' ' A' ' 4' ' ' LEU . 1.5 pt? -124.45 119.08 28.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.038 0.447 . . . . 0.0 111.08 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER -125.88 61.3 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.691 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' B' ' 28' ' ' CYS . 29.5 p -138.29 145.52 41.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.963 0.411 . . . . 0.0 111.472 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -150.85 131.43 13.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.805 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.634 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.0 p -100.19 99.9 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.162 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.428 ' HA ' ' HA3' ' B' ' 32' ' ' GLY . 0.9 OUTLIER 58.46 105.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.066 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.48 135.24 2.11 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.574 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.458 ' CE2' ' CB ' ' B' ' 36' ' ' SER . 5.0 t80 -158.98 93.86 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.762 0.315 . . . . 0.0 110.964 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.462 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 3.0 t-160 -81.23 -47.77 1.09 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.408 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 12' ' ' HIS . 87.7 Cg_endo -82.57 -177.5 3.45 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.469 2.112 . . . . 0.0 112.55 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -115.04 -60.45 1.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.665 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -112.09 104.45 12.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.644 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.8 pt -117.77 118.87 59.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.264 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -118.7 86.94 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.52 HG11 ' HE2' ' A' ' 3' ' ' PHE . 21.3 t -69.51 147.71 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.022 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -148.37 149.04 31.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.964 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.7 112.97 7.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 tp -58.98 -68.86 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.998 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.864 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.879 0.371 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -161.01 106.95 1.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.862 ' CZ ' HD11 ' C' ' 64' ' ' LEU . 77.9 t80 -101.92 122.11 43.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.92 122.28 43.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.723 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.441 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 8.8 t-20 -148.56 101.4 3.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.642 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 7.3 m -152.84 132.95 13.45 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.8 0.333 . . . . 0.0 111.753 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.535 ' CE2' ' HB2' ' C' ' 51' ' ' TYR . 0.1 OUTLIER -130.24 129.86 43.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.411 178.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.938 HG13 ' CG2' ' C' ' 52' ' ' VAL . 39.9 t -128.56 119.22 49.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.841 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 14.2 m 50.56 179.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.606 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 9' ' ' SER . . . 46.1 94.42 0.01 OUTLIER Glycine 0 C--N 1.332 0.355 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.835 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . 0.518 ' CE2' HG21 ' C' ' 60' ' ' ILE . 0.1 OUTLIER -130.08 -44.12 1.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.664 0.269 . . . . 0.0 111.214 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 63.61 137.58 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.717 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -51.53 93.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.432 2.088 . . . . 0.0 112.171 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.458 ' CB ' ' CE2' ' A' ' 11' ' ' PHE . 2.4 m -149.51 -167.0 2.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.034 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -141.0 142.62 34.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.073 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.712 HG13 HG22 ' C' ' 60' ' ' ILE . 0.8 OUTLIER -150.69 147.01 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.656 179.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -143.18 129.66 20.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.821 0.343 . . . . 0.0 111.133 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.631 ' HB ' HG13 ' C' ' 62' ' ' VAL . 44.3 t -110.63 120.66 61.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.826 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -118.73 94.13 4.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.837 ' HB2' HD22 ' C' ' 64' ' ' LEU . 3.0 mp -110.01 117.46 33.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.676 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.06 122.19 32.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.805 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.825 ' HB3' HD12 ' C' ' 65' ' ' LEU . 8.7 tttm . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.927 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.779 0.323 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 59.77 78.97 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.888 ' CZ ' HD13 ' D' ' 86' ' ' LEU . 31.7 t80 -87.64 102.86 15.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.632 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -103.92 103.24 13.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.903 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' ASN . . . . . 0.459 ' HB2' ' CZ ' ' C' ' 47' ' ' PHE . 1.9 t30 -127.04 116.44 20.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' CYS . . . . . 0.442 ' CB ' ' HB3' ' D' ' 72' ' ' CYS . 18.9 p -159.74 157.19 28.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.18 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.592 ' HE2' HD12 ' D' ' 82' ' ' ILE . 0.5 OUTLIER -162.78 147.21 11.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.771 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . 0.938 ' CG2' HG13 ' B' ' 30' ' ' VAL . 32.8 m -134.53 114.45 18.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.181 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 5.5 t 166.72 -86.39 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.767 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' GLY . . . . . 0.556 ' O ' ' CD1' ' C' ' 55' ' ' PHE . . . 108.92 -56.09 0.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.895 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . 0.556 ' CD1' ' O ' ' C' ' 54' ' ' GLY . 4.9 p90 43.02 -176.97 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.098 0.475 . . . . 0.0 111.99 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' HIS . . . . . 0.528 ' CB ' ' HD3' ' C' ' 57' ' ' PRO . 0.0 OUTLIER -99.51 -61.96 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.783 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' C' ' 56' ' ' HIS . 52.4 Cg_endo -88.27 -151.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.795 2.33 . . . . 0.0 112.027 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' C' ' 57' ' ' PRO . 1.0 OUTLIER 86.69 125.06 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.181 0.515 . . . . 0.0 111.375 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.445 ' HA ' ' CB ' ' D' ' 81' ' ' ASP . 8.1 t0 -112.51 95.51 5.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.213 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.797 HD11 HG22 ' D' ' 82' ' ' ILE . 0.2 OUTLIER -134.01 140.87 45.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.199 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -156.49 133.41 10.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.053 0.454 . . . . 0.0 111.185 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.631 HG13 ' HB ' ' B' ' 40' ' ' VAL . 48.0 t -109.29 121.01 61.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.647 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' ASP . . . . . 0.776 ' C ' HD23 ' C' ' 64' ' ' LEU . 5.1 p-10 -125.13 128.33 48.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.269 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' LEU . . . . . 0.862 HD11 ' CZ ' ' B' ' 25' ' ' PHE . 5.2 mt -124.78 110.05 13.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.563 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.825 HD12 ' HB3' ' B' ' 44' ' ' LYS . 0.5 OUTLIER 62.91 126.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.789 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 18.1 ttpt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.888 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.694 0.283 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -177.75 -35.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.297 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . 0.422 ' HB2' ' CD1' ' C' ' 47' ' ' PHE . 0.1 OUTLIER -120.37 170.67 9.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 110.79 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 24.0 tp -152.22 109.06 3.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.117 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 71' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -102.18 65.3 0.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.47 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 72' ' ' CYS . . . . . 0.442 ' HB3' ' CB ' ' C' ' 50' ' ' CYS . 50.9 t -75.03 101.66 4.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 73' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -107.15 128.86 54.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.103 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . 0.885 ' HB ' HG12 ' C' ' 52' ' ' VAL . 10.9 t -133.33 73.87 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.13 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' D' ' 74' ' ' VAL . 1.4 p 174.63 137.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.451 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . 0.485 ' O ' ' CG ' ' D' ' 77' ' ' PHE . . . -50.38 -87.02 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.679 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.657 ' HD1' HD11 ' D' ' 82' ' ' ILE . 0.4 OUTLIER 162.8 -60.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 122.482 0.313 . . . . 0.0 110.616 178.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 78' ' ' HIS . . . . . 0.467 ' HB3' ' HD2' ' D' ' 79' ' ' PRO . 20.0 m-70 58.54 164.62 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.545 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 79' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' D' ' 78' ' ' HIS . 18.7 Cg_endo -59.32 75.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.517 2.145 . . . . 0.0 112.344 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 80' ' ' SER . . . . . 0.444 ' N ' ' O ' ' D' ' 78' ' ' HIS . 9.7 p -127.61 -163.34 1.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.454 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 81' ' ' ASP . . . . . 0.445 ' CB ' ' HA ' ' C' ' 59' ' ' ASP . 0.2 OUTLIER -130.78 43.97 3.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.782 0.325 . . . . 0.0 111.31 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 82' ' ' ILE . . . . . 0.797 HG22 HD11 ' C' ' 60' ' ' ILE . 35.6 pt -99.7 117.85 45.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.882 0.372 . . . . 0.0 110.814 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -148.02 162.43 39.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.022 0.439 . . . . 0.0 111.523 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 84' ' ' VAL . . . . . . . . . . . . . 48.0 t -141.76 130.22 22.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.94 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -135.59 108.77 7.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.925 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.888 HD13 ' CZ ' ' C' ' 47' ' ' PHE . 0.4 OUTLIER -120.03 96.18 5.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.055 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mp 60.57 -81.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.054 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 88' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' D' ' 86' ' ' LEU . 3.4 tttp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.097 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.739 0.304 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -61.33 136.98 58.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.789 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.703 ' C ' HD13 ' A' ' 4' ' ' LEU . 46.5 t80 -145.67 129.08 16.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.73 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.72 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -147.48 83.87 1.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.295 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 6.5 t-20 -71.97 115.96 11.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.417 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.87 112.13 22.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.958 0.408 . . . . 0.0 111.714 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.47 ' OH ' ' CE1' ' B' ' 33' ' ' PHE . 0.1 OUTLIER -118.09 128.78 55.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.98 179.066 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.5 80.36 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.097 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 43.61 95.73 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.596 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.5 137.28 3.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.148 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.511 ' CD1' HD11 ' B' ' 38' ' ' ILE . 5.6 p90 -177.44 169.3 2.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.686 0.279 . . . . 0.0 110.733 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.588 ' HB3' ' HD2' ' A' ' 13' ' ' PRO . 1.8 m80 -58.89 176.04 0.3 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.719 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 12' ' ' HIS . 86.1 Cg_endo -81.68 175.45 9.42 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.367 2.045 . . . . 0.0 112.158 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 m 65.5 -161.56 0.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.743 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -106.36 118.39 36.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.971 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 17' ' ' GLU . 23.4 mm -79.24 159.11 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.977 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.473 ' N ' HG22 ' A' ' 16' ' ' ILE . 0.7 OUTLIER -146.16 59.56 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.191 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.73 118.46 10.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.498 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' B' ' 41' ' ' ASP . 3.1 p30 -134.76 161.98 33.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.957 0.408 . . . . 0.0 111.398 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.667 HD12 ' CE2' ' A' ' 3' ' ' PHE . 24.1 mt -152.95 122.9 6.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.894 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.586 ' N ' HD22 ' A' ' 21' ' ' LEU . 2.6 mm? 63.7 -178.69 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.731 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.852 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.851 0.358 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 43.01 46.71 4.84 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.463 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.95 ' CZ ' HD11 ' C' ' 64' ' ' LEU . 37.6 t80 -121.23 142.15 50.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.784 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -147.42 115.81 6.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.442 ' HB2' ' CE1' ' B' ' 25' ' ' PHE . 46.4 t30 -122.73 90.66 3.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.775 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 91.6 m -81.93 117.44 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.73 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.461 ' CZ ' HG13 ' C' ' 60' ' ' ILE . 1.7 t80 -111.69 104.79 13.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.014 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.453 ' HA ' ' CG2' ' C' ' 52' ' ' VAL . 15.3 t -104.04 105.29 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.567 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 13.8 m -57.21 -178.32 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.982 0.42 . . . . 0.0 111.276 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.18 50.72 0.76 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.464 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . 0.47 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -165.25 161.02 18.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.771 0.319 . . . . 0.0 111.233 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.637 ' N ' ' HD3' ' B' ' 35' ' ' PRO . 4.7 p80 -148.0 53.53 1.54 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.182 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.637 ' HD3' ' N ' ' B' ' 34' ' ' HIS . 2.3 Cg_endo -83.37 -72.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.08 2.52 . . . . 0.0 112.465 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 47.3 t -158.1 -119.94 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.185 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -126.83 163.94 22.49 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.86 0.362 . . . . 0.0 111.015 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.511 HD11 ' CD1' ' A' ' 11' ' ' PHE . 25.0 mt -145.57 136.04 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.927 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -129.92 145.36 51.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.94 0.4 . . . . 0.0 111.227 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.403 ' HB ' ' HA ' ' C' ' 62' ' ' VAL . 40.7 t -142.85 140.38 27.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.814 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 19' ' ' ASP . 14.5 t0 -162.61 118.1 1.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.658 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.589 ' HG ' HD23 ' B' ' 43' ' ' LEU . 0.4 OUTLIER -158.9 -171.0 3.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.051 0.453 . . . . 0.0 111.482 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.589 HD23 ' HG ' ' B' ' 42' ' ' LEU . 2.6 mm? 58.54 162.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.211 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.99 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.814 0.34 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' ASN . . . . . 0.411 ' CB ' ' HB2' ' D' ' 68' ' ' ASN . 3.8 p30 -175.9 174.39 2.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.102 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.643 ' CZ ' HD11 ' D' ' 86' ' ' LEU . 62.1 t80 -85.78 107.64 17.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.632 HD13 HD23 ' D' ' 70' ' ' LEU . 21.4 tp -117.37 83.5 2.0 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.983 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' ASN . . . . . 0.513 ' HB2' ' CZ ' ' C' ' 47' ' ' PHE . 3.7 t-20 -98.35 102.9 14.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.593 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.72 115.11 20.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.813 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -116.07 102.75 9.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.063 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . 0.559 HG23 ' O ' ' C' ' 52' ' ' VAL . 34.1 m -113.68 114.31 46.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 15.1 p -50.93 178.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.626 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.88 -30.49 2.16 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.087 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . 0.46 ' CZ ' ' CB ' ' D' ' 80' ' ' SER . 0.0 OUTLIER -92.73 -163.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 111.323 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' HIS . . . . . 0.483 ' CB ' ' HD3' ' C' ' 57' ' ' PRO . 0.0 OUTLIER -169.68 -55.63 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.81 179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . 0.483 ' HD3' ' CB ' ' C' ' 56' ' ' HIS . 69.0 Cg_endo -94.8 66.61 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.008 2.472 . . . . 0.0 112.617 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.0 158.07 32.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.97 0.414 . . . . 0.0 111.028 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.825 ' O ' HD13 ' C' ' 60' ' ' ILE . 0.2 OUTLIER -113.83 139.14 49.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.795 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.825 HD13 ' O ' ' C' ' 59' ' ' ASP . 6.1 mm -139.42 103.71 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.311 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.73 129.41 55.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.692 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.403 ' HA ' ' HB ' ' B' ' 40' ' ' VAL . 21.2 t -133.57 145.48 33.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.312 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' ASP . . . . . 0.544 ' O ' HD12 ' C' ' 64' ' ' LEU . 0.4 OUTLIER -139.52 148.7 43.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.027 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' LEU . . . . . 0.95 HD11 ' CZ ' ' B' ' 25' ' ' PHE . 0.6 OUTLIER -151.09 73.43 1.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.468 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.803 HD22 ' N ' ' C' ' 66' ' ' LYS . 1.2 tm? 157.65 137.17 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.449 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' LYS . . . . . 0.803 ' N ' HD22 ' C' ' 65' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.86 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.746 0.308 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . 0.411 ' HB2' ' CB ' ' C' ' 46' ' ' ASN . 22.4 m120 -56.76 129.25 40.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.048 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . 0.449 ' HE2' HD23 ' D' ' 86' ' ' LEU . 24.6 t80 -130.28 139.78 50.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 70' ' ' LEU . . . . . 0.632 HD23 HD13 ' C' ' 48' ' ' LEU . 12.7 tp -157.41 95.96 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.753 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 71' ' ' ASN . . . . . 0.46 HD21 HG21 ' D' ' 84' ' ' VAL . 50.0 t-20 -109.09 122.51 47.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.093 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -95.03 62.8 2.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.594 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.02 72.68 1.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.12 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.04 97.59 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.064 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 80.9 p -174.65 -76.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.923 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.75 -33.27 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.403 ' O ' ' CG ' ' D' ' 78' ' ' HIS . 22.6 m-85 62.74 104.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.734 0.302 . . . . 0.0 111.025 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 78' ' ' HIS . . . . . 0.46 ' CB ' ' CD ' ' D' ' 79' ' ' PRO . 2.0 m-70 -173.81 -64.04 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.946 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 79' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' D' ' 78' ' ' HIS . 33.1 Cg_endo -66.98 -75.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.366 2.044 . . . . 0.0 112.769 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 80' ' ' SER . . . . . 0.46 ' CB ' ' CZ ' ' C' ' 55' ' ' PHE . 35.3 p -58.9 -178.85 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.912 0.387 . . . . 0.0 111.167 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.3 108.47 13.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.829 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 82' ' ' ILE . . . . . 0.712 HG22 ' HB ' ' C' ' 60' ' ' ILE . 0.2 OUTLIER -141.55 161.56 21.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.228 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -168.94 126.45 0.99 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.811 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 84' ' ' VAL . . . . . 0.667 HG12 HD21 ' D' ' 86' ' ' LEU . 21.6 t -111.31 127.49 68.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -139.6 100.06 3.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.716 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.679 HD12 ' HB2' ' C' ' 64' ' ' LEU . 0.2 OUTLIER -103.1 -168.96 1.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.678 ' H ' HD13 ' D' ' 87' ' ' LEU . 0.0 OUTLIER -67.32 66.54 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.215 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.96 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 84.2 p . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.838 0.351 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 60.8 55.66 3.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.995 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.771 ' O ' HD12 ' B' ' 26' ' ' LEU . 90.0 t80 -59.96 114.76 2.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.805 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 4' ' ' LEU . 1.9 pp -124.1 98.48 5.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.811 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -83.79 93.01 7.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.889 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.9 m -89.07 102.59 15.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' B' ' 29' ' ' TYR . 8.3 t80 -108.21 117.91 35.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.69 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.745 ' HA ' HG22 ' B' ' 30' ' ' VAL . 7.1 p -121.39 87.64 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.962 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.418 ' CB ' ' HA3' ' B' ' 32' ' ' GLY . 67.0 p 46.54 -167.85 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.777 0.322 . . . . 0.0 111.084 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.61 159.77 34.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.042 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' B' ' 36' ' ' SER . 0.2 OUTLIER 177.22 113.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.826 0.346 . . . . 0.0 110.56 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.415 ' HB2' ' HD3' ' A' ' 13' ' ' PRO . 0.3 OUTLIER -92.12 -54.3 0.26 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.438 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.428 ' CG ' HG12 ' A' ' 16' ' ' ILE . 94.9 Cg_endo -83.53 -97.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.477 2.118 . . . . 0.0 112.646 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.404 ' O ' ' CZ ' ' A' ' 11' ' ' PHE . 14.8 p -178.67 -52.81 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.749 0.309 . . . . 0.0 111.102 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -114.86 86.43 2.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.266 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.75 HD12 ' N ' ' A' ' 17' ' ' GLU . 2.2 pp -156.32 -170.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.683 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.751 ' HG3' HG23 ' A' ' 18' ' ' VAL . 37.4 tp10 160.01 -82.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.527 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.788 ' HB ' HG13 ' B' ' 40' ' ' VAL . 47.7 t -139.8 139.45 37.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.96 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -154.34 83.42 1.12 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 3.2 mm? -86.91 87.26 7.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.765 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.764 HD11 ' HG3' ' B' ' 44' ' ' LYS . 0.9 OUTLIER 33.38 94.61 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.144 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.947 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 72.1 m . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.876 0.37 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 61.01 89.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.722 ' CZ ' HD12 ' C' ' 64' ' ' LEU . 56.5 t80 -106.35 117.83 35.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.677 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.771 HD12 ' O ' ' A' ' 3' ' ' PHE . 1.4 mp -131.71 95.85 3.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.077 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.462 ' HB2' ' CE1' ' B' ' 25' ' ' PHE . 0.1 OUTLIER -102.21 110.06 21.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.656 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' C' ' 50' ' ' CYS . 27.7 p -126.17 128.67 47.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.5 ' CE1' ' CE2' ' C' ' 55' ' ' PHE . 2.4 p90 -133.72 156.39 48.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.001 0.429 . . . . 0.0 111.39 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.745 HG22 ' HA ' ' A' ' 8' ' ' VAL . 16.6 m -129.05 134.13 64.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.754 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 3.0 t -44.74 167.53 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.644 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 9' ' ' SER . . . 150.89 -37.76 0.87 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.786 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . 0.483 ' CZ ' ' CE2' ' C' ' 55' ' ' PHE . 6.7 p90 -90.19 163.64 14.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 111.132 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.55 171.64 9.38 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.992 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.431 ' HD3' ' CD2' ' C' ' 56' ' ' HIS . 95.2 Cg_exo -42.45 94.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.746 2.297 . . . . 0.0 112.628 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.451 ' HB3' ' CE2' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -124.53 -165.37 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.806 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.81 106.4 10.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.981 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.451 HD12 ' CZ ' ' B' ' 33' ' ' PHE . 0.0 OUTLIER -107.94 116.25 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.521 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 18.6 pt-20 -128.19 117.43 21.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.859 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.788 HG13 ' HB ' ' A' ' 18' ' ' VAL . 39.5 t -93.62 122.64 45.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.997 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -127.76 93.75 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.438 ' CD1' ' CZ ' ' A' ' 3' ' ' PHE . 0.3 OUTLIER -106.53 108.51 20.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.004 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.574 HD13 HD12 ' C' ' 65' ' ' LEU . 4.4 mm? -112.8 35.4 3.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.03 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.764 ' HG3' HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.785 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.74 0.305 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -170.77 118.9 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.15 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.573 ' CE2' HD12 ' D' ' 86' ' ' LEU . 47.2 t80 -114.43 112.2 22.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.51 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.448 HD22 HD23 ' B' ' 26' ' ' LEU . 0.1 OUTLIER -120.47 94.21 4.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.212 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' ASN . . . . . 0.495 ' HB2' ' CZ ' ' C' ' 47' ' ' PHE . 36.3 t30 -110.12 80.63 1.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.026 0.441 . . . . 0.0 110.676 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' CYS . . . . . 0.495 ' HB3' ' CD2' ' D' ' 73' ' ' TYR . 32.0 p -107.83 154.04 22.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.595 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.499 ' CZ ' ' HA ' ' D' ' 72' ' ' CYS . 0.2 OUTLIER -148.24 160.58 42.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.457 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . 0.563 HG13 HG11 ' D' ' 74' ' ' VAL . 20.2 t -124.84 124.87 68.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.457 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.26 -172.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.096 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' D' ' 77' ' ' PHE . . . -122.76 172.35 15.81 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.636 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . 0.5 ' CE2' ' CE1' ' B' ' 29' ' ' TYR . 0.1 OUTLIER -143.86 60.21 1.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.33 . . . . 0.0 111.317 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' HIS . . . . . 0.527 ' HB3' ' HD2' ' C' ' 57' ' ' PRO . 3.0 m-70 59.89 165.47 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.466 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' C' ' 56' ' ' HIS . 34.9 Cg_endo -64.68 79.73 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.416 2.078 . . . . 0.0 112.282 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 1.5 t -96.83 -167.46 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.039 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.09 129.03 44.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.733 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.634 HD12 HG22 ' D' ' 82' ' ' ILE . 6.6 mt -127.8 120.1 53.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.294 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -111.04 77.47 1.04 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.552 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.596 HG12 HD11 ' C' ' 64' ' ' LEU . 22.3 t -79.26 124.69 37.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.29 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' ASP . . . . . 0.791 ' C ' HD13 ' C' ' 64' ' ' LEU . 6.6 t0 -149.9 121.22 7.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.759 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' LEU . . . . . 0.791 HD13 ' C ' ' C' ' 63' ' ' ASP . 0.0 OUTLIER -137.2 140.79 41.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.574 HD12 HD13 ' B' ' 43' ' ' LEU . 0.9 OUTLIER -89.3 -66.05 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.861 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.824 179.909 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.828 0.347 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 55.85 96.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.01 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -113.13 128.63 56.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.008 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 70' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' D' ' 70' ' ' LEU . 2.8 tp -155.49 88.0 1.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 71' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' D' ' 73' ' ' TYR . 17.9 p-10 -125.49 -157.53 0.79 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.356 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 72' ' ' CYS . . . . . 0.499 ' HA ' ' CZ ' ' C' ' 51' ' ' TYR . 36.1 t 55.82 -83.36 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.896 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 73' ' ' TYR . . . . . 0.495 ' CD2' ' HB3' ' C' ' 50' ' ' CYS . 1.0 OUTLIER 66.76 -93.66 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 177.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . 0.563 HG11 HG13 ' C' ' 52' ' ' VAL . 40.1 t -109.44 64.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 120.989 0.423 . . . . 0.0 110.848 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -60.83 -164.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.209 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.47 58.15 0.4 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.874 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.458 ' HB3' ' HA2' ' C' ' 54' ' ' GLY . 13.6 p90 -130.61 163.77 26.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 111.314 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 78' ' ' HIS . . . . . 0.469 ' CB ' ' HD2' ' D' ' 79' ' ' PRO . 0.4 OUTLIER -76.65 170.0 18.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.279 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 79' ' ' PRO . . . . . 0.469 ' HD2' ' CB ' ' D' ' 78' ' ' HIS . 9.4 Cg_endo -52.46 89.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.411 2.074 . . . . 0.0 112.13 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.99 119.69 39.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.709 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -54.02 96.39 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.835 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 82' ' ' ILE . . . . . 0.634 HG22 HD12 ' C' ' 60' ' ' ILE . 20.6 pt -111.43 125.21 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.364 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -113.11 107.68 16.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.531 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 84' ' ' VAL . . . . . 0.559 ' CG1' HD11 ' D' ' 86' ' ' LEU . 21.5 t -94.15 130.56 42.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.491 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . 0.418 ' O ' HD22 ' C' ' 64' ' ' LEU . 1.8 m-20 -134.33 92.6 2.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.664 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.642 ' H ' HD22 ' D' ' 86' ' ' LEU . 0.2 OUTLIER -88.46 80.05 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.929 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 27.0 tp 60.42 111.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.897 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.889 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.865 0.364 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -176.55 86.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.835 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.738 ' CZ ' HD11 ' B' ' 42' ' ' LEU . 4.9 t80 -109.03 160.06 16.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.756 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.493 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 13.9 tp -145.28 142.64 29.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.402 . . . . 0.0 111.346 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.466 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 5.3 t30 -159.02 115.27 2.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.468 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.7 t -126.85 146.23 50.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.316 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.402 ' HH ' ' HD2' ' B' ' 33' ' ' PHE . 0.5 OUTLIER -123.18 135.31 54.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.315 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.8 t -144.67 125.71 8.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.814 0.34 . . . . 0.0 111.404 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t 67.12 -160.38 0.23 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.041 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.97 -133.95 0.01 OUTLIER Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.757 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.443 ' CZ ' ' HB2' ' B' ' 36' ' ' SER . 0.0 OUTLIER -175.77 -164.89 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.743 0.306 . . . . 0.0 111.077 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.513 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -119.7 -70.02 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.324 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.513 ' CD ' ' CB ' ' A' ' 12' ' ' HIS . 19.1 Cg_endo -58.14 -164.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.312 2.008 . . . . 0.0 112.153 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -130.79 -63.65 0.86 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.934 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -97.84 96.26 8.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.729 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.1 mt -96.88 146.98 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.202 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -149.56 120.85 7.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.872 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.436 HG12 HD21 ' B' ' 42' ' ' LEU . 16.5 t -107.28 129.62 60.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.285 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -145.48 89.92 1.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.745 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.507 ' CB ' HD22 ' B' ' 42' ' ' LEU . 0.3 OUTLIER -111.1 127.7 55.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.051 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mp -134.98 -171.08 2.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.828 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.841 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.489 ' HA ' HD23 ' C' ' 64' ' ' LEU . 66.4 m . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.773 0.32 . . . . 0.0 111.313 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.37 55.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.956 0.408 . . . . 0.0 110.943 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.87 ' CE2' HD11 ' C' ' 64' ' ' LEU . 0.1 OUTLIER -169.35 159.03 8.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.144 0.497 . . . . 0.0 111.379 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.794 HD12 ' HB2' ' C' ' 48' ' ' LEU . 0.2 OUTLIER -106.91 119.28 38.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.512 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -97.86 155.69 16.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.264 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 38.1 t -163.74 153.43 14.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.758 0.313 . . . . 0.0 111.221 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.468 ' CD2' ' HB2' ' C' ' 51' ' ' TYR . 0.0 OUTLIER -176.07 125.55 0.2 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.984 0.421 . . . . 0.0 110.964 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 31.1 m -128.37 128.59 68.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.256 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 73.49 147.12 0.09 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.054 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.69 -148.43 1.62 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.584 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . 0.723 ' HE2' HD11 ' B' ' 38' ' ' ILE . 0.0 OUTLIER -179.05 37.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.651 0.263 . . . . 0.0 111.596 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.443 ' CG ' ' HD2' ' B' ' 35' ' ' PRO . 0.0 OUTLIER 60.74 178.38 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.698 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.443 ' HD2' ' CG ' ' B' ' 34' ' ' HIS . 90.2 Cg_exo -43.0 126.15 4.4 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.596 2.197 . . . . 0.0 112.776 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 11' ' ' PHE . 5.3 t 179.74 147.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.657 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.94 135.16 55.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.192 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.723 HD11 ' HE2' ' B' ' 33' ' ' PHE . 35.1 mt -135.91 111.43 11.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.88 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.14 82.94 1.75 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.749 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 42.2 t -73.43 120.36 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.969 0.414 . . . . 0.0 111.109 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.55 ' O ' HD23 ' B' ' 42' ' ' LEU . 16.7 m-20 -135.97 110.75 8.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.539 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.738 HD11 ' CZ ' ' A' ' 3' ' ' PHE . 80.6 mt -133.02 143.08 49.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.143 0.497 . . . . 0.0 111.234 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.401 ' HB3' ' N ' ' C' ' 66' ' ' LYS . 3.0 mt 71.47 137.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.571 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 11.5 mttt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.9 -179.84 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.86 0.362 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -94.11 125.37 38.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.028 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.69 ' CE1' HD13 ' C' ' 64' ' ' LEU . 50.1 t80 -131.72 135.4 46.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.81 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . 0.794 ' HB2' HD12 ' B' ' 26' ' ' LEU . 17.7 tp -130.2 128.67 42.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.69 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -130.34 95.3 3.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.388 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' CYS . . . . . . . . . . . . . 3.7 p -117.86 103.9 10.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.387 . . . . 0.0 111.833 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' D' ' 73' ' ' TYR . 3.2 p90 -135.45 153.66 51.7 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.874 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . 0.585 ' O ' ' CB ' ' C' ' 53' ' ' SER . 0.8 OUTLIER -176.03 162.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.954 -178.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' C' ' 52' ' ' VAL . 5.9 t 104.58 80.31 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.496 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.91 -63.26 0.05 OUTLIER Glycine 0 C--N 1.332 0.345 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.993 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . 0.541 ' CZ ' HG21 ' D' ' 82' ' ' ILE . 1.3 t80 78.79 78.37 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.819 0.342 . . . . 0.0 110.516 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' HIS . . . . . 0.595 ' N ' ' CD ' ' C' ' 57' ' ' PRO . 0.3 OUTLIER -140.36 38.86 0.32 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.132 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' C' ' 56' ' ' HIS . 36.5 Cg_endo -69.21 -77.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.109 1.872 . . . . 0.0 112.3 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . 0.423 ' OG ' ' HA ' ' B' ' 35' ' ' PRO . 0.4 OUTLIER 174.38 -79.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 110.689 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -134.42 134.74 41.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.871 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . . . . . . . . . 10.1 mt -151.7 106.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -107.21 103.08 12.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.1 t -91.32 124.23 43.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -128.02 129.66 47.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.036 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' LEU . . . . . 0.87 HD11 ' CE2' ' B' ' 25' ' ' PHE . 0.2 OUTLIER -139.54 98.1 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.512 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 5.8 mt -94.1 -92.86 0.18 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.372 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' LYS . . . . . 0.401 ' N ' ' HB3' ' B' ' 43' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.834 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.785 0.326 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -71.47 105.06 3.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.847 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' D' ' 71' ' ' ASN . 54.5 t80 -118.42 124.72 48.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.781 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 mt -143.83 95.09 2.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.736 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 71' ' ' ASN . . . . . 0.459 ' O ' ' CD2' ' D' ' 73' ' ' TYR . 2.5 t-20 -100.73 79.95 2.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 72' ' ' CYS . . . . . . . . . . . . . 1.4 m -73.57 109.31 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.459 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 73' ' ' TYR . . . . . 0.49 ' HB3' ' CE1' ' C' ' 51' ' ' TYR . 1.7 p90 -118.73 118.95 33.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.4 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . 0.525 ' HB ' ' HB ' ' C' ' 52' ' ' VAL . 3.5 t -132.72 86.86 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.019 0.438 . . . . 0.0 111.054 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 1.4 t 169.34 -53.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.689 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.38 -154.3 25.56 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.22 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . 0.459 ' HZ ' HG23 ' D' ' 84' ' ' VAL . 0.1 OUTLIER -177.19 88.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 111.183 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 78' ' ' HIS . . . . . 0.492 ' HB3' ' HD3' ' D' ' 79' ' ' PRO . 9.7 t-160 176.47 -57.94 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 79' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' D' ' 78' ' ' HIS . 55.5 Cg_endo -69.37 62.69 1.56 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.303 2.002 . . . . 0.0 112.389 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 80' ' ' SER . . . . . 0.423 ' CB ' HD12 ' D' ' 82' ' ' ILE . 1.9 m 178.77 159.49 0.58 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.935 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -96.37 60.26 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.604 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 82' ' ' ILE . . . . . 0.719 ' H ' HD13 ' D' ' 82' ' ' ILE . 0.2 OUTLIER -120.6 -179.87 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.243 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -176.57 145.49 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 84' ' ' VAL . . . . . 0.459 HG23 ' HZ ' ' D' ' 77' ' ' PHE . 80.2 t -112.69 117.58 55.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.979 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -138.31 112.57 8.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.543 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.674 HD11 ' CE2' ' C' ' 47' ' ' PHE . 1.9 pt? -173.22 175.71 3.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.299 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 55.66 89.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.037 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 5.4 mttt . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.75 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.845 0.355 . . . . 0.0 111.195 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.32 85.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.66 ' CE2' ' CD1' ' B' ' 42' ' ' LEU . 16.7 t80 -127.35 110.22 12.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.967 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.542 ' O ' HD12 ' A' ' 4' ' ' LEU . 0.4 OUTLIER -108.05 117.47 34.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.723 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 3' ' ' PHE . 1.1 p30 -129.45 67.97 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.047 0.451 . . . . 0.0 110.578 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 52.9 t -90.41 117.54 29.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.578 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.511 ' OH ' ' CE1' ' B' ' 29' ' ' TYR . 0.0 OUTLIER -119.98 132.59 55.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.252 0.549 . . . . 0.0 110.948 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.952 HG12 HG22 ' B' ' 30' ' ' VAL . 5.5 m -142.51 165.53 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.356 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 p 77.47 -166.47 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.394 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.77 -164.31 28.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.91 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.494 ' HB2' ' CD2' ' B' ' 33' ' ' PHE . 0.0 OUTLIER -130.85 -157.51 0.83 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.739 0.304 . . . . 0.0 110.76 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.443 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -175.15 -60.33 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.85 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 12' ' ' HIS . 34.0 Cg_endo -64.0 -22.94 68.01 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.326 2.017 . . . . 0.0 112.127 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.7 m 69.83 -64.34 0.35 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.226 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.59 127.24 32.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.036 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.795 HD13 ' N ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -158.1 138.81 4.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.197 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.795 ' N ' HD13 ' A' ' 16' ' ' ILE . 4.4 pt-20 -139.37 137.73 35.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.004 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.481 ' HB ' HG13 ' B' ' 40' ' ' VAL . 25.3 t -115.3 125.72 72.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.957 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.61 132.42 55.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.044 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.936 ' HB2' HD22 ' B' ' 42' ' ' LEU . 1.8 mt -170.44 35.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.695 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.591 HD23 ' OXT' ' A' ' 22' ' ' LYS . 2.5 tt -100.95 -61.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.884 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.591 ' OXT' HD23 ' A' ' 21' ' ' LEU . 2.7 mttm . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.915 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.587 ' HB2' HD13 ' B' ' 26' ' ' LEU . 5.9 p . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.875 0.369 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.432 ' HB3' ' CB ' ' C' ' 46' ' ' ASN . 31.8 t-20 65.36 -89.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.381 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.817 ' CZ ' HD11 ' C' ' 64' ' ' LEU . 9.2 t80 -125.59 105.31 8.93 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.73 0.3 . . . . 0.0 111.013 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.587 HD13 ' HB2' ' B' ' 23' ' ' SER . 9.3 mp -116.2 90.34 3.31 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.444 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.487 ' HB2' ' CZ ' ' B' ' 25' ' ' PHE . 7.0 t-20 -96.88 110.75 23.19 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.904 0.383 . . . . 0.0 110.751 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . . . . . . . . . 4.1 m -112.04 142.46 44.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.114 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.511 ' CE1' ' OH ' ' A' ' 7' ' ' TYR . 0.7 OUTLIER -148.71 102.91 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.551 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.952 HG22 HG12 ' A' ' 8' ' ' VAL . 19.5 m -127.51 135.95 61.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.425 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 76.46 87.66 0.08 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.838 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.63 -173.91 0.49 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.571 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . 0.494 ' CD2' ' HB2' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -163.33 -173.56 3.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 0.0 110.928 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.415 ' HB3' ' HD2' ' B' ' 35' ' ' PRO . 39.4 m-70 -59.44 162.21 8.86 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.743 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' B' ' 34' ' ' HIS . 83.6 Cg_exo -47.98 111.92 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.604 2.203 . . . . 0.0 112.639 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.411 ' HB2' ' CE1' ' B' ' 33' ' ' PHE . 12.7 m -133.2 159.87 38.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.724 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.409 ' C ' HD13 ' B' ' 38' ' ' ILE . 6.0 t0 -107.36 105.56 15.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.679 HG23 ' CG2' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -120.09 118.89 58.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.661 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -131.27 139.15 49.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.884 0.373 . . . . 0.0 111.118 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.481 HG13 ' HB ' ' A' ' 18' ' ' VAL . 62.0 t -134.11 119.08 30.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.956 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.796 ' C ' HD23 ' B' ' 42' ' ' LEU . 14.0 p-10 -122.75 105.1 9.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.765 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.936 HD22 ' HB2' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -133.82 176.79 8.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.052 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' C' ' 65' ' ' LEU . 1.3 tp -135.91 -48.86 0.68 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.784 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.98 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 29.8 p . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.825 0.345 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' ASN . . . . . 0.432 ' CB ' ' HB3' ' B' ' 24' ' ' ASN . 73.9 m-20 58.76 62.89 1.79 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.63 ' CZ ' HD12 ' D' ' 86' ' ' LEU . 6.1 t80 -105.36 120.09 40.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.52 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 43.4 tp -125.57 109.64 12.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.94 0.4 . . . . 0.0 111.264 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' ASN . . . . . 0.442 ' HB3' ' CE1' ' C' ' 47' ' ' PHE . 1.5 p30 -128.37 102.51 6.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.116 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' CYS . . . . . 0.4 ' HB2' ' HB3' ' D' ' 72' ' ' CYS . 13.8 p -116.69 134.35 54.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.372 . . . . 0.0 111.653 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.449 ' CZ ' ' HA ' ' D' ' 73' ' ' TYR . 27.9 p90 -136.96 125.69 23.93 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.771 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . 0.901 HG12 ' CG2' ' D' ' 74' ' ' VAL . 1.7 m -132.41 122.77 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.068 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' C' ' 52' ' ' VAL . 0.4 OUTLIER 165.35 -83.55 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.24 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' GLY . . . . . . . . . . . . . . . 180.0 -37.64 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.161 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . 0.426 ' O ' ' HG2' ' D' ' 79' ' ' PRO . 2.0 m-85 65.49 127.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.719 0.295 . . . . 0.0 111.43 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' HIS . . . . . 0.568 ' HB3' ' HD3' ' C' ' 57' ' ' PRO . 2.7 t60 177.82 -50.66 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.039 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' C' ' 56' ' ' HIS . 73.4 Cg_endo -92.3 -54.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.763 2.309 . . . . 0.0 113.245 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -53.02 158.24 1.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.215 0.531 . . . . 0.0 111.743 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.421 ' HA ' ' HB2' ' D' ' 81' ' ' ASP . 1.1 m-20 -140.1 100.52 3.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.474 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' ILE . . . . . 0.548 HG23 ' HB ' ' B' ' 38' ' ' ILE . 18.9 mt -115.28 144.1 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.388 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -136.12 83.81 2.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.077 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -85.93 119.56 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.273 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' D' ' 85' ' ' ASP . 6.6 p-10 -118.34 125.07 49.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 111.196 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' LEU . . . . . 0.817 HD11 ' CZ ' ' B' ' 25' ' ' PHE . 0.7 OUTLIER -117.13 131.86 56.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.834 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . 0.616 ' N ' HD22 ' C' ' 65' ' ' LEU . 2.4 mm? 60.36 -179.25 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.938 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.89 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.841 0.353 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 p30 54.55 17.97 1.83 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.703 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 69' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' D' ' 71' ' ' ASN . 62.1 t80 -137.98 92.91 2.71 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.777 0.323 . . . . 0.0 110.849 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.17 93.71 5.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.715 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 71' ' ' ASN . . . . . 0.504 ' HB2' ' CZ ' ' D' ' 69' ' ' PHE . 11.5 t-20 -99.67 105.86 17.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.072 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 72' ' ' CYS . . . . . 0.4 ' HB3' ' HB2' ' C' ' 50' ' ' CYS . 6.6 t -81.92 68.82 8.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.558 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 73' ' ' TYR . . . . . 0.449 ' HA ' ' CZ ' ' C' ' 51' ' ' TYR . 0.1 OUTLIER -73.53 79.23 1.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.622 -179.545 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . 0.901 ' CG2' HG12 ' C' ' 52' ' ' VAL . 0.1 OUTLIER -122.35 83.82 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.943 0.401 . . . . 0.0 110.935 179.493 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.38 -68.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.672 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.12 -52.6 0.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.318 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.82 94.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.964 0.412 . . . . 0.0 111.345 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 78' ' ' HIS . . . . . 0.505 ' CB ' ' HD3' ' D' ' 79' ' ' PRO . 0.2 OUTLIER -164.79 -56.59 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.498 179.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 79' ' ' PRO . . . . . 0.505 ' HD3' ' CB ' ' D' ' 78' ' ' HIS . 73.7 Cg_endo -96.4 -164.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.234 2.623 . . . . 0.0 111.57 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 80' ' ' SER . . . . . 0.416 ' OG ' ' N ' ' D' ' 81' ' ' ASP . 1.4 t 55.9 176.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.587 0.232 . . . . 0.0 110.527 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 81' ' ' ASP . . . . . 0.448 ' HB3' ' N ' ' C' ' 60' ' ' ILE . 1.6 t0 -85.17 104.26 14.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.321 . . . . 0.0 111.083 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 82' ' ' ILE . . . . . 0.795 HG22 ' H ' ' D' ' 84' ' ' VAL . 48.6 mm -2.4 -67.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 83' ' ' GLU . . . . . 0.753 ' HG3' HG23 ' D' ' 84' ' ' VAL . 0.0 OUTLIER 98.26 -29.83 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.053 0.541 . . . . 0.0 110.926 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 84' ' ' VAL . . . . . 0.795 ' H ' HG22 ' D' ' 82' ' ' ILE . 59.7 t -111.99 118.63 58.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.864 0.364 . . . . 0.0 111.754 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 85' ' ' ASP . . . . . 0.492 ' C ' HD13 ' D' ' 86' ' ' LEU . 2.0 m-20 -153.18 123.18 6.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.543 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.852 ' H ' HD22 ' D' ' 86' ' ' LEU . 0.0 OUTLIER -134.43 175.4 9.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.041 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 87' ' ' LEU . . . . . 0.64 ' O ' HD12 ' D' ' 87' ' ' LEU . 2.2 pp -39.04 107.62 0.07 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.794 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.923 179.825 . . . . . . . . 1 1 . 1 stop_ save_